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2 Summary 
 
Proteins, which are translated by the large molecular machines called ribosomes (Figure 1), are 
the essential basis for cellular function. Therefore, the production of proteins makes the 
ribosome (Figure 2) indispensable and a worthwhile target for detailed biochemical and 
structural research to obtain novel, insightful knowledge of one of the most important, yet most 
complex molecular processes within the cell.  
By analysing the ribosomal proteome from different archaeal species, we identified 
three hypothetical proteins that appear to be bona fide ribosomal proteins (r-proteins) of the 
Crenarchaeota Sulfolobus acidocaldarius (S. acid) ribosomal large subunit. In general, the 
analysis presents the first comprehensive two-dimensional PAGE (2D-PAGE) and mass 
spectrometry (MS) analysis of archaeal ribosomes isolated from the thermophilic Crenarchaeota 
Pyrobaculum aerophilum (P. aero) and the thermoacidophilic Crenarchaeota Sulfolobus 
acidocaldarius. Further, we identified possible promiscuous interactions of the r-proteins L7ae 
and S24e with both ribosomal subunits as well as possible binding positions of these proteins 
determined by cryo electron microscopy (cryo-EM). Thereby, this survey illustrates the 
potential of studying the archaeal ribosome to unravel the diversity of the ribosomal proteome, 
helping to understand the evolution of the ribosome and the development of ribosomal protein 
function.  
To counter the selection of resistant pathogens that are emerging because of the 
excessive use of antibiotics, there is a continuous need for antibiotic discovery and 
development. Three analogues compounds of the naturally produced thiopeptide antibiotic 
amythiamicin D were made available by de novo total synthesis. The characterisation of these 
compounds in vitro and in vivo activity revealed enhanced inhibitory activity of the 
hydroxymethyl derivative (compound 3a) on translation in an Escherichia coli (E. coli) based in 
vitro translation assay, compared to its parent compound. Further, we provide evidence that 
translation inhibition by amythiamicin D is due to binding to the bacterial elongation factor Tu 
(EF-Tu). Taken together, we provide tools and starting points for future studies aiming to 
understand the characteristics of various substitutions or alterations of the antimicrobial 
compounds. 
The non-canonical single-stranded DNA-binding protein related proteins (Thermo-
DBP-RP) found in some hyperthermophilic Crenarchaeota comprise two related groups (1 and 
2) of poorly characterized proteins, of which group 1 proteins were suggested to interact with 
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ribonucleic particles (RNP) and the archaeal ribosome. Here, we present the biochemical 
investigation of the nucleic acid binding properties and successful crystallization of Pyrococcus 
furiosus (P. fur) ThermoDBP-RP1 and Aeropyrum pernix (A. per) ThermoDBP-RP2, revealing 
their molecular structure and their mode of oligomerization. The structure provided insights into 
how the N-terminal domain, common to ThermoDBPs and ThermoDBP-RPs, interacts with 
nucleic acids. Furthermore, the structures provide indications for the function of ThermoDPB-
RP1 in the extremophile organisms, while the physiological relevance of a functional interaction 
with RNPs or the ribosome remains to be determined. 
Expression of the membrane protein biogenesis factor YidC2 from Bacillus subtilis (B. sub) is 
regulated by ribosome translation arrest on the upstream MifM leader peptide. By using cryo-
electron microscopy (cryo-EM) and single particle analysis we were able to reconstruct the 3D 
volume of the MifM stalled ribosome complex at 3.9Å resolution. This enabled us to build the 
first atomic model of a Gram-positive 70S ribosome. In addition, we show for the first time, 
how interaction of MifM within the ribosomal tunnel stabilizes a specific conformation of the 
ribosome, blocking an active conformation of the peptidyl transferase centre (PTC). Moreover, 
we identified a single amino acid determining the species-specificity of MifM dependent 
ribosome stalling in Bacillus subtilis. 
The eukaryotic signal recognition particle (SRP) recognizes signal sequences within the 
nascent polypeptide of secretory and membrane proteins and transiently slows down translation 
by its Alu domain for efficient targeting of the ribosome-nascent-chain complexes (RNC) to a 
membrane translocation site. Using cryo-EM we could, for the first time, visualize the 3D 
structure of a bacterial SRP containing an Alu domain, providing the functional and structural 
basis for co-translational targeting and SRP mediated translation arrest in Gram-positive 
bacteria. The unique structure of the B. sub SRP Alu RNA shows multiple interactions with the 
stalk base helices 43 (H43) and 44 (H44) and the α-sarcin-ricin loop (SRL). Thus, the entire B. 
sub Alu domain acts as a “dock and lock” system to slow down the translation machinery for 
efficient and proper targeting to a membrane translocation site. 
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8 Introduction 
 
8.1 The Universal Ribosome 
The ribosome (Figure 1) in its function of decoding genetic information and catalysing peptide 
bond formation is universally conserved throughout the three domains of life (Bacteria, Archaea 
and Eukarya). All ribosomes are composed of a small and a large subunit, both of which are 
built from RNA and proteins, however their composition and size can differ significantly 
(Melnikov et al., 2012). 
 
 Bacteria 
E. coli 
 
Archaea 
H. marismortui 
 
Eukarya 
H. sapiens 
 
 a  b  c  
 
 
54 proteins 
3 rRNAs 
 
59 proteins 
3 rRNAs 
 
79 proteins 
4 rRNAs 
 
 
Large subunit (50S): 
33 proteins 
23S rRNA – 2904 nts 
5S rRNA – 121 nts 
 
Large subunit (50S): 
34 proteins 
23S rRNA – 2923 nts 
5S rRNA – 122 nts 
 
Large subunit (60S): 
46 proteins 
23S rRNA – 2923 nts 
5.8S rRNA – 158 nts 
5S rRNA – 122 nts 
 
 
Small subunit (30S): 
21 proteins 
16S rRNA – 1542 nts 
 
Small subunit (30S): 
25 proteins 
16S rRNA – 1472 nts 
 
Small subunit (40S): 
33 proteins 
16S rRNA – 1800 nts 
 
 
Figure 1 ⏐  The bacterial, archaeal, and eukaryotic ribosome and its composition. (a) Structure of the bacterial 
70S ribosome from E. coli (Dunkle et al., 2011) with rRNA/r-proteins colored in gold/yellow and grey/blue for the 
small and large ribosomal subunit, respectively. (b) Structure of the archaeal large ribosomal subunit from 
Haloarcula marismortui (Gabdulkhakov, Nikonov, & Garber, 2013) with rRNA/r-proteins colored as in a. (c) 
Structure of the eukaryotic 80S ribosome from Homo sapiens (Anger et al., 2013) with rRNA/r-proteins colored as in 
(a). The small and the large ribosomal subunit are indicated as 30S and 50S or 40S and 60S, respectively. 
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The archaeal and the bacterial small and large ribosomal subunit sediment with a coefficient of 
30 and 50 Svedberg units (S), respectively, and together form the complete prokaryotic 
ribosome with a sedimentation coefficient of 70S. The sedimentation coefficients for the 
eukaryotic ribosomal small and large subunit have been estimated at 40S and 60S, respectively, 
with an estimated sedimentation coefficient of 80S for the whole eukaryotic ribosome. These 
differences in sedimentation speed reflect the differences in size and mass of the particles and 
have led the prokaryotic and eukaryotic ribosomes to be simply referred to as 70S and 80S 
ribosomal particles, respectively. Compared to the bacterial 70S ribosome of E. coli, the human 
80S ribosome contains, an additional 2MDa of mass. This extra mass is in part due to additional 
ribosomal RNA (rRNA) as well as due to eukaryote-specific ribosomal proteins and r-protein 
extensions (Jenner et al., 2012; Melnikov et al., 2012; D.N. Wilson & Cate, 2012). Although the 
archaeal ribosome has about the size and the mass of the bacterial ribosome, only about half of 
its protein families have homologous bacterial r-proteins while the other half is specific to 
archaea and eukarya (Lecompte, Ripp, Thierry, Moras, & Poch, 2002). These differences in size 
and composition reflect the different evolutionary routes towards cellular complexity and thus 
the need for a more complex regulation of translation as well as the need to adapt to a diverse 
variety of living environments. In spite of the differences, all ribosomes possess a conserved 
core that contains all facets necessary for the basic functions of translation (Melnikov et al., 
2012).  
8.2 Prokaryotic Translation and the Translation Cycle 
Protein synthesis, in all living organisms, is carried out on ribosomes in a series of reactions 
describes in the translation cycle (Figure 2). This translation cycle proceeds through four stages, 
namely initiation, elongation, termination and recycling, within which the elongation phase can 
itself be described as a cyclic process (as reviewed in (Voorhees & Ramakrishnan, 2013)). 
During initiation the ribosome has to assemble on the start codon of the mRNA with the 
initiator tRNA positioned in the ribosomal P-site, ready to engage in translation elongation. 
During elongation, the polypeptide chain the product of translation, is produced by the recurring 
joining of amino acids, which occurs at the peptidyl transferase centre located on the large 
subunit of the ribosome. With the exception of the first initial methionine, each subsequent 
amino acid is delivered to the ribosome in the form of an aminoacyl-tRNA by the elongation 
factor Tu (EF-Tu). The aminoacyl-tRNAs are monitored by the ribosome based on the 
complementarity between the mRNA codon displayed in the decoding centre of the small 
ribosomal subunit and the anticodon of the tRNA, in a process termed decoding and 
proofreading. Correct decoding stimulates the GTPase activity of EF-Tu, releasing it from the 
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ribosome and allowing the aminoacyl-tRNA to accommodate at the A-site on the large subunit. 
This allows the fMet (or the nascent polypeptide chain in subsequent elongation cycles) to be 
transferred from the P-tRNA onto the aminoacyl tRNA in the A-site, and thereby, the growing 
peptide chain is prolonged by one amino acid. As the nascent chain is prolonged it traverses the 
large ribosomal subunit’s body, through a ribosomal tunnel towards the exit on the solvent side 
of the ribosome. After transfer of the nascent peptide the ribosome is left with a peptidyl-tRNA 
in the A-site and a deacetylated tRNA in the P-site.  
 
 
 
Figure 2 ⏐  Overview of the prokaryotic translation cycle. The four stages of the translation cycle include: 
Translation initiation, elongation of the polypeptide chain, translation termination and recycling of the ribosome. 
Each of these steps is assisted by protein factors. During the initiation phase (blue) IF1, IF2, IF3, mRNA, initiator 
tRNA and the 30S subunit together form the 30S initiation complex (30S IC). Joining of the 50S subunit releases the 
initiation factors and renders the ribosome ready to enter the elongation step (green) of the translation cycle. During 
elongation aminoacyl-tRNA (aa-tRNA) is delivered to the ribosomal A-site in a ternary complex with EF-Tu?GTP. 
After A-tRNA accommodation, subsequent peptide bond formation is catalysed by the ribosome transferring the 
nascent peptide chain from the peptidyl-tRNA in the P-site onto the aa-tRNA in the A-site prolonging the nascent 
peptide by one amino acid. Binding of EF-G?GTP then stabilizes the tRNA hybrid state formation. Thereupon, EF-G 
hydrolyses GTP and catalyses tRNA2–mRNA translocation, which causes movement of the mRNA by one codon and 
leaves an empty A-site for the next aa-tRNA to be delivered to the ribosome. Translation termination (red) is 
signalled by a stop codon on the mRNA. The stop codon displayed in the decoding centre in the A-site recruits RF1 
or RF2 and RF3 releasing the fully translated protein from the ribosome. Cooperative binding of RRF and EF-G leads 
to splitting of the ribosome, recycling its components for the next round of translation. Figure modified from 
(Sohmen, Harms, Schlunzen, & Wilson, 2009) 
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To restore the canonical state of the ribosome for another round of elongation both tRNAs and 
the mRNA have to be translocated by the action of elongation factor G (EF-G) and GTP 
hydrolysis from the A- and P-site to the P- and E-site of the ribosome (Holtkamp, Cunha, et al., 
2014; Holtkamp, Wintermeyer, & Rodnina, 2014). This leaves an empty A-site, which is ready 
to accept the next incoming aminoacyl-tRNA. The elongation cycle repeats until a stop codon 
rather than a sense codon of the mRNA enters the ribosomal A-site. The stop codon signals 
translation termination, whereby the completed protein gets released from the ribosome by the 
action of release factors. Termination is followed by factor-aided recycling of the ribosomal 
machinery to ready its parts to engage the next messenger RNA transcript for another round of 
translation. 
8.2.1 Initiation 
Formation of the bacterial 30S translation initiation complex (30S IC) requires assembling 
translation initiation factors 1-3 (IF1, IF2, IF3), messenger RNA and initiator tRNA fMet-
tRNAfMet on the small ribosomal subunit (Julian et al., 2011; Simonetti et al., 2009). The small 
subunit can bind mRNA directly by recognising its Shine-Dalgarno sequence (SD; 
5’AGGAGGU) (Lim, Kobayashi, & Nakai, 2014; Shine & Dalgarno, 1974) with its 
complementary 3’ end of the 16S rRNA (anti-Shine-Dalgarno sequence (anti-SD)). The SD 
sequence is located upstream of the start codon, usually spaced by a distance of 7-10 
nucleotides from the first position of the start codon, thereby positioning the start codon in the 
P-site of the 30S subunit.  
IF3, IF2 and IF1 bind, independent of the recruitment of the mRNA, to the 30S ribosomal 
subunit. IF2 promotes binding of fMet-tRNAfMet (Milon et al., 2010) and in concert with IF1 and 
IF3 kinetically control and the fidelity of fMet-tRNAfMet during 30S IC formation (Milon, 
Maracci, Filonava, Gualerzi, & Rodnina, 2012). To form the 70S IC, IF3 has to dissociate to 
allow docking of the large ribosomal subunit (50S) to the 30S IC (Allen, Zavialov, Gursky, 
Ehrenberg, & Frank, 2005; Grigoriadou, Marzi, Pan, Gualerzi, & Cooperman, 2007). Docking 
of the 50S subunit then triggers GTP hydrolysis by IF2 (H. Qin, Grigoriadou, & Cooperman, 
2009), making the choice of the start site irreversible (Grigoriadou, Marzi, Kirillov, Gualerzi, & 
Cooperman, 2007) and subsequent release of IF2 and IF1 from the 70S IC renders the complex 
ready to enter the translation elongation cycle. 
8.2.2 Decoding 
During translation, the correct or cognate aminoacyl-tRNA (in complex with EF-TuGTP) has 
to be chosen or discriminated from many incorrect or near-/non-cognate aminoacyl-tRNAs by 
the ribosome (Zaher & Green, 2009a). This process is based on the tRNA anticodon’s ability to 
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base-pair with the mRNA codon presented in the A-site (Demeshkina, Jenner, Westhof, 
Yusupov, & Yusupova, 2013; Voorhees & Ramakrishnan, 2013). In the first step of this 
multistep decision, codon-sampling, sampling of the codon by the tRNA is sensed by the 
ribosome via the bases A1492, A1493 and G530 of the 16S rRNA in the decoding centre on the 
small subunit. Thereby, A1492 and A1493 probe the codon anticodon interaction via A-minor 
interactions with the helix formed by the anticodon of the tRNA and the mRNA (Carter et al., 
2000; Wimberly et al., 2000). While non-cognate tRNAs will most likely be rejected at this 
step, recognition of a cognate tRNA being bound triggers an overall conformational change of 
the 30S subunit (domain closure) (Demeshkina, Jenner, Westhof, Yusupov, & Yusupova, 2012; 
Ogle, Murphy, Tarry, & Ramakrishnan, 2002) of the ribosome. Interestingly, it has recently 
been shown in a crystal structure that also a near-cognate tRNA can induce the closed 
conformation of the 30S subunit (Demeshkina et al., 2012, 2013) and that A1492 and A1493 
not only probe the codon anticodon helix but rather restrict the geometry of the base pairing as 
seen in the case for GU base pair at the first codon position adopting Watson-Crick geometry 
rather than the GU wobble pair geometry. This finding thereby changes our current 
understanding of the decoding mechanism at the codon-sampling step. It suggests that the 
formation of a highly restrictive decoding centre destabilizes incorrect base pairing, finally 
leading to the release of near-cognate tRNAs, rather than the decoding centre promoting the 
conformational change on the 30S ribosomal subunit only when the formation of Watson–Crick 
base pairs at the first two positions of the codon–anticodon helix have been detected. 
Domain closure of the 30S subunit leads to a distortion of the tRNA body and brings the 
shoulder region of the small subunit closer to EF-Tu, inducing conformational changes in EF-
Tu that finally lead to the activation of the GTPase activity of EF-Tu. The induced interaction 
with the α-sarcin-ricin loop (SRL) of the 23S rRNA opens the so-called “hydrophobic gate” and 
stabilizes the active conformation of a highly conserved histidine which is coordinating a water 
molecule in the active site, positioned to catalyse hydrolysis of the γ-phosphate group of the 
bound GTP (Schmeing et al., 2009; Voorhees, Schmeing, Kelley, & Ramakrishnan, 2010). 
Conversion of GTP to GDP by EF-Tu is associated with conformational changes in EF-Tu that 
results in lower affinity for the ribosome and therefore dissociation of EF-Tu from the ribosome 
following release of the γ-phosphate group (Pi) of GTP. 
After dissociation of EF-Tu, the ribosome again has the chance to reject near- or non-cognate 
tRNAs based on the properties of the codon anticodon interaction in a second discrimination 
step, proofreading (Blanchard, Gonzalez, Kim, Chu, & Puglisi, 2004; Gromadski & Rodnina, 
2004; Hopfield, 1974; Ninio, 1975), before the tRNA can accommodate. For accommodation 
the tRNA’s aminoacylated acceptor arm swings into the peptidyl transferase centre, followed by 
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rapid peptide bond formation and transfer of the nascent peptide chain from the P- to the A-site 
tRNA and even after incorporation of the aminoacyl tRNA into the growing peptide it seems 
that the ribosome has means to further iterate probing the identity of the tRNA post peptide 
bond formation, with a quality control mechanism that leads to release of unwanted peptidyl-
tRNAs via sense-codon directed release factor dependent translation termination (Zaher & 
Green, 2009b). Taken together these tRNA discriminating steps allow translation to proceed 
with a misincorporation rate of 1 amino acid in 103-104 (Kramer & Farabaugh, 2007). 
8.2.3 Peptide bond formation 
Peptide bond formation is catalysed at the peptidyl transferase center (PTC), located on the 
large subunit of the ribosome. The PTC consists almost exclusively of RNA, with the N-
terminus of L27 being the closest protein moiety to the reactive center by a distance of 8-10A. 
Therefore, the ribosome is regarded as a ribozyme, with the RNA being the major contributor to 
peptide bond catalysis (Nissen, Hansen, Ban, Moore, & Steitz, 2000). Ribosomal RNA creates 
the environment for the nucleophilic attack of the α-amino group of the aminoacyl tRNA in the 
A-site on the carbonyl carbon of the aminoacyl ester of the peptidyl tRNA in the P-site that 
leads to transfer of the nascent polypeptide bound to the tRNA in the P-site to the aminoacyl 
tRNA located in the A-site, adding one amino acid to the peptide chain. The ribosome enhances 
the rate of peptide bond formation by at least six orders of magnitude, utilising an induced-fit 
mechanism in which substrates and active site residues are repositioned to facilitate the peptidyl 
transferase reaction (Sievers, Beringer, Rodnina, & Wolfenden, 2004). Proper accommodation 
of an aminoacyl-tRNA in the A-site induces specific movements of 23S rRNA nucleotides (Ec) 
2583–2585 and 2506, thereby reorienting the ester group of the peptidyl tRNA rendering it 
accessible for a nucleophilic attack (Schmeing, Huang, Strobel, & Steitz, 2005). In the absence 
of an appropriate A-site substrate, the ester link of the peptidyl tRNA is protected by the 
conformation of the peptidyl transferase center precluding a nucleophilic attack by a water 
molecule (Schmeing, Huang, Strobel, et al., 2005). Residues A2451 (Muth, Ortoleva-Donnelly, 
& Strobel, 2000; Nissen et al., 2000) and A76 of P-tRNA have been implicated to be major 
contributors to peptide bond catalysis (Koch, Huang, & Sprinzl, 2008). Removal of the 2’ OH 
group of A2451 (Erlacher et al., 2005) or replacement of the 2’ OH of A76 by 2’ H or 2’ F 
showed a significant decrease in catalysis rate but did not abolish catalysis (Zaher, Shaw, 
Strobel, & Green, 2011). Therefore, the central importance of these residues in performing the 
catalysis has to be questioned. Due to its intrinsically high pKa and a missing corresponding pKa 
in the reaction or cofactors, like Mg2+-ions, that could lower its pKa, it was reasoned that A76 is 
unlikely to be acting as a general base in an acid-base catalysis mechanism. Instead it has been 
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proposed that the 2’ hydroxyl group of A76 plays an important role in positioning the substrates 
for catalysis (Schmeing, Huang, Strobel, et al., 2005), in agreement with the ribosome primarily 
enhancing peptide bond formation rate by acting as an entropy trap (Sievers et al., 2004). 
Moreover, the 2’ hydroxyl group of A76 could be part of a proton shuttle mechanism (Dorner, 
Panuschka, Schmid, & Barta, 2003; Polikanov, Steitz, & Innis, 2014; Schmeing, Huang, 
Kitchen, Strobel, & Steitz, 2005) where at least three protons have to be moved for the peptidyl 
transfer reaction (Kuhlenkoetter, Wintermeyer, & Rodnina, 2011). High-resolution structures of 
the ribosome with different substrate and transition state analogs (Hansen, Schmeing, Moore, & 
Steitz, 2002; Polikanov et al., 2014; Schmeing, Huang, Kitchen, et al., 2005; Schmeing, Huang, 
Strobel, et al., 2005; Schmeing et al., 2002) have been solved and have provided insight to the 
peptidyl transfer reaction, but although these structures reveal a network of potentially 
important interactions, the underlying mechanism of peptide bond catalysis is still not fully 
understood (Erlacher et al., 2005; Polikanov et al., 2014; Schmeing, Huang, Kitchen, et al., 
2005; Trobro & Aqvist, 2006; Wallin & Aqvist, 2010).  
8.2.4 tRNA translocation 
After peptide bond formation the ribosome is left with a peptidyl tRNA in the A-site and a 
deacetylated tRNA in the P-site. To initiate a new elongation cycle both tRNAs have to be 
translocated from the A- and P- to the P- and E-site of the ribosome, and the mRNA has to be 
moved by one codon. This translocation reaction is mainly driven by large-scale conformational 
changes and movements of the ribosome, catalysed by elongation factor G (EF-G) (reviewed in 
(Achenbach & Nierhaus, 2014)). In the PRE translocation state, with tRNAs in the A- and P-
site, the ribosomal subunits can spontaneously rotate with respect to one another by 7° and form 
the rotated PRE state, also referred to as ratcheted state (J. Frank & Agrawal, 2000; Julian et al., 
2008; Valle et al., 2003). This counter-clockwise rotation of the subunits to each other facilitates 
movement of the tRNAs on the large subunit from the A- to the P- and from the P- to the E-
position, into hybrid position 1 termed A/P and P/E, respectively, with the first letter of the term 
referring to the position of the tRNA on the small subunit and the latter referring to the position 
of the tRNA on the large subunit (Moazed & Noller, 1989). Munro et al. (Munro, Altman, 
O'Connor, & Blanchard, 2007), using single-molecule fluorescence resonance energy transfer 
(smFRET) measurements identified an second, short lived, hybrid state 2, were only the P-site 
tRNA is shifted to the P/E position while the A-site tRNA adopts the classical A/A 
conformation. The rotated PRE state is not stable and the ribosome fluctuates between the 
classical and the rotated PRE state. While tRNAs on the large subunit will translocate dependent 
on intersubunit rotation a second movement of the head of the small subunit has to be induced 
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by the action of EF-G to facilitate translocation of mRNA and tRNAs (tRNA2-mRNA) on the 
small subunit (J. Frank, Jr. & Gonzalez, 2010; Rodnina, Savelsbergh, Katunin, & Wintermeyer, 
1997). Bound to the ribosomal complex EF-G contacts h34 of the head of the small subunit and 
the minor groove of the codon-anticodon duplex in the decoding center on the small subunit, via 
two highly conserved loops on the tip of domain IV (Ramrath et al., 2013). These interactions 
lead to the disruption of a network of hydrogen bonds between the decoding centre and the 
codon-anticodon duplex, inducing a rotation of the head (also called swivelling of the head) of 
the 30S subunit, turning it by 18° toward the E-site, thereby facilitating translocation of the 
tRNA2-mRNA module (Ermolenko & Noller, 2011; Holtkamp, Wintermeyer, et al., 2014; G. 
Liu et al., 2014; Salsi, Farah, Dann, & Ermolenko, 2014). This translocation step has been 
shown to involve an intra-subunit hybrid state, where the mRNA and the anticodon stem loop 
(ASL) of the tRNAs simultaneously interact with components of the A- and P-site (ap/P) and 
the P- and E-site (pe/E) on the small subunit (Ramrath et al., 2013; Ratje et al., 2010). 
A more recent study by crystallography visualised a previously unknown, compact 
conformation of EF-G bound to the PRE state of the ribosome in the presence of the antibiotic 
dityromicin (Lin, Gagnon, Bulkley, & Steitz, 2015). In this conformation, domains III-V of EF-
G are rotated away from the A-site on the small subunit (Lin et al., 2015). Additional FRET 
studies provide further evidence that the compact form of ribosome bound EF-G might resemble 
an authentic, short lived translocation intermediate preceding the extended conformation that 
EF-G adopts shortly after its interaction with the ribosome, but still previous to GTP hydrolysis 
and tRNA2-mRNA translocation (Salsi, Farah, Netter, Dann, & Ermolenko, 2015). 
The action of EF-G results in a ribosomal complex after translocation (POST-state) containing 
peptidyl-tRNA in the P site, deacylated tRNA in the E site, and a vacant A site (Lin et al., 
2015). Interestingly, the ribosome, as a Brownian machine, has the intrinsic capability to 
spontaneously translocate tRNAs both ways, forward and backward (Gavrilova & Spirin, 1971). 
Nevertheless, EF-G is needed for contributing to the efficiency of the translocation process. 
Moreover, a translational GTPase (EF4/LepA) that is structurally related to EF-G has been 
identified to catalyse a backwards movement of the tRNA2–mRNA module when the ribosome 
stalls, which is termed back-translocation (Y. Qin et al., 2006; Shoji, Walker, & Fredrick, 2006; 
Yamamoto et al., 2014). 
How exactly EF-G binds to the ribosome and how the EF-G/ribosome interaction results in GTP 
hydrolysis and translocation are questions that are still not fully answered (Achenbach & 
Nierhaus, 2014; Yamamoto et al., 2014). The number of recent high-resolution structures of the 
ribosome in complex with EF-G though (Brilot, Korostelev, Ermolenko, & Grigorieff, 2013; 
Chen, Feng, Kumar, Ero, & Gao, 2013; Lin et al., 2015; Pulk & Cate, 2013; Tourigny, 
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Fernandez, Kelley, & Ramakrishnan, 2013) provide additional insights into the proposed 
mechanism of catalysis. The interaction with the α-sarcin-ricin loop (SRL) of the 23S rRNA 
stabilizes the conformation of a highly conserved histidine coordinating a water molecule that is 
positioned to catalyse hydrolysis of the γ-phosphate group of the bound GTP. This scenario is 
proposed to be crucial for the activation of the conserved histidine, in a similar manner as 
previously observed for activation of EF-Tu (Voorhees et al., 2010). 
8.2.5  Termination and recycling 
In most species there are three stop codons, namely UAA, UAG and UGA. These are not 
recognised by an aminoacyl-tRNA but signal translation termination instead (reviewed in 
(Dunkle & Cate, 2010)). In eubacteria, translation termination is mediated by two class I release 
factor proteins, RF1 and RF2, which recognise the stop codons UAA and UAG or UAA and 
UGA, respectively. RF1 and RF2 are homologous in sequence and three-dimensional structure 
(Vestergaard et al., 2001) and bind to the ribosome in a way so that domains 2-4 would overlap 
with a tRNA bound to the ribosomal A-site (A. Korostelev et al., 2008; Laurberg et al., 2008). 
Thereby, domain 2 of the release factor is positioned to reach to the decoding center on the 30S 
subunit of the ribosome for stop codon recognition. Domain 2 contains highly conserved protein 
motifs for stop codon recognition that’s bases conformation is strikingly different from a sense 
codon (A. Korostelev, Zhu, Asahara, & Noller, 2010; A. A. Korostelev, 2011) (Laurberg et al., 
2008; A Weixlbaumer et al., 2008). The first base of the stop codon, universally restricted to 
uridine, is recognized via backbone interactions with the GXXE peptide-motive located on the 
N-terminal part of helix-α5, while the identity of the second nucleobase is discriminated via a 
conserved tripeptide sequence, either PA/VT or SPF for RF1 or RF2, respectively, in which, for 
a great part, the identity of the Thr and the Ser, within the context of the recognition loop define 
the specificity (Ito, Uno, & Nakamura, 2000; Young, Edgar, Poole, & Tate, 2010). The third 
position nucleobase is recognised by a Thr and a Gln in RF1 that can accept a hydrogen-bond 
from the adenine or donate a hydrogen-bond to the guanine while RF2 has Val instead of Gln 
that’s hydrophobic side chain would be positioned to exclude a needed water molecule from 
forming an hydrogen-bond with a guanine and therefore discriminates against guanine at this 
position (A. Korostelev et al., 2008; A. Korostelev et al., 2010; Laurberg et al., 2008; A 
Weixlbaumer et al., 2008). To catalyse hydrolysis of the ester bond between the terminal A76 of 
the P-site tRNA and the nascent peptide, the universally conserved GGQ motive of domain 3 is 
positioned to reach into the PTC, placing Gln230 adjacent to A76. Although, mutations of 
Gly228 or Gly229 show a drastic decrease in catalytic activity does mutation of Gln230 to any 
amino acid but proline only show a mild effect on peptide release activity (A. Korostelev et al., 
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2008). In line with this observation it was found that the NH group of the protein backbone is 
within hydrogen bonding distance to the 3’ hydroxyl of the ribose of A76 while the side chain 
of Gln230 is oriented away from the peptidyl-tRNA’s ester bond. Therefore it has been 
proposed that the backbone NH group of Gln230 takes part in stabilizing the tetrahedral 
transition-state intermediate by establishing an hydrogen-bond to the developing oxyanion and 
in product stabilization by hydrogen-bonding to the 3’-OH of the deacylated tRNA (A. 
Korostelev et al., 2008; A. Korostelev et al., 2010; Laurberg et al., 2008; Santos, Zhu, Donohue, 
Korostelev, & Noller, 2013).  
After peptidyl-tRNA hydrolysis, the bacterial class II release factor RF3 stimulates dissociation 
of RF1 and RF2 from the ribosome (Koutmou, McDonald, Brunelle, & Green, 2014; F. Peske, 
Kuhlenkoetter, Rodnina, & Wintermeyer, 2014). RF3 binds at the entry of the factor-binding 
site of the ribosome, similar to EF-G or EF-Tu and contacts the highly conserved SRL of the 
23S rRNA, L6, h5 and h15 of the 16S rRNA as well as S12. Like for RF1 and RF2, the solution 
structure of RF3 differs from its structure bound to the ribosome. Domain II is rotated by 7° and 
domain III by a whole 55° relative to domain I in solution (Jin, Kelley, & Ramakrishnan, 2011b; 
J. Zhou, Lancaster, Trakhanov, & Noller, 2012). RF3 is a GTPase and the GTP form of the RF3 
stabilizes the rotated state of the ribosome inducing tRNA hybrid conformation (Jin, Kelley, & 
Ramakrishnan, 2011a). GTP hydrolysis by RF3 promotes the release of the class I RFs as well 
as itself from the ribosome (H. Gao et al., 2007; Koutmou et al., 2014). Interestingly RF3 has 
been found to be non-essential in E. coli (Grentzmann, Brechemierbaey, Heurgue, Mora, & 
Buckingham, 1994; Mikuni et al., 1994) and is absent from many groups of bacteria as for T. 
thermophilus (Y. Zhou, Asahara, Gaucher, & Chong, 2012). 
The final step in the translation cycle is ribosome recycling. In prokaryotes, ribosome recycling 
is performed by the ribosome-recycling factor (RRF) in concert with EF-G (F Peske, Rodnina, 
& Wintermeyer, 2005; Zavialov, Hauryliuk, & Ehrenberg, 2005). Their actions result in 
splitting of the ribosome into its subunits along with release of the mRNA and deacylated tRNA 
to make the involved components available for the next round of translation (Hirokawa et al., 
2005; Karimi, Pavlov, Buckingham, & Ehrenberg, 1999).  
The interaction of RRF with the ribosome has been studied by using a variety of biochemical 
and structure biological methods, such as chemical probing (Lancaster, Kiel, Kaji, & Noller, 
2002), cryo-EM (Agrawal et al., 2004; Gao, Zavialov, Ehrenberg, & Frank, 2007; Gao et al., 
2005; Yokoyama et al., 2012) and protein crystallography (Borovinskaya et al., 2007; Dunkle et 
al., 2011; L. Wang et al., 2012; A. Weixlbaumer et al., 2007; D. N. Wilson et al., 2005). All 
together, the conducted experiments data analyses suggest a predominate interaction of RRF 
with the ribosome, with domain I of RRF bound to the ribosomal intersubunit space, interacting 
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with parts of the ribosomal A- and P-site and with domain II being located in between 
ribosomal protein S12 and the L11 stalk-base. This interaction stabilizes the ratcheted 
conformation of the ribosome with the deacylated tRNA in the P/E hybrid state. Subsequent 
binding of EF-G?GTP leads to splitting of the ribosome by the concerted action of RRF and EF-
G, hydrolysing GTP. The proximate interplay with IF3 prohibits re-association of the 
deacetylated tRNA as well as 70S formation (Hirokawa et al., 2005; Karimi et al., 1999; Singh, 
Das, Seshadri, Sangeetha, & Varshney, 2005) integrating the step of ribosome recycling into the 
guided assembly of the 30S translation initiation complex. 
8.3 Stalling and its Biological Relevance 
The growing product of the ribosome, the nascent peptide, can act as a cis-specific factor from 
within the ribosomal tunnel to modulate translation, leading to translation slowdown and arrest. 
Translation arrest is thereby mediated by the specific amino acid sequence of the nascent 
peptide. These nascent peptides, so-called ribosome arrest peptides (RAP) differ in size and 
amino acid composition and can be found in a variety of organisms. Each RAP interacts with 
the ribosome in a unique way and some require for their function the presence of an effector 
molecule. Nascent peptide mediated translation arrest plays an important role in the regulation 
of gene expression, and many open reading frames containing arrest motifs have been identified 
due to their function. They can act as genetic switches, in response to (i) defects in protein 
translocation and membrane protein biogenesis (Chiba, Lamsa, & Pogliano, 2009; McNicholas, 
Salavati, & Oliver, 1997; Sarker, Rudd, & Oliver, 2000), (ii) changes in amino acid metabolism 
(Gollnick & Yanofsky, 1990; Z. Wang, Fang, & Sachs, 1998), (iii) the presence of antibiotic 
(reviewed in (Ramu, Mankin, & Vazquez-Laslop, 2009)) as well as (iv) other functions of the 
cell (reviewed in (Ito & Chiba, 2013)). 
In recent years significant progress has been made to identify determinants of nascent peptide 
mediated translation arrest. Amino acid sequences of several ribosomal arrest peptides, critical 
for stalling have been characterized (Figure 3) (Gong & Yanofsky, 2002; Ito, Chiba, & 
Pogliano, 2010; Mayford & Weisblum, 1989; Vazquez-Laslop, Thum, & Mankin, 2008) and a 
number of rRNA and protein residues within the PTC and the ribosomal exit tunnel, involved in 
ribosome arrest have been identified (Nakatogawa & Ito, 2002; D.N. Wilson & Beckmann, 
2011). However, stalling sequences are quite divergent and interact with the ribosome in distinct 
ways utilising different strategies to render the PTC inactive (Ito & Chiba, 2013). The first cryo-
EM structures of stalled ribosome complexes (SRC) at resolutions below 6Å gave insights into 
the geometric disposition of arrest-essential residues, disclosing the paths of the RAPs from the 
PTC through the ribosomal exit tunnel and contacts with tunnel wall components (Bhushan et 
8  Introduction 25 
al., 2011; Bhushan et al., 2010; Seidelt et al., 2009). And more recently published structures of 
stalled ribosome complexes at resolutions below 4Å, allowing molecular model building and 
interpretation, now aim to establish a basic framework for understanding mechanistically how 
RAPs induce translation arrest (Arenz, Meydan, et al., 2014; Arenz, Ramu, et al., 2014; 
Bischoff, Berninghausen, & Beckmann, 2014). 
 
 
 
Figure 3 ⏐  Stalling sequences of ribosome arrest peptides (RAP). Relative position of arrest-critical and arrest-
important amino acids identified by comprehensive mutational analysis. The arrest sequence segments are illustrated 
as circles that represent amino acid residues. Sequences are aligned on the amino acid residue in the ribosomal P-site 
(P-site position is defined as position 0) in the stalled ribosomal complex. Residues critical for ribosome stalling are 
highlighted in green (Mid-tunnel elements) and blue (PTC-proximal elements), although some arbitrariness for the 
boundaries could not be avoided. The arrest-important acidic cluster in MifM is highlighted in light blue with italic 
letters. Abbreviations: P, P-site peptidyl-tRNA; A, A-site aminoacyl-tRNA, an asterisks indicates a stop codon. 
Figure modified from (Ito & Chiba, 2013). 
 
8.3.1 Mechanisms of RAP mediated regulation of gene expression 
RAP mediated translation arrest, stopping the ribosome on a specific position on the mRNA for 
a prolonged time, can affect translation of a downstream gene(s) (Ito & Chiba, 2013; Lovett & 
Rogers, 1996; Tenson & Ehrenberg, 2002). Ribosome stalling within a number of leader 
peptides, for example antibiotic-resistance genes (ermCL, ermAl1, catA86, cmlA) (Ramu et al., 
2009), the secretion monitor (secM) (Nakatogawa & Ito, 2001a) and the membrane insertion 
and folding monitor (mifM) (Chiba et al., 2009), leads to disruption of a hairpin structure in the 
mRNA intergenic region, releasing the ribosomal binding site and thereby inducing expression 
of the downstream gene(s) (Figure 4 a, 5).  
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In contrast, ribosome stalling on the TnaC leader peptide blocks access of the Rho transcription 
termination factor to its binding site on the mRNA, thereby allowing transcription (and 
translation) of the downstream genes (L. R. Cruz-Vera, Yang, & Yanofsky, 2009; Konan & 
Yanofsky, 1997, 2000). A mechanism similar to the regulation of the tnaCAB operon has been 
recently proposed for the regulation of the bmrBCD operon in B. subtilis (Reilman, Mars, van 
Dijl, & Denham, 2014) (Figure 4 b), regulating bmrBCD operon gene expression in response to 
different antibiotics. 
 
 
 
Figure 4 ⏐  Mechanisms of ribosome arrest peptide (RAP) mediated regulation of gene expression. (a) RAP 
mediated ribosome stalling on a leader peptide. Stalling of the ribosome leads to disruption of an mRNA secondary 
structure, exposing the SD region of the downstream gene. (b) RAP mediated ribosome stalling hinders access of the 
Rho transcription termination factor to its rut binding site. Blocking Rho’s access to the mRNA allows transcription 
of the downstream gene(s). (c) RAP mediated ribosome stalling blocks movement of scanning ribosome to a 
downstream translation initiation site. (d) RAP mediated ribosome stalling induces mRNA cleavage by an 
endonuclease. (e) An unusual termination and reinitiation “StopGo” event. A 2A peptide mediated recoding 
mechanism allows translation of two separate peptides (1D, 2B) by the same ribosome. (f) RAP mediated localization 
of the mRNA to the membrane via a determinant of a nascent chain (HR2). Localization of the mRNA to the 
membrane allows efficient splicing of the XBP1u mRNA. Abbreviations: ER, endoplasmic reticulum; RNAP, RNA 
polymerase; SD, Shine-Dalgarno sequence; uORF, upstream open reading frame. Figure modified from (Ito & Chiba, 
2013). 
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In general, it is found that RAP mediated regulation of gene expression in prokaryotes leads to 
induction of gene expression by destabilizing mRNA secondary structure, while RAP mediated 
regulation of gene expression in eukaryotes leads to gene repression by preventing ribosomal 
scanning for initiation sites (D.N. Wilson & Beckmann, 2011). For example, in eukaryotes, 
regulation of arginine biosynthesis requires translation of the arginine attenuator peptide (AAP) 
(Z. Wang & M.S. Sachs, 1997; Z. Wang & M. S. Sachs, 1997). In the presence of arginine, the 
AAP stalls translation at the step of termination, inhibiting the ribosome preinitiation complex 
from scanning for downstream ORFs thereby preventing scanning preinitiation complexes to 
reach the downstream gene (N. crassa (arg-2) and S. cerevisiae (CPA1)). The mRNA of the 
AAP stalled ribosomal complex is also subject to nonsense-mediated decay (NMD) in S. 
cerevisiae (Gaba, Jacobson, & Sachs, 2005).  
Similarly, polyamine-dependent stalling during translation termination of the S-
adenosylmethionine decarboxylase (AdoMet-DC) upstream ORF (uORF) (Hill & Morris, 1993; 
Law, Raney, Heusner, & Morris, 2001; Mize, Ruan, Low, & Morris, 1998), sucrose-dependent 
stalling during translation of the bZIP11 uORF2 (Sucrose control peptide) (Hummel, Rahmani, 
Smeekens, & Hanson, 2009; Rahmani et al., 2009; Rook, Weisbeek, & Smeekens, 1998; Wiese, 
Elzinga, Wobbes, & Smeekens, 2004, 2005), and effector molecule independent stalling during 
translation termination of the UL4 (gp48) uORF2 (Cytomegalovirus) (Cao & Geballe, 1996; 
Degnin, Schleiss, Cao, & Geballe, 1993; Schleiss, Degnin, & Geballe, 1991), inhibit scanning 
of ribosome preinitiation complexes for downstream ORFs (Figure 4 c). 
Expression of cystathione-γ-synthase (cgs1), involved in regulation of methionine biosynthesis 
in A. thaliana (Onouchi et al., 2005), depends on translation of a RAP encoded within the first 
exon of the cgs1 coding sequence, stalling translation in response to free S-adenosyl-L-
methionine (SAM). Translation arrest on cgs1 not only halts ribosome progression but also 
induces mRNA cleavage in A. thaliana (Figure 4 d). 
Furthermore, RAP dependent mechanisms involved in gene expression regulation in eukaryotic 
cells have been shown to affect transcription termination and recoding (Figure 4 e) (Atkins et 
al., 2007; Ryan, King, & Thomas, 1991; Sharma et al., 2012), mRNA splicing (Figure 4 f) and 
other events effecting gene expression (Ito & Chiba, 2013). 
8.3.2 Sensing metabolites & drugs 
There are multiple examples of ribosome arrest peptides that control the expression of genes 
conferring resistance to a range of antibiotics inhibiting protein synthesis. Some of the best 
studied are the leader peptides of the Erm-type methyltransferases, including ErmCL and 
ErmBL (Dubnau, 1985; Min, Kwon, Yoon, Shim, & Choi, 2008; Narayanan & Dubnau, 1987). 
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Sub-lethal concentrations of the effector drug induce expression of a downstream 
methyltransferase gene. The Erm-type methyltransferases confer resistance to erythromycin and 
other antibiotics (macrolides, ketolides, lincosamides, streptogramin B) by mono-/dimethylation 
of A2058 of the 23S rRNA (M. Liu & Douthwaite, 2002). The same regulatory principle applies 
for the induction of the expression of resistance genes that confer resistance against the 
ribosome targeting antibiotic chloramphenicol (reviewed in (Lovett, 1996)). Detoxifying or 
evading the antibiotic by inducing expression of catA86 or cmlA, coding for a chloramphenicol 
acetyltransferase and an efflux pump, respectively, as this regulatory principal might apply for 
the control of other substrate induced resistance marker (Ramu et al., 2009; Reilman et al., 
2014; Y. Wang, Rotman, Shoemaker, & Salyers, 2005). 
One well-studied example of ribosome arrest peptide mediated regulation of gene expression 
controlling a metabolic pathway is the E. coli tnaCAB operon (Gong & Yanofsky, 2003). 
Elevated intracellular levels of the free amino acid tryptophan (L-Trp) induce expression of the 
tnaCAB operon encoding the L-Trp catabolising enzyme tryptophanase (tnaA) and a 
tryptophan-specific permease (tnaB). A recently published cryo-EM structure of the ribosome 
stalled by the tnaC arrest peptide in the presence of tryptophan showed two tryptophan 
molecules in the ribosomal tunnel coordinated by the nascent peptide and parts of the ribosomal 
tunnel, explaining how the translating ribosome can act as a small molecule sensor (Bischoff et 
al., 2014). While ribosome stalling on the arginine attenuator peptide (AAP) (Z. L. Luo & 
Sachs, 1996) in response to the free amino acid L-arginine leads to down regulation of gene 
expression of the small subunit of the arginine-specific carbamoyl phosphate synthase. In 
Arabidopsis thaliana (A. thaliana), the transcriptional activator basic region-leucine zipper 
transcription factor 11 (bZIP11) represents a sucrose-level dependent controlled protein. Here, 
sucrose-sensing is regulated by one of its four uORFs (uORF2) on the 5’ leader mRNA which 
encodes for the conserved sucrose control peptide (SC-peptide). SC-peptide translating 
ribosomes get stalled at the uORF2 stop codon, only in response to sucrose, efficiently blocking 
scanning ribosomes from translating key metabolism regulation proteins located further 
downstream. The molecular details of this stalling event are presently still under investigation, 
however it is assumed that the interaction of four conserved amino acids (serine29, serine31, 
leucine35 and tyrosine39) is essential for the peptide-mediated stalling mechanism (Hummel et 
al., 2009; Rahmani et al., 2009). 
8.3.3 Monitoring physiological functions 
Some RAPs stall translation independent of the presence of an effector molecule. Their ability 
to modulate translation is mediated by the amino acid sequence identity of the stalling sequence 
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alone. Nevertheless, effector independent translation arrest can also regulate gene expression in 
response to environmental and physiological changes.  
The N-terminal segment of the E. coli secretion monitor (SecM) (Nakatogawa & Ito, 2001a) 
and the B. subtilis membrane insertion and folding monitor (MifM) (Chiba et al., 2009) is long 
enough to have emerged from the ribosome when translation is stalled by the following C-
terminal arrest sequence located in the ribosomal tunnel. The N-terminal segment plays a 
pivotal role in releasing the translational arrest, as under physiological conditions SecM and 
MifM mediated translation arrest is abrogated by interaction with the cellular protein 
translocation machinery. 
 
 
 
Figure 5 ⏐  Schematic for regulation of yidC2 expression. (a) Under YidC1 (spoIIIJ)-deficient conditions MifM 
insertion into the cell membrane is compromised. The prolonged MifM dependent ribosome stalling maintains the 
unfolded conformation of the mifM-yidC2 mRNA, which allows ribosome binding to the downstream ribosomal 
binding site (RBS) and expression of the yidC2 gene (blue). (b) The expression of YidC2 (yqjG) restores the 
membrane protein insertion capacity of the cell. Interaction of the N-terminal transmembrane (TM) segment (orange) 
within the MifM nascent chain with YidC2 abrogates ribosome stalling. Subsequent progression and release of the 
ribosome from the mRNA leads to the reformation of a stem-loop structure within the mifM-yidC2 mRNA that 
sequesters the ribosome-binding site (RBS) of the yidC2 gene leading to repression of the yidC2 gene (blue). 
 
Truncation of the N-terminal segment causes SecM and MifM to stall translation constitutively 
(Chiba et al., 2009; Nakatogawa & Ito, 2002) and translation arrest is prolonged when the 
activity/capacity of the protein translocation machinery is diminished. Prolonged ribosome 
arrest by SecM leads to upregulation of SecA ATPase (Nakatogawa & Ito, 2001b), a molecular 
motor to promote protein secretion at a Sec translocon (Chatzi, Sardis, Economou, & 
Karamanou, 2014; van der Sluis & Driessen, 2006). Prolonged ribosome arrest by MifM leads 
to upregulation of YidC2 (yqjG) a protein insertase from the YidC/Oxa1/Alb3 protein family 
(Funes, Kauff, van der Sluis, Ott, & Herrmann, 2011), restoring the membrane protein 
biogenesis capacity of the cell (Figure 5) (Chiba et al., 2009). This suggests that E. coli SecM 
and B. subtilis MifM have evolved to monitor the capacity of the protein translocation/insertion 
machineries of the cell by probing the respective machinery with their N-terminal determinants 
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for secretion (SecM) or membrane integration (MifM) activity, respectively, engaged in the 
translocation/insertion reaction. 
8.3.3.1 The membrane insertion and folding monitor 
The mifm uORF is found in a subset of species of the Bacillaceae (Chiba et al., 2009). Bacillus 
subtilis (B. subtilis) MifM is encoded by a 95 codon long open reading frame 30 nucleotides 
upstream of YidC2 (yqjG) (Chiba et al., 2009). Translation of MifM was shown to stall the 
ribosome close to the end of the coding sequence. Remarkably, it was found that MifM 
undergoes elongation arrest at multiple consecutive stall sites with the residues D89, A90, G91 
or S92 in the ribosomal P-site (Figure 6) (Chiba & Ito, 2012).  
 
 
 
Figure 6 ⏐  Schematic for MifM translation arrest dependent regulation of yidC2 expression. (a) Schematic of 
the mifM-yidC2 mRNA illustrating the stem-loop structure that sequesters the ribosome-binding site (RBS) of the 
yidC2 gene (blue). (b) Multisite ribosome stalling (0, +1, +2 and +3) during translation of MifM maintains the 
unfolded conformation of the mRNA allowing ribosome binding and induction of yidC2 expression. The MifM 
stalling sequence (residues 69–89) is indicated with critical residues in boldface. The amino acids of the acidic cluster 
are marked italic. The N-terminal trans-membrane (TM) segment (orange) is indicated within the nascent peptide 
chain. Abbreviations: P, P-site peptidyl-tRNA; A, A-site aminoacyl-tRNA. An asterisk indicates a stop codon. 
 
Moreover, residues critical for stalling of MifM have only been identified in the mid- and 
lower-tunnel region within a stalling relevant sequence of at least 21 amino acids: 
R69ITTWIRKVFRMNSPVNDEED89A90G91S92 (amino acids critical for stalling are marked as 
boldface letters, the cluster of acidic amino acids is marked italic, the four consecutive stall sites 
are underlined). The importance of the mid-tunnel region for MifM stalling is corroborated by a 
mutant which is defective in MifM dependent translation arrest, carrying a duplication of seven 
amino acids in the β–hairpin of ribosomal protein L22 lining the ribosomal tunnel wall close to 
the mid-tunnel constriction (Chiba et al., 2009). Further, the conserved cluster of acidic amino 
acids (D86EED89) was found to be critical for MifM dependent stalling. Single substitutions of 
these PTC-proximal amino acids showed only minor effects on MifM function, but stalling was 
lost if all four acidic amino acids were changed to alanine altogether (Chiba & Ito, 2012). 
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Consistent with finding amino acids critical for stalling only within the mid- and lower-tunnel 
regions, stalling was hardly affected by insertion of an alanine between the mid-tunnel element 
and the PTC-proximal acidic cluster (Chiba & Ito, 2012). Most interestingly, MifM has been shown 
to arrest translation on B. subtilis ribosomes but not efficiently on Escherichia coli (E. coli) ribosomes 
(Chiba et al., 2011; Vazquez-Laslop & Mankin, 2011). A similar species-specific activity has been 
shown for the secretion monitor (SecM) where stalling solely works in E. coli (Chiba et al., 2011; 
Vazquez-Laslop & Mankin, 2011). However, MifM and SecM do not exhibit species-exclusive 
regulation. Replacement of the N-terminal trans-membrane region of MifM with the N-terminal 
signal-sequence of a Sec dependently secreted protein successfully converts MifM to sense 
SecA-dependent protein secretion rather than YidC-dependent protein integration into the 
membrane. (Chiba et al., 2011). MifM stop-codon mutants, programming the A-site with the 
introduced stop codon, revealed that MifM stalling can as well impair translation at the step of 
termination, while MifM stalled peptidyl-tRNAs produced from a truncated mRNA template are 
resistant to treatment with puromycin, indicating inhibition of PTC activity (Chiba & Ito, 2012). 
8.3.3.2 Mechanism of MifM mediated translation arrest release 
MifM mediated ribosomal elongation-arrest is released by co-translational membrane insertion 
of its N-terminal TM region by SpoIIIJ (YidC1) (Chiba et al., 2011; Chiba et al., 2009; Ito et al., 
2010). The current model for YidC-dependent membrane protein integration assumes that 
release of the substrate from the YidC insertase into the membrane is facilitated by the 
hydrophobic interaction between the TM region and the lipid interior of the membrane, as well 
as the membrane potential attracting negatively charged residues of the extracellular region of 
the membrane protein by electrostatic attraction (Ismail, Hedman, Linden, & von Heijne, 2015; 
Kumazaki, Chiba, et al., 2014). Therefore, it is conceivable that insertion of the N-terminal 
MifM TM region into the membrane would exert a pulling force on the nascent polypeptide that 
could physically disrupt further C-terminal arrest-important interactions between residues of 
MifM and the ribosomal exit tunnel (Cymer, Hedman, Ismail, & von Heijne, 2015; Cymer, 
Ismail, & von Heijne, 2014; Cymer, von Heijne, & White, 2015). 
The pulling force model was first proposed to explain relief of SecM mediated ribosome 
translation arrest by the pulling force generated by the ATP consuming motor protein SecA, 
which has been shown to drive protein translocation across the membrane (Butkus, Prundeanu, 
& Oliver, 2003; Gumbart, Schreiner, Wilson, Beckmann, & Schulten, 2012). But, it was also 
shown that an engineered stop transfer-membrane anchor sequence is sufficient to release SecM 
mediated stalling by the pulling force exerted on the nascent peptide, when the membrane 
anchor reaches the membrane and when it is fully transferred to the height of the membrane 
leaving the translocon into the lipid bilayer (Ismail, Hedman, Schiller, & von Heijne, 2012). 
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Due to the observed pulling force profile, SecA is assumed not to be a major contributor to the 
force generated to overcome the ribosomal translation halt, but the process of membrane protein 
insertion itself can generate a pulling force strong enough to resume arrested translation. 
Therefore, SpoIIIJ-mediated membrane insertion of MifM might well provide sufficient pulling 
force to release elongation arrest. 
Though, to relieve stalling by the interaction with the translocon, the stop transfer-membrane 
anchor sequence has to be positioned at a certain distance from the arrest sequence, with force 
profiles peaking at sequences around a length of 30 and 40 amino acids in between the 
membrane anchor and the PTC. Noteworthy, the distance between the C-terminal end of the TM 
segment of the MifM leader peptide and the amino acid located in the P-site at the first stalling 
site of the MifM arrest sequence is 54 amino acids, posing a challenge for the pulling force 
model with the nascent chain envisioned as a simple rope to pull on.	   Investigation	   of	   internal	  
substitution	  and	  deletion	  mutants	  of	  the	  SecM	  arrest	  peptide	  identified	  a	  stretch	  of	  amino	  acids	   in 
the middle of the peptide required for the export-coupled release of the SecM nascent chain 
(Nakamori, Chiba, & Ito, 2014). Additional	   experiments	   are	   therefore	   needed	   to	   elucidate	   the	  
contribution	  of	  the	  force	  generated	  by	  the	  integration	  of	  the	  TM	  segment	  of	  the	  MifM	  leader	  peptide	  
into	  the	  membrane	  and	  of	  the	  functional	  interactions	  of	  the	  MifM	  nascent	  chain	  with	  the	  ribosome	  
and	  SpoIIIJ	  to	  the	  regulation	  of	  the	  translation	  arrest. 
8.3.3.3 Protein insertases of the YidC/Oxa1/Alb3 family and substrates 
Bacillus subtilis YidC1 (spoIIIJ) and YidC2 (yqjG) are homologues of the membrane protein 
insertase Oxa1p (Murakami, Haga, Takeuchi, & Sato, 2002; Saller, Fusetti, & Driessen, 2009) 
and belong to the YidC/Oxa1/Alb3 family of proteins. Membrane protein insertases of the 
YidC/Oxa1/Alb3 protein family are present in the inner membrane of eubacteria (YidC, 
YidC1/YidC2), the inner mitochondrial membrane (Oxa1/Cox18) and the thylakoid membrane 
of Chloroplasts (Alb3/Alb4) (Funes et al., 2011), assisting in membrane protein insertion in the 
lipid bilayer (Samuelson et al., 2000). Most likely due to an early gene duplication event, two 
YidC genes can be found in the genomes of most Gram-positive bacteria as in species from 
Bacillus, Lactobacillus, Clostridium and some Actinobacteria. The two paralogues differ in their 
phylogeny and therefore have been classified as different subgroups designated as YidC1 and 
YidC2 (Funes et al., 2009; Funes et al., 2011).  
Initially mutation of spoIIIJ (YidC1) in Bacillus subtilis was found to abolish transcription of 
pre-spore specific genes blocking sporulation after pre-spore engulfment (Errington et al., 1992; 
Murakami et al., 2002) with no observable phenotype during vegetative growth. Likewise, 
deletion of yqjG (YidC2) did not affect vegetative growth or sporulation and SpoIIIJ and YqjG 
have been shown to be largely exchangeable in function (Saller et al., 2009), though YqjG 
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cannot complement SpoIIIJ activity in spore formation and has been implicated to have a 
specific function in genetic competence development (Saller et al., 2011). Double mutation of 
spoIIIJ and yqjG though is lethal. 
YidC like insertases of the YidC/Oxa1/Alb3 family of proteins share a conserved membrane 
region constituted from 5-6 trans-membrane (TM) helices (6TM helices in Gram-negative 
bacteria) and resent crystal-structures of E. coli YidC and YidC2 from B. halodurans by 
Kumazaki et al. (Kumazaki, Chiba, et al., 2014; Kumazaki, Kishimoto, et al., 2014) revealed, 
that unlike other known proteins and protein complexes involved in membrane protein 
biogenesis, YidC like insertases do not form a pore in the membrane but a hydrophilic groove in 
between TM3 and TM5. This hydrophilic groove shows an opening towards the membrane 
interior and the cytoplasmic side and is meant to provide a hydrophilic environment within the 
membrane to receive the hydrophilic region of a substrate (termini, loops) guiding its 
integration (Jiang et al., 2003). YidC has been shown to interact with components of the Sec 
machinery and it is known for YidC to facilitate integration of membrane proteins into the lipid 
bilayer in a YidC-dependent (YidC-only) and a Sec-dependent way (Robinson & Woolhead, 
2013; Serek et al., 2004) as part of the SecDF-YajC-YidC complex (Nouwen & Driessen, 2002) 
and the “holo-translocon” (SecYEG-YidC-SecDF-YajC) complex (Schulze et al., 2014) 
assisting in TM integration and assembly of multimeric membrane protein complexes (Kol, 
Nouwen, & Driessen, 2008). 
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9.1 Paper 1⏐Proteomic Characterization of Archaeal Ribosomes 
Reveals the Presence of Novel Archaeal-Specific Ribosomal Proteins  
 
Viter Márquez, Thomas Fröhlich, Jean-Paul Armache, Daniel Sohmen, Alexandra 
Dönhöfer, Aleksandra Mikolajka, Otto Berninghausen, Michael Thomm, Roland 
Beckmann, Georg J. Arnold and Daniel N. Wilson 
 
Journal of Molecular Biology 405, 1215–1232 (2011) 
 
The appearance of archaea resembles that of a bacterial cell. Previously, archaea had been 
confused with bacteria and their genera were found combined under the term prokaryota. The 
autonomous position of archaea in the tree of live was first uncovered by comparison of 16S 
rRNA sequences, establishing archaea as an independent phylogenetic domain of life in addition 
to bacteria and eukarya (Woese & Fox, 1977). However, archaea have a lot in common with 
their prokaryotic relatives at the molecular level. They have a small circular genome, a compact 
gene organization, with functionally related genes organized within operons. At the same time 
archaea also resemble the eukaryotic cell in many ways. Many archaeal proteins are 
homologous or more similar to their eukaryotic counterpart. Therefore, at the molecular level, 
archaea are often described as of intermediate complexity between bacteria and eukaryotes 
(Forterre, 2013; Olsen & Woese, 1997; Zillig, 1991).  
The ribosomes of the well-studied bacterial model organism E. coli contain 54 r-
proteins, 21 in the small subunit and 33 in the large subunit. Further genomic analyses have 
identified ∼57 r-protein families that are almost universally present in the bacterial ribosome. 34 
of which are universally conserved having homologues in eukarya and archaea, 23 are bacteria 
specific. Proteomic together with genomic analyses (Desmond, Brochier-Armanet, Forterre, & 
Gribaldo, 2010; Lecompte et al., 2002; Yutin, Puigbo, Koonin, & Wolf, 2012) of eukaryotic 
ribosomes ranging from yeast, to human, identified ∼78 r-protein families to be present in the 
eukaryotic ribosome and 11 r-proteins specific to eukarya. The archaeal ribosome can be 
compared to the bacterial 70S ribosomal particle in terms of size and rRNA content. It contains 
3 rRNAs (5S, 16S and 23S rRNAs) as opposed to 4 rRNAs in the eukaryotic ribosome. The 
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archaeal ribosome is composed of ∼68 r-protein families of which ∼33 have homologues to be 
found only in ribosomes from eukarya, while there are no r-proteins that are bacteria and 
archaea specific, and only one r-protein that is archaea specific. But while the protein 
composition of many bacterial and eukaryotic ribosomes has been well characterised, a 
comprehensive investigation, cataloguing the protein composition of archaeal ribosomes so far 
was missing.  
To close this gap, the composition of the ribosomes of the thermophilic Crenarchaeota 
Pyrobaculum aerophilum and the thermoacidophilic Crenarchaeota Sulfolobus acidocaldarius 
were analysed by 2D gel electrophoresis coupled with LC tandem mass spectrometry (MS/MS) 
and single particle electron microscopy (EM). These analyses could identify all of the predicted 
r-proteins almost completely. Only S26e and S30e of the Sulfolobus acidocaldarius ribosome 
were not found in the preparations. Further MS analyses of S. acidocaldarius L7ae, L29p, P0 
and LX and P. aerophilum L7ae, L12p and P0, that were previously found in multiple spots of 
2D PAGE preparations were shown to be post-translational modified isoforms in most cases.  
Additionally three new r-proteins of the Sulfolobus acidocaldarius large subunit were 
discovered and proposed to be renamed L45a, L46a and L47a. L45a, L46a and L47a were 
shown to be integral parts of the ribosome, embedded deeply into the ribosomal structure as 
shown by LiCl fractionation and 2D gel quantification. Homology searches in all available (91 
at the time published) completely sequenced archaeal genomes revealed that L45a is present in 
all Sulfolobus species with one exception (Sulfolobus tokodaii str. 7). L46a is more widely 
distributed in all Thermoprotei and L47a can be found in all Sulfolobaceae. A similar 
phylogenetic distribution has also later been found in an automated computational search 
performed by Yutin et al.(Yutin et al., 2012).  
To identify putative binding sites of the novel r-proteins, 3D models of purified 
ribosomal 50S subunits from S. acidocaldarius and P. aerophilum were reconstructed by cryo-
EM single particle analysis to a resolution of 27Å and 25Å (0.5 FSC), respectively. Comparison 
of the 3D models with the ribosomal structure of Haloarcula marismortui 50S led to the 
identification of additional densities in the model of Sulfolobus acidocaldarius as potential 
binding sites for the novel r-proteins. Reproducible	  appearance	  of	  L7ae	  and	  S24e	  in	  preparations	  
of	  both,	  the	  small	  and	  the	  large	  subunit	  of	  Sulfolobus acidocaldarius,	  were	  discussed	  as	  to	  hint	  to	  
possible	  promiscuous	  interactions	  of	  the	  proteins	  with	  both	  ribosomal	  subunit.	  But unambiguous 
assignment of density for the discovered novel r-proteins or additional copies of L7ae or S24e 
was not possible due to the limited resolution. Armache	  et	  al.	  (Armache et al., 2013) later indeed 
discovered L7ae and S24e in both subunits of 3D ribosomal reconstructions of Pyrococcus 
furiosus and Thermococcus kodakarensis. Together these findings suggest that there probably 
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still is a number of r-proteins existing in archaea that have not been described yet and their 
discovery could help to understand the evolution of the ribosome and the development of r-
protein functions. 
 
9.2 Paper 2⏐Amythiamicin D and Related Thiopeptides as Inhibitors 
of the Bacterial Elongation Factor EF-Tu: Modification of the Amino 
Acid at Carbon Atom C2 of Ring C Dramatically Influences Activity 
 
Stefan Gross, Fabian Nguyen, Matthias Bierschenk, Daniel Sohmen, Thomas Menzel, 
Iris Antes, Daniel N. Wilson, and Thorsten Bach 
 
ChemMedChem, 8, 1954–1962 (2013) 
 
The translational GTPase elongation factor Tu (EF-Tu) is a major factor in bacterial protein 
biosynthesis. EF-Tu delivers aminoacyl-tRNA to the ribosomal A-site and functionally 
contributes to tRNA selection by the ribosome. On account of its function, EF-Tu is also a 
potential target for antimicrobial compounds and currently four families of antibiotics of 
unrelated structure are known to efficiently inhibit EF-Tu actions, with kirromycin, enacycloxin 
IIa, pulvomycin, and GE2270A as prototypic examples. GE2270A belongs to the thiopeptide 
antibiotics, a group of ribosomally synthesised and extensively posttranslationally modified, 
antimicrobial peptides. Multiple chemical modification studies of GE2270A have been 
conducted to identify structural and functional important parts of the drug. One region that has 
been indentified is a phenyl-glycine-derived moiety with a α-hydroxybenzyl group located in 
the northeastern part of GE2270A. Deletion of the α-hydroxybenzyl group renders GE2270A 
inactive. The crystal structure of GE2270A bound to EF-Tu?GTP shows the α-hydroxybenzyl 
group to be located close to the helix of the switch II loop in domain D1 of EF-Tu, implicated in 
catalytic activity of EF-Tu, making this position attractive for further studies. Therefore, non-
natural thiopeptides have been utilized to study the influence of this region on translation 
inhibition. Three analogues of the naturally produced antibiotic amythiamicin D, with different 
substitutions of the α-hydroxybenzyl group, that could not be obtained other wise, were made 
available, for the first time, by de novo total synthesis. One of the derivatives reduced growth of 
Gram-positive bacteria with a minimal inhibitory concentration (MIC) comparable to 
amythiamicin D and inhibited translation in cell free in vitro translation experiments even more 
effective than amythiamicin D, while the other analogues were found to be inactive in both, 
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bacterial growth inhibition and in vitro translation experiments. Therefore, binding of 
amythiamicin D and its derivatives to EF-Tu was investigated by molecular dynamics (MD) 
simulations. Simulations resulted in binding positions similar to GE2270A only for 
amythiamicin D and its active derivative, with the analogue’s hydroxyl group of its 
hydroxymethyl substitution suggested to be able to form an additional hydrogen bond with 
residues of EF-Tu, comparable to the hydroxyl group of the α-hydroxybenzyl moiety of 
GE2270A. Therefore his study provides tools and insights for the generation of new non-natural 
thiopeptides and derivatives by de novo total synthesis to study their physiochemical properties 
as translation inhibitors and antimicrobial agents. 
 
9.3 Paper 3⏐Entrapment of DNA in an intersubunit tunnel system of a 
single-stranded DNA-binding protein 
 
Homa Ghalei, Holger von Moeller, Detlef Eppers, Daniel Sohmen, Daniel N. Wilson, 
Bernhard Loll and Markus C. Wahl 
 
Nucleic Acids Research, 42, 6698–6708 (2014) 
 
Single strand DNA-binding proteins (SSBs) are among the most widespread proteins in 
eukarya, bacteria and archaea, and are involved in major cellular processes like DNA 
replication, recombination and repair (reviewed in (Pestryakov & Lavrik, 2008)), which 
underlines their importance for the cell. SSBs are ubiquitous in nature, except in some 
hyperthermophilic Crenarchaeota that lack a canonical SSB, but instead encode non-canonical 
SSBs with unique ssDNA-binding domains termed “ThermoDBPs” (Paytubi et al., 2012). 
Two other only poorly characterised groups (1 and 2) of proteins with a broader 
phylogenetic distribution, related to ThermoDBPs, sharing the ThermoDBP’s N-terminal DNA-
binding domain (NTD) are known to co-exist with ThermoDBPs and other SSBs. Previously, 
Rbp18 from Sulfolobus solfataricus P2 (S. solfa), belonging to group 1 of ThermoDBP related 
proteins (ThermoDPB-RP1), was found to be associated with box C/D sRNAs as well as with 
the small subunit of the S. solfa ribosome (Ciammaruconi, Gorini, & Londei, 2008). However, 
no ThermoDPB-RP1 protein was detected in a subsequent proteomic analysis of archaeal 
ribosomes from Sulfolobus acidocaldarius (Marquez et al., 2011) or after enrichment for 
ssDNA binding proteins from Thermoproteus tenax (Paytubi et al., 2012). Therefore, we set out 
to further characterize the structure and function of ThermoDBP-RP1 and ThermoDBP-RP2 
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from Pyrococcus furiosus (pfuThermoDBP-RP1) and Aeropyrum pernix (apeThermoDBP-
RP2), respectively.  
In our experiments, binding of pfuThermoDBP-RP1 to box C/D sRNAs in vitro was 
efficiently competed by the presence of E. coli tRNA. Further, only a weak, salt sensitive 
interaction of pfuThermoDBP-RP1 and apeThermoDBP-RP2 with archaeal Thermococcus 
kodakarensis (T. kod) ribosomes was detected. Both results indicate a nonspecific interaction of 
pfuThermoDBP-RP1 and apeThermoDBP-RP2 with box C/D sRNAs and the T. kod ribosome 
in vitro, yet, they do not rule out a possible interaction of ThermoDBP-RP proteins with box 
C/D sRNAs and/or the ribosome in vivo. Therefore, we looked to investigate the interaction of 
the ThermoDBP-RP proteins with other nucleic acids. Indeed, we could show, that 
apeThermoDBP-RP2 specifically binds to mixed sequence or homopyrimidin stretches of 
ssDNA in vitro with high affinity. In addition, we were able to solve the structure of 
apeThermoDBP-RP2 in complex with single strand oligo-dT DNA at 2.9Å resolution. 
Moreover, we solved the crystal structures of pfuThermoDBP-RP1 and apeThermoDBP-RP2 at 
2.43Å and 2.05Å, respectively. Both proteins were found to form homotetramers, using 
different mechanisms for oligomerization, revealing how the N-terminal domain of 
apeThermoDBP-RP2 contacts the nucleic acid to facilitate specific binding of single-stranded 
DNA molecules within the symmetric homotetrameric protein complex. The ssDNA bound 
traverses an internal, intersubunit tunnel system in the apeThermoDBP-RP2 tetramer. This 
mode of binding ssDNA is unique and distinguishes apeThermoDBP-RP2 from canonical SSBs 
binding ssDNA via interactions on the outside of the ssDNA-binding domain.  
The loss of a canonical SSB in this particular group of Crenarchaeota, having acquired 
special SSBs to protect single stranded stretches of DNA in an intersubunit tunnel system, may 
have been a necessity to adapt to the particularly challenges in the living environment of these 
hyperthermophilic organisms. 
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9.4 Paper 4⏐Structure of the Bacillus subtilis 70S ribosome reveals the 
basis for species-specific stalling 
 
Daniel Sohmen, Shinobu Chiba, Naomi Shimokawa-Chiba, C. Axel Innis,  
Otto Berninghausen, Roland Beckmann, Koreaki Ito & Daniel N. Wilson 
 
Nature communications 6, 6941 (2015) 
 
To uncover the structural basis of MifM dependent translational stalling and to provide insight 
into the species specificity of MifM arrested translation, a B. subtilis MifM-SRC was 
reconstructed from 305,045 electron microscopy single particle images (cryo-EM) at a 
resolution of 3.5-3.9Å. Prior to generating a homogeneous MifM-SRC sample suitable for 
single particle analysis, a cell-free B. subtilis in vitro translation system had to be developed. 
The final reconstruction allowed the first 70S ribosome model of a Gram-positive bacterium to 
be built. Density for the nascent peptide chain, observed throughout the entire length of the 
ribosomal exit tunnel allowed modelling of the MifM arrest peptide, localizing the three pairs of 
MifM residues critical for stalling (Ito et al., 2010), at the sites of contact with components of 
the ribosomal tunnel - the constriction, the β-hairpin of L22 and H50 at the tunnel exit. 
Subsequent analysis of sequence and structure conservation of the ribosomal tunnel components 
between B. subtilis and E. coli identified a number of amino acid exchanges between B. subtilis 
and E. coli L22, suggesting L22 as one of the determinants for species specificity. Genetic 
replacement of the B. subtilis L22 β-hairpin with the corresponding sequence from E. coli 
strongly reduced stalling on a MifM-LacZ reporter. Strikingly, reverting a single amino acid 
(K90M) in the sequence of the β-hairpin of L22 from E. coli (K90) back to B. subtilis (M90) 
was shown to be sufficient to restore stalling, thereby identifying M90 of L22 as a key 
determinant for species specificity of MifM stalling. Comparison of the conformation of 
nucleotides of the MifM-SRC PTC with the PTC in different states of peptide bond formation 
(Schmeing, Huang, Kitchen, et al., 2005; Schmeing, Huang, Strobel, et al., 2005; Schmeing et 
al., 2002; Voorhees, Weixlbaumer, Loakes, Kelley, & Ramakrishnan, 2009) showed that the 
defined conformation of MifM residue E87 close to the PTC stabilises the uninduced state of 
the PTC by sterically preventing nucleotides U2506 and U2585 from adopting their induced 
conformational states, thereby inhibiting peptide bond formation by preventing accommodation 
of the incoming A-tRNA. 
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9.5 Paper 5⏐Structural basis for targeting and elongation arrest of 
Bacillus signal recognition particle 
 
Bertrand Beckert, Alexej Kedrov, Daniel Sohmen, Georg Kempf, Klemens Wild, 
Irmgard Sinning, Henning Stahlberg, Daniel N. Wilson and Roland Beckmann 
 
Unpublished manuscript (2015) 
 
Signal sequence recognition of the nascent peptide on the ribosome by the signal recognition 
particle (SRP) results in co-translational targeting of membrane and secretory proteins to the 
protein conducting channel (Akopian, Shen, Zhang, & Shan, 2013; Halic & Beckmann, 2005; 
Nyathi, Wilkinson, & Pool, 2013). The mammalian and the “long-type" SRP of Gram-positive 
bacteria (Larsen & Zwieb, 1991; Struck, Vogel, Ulbrich, & Erdmann, 1988) can be divided into 
two functional domains: The S domain which recognizes the signal sequence while the 
interaction of the Alu domain with the ribosome imposes an elongation arrest/slow-down by 
blocking the elongation factor binding site (Halic et al., 2004; Halic, Gartmann, et al., 2006; 
Mason, Ciufo, & Brown, 2000; Powers & Walter, 1997; Siegel & Walter, 1985; Walter & 
Blobel, 1981). However, interaction of the bacterial Alu domain (Rosenblad, Larsen, 
Samuelsson, & Zwieb, 2009; Zwieb & Bhuiyan, 2010) with the ribosome has been shown to be 
different from the mammalian in many ways (Kempf, Wild, & Sinning, 2014). 
To characterise the prokaryotic SRP/ribosome interaction an SRP-RNC “targeting 
complex” was assembled from reconstituted Bacillus subtilis (B. sub) SRP and stalled B. sub 
ribosomes exposing a signal sequence. Next, based on our 3D reconstruction of this B. sub SRP-
RNC “targeting complex” by cryo-EM and single particle analysis, the complete molecular 
model of the B. sub SRP bound to the ribosome could be constructed, reaching from the 
ribosomal tunnel exit site to the translation factor binding site. The S domain of the B. sub SRP, 
located at the tunnel exit was found to be structurally similar to the S domain of the E. coli SRP 
bound to the ribosome (Batey, Rambo, Lucast, Rha, & Doudna, 2000; Halic & Beckmann, 
2005; Wild, Halic, Sinning, & Beckmann, 2004) with the rod like density of the signal anchor 
accommodated in the open conformation of the M domain of SRP54 (Halic, Blau, et al., 2006; 
Janda et al., 2010; von Loeffelholz et al., 2015). 
Furthermore, our structure revealed that the B. sub SRP Alu domain almost exclusively 
interacts with the large ribosomal subunit via RNA:RNA interactions contacting the ribosomal 
stalk base and the α-sarcin-ricin loop in the factor binding site. In comparison, the Alu domain 
of the mammalian SRP, based on the interpretation of our additional cryo-EM reconstruction of 
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the mammalian ribosome “targeting complex” (this study) (Halic et al., 2004; Halic, Gartmann, 
et al., 2006) assembled from Canis familiaris SRP and stalled Triticum aestivum ribosomes, 
only shows interactions with the ribosome via protein:RNA contacts. Thereby, the mammalian 
SRP Alu RNA contacts uL11 above the stalk base on the large ribosomal subunit.  
Moreover, the mammalian Alu domain establishes additional contacts with the small 
ribosomal subunit RNA via the mammalian-specific SRP9/14 protein heterodimer, which is 
absent in B. sub. Yet the unique structure of the B. sub SRP Alu RNA domain allows multiple 
interactions with the stalk base helices H43 and H44 as well as the SRL, stabilized by additional 
interactions with uL11 Pro22 and the C-terminal end of uL6. Thus, the entire B. sub Alu domain 
acts as a “dock and lock” system in which the translation factor binding site of the ribosome is 
locked temporarily in order to slow down the translation machinery for efficient and proper 
targeting to a membrane translocation site. 
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10 Discussion 
 
10.1 Paper 1⏐Proteomic Characterization of Archaeal Ribosomes 
Reveals the Presence of Novel Archaeal-Specific Ribosomal Proteins 
 
Viter Márquez, Thomas Fröhlich, Jean-Paul Armache, Daniel Sohmen, Alexandra 
Dönhöfer, Aleksandra Mikolajka, Otto Berninghausen, Michael Thomm, Roland 
Beckmann, Georg J. Arnold and Daniel N. Wilson 
 
Journal of Molecular Biology 405, 1215–1232 (2011) 
 
The archaeal ribosomal proteome shows considerable heterogeneity across the archaeal domain 
of life. Analyses of archaeal genomes implicate that Archaea have undergone progressive loss 
of ribosomal proteins (r-proteins) as part of a reductive evolution of their translation apparatus 
(Lecompte et al., 2002). Within the archaeal domain, Crenarchaeota still contain the highest 
number of r-proteins, while genome analyses show a gradual reduction of the number of r-
proteins within the phylum of the Euryarchaeota (Lecompte et al., 2002). Comparison with 
ribosomal proteomes from Bacteria and Eukarya shows that the r-proteins (excluding the 
archaeal-specific r-protein LXa) that have been lost in Archaea are also absent in Bacteria but 
are found in a wide range of Eukarya (Fujita, Baba, & Isono, 1998; Kenmochi et al., 1998; 
Uechi, Tanaka, & Kenmochi, 2001). The presence of these r-proteins in early divergent 
representatives of Eukarya and Archaea suggests their existence in the common ancestor of both 
domains in a more complex ribosome, emphasizing the need for experimental study of the 
archaeal ribosome to understand the evolution of the ribosome and the development of r-protein 
functions. 
Analyses of the ribosomes from the Crenarchaeota species Pyrobaculum aerophilum (P. 
aero) and Sulfolobus acidocaldarius (S. acid) by 2D PAGE and MS led to the discovery of three 
new r-proteins: L45a-47a. Their phylogenetic range, revealed by homology searches showed 
homologues of L45a and L47a in all known species of the Sulfolobales and homologues of L46a 
in all but one species of the Thermoprotei genera (this study) (Yutin et al., 2012), while no 
sequence homology to other known proteins was indicated. The NMR structure of an L46a 
homologue from Sulfolobus solfataricus P2 in solution, determined by Feng et al. (Feng et al., 
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2014), revealed a novel protein fold and a conserved potential rRNA-binding site of L46a. 
However, neither computational	   searches	   for	   structural	   homologues	   could	   identify	   such	  
structural	  homologues	  convincingly,	  nor	  did	  L46a’s	  structural	  features	  relate	  to	  structural	  
similar	  proteins	  and	  their	  function.	  Efforts to localize the new r-proteins within the volume of 
the 50S ribosomal subunit from S. acid, reconstructed by cryo-EM single particle analysis, led 
to ambiguous results due to the limited resolution of the reconstruction.  
Reproducible appearance of L7ae (L8e) and S24e in preparations of both the small and 
the large subunits of Sulfolobus acidocaldarius were discussed as to hint to a possible 
promiscuous interaction of the proteins with both ribosomal subunits. However, unambiguous 
assignment of density for additional copies of L7ae (L8e) or S24e was again not possible due to 
the limited resolution and the lack of small ribosomal subunit in the reconstruction. One 
impediment for studies of many archaeal ribosomes is the lack of protocols for the purification 
of 70S ribosomal particles. Ribosomes from species from the phylum of the Crenarchaeota, 
using common bacterial buffer systems, show a strong tendency to dissociate into subunits 
during preparation. The development of protocols specifically designed for the preparation of 
70S ribosomal particles from different archaeal species would be desirable in order to improve 
future possibilities to study whole archaeal ribosomal complexes. In addition, 50S ribosomal 
particles have been found to be a less optimal sample for cryo-electron microscopy single 
particle analysis, limiting the resolution of the reconstruction. 
Armache	   et	   al.	   (Armache et al., 2013) later indeed discovered promiscuous inter- and intra-
subunit binding of archaeal r-proteins and identified secondary binding sites for L7ae (L8e) and 
S24e on the small and the large subunit, respectively. Unambiguous localisation of proteins was 
thereby made possible due to the 3D ribosomal reconstructions of the 70S ribosomal particle 
from the Euryarchaeota Thermococcus kodakarensis and Methanococcus igneus and the 50S 
large subunit of the Crenarchaeota Staphylothermus marinus. Their interpretation by the atomic 
model of the Pyrococcus furiosus ribosome (Armache et al., 2013) based on a 3D reconstruction 
at 6.6Å resolution (Becker et al., 2012) enabled Armache et al. to model protein domains.  
Together these findings highlight the importance of studying the archaeal ribosome helping to 
understand the evolution of the ribosome and the development of r-protein functions (Matte-
Tailliez, Brochier, Forterre, & Philippe, 2002). In particular structures of higher resolution will 
be of importance to a mechanistic understanding of the structure/function relations of yet 
unknown, non-canonical, ancient or lost r-proteins in the context of the modern ribosome. 
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10.2 Paper 2⏐Amythiamicin D and Related Thiopeptides as Inhibitors 
of the Bacterial Elongation Factor EF-Tu: Modification of the Amino 
Acid at Carbon Atom C2 of Ring C Dramatically Influences Activity 
 
Stefan Gross, Fabian Nguyen, Matthias Bierschenk, Daniel Sohmen, Thomas Menzel, 
Iris Antes, Daniel N. Wilson, and Thorsten Bach 
 
ChemMedChem, 8, 1954–1962 (2013) 
 
Three analogues (compounds 3a-3c) of the naturally produced thiopeptide antibiotic 
amythiamicin D, which could not be obtained by any other method, have been made available 
by de novo total synthesis. The hydroxymethyl derivative (compound 3a) showed enhanced 
inhibitory activity, compared to its parent compound, on translation in an E. coli based in vitro 
translation assay, suggesting the introduced hydroxyl group at R1 to contribute to improved 
binding of the synthetic compound to its target. Although the target of amythiamicin D in the 
bacterial cell is unknown, strong evidence from in vitro translation and rescue experiments is 
provided for the drug to inhibit the translation cycle by inhibition of the bacterial elongation 
factor Tu (EF-Tu), the established target of the structurally closely related antimicrobial 
compound GE2270A (Anborgh & Parmeggiani, 1991). Similarly, as suggested for compound 
3a, GE2270A forms a hydrogen bond with its hydroxyl group corresponding to the hydroxyl 
moiety introduced in compound 3a and the side chain of D216 of EF-Tu, contributing to target 
binding (Parmeggiani, Krab, Okamura, et al., 2006). Therefore, in the absence of structural 
studies verifying the binding mode of amythiamicin D or its derivatives to EF-Tu, (though 
preliminary NMR experiments of the free compounds in combination with in silico docking 
experiments by molecular dynamics simulations were performed) additional translation 
experiments in the presence of D216A mutant EF-Tu (Doi, Ohtsuki, Shimizu, Ueda, & Sisido, 
2007) could help to evaluate the proposed contribution of the hydroxyl moiety of compound 3a 
to its binding to EF-Tu and its inhibitory activity. 
On the other hand, compounds 3b and 3c were found to be completely inactive, 
showing no translation inhibition activity even at high concentrations. Inactivity of 3b is thereby 
most likely due to a significantly changed ring conformation caused by the changed stereogenic 
center at R1, abrogating a bridge like hydrogen bond across the large cyclic structure. In 
compound 3c, the ring structure resembles that of amythiamicin D, however, the relatively large 
addition of the benzyloxymethyl (BOM) group at R1 seems to prevent stable binding to EF-Tu. 
Unstable binding was indicated by the preliminary NMR experiments of the free compound in 
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combination with molecular dynamics simulations and in silico docking experiments, though 
binding of the BOM group to EF-Tu was in principle not excluded due to a number of charged 
and polar side chains within the proposed binding area of the group.  
Although compound 3a showed enhanced inhibitory activity in cell free in vitro 
translation experiments, its potency to inhibit growth of live cells was diminished by two- to 16-
fold compared to amythiamicin D (for the bacterial strains tested). This reduction in growth 
inhibition activity is possibly due to the introduced, negatively charged group, reducing the 
drug’s propensity to cross the bacterial cell membrane, thereby emphasising that, next to target 
specificity and binding properties, also properties like cell membrane permeability, solubility 
and stability can affect a compound activity and should be considered in the experimental setup 
and for the design of derivative compounds (Bolla et al., 2011).  
The total de novo synthesis of compounds not only allows examining the effect of 
various particular substitutions, but also can give access to certain parts and precursor 
compounds of the drug, which can help to dissect the drug’s mechanism of action and to 
characterise the contribution of its different parts to its activity. Access to precursors can also 
provide the means to identify potential lead compounds for the development of novel 
therapeutics (Starosta et al., 2009). In addition, some precursor compounds screened by Starosta 
et al. (Starosta et al., 2009) showed the ability to bind both EF-Tu and the ribosome, suggesting 
the feasibility of developing antimicrobial drugs with dual inhibitory activity. Such innovative 
compounds would make it much less likely for bacteria to develop spontaneous resistance by 
acquiring mutations.  
Furthermore, the combination of chemical synthesis and structure-aided design of 
complex compounds based on the number of crystal (D.N. Wilson, 2014), and most recently 
cryo-EM structures (Arenz, Meydan, et al., 2014; Arenz, Ramu, et al., 2014; Wong et al., 2014) 
of antibiotics bound to their drug target, could help to develop semi-synthetic compounds with 
improved antimicrobial properties (Fischbach & Walsh, 2009). For example, it has been 
suggested to construct a chimeric antibiotic compound with increased binding affinity to EF-Tu 
consisting of the head moiety of enacycloxin IIa and the tail moiety of kirromycin 
(Parmeggiani, Krab, Watanabe, et al., 2006) based on their crystal structures bound to EF-Tu 
that have been solved previously (Parmeggiani, Krab, Watanabe, et al., 2006). Although, one 
drawback of compounds, which have been derived from naturally occurring antibiotics, can be 
that they are likely to be, at least partially, structurally similar to existing antibiotics, and they 
could, therefore, easily encounter bacteria that already possess a resistance or that could rapidly 
adapt to become resistant. Therefore, it is important to look at known resistance mechanisms to 
design effective compounds with a reduced risk of resistance onset by microorganisms. 
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Moreover, to not only avoid early onset of resistance but to even overcome bacterial resistance 
it would be necessary to design compounds which are effective against mutants already 
conferring resistance. In some cases, such compounds, so-called “resistance breakers”, 
administered in combination with the mother compound can actually restore the antimicrobial 
activity of the mother compound (Tan, Tillett, & McKay, 2000). This is known as phenotypic 
conversion. 
 Taken together, the total de novo synthesis of non-natural antibiotics, like the 
amythiamicin D derivatives and especially the construction of compound 3a with altered 
biochemical and physiochemical properties provide tools and starting points for future studies 
trying to understand the characteristics of various substitutions or alterations which build the 
foundation for the successful development of new derivatives of antimicrobial compounds. 
 
10.3 Paper 3⏐Entrapment of DNA in an intersubunit tunnel system of 
a single-stranded DNA-binding protein 
 
Homa Ghalei, Holger von Moeller, Detlef Eppers, Daniel Sohmen, Daniel N. Wilson, 
Bernhard Loll and Markus C. Wahl 
 
Nucleic Acids Research, 42, 6698–6708 (2014) 
 
The single-stranded DNA-binding proteins (SSB) based on the oligonucleotide-binding fold 
(OB-fold) are considered ubiquitous in nature and essential for genome maintenance 
(Mushegian & Koonin, 1996). However, it was discovered that thermoproteales, a clade of 
hyperthermophilic Crenarchaeota, lack canonical SSBs. Instead, they encode a distinct ssDNA-
binding protein termed ThermoDBP (X. Luo et al., 2007; Paytubi et al., 2012). Furthermore, 
two related groups of proteins, termed ThermoDBP related proteins (ThermoDBP-RP) 1 and 2, 
showing a wider phylogenetic range have been found to co-exist with ThermoDBPs and/or 
other SSBs. ThermoDBP-RPs share the ThermoDBP N-terminal oligonucleotide-binding 
domain (NTD), but their function remains elusive. 
Rbp18 from Sulfolobus solfataricus P2 (S. solfa), belonging to the group of 
ThermoDBP-RP1 proteins, was first purified by Ciammaruconi et al. (Ciammaruconi et al., 
2008) from cell lysates via biotinylated oligonucleotides complementary to S. solfa box C/D 
sRNAs. Ciammaruconi et al. also found Rbp18 to be associated with the small subunit of the S. 
solfa ribosome. In their experiments Rbp18 protein remained stably associated with the 
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ribosomal subunit even after high salt treatment either with 2 M NH4Cl, 2 M KCl or 0.5 M LiCl 
before sucrose gradient density separation, suggesting Rbp18 to be part of a ribonucleoprotein 
(RNP) complex and the ribosome.  
However, the homologous ThermoDBP-RP protein from Thermoproteus tenax (T. 
tenax) could neither be enriched by biotinylated oligonucleotides from T. tenax cell lysate 
(Paytubi et al., 2012) nor was a ThermoDBP-RP protein found to be present in the ribosomal 
proteome of Sulfolobus acidocaldarius ribosomes (Marquez et al., 2011). Further, in our 
experiments, binding of recombinantly expressed ThermoDBP-RP1 or 2 from Aeropyrum 
pernix and Pyrococcus furiosus, respectively, only showed a weak, salt-sensitive interaction 
with ribosomal particles from Thermococcus kodakarensis or its ribosomal subunits, indicating 
rather unspecific binding of the proteins. Further, binding of pfuThermoDBP-RP1 to box C/D 
sRNAs in vitro was efficiently competed by the presence of E. coli tRNA also indicating 
sequence unspecific binding. 
The apo-crystal structure of the Pyrococcus furiosus ThermoDBP-RP1 
(pfuThermoDBP-RP1) presented in our paper revealed that the orientation of the N-terminal 
oligonucleotide-binding domain within the pfuThermoDBP-RP1 homotetramer, relative to the 
C-terminus, does not allow oligonucleotide binding, as shown by comparison with the crystal 
structure of the truncated NTD from the homologous ThermoDBP-RP1 protein from 
Thermoproteus tenax (tteThermoDBP-RP1, Ttx1576) (Paytubi et al., 2012). Therefore, it can be 
speculated that the C-terminus of pfuThermoDBP-RP1 exhibits an auto-inhibitory function that 
blocks the nucleic acid binding site. Additional factors interacting with pfuThermoDBP-RP1 
protein might be necessary to induce a structural rearrangement to expose the oligonucleotide-
binding surface of the protein to allow amino acid binding.  
The previously found interaction of S. solfa ThermoDBP-RP1’s (Rbp18) with box C/D 
sRNA suggests it to be part of an RNP complex (Ciammaruconi et al., 2008). Thus, binding to 
the RNP complex might provide additional interactions necessary to induce an active 
conformation of the protein, but no interaction with proteins involved in RNP complex 
formation (Nop56, Nop58, fibrillarin) could be confirmed (Ciammaruconi et al., 2008). 
However, it should be mentioned that aL7ae, a protein known to interact with the RNP 
complex, could also not be found interacting with components of the RNP complex in the 
experimental setup (Ciammaruconi et al., 2008). Therefore, taken together, it still remains 
unclear whether ThermoDBP-RP1 proteins can functionally interact with box C/D sRNAs, 
RNPs or the ribosome.  
Expression and purification of the pfuThermoDBP-RP1 NTD alone was not feasible, 
but based on the crystal structure, different C-terminal truncated mutants and mutants defective 
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in tetramer formation of pfuThermoDBP-RP1 could be designed to verify the postulated auto 
inhibition and to identify pfuThermoDBP-RP1 substrates. 
In contrast to pfuThermoDBP-RP1, we could show that Aeropyrum pernix 
ThermoDBP-RP2 (apeThermoDBP-RP2) protein binds ssDNA with high selectivity over 
ssRNA, dsDNA or dsRNA in vitro. Further, we found that apeThermoDBP-RP2 binds to 
circular ssDNA lacking free termini, suggesting that apeThermoDBP-RP2 could act as a SSB 
for example involved in recombination or DNA repair. The crystal structure of apeThermoDBP-
RP2 we present revealed that nucleic acid binds to a symmetric apeThermoDBP-RP2 
homotetramer in a unique way. While other known SSBs bind ssDNA on their surface or along 
a channel in the oligonucleotide-binding domain, ssDNA bound to apeThermoDBP-RP2 is 
found to traverse an internal, intersubunit tunnel system of the ThermoDBP-RP2 homotetramer. 
These findings indicate a function of ThermoDBP-RP2 to maintain and to protect ssDNA in its 
single-stranded state from thermal and other types of stress in the particular challenging living 
conditions of many archaea. This is also explaining the requirement for such specialized SSBs 
to have evolved in extremophile archaea species. Although, while these results suggest that 
ThermoDBP-RP2 proteins can function as SSBs in vitro, a similar activity in vivo remains to be 
demonstrated. 
 
10.4 Paper 4⏐Structure of the Bacillus subtilis 70S ribosome reveals 
the basis for species-specific stalling 
 
Daniel Sohmen, Shinobu Chiba, Naomi Shimokawa-Chiba, C. Axel Innis,  
Otto Berninghausen, Roland Beckmann, Koreaki Ito & Daniel N. Wilson 
 
Nature Communications 6, 6941 (2015) 
 
In contrast to other stalling sequences, amino acids critical for stalling of MifM reside at 
positions starting from -8 to further upstream of the first arrest site (Chiba et al., 2009). In the 
stalled complex, the invariant N81 and M80 of MifM, at the positions -8 and -9, respectively, 
localize at the constriction in between the tip of the β-hairpin of L22, R66 of L4 and A751 of 
the 23S rRNA, suggesting such interaction with the constriction to make a major contribution to 
the peptide arrest. Consistent with this, we find the electron density for the nascent chain at the 
constriction to be well resolved and the contact to A751 to be one of the strongest fusions of 
density between the tunnel wall and MifM. M90, localized at the tip of the β-hairpin of L22, has 
10  Discussion 49 
been identified as being of critical importance for MifM stalling. In addition, it is considered a 
key determinant for species specificity, albeit contacts at the tip of the β-hairpin with the 23S 
rRNA are conserved between E. coli and B. subtilis (besides a possible M-sulfur aromatic 
interaction between the side chain of M90 and G748 of the 23S rRNA). Furthermore, no direct 
contact between MifM and L22 is observed at the constriction, suggesting that the identity of 
the amino acid at position 90 of L22 indirectly influences the interaction of MifM with A751, 
possibly through its interaction with G748 or via backbone interaction with the phosphate group 
of A751. Interaction with the rRNA at the constriction, especially with the 750-loop, has been 
shown previously to be important for stalling translation of E. coli SecM and TnaC: Nucleotide 
insertion into the 750-loop of the 23S rRNA eliminates translation arrest on both peptides (L. 
Cruz-Vera, Rajagopal, Squires, & Yanofsky, 2005; L. R. Cruz-Vera, New, Squires, & 
Yanofsky, 2007; Nakatogawa & Ito, 2002) and mutation of A752 to C or T reduces stalling on 
TnaC (L. R. Cruz-Vera et al., 2007). Bischoff et al. (Bischoff et al., 2014) found a coordinated 
tryptophan close to the constriction, in concert with the nascent chain, to stabilize an A752 base 
pair interaction with U2609 as part of a proposed potential relay mechanism involved in PTC 
inactivation. Prospective mutation studies of the 750-loop region in B. subtilis could help to 
further elucidate the details of the interaction of the β-hairpin of L22 with the 750-loop region 
of the 23S rRNA and its particular contribution to stalling. Thus, consistent with MifM 
interacting with the ribosome in a species-specific manner (Chiba et al., 2011), stalling with 
high efficiency only on ribosomes of the homologous species, B. subtilis, replacing the β-
hairpin of B. subtilis L22 with the corresponding sequence from E. coli L22 led to a drastic 
reduction in stalling efficiency of MifM. Solely reverting E. coli K90 back to M90 as in B. 
subtilis L22 almost completely restored stalling efficiency of MifM, disclosing it contributing to 
the species specificity of MifM stalling. On the contrary, it is still unknown whether mutation of 
position 90 in E. coli L22, or replacing the β-hairpin of E. coli L22 with the corresponding 
sequence from B. subtilis L22 can alter the stalling efficiency of E. coli ribosomes on MifM. 
Such further mutational studies of chimeric ribosomes on a heterologous species could reveal 
further determinants of the species specificity and its molecular mechanism. 
The finding that amino acids critical for MifM elongation arrest are only found further 
upstream of the PTC is accompanied by the finding that translation on MifM can stall the 
ribosome at more than one stall site. Ribosomes stalled from D89 can spontaneously resume 
elongation by one amino acid to the next stall site (Chiba & Ito, 2012). This unique mode of 
multisite stalling, spanning four consecutive stall sites (89DAGS92), has been shown to be 
dependent on the presence of a conserved cluster of acidic amino acids (86DEED89) including 
the first stall site. However, multiple residues within the DEED motif have to be converted to A 
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to abolish stalling completely (Chiba & Ito, 2012), displaying the functional plasticity of the 
region including E87. 
Inspection of our cryo-EM structure revealed the presence of a post-initiation SD-like 
helix (Yusupova, Jenner, Rees, Moras, & Yusupov, 2006) formed between the MifM mRNA 
and the 5’ end of the 16S rRNA. Internal SD-like sequences within the coding region of 
mRNAs have been reported before to induce translational pausing in bacteria (Li, Oh, & 
Weissman, 2012). Since breaking of the SD-like helix is slow, such interaction within the MifM 
stalled ribosome structure should be discussed as a possible contributor to regulation of 
multisite stalling. It was also previously shown that a single nucleotide insertion within the 
MifM leader peptide mRNA, which introduces a frame shift from before the amino acid at 
position -12, and thereby abrogates critical interactions of MifM with the ribosome at the 
constriction, abolishes translational stalling (Chiba et al., 2009). This finding indicates that the 
presence of the SD-like helix alone is insufficient to induce pausing. To test the contribution of 
the observed 16S rRNA/mRNA interaction to the regulation of multisite stalling of MifM, 
mutations within the mRNA from three codons upstream of the D89 stall site codon in the P-
site, altering the 16S rRNA/mRNA interaction without abrogating critical interactions of MifM 
with the ribosome, could be a starting point to separate the contribution of the SD-like helix to 
the regulation of multisite stalling.  
Since the aforementioned multiple translational stalling at four different sites would 
lead to non-homogeneity of the sample and therefore pose a limit to obtain high resolution in 
cryo-EM, the MifM ribosomal complex in our structure was designed to be homogeneously 
stalled at D89. Here, E87 has been found in a position incompatible with the induced state of the 
ribosome, preventing A-tRNA accommodation. To allow A-tRNA accommodation U2585 (E. 
coli numbering is used) has to rotate by 19°. Together with U2585, U2506 has to shift to avoid a 
steric clash with U2585. The side chain of E87 is found in a position that is incompatible with 
both movements, thereby interfering with the induced state of the PTC and consequently 
preventing A-tRNA accommodation. In contrast, in the PTC of the high-resolution cryo-EM 
structure of the TnaC stalled ribosome (Bischoff et al., 2014) nucleotides U2585 and A2602 
adopt conformations incompatible with productive binding of RF2, while an aminoacyl-tRNA 
in the A-site would not clash with the observed conformation of U2585 or A2602. This 
interpretation of the structure is thereby corroborated by the finding that placing a sense codon 
in the A-site can alleviate TnaC stalling (L. R. Cruz-Vera, Gong, & Yanofsky, 2006; Martinez 
et al., 2014). Within the structure of the MifM ribosomal complex, nucleotide A2602 is also 
found in a position incompatible with productive docking of the release factors as well as A-
tRNA accommodation, thereby explaining the previously observed behaviour of the MifM-
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stalled ribosomal complexes to inhibit translation at the step of termination as well as peptide 
bond formation (Chiba & Ito, 2012). Further, A2602 seems to be one of the major determinants 
of the ErmCL stalled ribosome interfering with A-tRNA accommodation, while the positions of 
nucleotides U2585 or U2506 in the ErmCL stalled ribosome do not obviously interfere with A-
tRNA binding (although U2585 is definitely found in an extreme position) (Arenz, Meydan, et 
al., 2014). 
With respect to multisite stalling in MifM, it can be speculated that in an E87A mutant 
background the role of E87 in blocking the induced state of the PTC would be resumed by the 
following E88, stalling the ribosome on the consecutive stall site. This scenario could indeed 
explain multisite stalling for the first three consecutive stall sites, assuming a compaction of the 
nascent chain in the upper part of the tunnel. While for stalling at S92, the side chain of A90 at 
the -2 position is unlikely to interfere with the induced state of the PTC and A-tRNA 
accommodation. However, without determining further structures of individual mutant MifM-
SRCs, it will be difficult to validate this theoretical scenario. Interestingly, it has been 
demonstrated that the bacterial secretion monitor (SecM) and the eukaryotic arginine attenuator 
peptide (AAP) also have the unusual property of interfering with PTC function, stalling 
ribosomal translation across a window spanning at least four consecutive codons (Tsai, 
Kornberg, Johansson, Chen, & Puglisi, 2014; Wei, Wu, & Sachs, 2012). However, why arrest 
peptides with multiple consecutive stall sites have evolved still poses questions. It can be 
speculated that RAPs might use multisite arrest as a strategy to attain a stalling duration 
sufficient for the target gene expression and therefore include time as another variable for 
translation regulation. 
 The rapidly developing method of cryo-EM has, especially lately, enormously 
contributed to the understanding of several arrest-peptides and their underlying molecular 
stalling mechanisms. Even though our cryo-EM structure, supported by biochemical data, can 
already provide an insightful basis for comprehending the MifM stalled ribosome and its 
regulation, we can only reveal a snapshot of the stalling event. Why nature has chosen such 
mode of regulation for the membrane protein biogenesis factor YidC2 and therefore high 
efficiency stalling in a species-specific manner still requires further investigation. Moreover, the 
extend to which the SD interaction contributes to translational stalling or if stalling is induced 
similarly at the three additional stalling sites are only a small selection of the questions which 
remain to be elucidated. 
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Unpublished manuscript (2015) 
 
The presented 3D reconstruction of the B. sub SRP-RNC “targeting complex” from cryo-EM 
data, collected using a conventional CCD detector resulted in a reconstruction of ~7Å 
resolution. The volume shows continuous ligand density that allowed the complete molecular 
model of the B. sub SRP to be built. However, further attempts to obtain a higher resolved 
structure using data collected on K2 Summit and Falcon 2 direct electron detectors did not 
reveal any further details of the ligand. Instead, only weakly represented density for SRP was 
present in the reconstructions, although the overall resolution of the ribosome could be 
improved by ~2Å. The weak density for SRP could also not be attributed to different sub-states 
of the ligand, as further computational sorting failed, suggesting an intrinsic flexibility of 
ribosome bound SRP. Inspection of the density and local resolution determination of the 
structure further revealed that within the structure the local resolution for the S domain is lower 
(reflecting its higher flexibility) than for the Alu domain, although high affinity binding to the 
ribosomal complex has been shown to be dependent on interactions with the S domain (Lutcke, 
High, Romisch, Ashford, & Dobberstein, 1992; Romisch, Webb, Lingelbach, Gausepohl, & 
Dobberstein, 1990). Flexibility of the S domain of SRP has already been observed before in 
cryo-EM reconstructions of the SRP receptor-SRP “docking complex” (Estrozi, Boehringer, 
Shan, Ban, & Schaffitzel, 2011; Halic, Gartmann, et al., 2006; von Loeffelholz et al., 2015) as 
well as for the free state of the SRP core (Rosendal, Wild, Montoya, & Sinning, 2003). The 
flexibility of the SRP S domain is thereby provided via a flexible hinge region in the SRP RNA 
and the flexible domain architecture of Ffh (Rosendal et al., 2003), uncoupling Alu and S 
domain. It can be assumed that the flexibility of the S domain is important for SRP function, 
enabling SRP to interact with a variety of substrates (Noriega et al., 2014; Walter, Ibrahimi, & 
Blobel, 1981) and to adapt to structural changes of the complex when adopting different states 
in the SRP cycle to successfully engage the translocon (Halic & Beckmann, 2005). Additional 
high-resolution X-ray and cryo-EM structures of the SRP-RNC complex in different functional 
states should provide the missing details of the structural rearrangements within SRP and the 
ribosome during the SRP cycle. 
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The SRP Alu domain, upon signal sequence recognition, locates in a defined space at 
the ribosomal subunit interface, thereby blocking the factor binding site, imposing elongation 
arrest. In higher eukaryotes, the Alu domain comprises the 5′ and 3′ extremities of the SRP 
RNA bound to the SRP9/14 heterodimer. SRP9/14 stabilize the complex fold of the Alu RNA 
and contribute to ribosome binding by interacting with the small ribosomal subunit (Halic et al., 
2004; Weichenrieder et al., 2001; Weichenrieder, Wild, Strub, & Cusack, 2000). However, 
homologues of SRP9/14 have not been found in archaeal or bacterial (Andersen et al., 2006). 
The DNA-binding protein HU1 has been suggested to interact with the B. sub Alu domain 
(Nakamura, Yahagi, Yamazaki, & Yamane, 1999; Yamazaki, Yahagi, Nakamura, & Yamane, 
1999). HU1 was found to bind to B. sub SRP RNA in vitro and was also found associated with 
the SRP RNA after immunoprecipitation of HU1 from cell lysates (Nakamura et al., 1999). 
Further, its functional interaction with the protein sorting machinery was suggested: Depletion 
of HU1 from the cell led to the upregulation of the intracellular SRP RNA level and to 
accumulation of secretory protein precursors indicating defective translocation (Yamazaki et al., 
1999). Yet, in contrast to the previously published results, in our case HU1 did neither bind to 
B. sub SRP RNA during in vitro reconstitution, nor was it found in in vivo pullouts. 
Consequently, we do not consider HU1 to be part of the B. sub SRP. Further support for this 
assumption comes from the recently solved crystal structures of the complete B. subtilis Alu 
domain (Kempf et al., 2014) and the chimeric Alu domain of the archaea Pyrococcus hirokoshii 
together with human SRP9/14 (Bousset et al., 2014). The detailed interpretations of both 
structures showed that extra RNA sequences at the SRP RNA 5′ and 3′ ends form an additional 
helix (H1) in the Alu domain, which stabilizes the closed conformation of the Alu domain 
instead of SRP9/14. Further, the B. sub SRP was found fully folded and stably bound to the 
ribosome in our reconstruction. Noteworthy, the human SRP9/14 heterodimer was still able to 
bind to the Pyrococcus hirokoshii Alu domain in an essentially identical manner as observed 
previously in the structure of the human Alu domain (Weichenrieder et al., 2000). Our structure 
revealed that the B. sub SRP Alu domain binds to the ribosome in a similar manner to the 
mammalian Alu domain, blocking the elongation factor binding site. However, the B. sub Alu 
domain interacts with the ribosome via an entirely different set of interactions. The mammalian 
Alu domain interacts via the Alu RNA with uL11 on top of the stalk base on the large subunit 
and with h4/15 of the small subunit via SRP9/14, while the B. sub SRP Alu domain interacts 
with the ribosome mainly via RNA:RNA interactions with H43/H44 of the stalk base and the α-
sarcin-ricin loop (H95) of the large subunit. Therefore, although the fold and the structure of the 
Alu RNA have been conserved, it appears that the mammalian and the bacterial Alu domain 
have developed distinctive ways of interacting with the ribosome. Especially the interaction 
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with the small subunit via SRP9/14 found in the mammalian SRP might provide additional 
control over elongation factor independent, intrinsic intersubunit movements of the ribosome. A 
posing question that could be addressed in future studies using single particle FRET or related 
techniques.  
Interestingly, the common Alu domain RNA core resembles the structure of the 
canonical tRNA (Chang, Newitt, Hsu, Bernstein, & Maraia, 1997) and in several protozoa such 
as trypanosomes, a tRNA-like RNA has been found to be associated with a significantly 
reduced Alu domain suggesting a potential general evolutionary relationship of the Alu domain 
with tRNA (Beja, Ullu, & Michaeli, 1993; L. Liu et al., 2003). This could be one possible 
explanation why bacterial SRP interacts with the ribosome almost exclusively via RNA:RNA 
contacts. However, evolution and interaction of the Alu domain with the ribosome are still only 
poorly understood. A number of SRPs with phylogenetically shared divergent features and of 
variable composition have been identified by genomic analysis in all domains of life (Rosenblad 
et al., 2009; Zwieb & Bhuiyan, 2010). Additional reconstructions of distinct SRP-RNC 
complexes will help to better understand the evolution of the SRP-RNC interaction and its 
function in protein targeting.  
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Protein synthesis occurs in large macromolecular
particles called ribosomes (reviewed by Schmeing and
Ramakrishnan1). Ribosomes are composed of RNA
and proteins. In bacteria, the 70S ribosome can be split
into small (30S) and large (50S) ribosomal subunits.
Although the active sites of small and large subunits
responsible for decoding and peptide bond formation,
respectively, are composed predominantly of RNA,
the contribution of ribosomal proteins (r-proteins) is
not to be overlooked.2,3 At the decoding site, r-protein
S12 contributes to the fidelity of the codon–anticodon
interaction of the mRNA–tRNA duplex,4 whereas at
the peptidyltransferase center, the N-terminal exten-
sion of the r-protein L27 of bacterial ribosomes and the
loop of L10e in eukaryotic ribosomes contacts the
terminal CCA end of the P-site tRNA.5–8 R-proteins
comprise the tRNA binding sites, stabilizing their
interaction with and passage through the ribosome
during translation.8–13 Moreover, many r-proteins
play critical roles in facilitating various aspects of
translation ranging from biogenesis to recruitment of
translation factors and chaperones (reviewed by
Wilson and Nierhaus2 and Brodersen and Nissen3).
The Escherichia coli 70S ribosome contains 54 r-
proteins: 21 in the small subunit (S1–S21) and 33 in the
large subunit (L1–L36). R-proteins were originally
numbered according to their position on two-dimen-
sional (2D) PAGE; as a consequence, large acidic
proteins have small numbers, and small basic proteins
have large numbers.14 L7 is the N-acetylated version
of L12; L8 was later found to be the pentameric
complex of L10·(L7/L12)4; and L26 was later reas-
signed as S20. The genes for 48 of the 54 E. coli r-
proteins are present in the genomes of all bacteria,
whereas S1, S21, and S22 of the small subunit, as well
as L25 and L30 of the large subunit, are missing in
some bacteria. In fact, S22 associates with the
ribosome during stationary phase and is therefore
considered a ribosomal factor rather than a bona fide r-
protein. Chloroplast ribosomes have homologues to
all the E. coli r-proteins, except for L25 and L30, but in
addition have six plastid-specific r-proteins,15,16 one of
which (PSRP1) was subsequently shown to be a
ribosomal factor rather than an r-protein.17,18 Mito-
chondrial ribosomes are even more diverse, with 81 r-
proteins identified in the human mitochondrial 55S
ribosome, 33 r-proteins identified in the small subunit,
and 48 r-proteins identified in the large subunit.19–21
Proteomic analysis of eukaryotic ribosomes rang-
ing from yeast,22,23 fruit flies,24 and plants25 torodents26–28 and humans,29,30 together with genomic
analysis,31 has identified ∼78 r-proteins, 34 of which
have homologues in bacteria. In contrast, no sys-
tematic study cataloguing the protein composition of
archaeal ribosomes has been performed. Archaeal r-
proteins have been characterized individually (e.g.,
see Kimura et al.32 and Auer et al.33,34), leading to the
identification of archaeal-specific r-protein LX,35 or
collectively, using 2D-PAGE.36–39 However, assign-
ment of individual r-proteins by comparing 2D-
PAGE profiles with data obtained from E. coli
ribosomes is often ambiguous due to different
buffer/running conditions, as well as the increased
complexity of archaeal ribosomes. Genomic analysis
indicates that archaeal ribosomes are intermediate in
terms of composition between bacterial ribosomes
and eukaryotic ribosomes, containing up to 68 r-
protein families, of which 34 are common to bacteria
and eukaryotes, 33 are present in eukaryotes only,
and 1 (LX) is archaeal-specific.31 Ten of the r-protein
families exhibit a heterogeneous distribution within
archaea, with the ribosomes from Euryarchaeota
predicted to have fewer r-proteins than their
counterparts in Crenarchaeota (Fig. 1).31
Using 2D-PAGE and LC tandemmass spectrometry
(MS/MS), we identified all 66 r-proteins of the small
and large subunits of the thermophilic Pyrobaculum
aerophilum. In addition to all but two (62 of 64; 97%) r-
proteins of the Sulfolobus acidocaldarius small and large
subunits, we identified three hypothetical proteins
that are present in the thermoacidophilic S. acidocal-
darius large subunit. These proteins interact more
tightly with the large subunit than some integral r-
proteins, suggesting that they are bona fide r-proteins.
Cryo electron microscopy (EM) reconstructions of the
S. acidocaldarius and P. aerophilum 50S subunits
identified multiple potential binding sites for the
novel r-proteins. In fact, in total, nine hypothetical
proteins with pI values of N9 were identified within
the small and large ribosomal subunits of these two
Crenarchaeota, suggesting that the number of novel r-
proteins in archaeal species may far exceed the
predictions based on genomic analyses.
Results and Discussion
Near-complete proteomic characterization
of Crenarchaeota r-proteins
Since genomic analyses indicate that, compared to
Crenarchaeota, Euryarchaeota lineages appear to
Fig. 1. Heterogeneous distribution of archaeal r-proteins (modified from Lecompte et al.31).
1217Identifying Novel Archaeal Ribosomal Proteinslack many r-protein families (Fig. 1),31 we selected
two Crenarchaeota with completely sequenced
genomes—S. acidocaldarius and P. aerophilum—
from which ribosomes were isolated and their r-
protein content was characterized. For example, the
genome of the euryarchaeon Haloarcula marismortui
predicts a total of 56 (25 small subunits/31 large
subunits) r-proteins in the H. marismortui 70S
ribosome, whereas the 70S ribosomes of the Cre-
narchaeota S. acidocaldarius and P. aerophilum are
predicted to comprise 64 (28 and36) and66 (28 and38)
r-proteins, respectively. S. acidocaldarius is a thermo-
acidophilic crenarchaeon that grows optimally at 75–
80 °C and pH 2–3, whereas P. aerophilum grows
optimally at 100 °C and pH 7.0 (see Materials and
Methods). Both Crenarchaeota can grow aerobically
and, in fact, the species name aerophilum translates as
“air-loving,” reflecting its ability to respire aerobically.
Nevertheless, both archaea are slow-growing, and
large-scale fermentation was required to obtain
sufficient yields for the isolation and characterization
of the ribosomes. Furthermore, ribosome yields were
reduced by the necessity for repeated high-salt
washing and centrifugation steps through sucrose
cushions to obtain clarified ribosomal pellets.
The high-salt-washed (HSW) ribosomal fractions
from S. acidocaldarius and P. aerophilum were ana-
lyzed by 2D-PAGE using the method of Kaltschmidt
and Wittmann, and protein spots were identified by
mass spectrometry (MS) (Fig. 2, Tables 12).14 From
2D-PAGE, it was possible to clearly identify spots
corresponding to 51 of 64 (80%) r-proteins of the S.
acidocaldarius 70S ribosome and 51 of 66 (78%) r-
proteins of the P. aerophilum 70S ribosome. Missing r-
proteins, such as S27ae, S27e, and S30e in the small
subunit, as well as L24e, L39e, and L40e in the largesubunit, are between 6 kDa and 8 kDa and therefore
are not resolved under these running conditions,
which were optimized for the separation of higher-
molecular-weight r-proteins. However, S. acidocaldar-
ius and P. aerophilum ribosomal subunits were
subsequently purified using sucrose gradients, and
LC-MS/MS analysis of the purified fractions led to
further identification of 26 of 28 (93%) and 36 of 36
(100%) r-proteins of the S. acidocaldarius 30S and 50S
subunits, respectively, and 28 of 28 (100%) and 37 of
38 (97%) r-proteins of the P. aerophilum small and
large subunits (Tables 1 and 2). Thus, in summary,
only two r-proteins (S26e and S30e) from the S.
acidocaldarius 30S subunit were not detected in any of
the analyses.
Curiously, some r-proteins were assigned to
multiple distinct spots on 2D-PAGE, such as L7ae,
L29p, P0, and LX in S. acidocaldarius (Fig. 2a), and
L7ae, L12p, and P0 in P. aerophilum (Fig. 2b).
Consistently, we find that both LX and L29p are
monomethylated on Lys residues 66 and 29,
respectively (Fig. 3a and b). The stalk proteins P0
(L10 in bacteria) and L12p (P1–P2 in eukaryotes) are
known to be modified in other organisms. In fact, L7
was originally mistakenly identified as a unique r-
protein and was subsequently shown to be the N-
terminally acetylated form of L12.40 E. coli L12 is also
methylated at K81 position.41 Likewise, in eukar-
yotes, P1 is acetylated42 and phosphorylated,42,43
and P2 is phosphorylated.44 P0 is phosphorylated at
the C-terminus in yeast;45 in E. coli, the N-terminal
Met of L10 is removed, and Lys residues 37 and 105
are acetylated.40,46 We also find that L12p is N-
terminally acetylated; however, unlike in E. coli, the
N-terminal methionine is not cleaved (Fig. S1). In
addition, we could identify two distinct methylation
Fig. 2. Two-dimensional PAGE of crude ribosomes from S. acidocaldarius and P. aerophilum. Coomassie-blue-stained 2D
gel of HSW ribosomes from (a) S. acidocaldarius and (b) P. aerophilum (left) showing schematic spot assignments based on
LC-MS/MS analysis (right). The directions of the first dimension (1D; based on charge) and of the second dimension (2D;
based on mass) are indicated with arrows. Spots identified as proteins not previously assigned as r-proteins are shaded
gray. NI indicates that the protein was not identified within the spot.
1218 Identifying Novel Archaeal Ribosomal Proteinssites in L12p, namely K39 and K89 (Fig. S1). To our
knowledge, distinct forms of L7ae have not been
previously reported. We can show that the N-
terminal methionine of L7ae is cleaved and that
Ser2 is N-terminally acetylated (Fig. S2). In addition,
Lys residues 74, 108, and 116 are monomethylated
(Fig. 3c; Fig. S2). In archaea, L7ae is a subunit of
RNase P, H/ACA, and C/D snoRNPs, as well as a
component of the ribosome;47 thus, it will be
interesting to investigate whether posttranslational
modifications play a role in regulating the involve-
ment of L7ae in these diverse complexes.
Identification of potential ribosome-associated
proteins
In addition to the expected r-proteins, a number of
additional proteins were identified in the 2D gels of
the HSW ribosomal fractions, as well as in the LC-MS/MS of the purified 30S and 50S fractions from S.
acidocaldarius and P. aerophilum (Fig. 2, Table 3). The
presence of these proteins can reflect a stable
interaction with the pelleted ribosomal particles or
can reflect that the proteins pellet or migrate
similarly to ribosomal particles, due to their being
associated with membrane fragments [e.g., ABC
transporter and nitrate reductase (NarGHI)] or their
being part of a large macromolecular complex [e.g.,
the 19S proteasome or the α-subunit and the β-
subunit of the thermosome (eukaryotic chaperonin
CCT/TRiC), which forms a hexadecameric (αβ)4
(αβ)4 complex of ∼1 MDa].48 Consistent with their
size, the thermosome subunits were detected in the
HSW ribosomal fraction, as well as the purified 30S
subunit but not in the purified 50S subunit fraction
(Table 3). Moreover, the archaeal thermosome has
been reported to be an RNA binding protein
involved in rRNA processing.49 Other proteins
Table 1. R-proteins of S. acidocaldarius identified by LC-
MS and 2D-PAGE
Protein
family LC-MS 2D
Amino
acids gia
Molecular
mass (kDa) pI
Small subunit r-protein
S2p ✓ ✓ 225 70605938 25.7 5.8
S3ae ✓ — 197 70606435 22.6 10.2
S3p ✓ — 231 70606406 25.4 10.1
S4e ✓ ✓ 244 70606400 27.8 10.1
S4p ✓ ✓ 176 70605931 20.4 10.3
S5p ✓ ✓ 214 70606392 23.9 9.8
S6e ✓ ✓ 213 70606621 23.7 10.0
S7p ✓ ✓ 195 70606489 22.1 10.2
S8e ✓ ✓ 128 70606557 14.4 10.4
S8p ✓ ✓ 133 70606397 14.9 9.9
S9p ✓ ✓ 138 70605936 15.8 10.2
S10p ✓ — 102 70606487 11.9 10.5
S11p ✓ ✓ 132 70605932 14.1 11.5
S12p ✓ ✓ 147 70606491 16.1 11.3
S13p ✓ ✓ 170 70605930 19.4 10.5
S14pb ✓ — 63 68567046 7.6 10.2
S15p ✓ ✓ 153 70606619 17.8 10.5
S17e ✓ ✓ 82 70606477 9.6 5.3
S17p ✓ ✓ 108 162139951 12.3 9.9
S19e ✓ ✓ 154 70607213 18.0 10.6
S19p ✓ ✓ 140 70606408 16.4 10.6
S24e ✓ ✓ 118 70606643 13.3 10.3
S25e ✓ ✓ 109 70606631 12.3 10.5
S26e — — 95 68567938 10.8 9.9
S27ae ✓ — 67 70606642 7.8 9.9
S27e ✓ ✓ 66 70607041 7.3 10.4
S28e ✓ ✓ 84 70606501 9.5 10.5
S30e — — 54 68567754 6.2 11.8
Large subunit r-protein
L1p ✓ ✓ 221 162139946 24.9 10.4
L2p ✓ ✓ 238 70606409 25.2 11.4
L3p ✓ ✓ 342 70606412 38.5 10.5
L4p ✓ ✓ 266 70606411 29.2 10.7
L5p ✓ ✓ 178 70606399 20.2 10.8
L6p ✓ ✓ 189 3914762 21.2 9.8
L7ae ✓ ✓ 126 70607262 13.7 8.2
L10e ✓ ✓ 176 70606018 19.9 10.4
L11p ✓ ✓ 170 70607203 18.2 9.5
L12p ✓ ✓ 105 70607200 11.1 4.8
L13p ✓ ✓ 148 70605935 16.7 10.9
L14e ✓ ✓ 96 70606603 10.7 9.9
L14p ✓ ✓ 138 70606402 15.2 10.9
L15e ✓ ✓ 217 70606432 26.0 11.7
L15p ✓ — 144 70606390 16.4 10.5
L18e ✓ ✓ 110 70605934 12.5 10.8
L18p ✓ ✓ 197 70606393 22.1 10.3
L19e ✓ ✓ 150 70606394 17.8 11.3
L21e ✓ ✓ 103 70606441 11.8 10.9
L22p ✓ ✓ 156 70606407 18.1 10.4
L23p ✓ ✓ 82 70606410 9.4 10.2
L24e ✓ — 62 70606500 7.1 10.4
L24p ✓ ✓ 134 70606401 15.5 10.6
L29p ✓ ✓ 69 70606405 8.1 10.5
L30e ✓ ✓ 104 70606493 11.5 9.8
L30p ✓ ✓ 156 70606391 17.9 10.2
L31e ✓ ✓ 129 70607210 15.2 10.8
L32e ✓ ✓ 131 70606395 15.2 11.1
L34e ✓ ✓ 87 70606386 10.1 10.5
L37eb ✓ ✓ 61 70606453 6.9 11.9
L37ae ✓ — 70 70606423 8.1 10.4
L39eb ✓ — 53 70607211 6.3 12.6
L40e ✓ ✓ 56 70606562 6.4 11.0
L44e ✓ ✓ 95 15921177 11.1 10.7
Table 1 (continued)
Protein
family LC-MS 2D
Amino
acids gia
Molecular
mass (kDa) pI
LX ✓ ✓ 86 70607208 10.1 10.1
P0 ✓ ✓ 335 70607201 36.5 9.1
a gi refers to the GenInfo identifier for retrieval from NCBI.
b Identified with only a single peptide.
1219Identifying Novel Archaeal Ribosomal Proteinsthat are better known to be associated with the
translational machinery, such as elongation factor
1α (EF-1α) and the translation initiation factors IF-6
and Sui1 (eIF1), were also identified (Table 3). In
addition, the ribosome biogenesis factors CBF5
(pseudo-uridine synthetase) and fibrillarin (rRNA
2′-O-methyltransferase), and rRNA processing pro-
teins such as NOP56/58 were identified (Table 3).
Fibrillarin and NOP56/58, together with the archae-
al r-protein L7ae, interact with C/D box sRNAs to
form an RNP complex involved in 2′-OH ribose
methylation, whereas CBF5, L7ae, NOP10, and Gar1
interact with H/ACA sRNAs to direct rRNA
pseudo-uridinylation.47
Four proteins containing putative DNA/RNA-
binding domains, which may be present due to
interaction with nucleic acids [i.e., chromatin-like
protein (CLP), TBP-interacting protein TIP49,
transcription factor NusA-like protein, and zinc-
ribbon RNA-binding domain protein], were iden-
tified (Table 3). Interestingly, we identified six and
eight hypothetical proteins in the S. acidocaldarius
and P. aerophilum ribosomal fractions, respectively,
that have no known motifs and no sequence
homology to any protein with a known function,
yet many had pI values of N9.0, characteristic of
r-proteins (Tables 1 and 2). While most of the
spots for the additional proteins were significantly
less intense than the r-protein spots (Fig. 2), there
were a number of exceptions—particularly evident
in the S. acidocaldarius 2D gel were the spots for
hypothetical proteins Saci_1218, Saci_1337, and
Saci_1586; CLP; and the universal stress protein
(USP), all of which appeared to be stoichiometric
with, or even more intense, than the majority of
r-proteins (Fig. 2a). We thus considered the
possibility that these proteins may be novel integral
r-proteins of the S. acidocaldarius ribosome.Identification and distribution of novel
S. acidocaldarius large subunit r-proteins
In order to determine if the potential ribosome-
associated proteins were bona fide r-proteins and
whether they are integral to the small subunit or the
large subunit, we applied the HSW ribosomal
fractions onto 10–40% sucrose gradients. In contrast
Table 2. R-proteins of P. aerophilum identified by LC-MS
and 2D-PAGE
Protein
family LC-MS 2D
Amino
acids gia
Molecular
mass (kDa) pI
Small subunit r-protein
S2p ✓ ✓ 208 18312202 23.9 9.0
S3ae ✓ ✓ 221 18314093 24.7 10.3
S3p ✓ ✓ 218 27734520 25.0 10.4
S4e ✓ ✓ 238 18313980 26.7 10.4
S4p ✓ ✓ 159 26399437 18.5 10.9
S5p ✓ ✓ 218 18312458 24.2 10.1
S6e ✓ ✓ 148 18312675 15.9 9.9
S7p ✓ ✓ 223 18312139 25.3 9.6
S8e ✓ ✓ 131 18313995 14.3 11.2
S8p ✓ ✓ 130 18313095 14.9 9.9
S9p ✓ ✓ 146 18312094 16.4 10.6
S10p ✓ ✓ 106 18313679 12.3 11.7
S11p ✓ ✓ 133 18313881 14.1 11.4
S12p ✓ ✓ 147 20140085 16.5 10.9
S13p ✓ — 152 18313810 16.7 10.6
S14p ✓ — 54 18313094 6.4 10.5
S15p ✓ ✓ 151 18314103 17.7 10.6
S17e ✓ ✓ 71 18312190 8.2 10.3
S17p ✓ ✓ 146 18160326 17.0 10.5
S19e ✓ ✓ 158 18313782 17.7 10.7
S19p ✓ ✓ 158 18312838 18.2 10.6
S24e ✓ ✓ 121 18313342 14.2 11.0
S25e ✓ ✓ 110 18313166 12.5 10.6
S26e ✓ — 98 18313151 11.3 10.7
S27ae ✓ — 65 18313341 7.6 10.3
S27e ✓ — 67 18313776 7.3 10.4
S28e ✓ ✓ 77 18314007 8.6 10.4
S30e ✓ — 55 18313356 6.2 12.4
Large subunit r-protein
L1p ✓ ✓ 222 18313826 24.7 10.7
L2p ✓ ✓ 246 18312189 26.2 10.9
L3p ✓ ✓ 338 18313001 37.4 10.8
L4p ✓ ✓ 283 18313002 31.1 10.4
L5p ✓ ✓ 179 18314167 20.1 10.9
L6p ✓ ✓ 196 18313300 21.9 9.8
L7ae ✓ ✓ 151 18314009 16.1 9.4
L10e ✓ ✓ 180 18314160 20.2 10.5
L11pb ✓ — 167 18313825 18.6 9.6
L12p ✓ ✓ 110 18312824 11.5 4.5
L13e ✓ ✓ 159 18312773 18.1 11.6
L13p ✓ — 187 18312093 21.8 10.7
L14e ✓ ✓ 103 18312232 11.4 10.2
L14p ✓ ✓ 144 18313850 15.8 11.3
L15e ✓ ✓ 191 18312915 22.9 11.5
L15p ✓ ✓ 156 18314064 17.4 10.9
L18e ✓ ✓ 122 18312092 13.3 12.1
L18p ✓ ✓ 205 18313098 23.4 10.5
L19e ✓ ✓ 147 18313097 17.4 11.2
L21e ✓ — 100 18313998 11.5 10.7
L22p ✓ ✓ 168 18312876 19.6 11.1
L23p — ✓ 81 18313003 9.3 10.3
L24e ✓ — 58 18314008 6.7 10.6
L24p ✓ ✓ 123 18313979 14.2 11.8
L29p ✓ ✓ 75 18312872 9.0 11.6
L30eb ✓ ✓ 102 18312088 10.9 9.2
L30p ✓ — 178 18312459 20.3 10.3
L31e ✓ ✓ 91 18313818 10.6 10.9
L32e ✓ ✓ 152 18313096 18.0 11.7
L34e ✓ — 84 18313920 9.5 12.2
L37e — — 52 NAc 12.3 5.4
L37ae ✓ ✓ 105 18313176 11.8 10.8
L38e ✓ ✓ 67 18312825 7.9 9.8
L39ed ✓ — 51 29427908 6.0 13.4
L40e ✓ — 53 18313942 6.4 11.2
Table 2 (continued)
Protein
family LC-MS 2D
Amino
acids gia
Molecular
mass (kDa) pI
L44e ✓ ✓ 91 18313777 10.6 10.9
LX ✓ ✓ 78 18313820 8.9 9.7
P0 ✓ ✓ 345 18313827 38.0 9.9
a gi refers to the GenInfo identifier for sequence retrieval from
NCBI.
b Identified with only a single peptide
c Not annotated in NCBI, but reading frame identified by
Lecompte et al.31
d Inferred by sequence homology identity to Pyrobaculum
calidifontis JCM 11548.
1220 Identifying Novel Archaeal Ribosomal Proteinsto E. coli, where a low level of magnesium was
necessary to split the 70S ribosomes into the
component subunits (Fig. 4a), 30S and 50S subunits
and little or no 70S ribosomes were observed for S.
acidocaldarius and P. aerophilum even with low-salt
and high -magnesium (30 mM) concentrations (data
not shown). Similar observations have been
reported previously for a variety of Desulfurococcus
ribosomes, with 70S particles only being observed
when cross-linking agents, such as formaldehyde,
were used on actively translating ribosomes.50 The
fractions corresponding to the S. acidocaldarius and
P. aerophilum 30S and 50S subunits were collected,
pooled, and pelleted (Fig. 4a–c). The purified
subunits were analyzed by negative-stain EM, as
performed previously for archaeal subunits.51 The
images indicate that the purified subunits were
homogeneous, although some contamination of the
30S subunits by chaperonins was evident, consistent
with LC-MS/MS analysis (Fig. 4d). The purified S.
acidocaldarius 30S and 50S subunits were then
analyzed by 2D-PAGE, and the protein spots were
identified by LC-MS/MS (Fig. 4e and f).
The r-protein assignments were consistent with
those of the 2D gels of the high-salt ribosomal
fraction and corresponded to the expected respec-
tive subunit composition (Fig. 2a). However, L7ae
was also found at lower stoichiometry in the 30S
fraction (Fig. 4e), which may reflect a promiscuous
interaction with the 30S subunit, although we
cannot exclude that it also results from the afore-
mentioned involvement of L7ae in other biogenesis
or processing complexes. Similarly, S24e is found at
a surprisingly higher stoichiometry in the 50S
subunit compared to the 30S subunit (Fig. 4e and
f), possibly reflecting an as yet uncharacterized
interaction of this protein with both ribosomal
subunits. In contrast, it was immediately apparent
that the spots for the CLP and the USP were absent.
We also did not detect Rbp18 (Saci_1216), which has
been proposed to interact with the Sulfolobus
solfataricus 30S subunit,52 suggesting that CLP,
USP, and Rbp18 are not integral r-proteins but
may instead be only transiently associated with the
Fig. 3. MS identification of r-protein modifications. MS/MS spectra (left) and fragmentation tables (right) used for the
identification of the monomethylation sites of r-proteins (a) LX, (b) L29p, and (c) L7ae. Monomethylated lysines within the
peptide sequences are underlined and marked in boldface. Detected b-ions are highlighted in red, and y-ions are
highlighted in blue.
1221Identifying Novel Archaeal Ribosomal Proteinsribosome. In contrast, the three hypothetical pro-
teins Saci_1218, Saci_1337, and Saci_1586 were
present in the 2D gel of the S. acidocaldarius 50S
subunit (but not in the 30S subunit), with intensities
paralleling those of bona fide r-proteins (Fig. 4f).
Saci_1218, Saci_1337, and Saci_1586 are composed
of 125 aa (14.6 kDa), 75 aa (8.8 kDa), and 80 aa
(9.3 kDa), with pI values of 9.3, 9.9, and 8.0,
respectively. We propose to rename Saci_1218,Saci_1337, and Saci_1586 as L45a, L46a, and L47a,
respectively, continuing the numerical nomencla-
ture of known archaeal r-proteins.
At the time of writing, the genomes of 91 archaeal
species had been completely sequenced. Homology
searches against these genomes revealed that L45a
(Saci_1218) has homologues present in all Sulfolobus
species, with the exception of Sulfolobus tokodaii str. 7
(Fig. 5a). In contrast, L46a (Saci_1337) appears to be
Table 3. Potential ribosome-associated proteins identified by LC-MS/MS and 2D-PAGE
Protein group Protein description Species gia LC-MS 2D
Translation-related factors Elongation factor 1α (EF-1α) PAE 18313751 30S ✓
SAC 70606488 — ✓
Translation initiation factor IF-6 PAE 18313819 30S/50S —
SAC 70607209 50S —
Translation initiation factor Sui1 PAE 18314004 30S —
SAC 70606655 30S —
Ribosome biogenesis factors Cbf5 (pseudo-uridine synthetase) SAC 212373368 30S —
Fibrillarin (rRNA 2′-O-methyltransferase) PAE 18313923 30S —
SAC 70607104 30S/50S —
NOP56 subunit (pre-rRNA processing protein) PAE 18313924 30S/50S ✓
SAC 70607105 50S —
Dim2p-like rRNA processing protein PAE 18314094 30S/50S —
SAC 70606751 30S —
RNA/DNA binding proteins Chromatin-like protein (CLP) PAE 18313194 30S/50S
SAC 70607080 30S/50S ✓
TBP-interacting protein TIP49 PAE 18312811 — ✓
Transcription factor NusA-like protein SAC 162139950 30S
Zn-ribbon RNA binding protein (RBP) PAE 18312108 30S ✓
SAC 70606567 30S —
Proteases, heat shock proteins,
and chaperones
AAA+ protease PAE 18313875 30S —
FKBP-type PPIase PAE 18312191 30S ✓
Hsp20 PAE 18313227 30S ✓
SAC 70607398 — ✓
Proteasome, α-subunit PAE 18313186 30S —
SAC 70606428 50S —
Thermosome (chaperonin), α-subunit PAE 18313108 30S ✓
Thermosome (chaperonin), β-subunit PAE 18313954 30S ✓
SAC 70606473 — ✓
Universal stress protein (USP) SAC 70607374 — ✓
Other ABC transporter SAC 70606787 — ✓
Acetyl-CoA acetyltransferase PAE 18160913 30S ✓
Acetyl-CoA acetyltransferase-associated protein PAE 18313383 30S —
Nitrate reductase, α-subunit (narG) PAE 18161785 30S/50S —
Nitrate reductase, β-subunit (narH) PAE 18161786 30S/50S —
Succinate dehydrogenase subunit PAE 18159558 50S —
Sulfurtransferase SAC 70607907 — ✓
Hypothetical proteins PAE0659 (pI=9.3) PAE 18312079 50S —
PAE0944 (pI=6.1) PAE 18312296 30S —
PAE1347 (pI=6.5) PAE 18312573 30S/50S —
PAE1683 (pI=9.2) PAE 18160290 30S/50S ✓
PAE1820 (pI=8.1) PAE 18160397 30S —
PAE2358 (pI=9.3) PAE 18160809 50S ✓
PAE3143 (pI=7.8) PAE 18313855 30S/50S —
PAE3432 (pI=9.3) PAE 18161642 30S/50S —
Saci_0899 (pI=6.2) SAC 70606685 30S —
Saci_1218 (pI=9.3) SAC 70606987 50S ✓
Saci_1237 (pI=9.4) SAC 70607006 30S —
Saci_1337 (pI=9.9) SAC 70607095 50S ✓
Saci_1435 (pI=9.5) SAC 70607187 30S —
Saci_1586 (pI=8.0) SAC 70607322 50S ✓
a gi refers to the GenInfo identifier for sequence retrieval from NCBI.
1222 Identifying Novel Archaeal Ribosomal Proteinsmore widely distributed, with homologues being
found in all Thermoprotei genera (Fig. 5b) and with
L47a (Saci_1586) being found in all Sulfolobaceae
(Fig. 5c). Initial homology searches did not reveal a
homologue of L47a within the genome of S. tokodaii
str. 7; however, careful inspection of the genome
context of the neighboring genes of L47a, namely
asnC and rpoM, revealed the presence of an
unannotated open reading frame, which encodes a
protein with 64% identity to L47a (Fig. 5g). While
most archaeal r-proteins are organized either withinthe major conserved operons (α, str, spc, and S10)
as in bacteria or in one of 10 archaeal-unique
operons,53 11 archaeal r-proteins are not associated
with any specific genomic context. Likewise, L45a
and L46a do not appear to be within conserved
operon structures, nor associated with any particu-
lar genes, although we note that the gene
(Saci_1216) encoding the 30S subunit binding
protein Rbp18,52 the ribosome biogenesis factor
Gar1, and Ser-tRNA synthetase are in close proxim-
ity to L45a, L46a, and L47a (Fig. 5d–f), respectively.
Fig. 4. Characterization of purified archaeal ribosomal subunits. Sucrose density gradient centrifugation profiles of
HSW ribosomes from (a) E. coli as control, comparedwith (b) S. acidocaldarius and (c) P. aerophilum (left). (d) Negative-stain
EM of 30S and 50S fractions isolated from (a)–(c) at a magnification of 90,000×. The arrow indicates chaperonin particles in
ribosome preparations. Two-dimensional PAGE of S. acidocaldarius (e) 30S and (f) 50S subunits. The positions of the novel
r-proteins Saci_1218, Saci_1337, and Saci_1586 are indicated by arrows in (e) and (f).
1223Identifying Novel Archaeal Ribosomal ProteinsR-proteins identified in archaeal-unique operons are
often found together with components of the
transcriptional machinery (e.g., L30e is found
together with genes encoding the transcription
elongation factor NusA and the DNA-dependent
RNA polymerase subunits RpoA, RpoB, and RpoH).
This finding has been suggested to reflect the
increasing coordination in the regulation of tran-
scription and translation that has evolved in
archaeal (and eukaryotic) lineages since the separa-
tion from bacterial phyla.53 L45a neighbors the gene
for a transcription regulator (Lrs14), whereas L46a is
downstream of tflD, encoding the TATA binding
protein of the transcription factor TFIID. Similarly,L47a is often found downstream of genes encoding
the transcriptional regulator AsnC and the DNA-
directed RNA polymerase subunit M (RpoM).
NTPase activities of S. acidocaldarius small
and large subunits
Ribosomes from higher eukaryotes, such as rat
and bovine liver and rabbit reticulocytes, have
been documented to harbor intrinsic ATPase
activities.54,55 This prompted us to examine the
purified archaeal ribosomes to assess whether any
intrinsic ATP or GTP activities could be detected. As
controls, the intrinsic ATPase/GTPase activities of
Fig. 5. Distribution and genomic organization of Saci r-proteins. Subsection of the archaeal taxonomic tree showing the
relative distributions of (a) Saci_1218 (L45a), (b) Saci_1337 (L46a), and (c) Saci_1586 (L47a). Genomic organization of (d)
Saci_1218 (L45a), (e) Saci_1337 (L46a), and (f) Saci_1586 (L47a). (g) Identification of a homologue of Saci_1586 in S. tokodaii
str. 7 based on genomic context. Lrs14, transcription regulator Lrs14-like protein; PBP, periplasmic binding protein; tflD,
TATA binding protein of the transcription factor TFIID; tfb2, transcription initiation factor 2; PAAD, phenylacetic acid
degradation protein; Ser-tRNA RS, Ser-tRNA aminoacyl synthetase; RpoM, DNA-dependent RNA polymerase subunit
M; Lrp, transcription regulator Lrp; HIT, histidine triad nucleotide binding protein.
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E. coli elongation factor G (EF-G), were tested in the
presence and in the absence of E. coli 70S ribosomes.
As seen in Fig. S3, no intrinsic ATPase or GTPase
activity was detected for E. coli 70S ribosomes, nor
for S. acidocaldarius 30S or 50S subunits, at 37 °C
within 1 h. In comparison, high GTPase activity was
detected within 1 h when E. coli EF-G was incubated
together with E. coli 70S ribosomes. Similarly, after
24-h incubations, no intrinsic ATPase/GTPase ac-
tivities were detected for E. coli 70S ribosomes.
However, low ATPase and GTPase activities were
detected for both S. acidocaldarius 30S or 50S
subunits at levels similar to the intrinsic GTPaseFig. 6. Two-dimensional gels for the incremental washin
stained 2D-PAGE of 1–4 M LiCl wash fractions from purified
proteins in the core 50S subunit after treatment with 4 M L
50S subunit r-proteins that are removed with increasing co
those remaining in the core after 4 M washing (blue). (c) Tw
with r-proteins removed by 1.0 M, 1.5–2 M, and 3–4 M washi
in red, orange, lime, and blue, respectively.activity of E. coli EF-G (Fig. S3). Similar experiments
were performed with Thermus thermophilus 70S
ribosomes and S. acidocaldarius 30S or 50S subunits
at 60 °C, and no intrinsic ATPase or GTPase activity
was detected after 1 h (data not shown). Longer
incubations were not possible because of the
elevated background signal due to a spontaneous
cleavage of NTPs at 60 °C. Although we cannot
completely rule out the presence of an intrinsic
ATPase/GTPase activity of the archaeal subunits,
we believe that the low activities detected are more
consistent with the presence of residual contaminat-
ing factors, such as AAA+ proteases or EF-1α, that
were detected in the samples byMS (Table 3). Such ag of S. acidocaldarius 50S subunits. (a) Coomassie-blue-
S. acidocaldarius 50S subunits, as well as the remaining r-
iCl. (b) Scheme illustrating the subset of S. acidocaldarius
ncentrations of LiCl (red, orange, and lime), as well as
o views of a model for the S. acidocaldarius 50S subunits
ng, as well as those remaining after 4 M washing, shown
Fig. 6 (legend on previous page)
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1226 Identifying Novel Archaeal Ribosomal Proteinsconclusion would be consistent with the lack of any
highly conservedATP and/orGTP bindingmotifs in
any of the archaeal r-proteins.
Stepwise dissociation of archaeal 50S ribosomal
subunits by LiCl
To investigate the interaction and stability of the
novel archaeal r-proteins L45a, L46a, andL47a on theFig. 7. Cryo-EM reconstructions of 50S subunits from S. acidoca
maps (gray mesh) of 50S subunits from (a) S. acidocaldarius an
marismortui 50S subunit (PDB code 3CC2)63 shownwith RNA (cya
eukaryotic-specific r-proteins included fromArmache et al.8 (c) Co
aerophilum (blue mesh). The density for r-proteins L30e and L3
subunits, whereas the density for L13e andL38e is present in only
acidocaldarius and P. aerophilum are indicated with asterisks and l50S subunit relative to other known r-proteins, we
washed the S. acidocaldarius 50S subunit with
increasing concentrations of LiCl (1 M, 1.5 M, 2 M,
3 M, or 4 M), precipitated the r-proteins that
dissociated from the particles, and analyzed them
by 2D-PAGE (Fig. 6a). In addition, 2D-PAGE was
also performed on the core r-proteins that remain
attached to the rRNA after washing with 4 M LiCl
(Fig. 6a). A representation summarizing the order ofldarius andP. aerophilum. Three different views of the cryo-EM
d (b) P. aerophilum, with a fitted crystal structure of the H.
n) and r-proteins (blue) as ribbons, with additional archaeal/
mparison of the densitymaps of S. acidocaldarius (gray) and P.
4e is present in both S. acidocaldarius and P. aerophilum 50S
P. aerophilum. Potential locations for additional r-proteins in S.
abeled S1–S3 and P1–P4, respectively.
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Fig. 6b and graphically on a molecular model for the
S. acidocaldarius 50S subunit in Fig. 6c. Surprisingly,
although many integral r-proteins (L5p, L6p, L11p,
L12p, L21e, L37ae, L44e, LX, and P0) were washed
from the 50S subunit with 1 M LiCl, the r-proteins
L45a, L46a, and L47a were not. L46a was removed
with 1.5 M LiCl, whereas L45a and L47a only started
to appear in the supernatant with 2–3 M LiCl
washing, suggesting a tighter association with the
50S subunit (Fig. 6a). Generally, the trend is that the
3–4 M LiCl wash and core fractions contain
predominantly universally conserved families [L1p,
L2p, L3p, L4p, L13p, L14p, L16p (L10e), L18p, L22p,
L24p, L29p, and L30p], with only a few archaeal/
eukaryotic-specific families present (L7ae, L15e,
L18e, L30e, L31e, and L34e). In contrast, the reverse
trend is observed in the 1–2 M LiCl wash fractions,
which contain more archaeal/eukaryotic-specific r-
proteins than universal r-proteins. The dissociating
universal r-proteins include L11p, L12p, and P0
(L10p) that form the stalk region, which is known to
be easily removable from the ribosome.56,57 Studies
using bacterial ribosomes have revealed that the
susceptibility of r-proteins to removal by LiCl
washing corresponds inversely to the order of
assembly of r-proteins in vivo and from reconstitu-
tion studies.58 Two-dimensional PAGE analysis of
the S. solfataricus 50S core r-proteins following
treatment with 3 M LiCl/6 M urea revealed a
number of r-proteins; however, no direct identifica-
tion of the r-proteins was performed.39 Although the
in vitro reconstitution of S. solfataricus and Haloferax
mediterranei large ribosomal subunits was success-
fully performed, the order and dependency of r-
proteinswere not investigated.59,60 Nevertheless, the
findings here are generally consistent with the LiCl
treatment61 and in vivo analysis of the yeast 60S
subunit assembly.62
Cryo-EM reconstruction of archaeal large
ribosomal subunits
Cryo-EM reconstructions of the S. acidocaldarius
and P. aerophilum 50S subunits were determined to
27 Å and 25 Å (0.5 FSC) resolutions, respectively
(Fig. 7). The resolution was limited by the need to
use 50S subunits, rather than 70S ribosomes, in part
due to an orientation bias of the 50S subunits on the
cryogrids. Nevertheless, there was an excellent fit of
the crystal structure of the archaeal H. marismortui
50S subunit63 into both cryo-EM maps (Fig. 7a and
b). The 23S rRNA sequences of S. acidocaldarius and
P. aerophilum are very similar to that of H.
marismortui; however, S. acidocaldarius and P. aero-
philum 50S subunits contain additional r-proteins
that are not present in H. marismortui (Fig. 1).31
Consistently, both maps had additional regions of
density that were not occupied by theH. marismortui50S subunit model (Fig. 7). Extra density is located
on both maps on the interface side of the 50S
subunit, just below the L1 stalk, consistent with the
positions of L30e and L34e in eukaryotic 80S
ribosomes8,64 (Fig. 7a and b). Similarly, additional
density is located between the L11 stalk and the
central protuberance on the solvent side of the large
subunit where L14e is located.8 The P. aerophilum
50S subunit has two r-proteins (L13e and L38e) that
are not found in S. acidocaldarius or H. marismortui
50S subunits (Fig. 1).31 Additional density (which is
absent in the S. acidocaldarius 50S map) is observed
in the P. aerophilum 50S map in the two positions
where L13e and L38e are located in eukaryotic 80S
ribosomes8 (Fig. 7c). The location of the archaeal-
specific r-protein LX, which is present in both S.
acidocaldarius and P. aerophilum, cannot be localized
at this resolution. We could, however, identify at
least three regions (S1–S3) with the remaining
additional density in the S. acidocaldarius 50S map
that are not present in the P. aerophilum 50S map,
which could potentially be due to the additional S.
acidocaldarius L45a, L46a, and L47a identified in this
study; however, a higher resolution will be required
to confirm this. Four regions (P1–P4) of additional
density that are specific for the P. aerophilum 50S
map were also observed (Fig. 7b and c), possibly
reflecting the presence of additional as yet unknown
P. aerophilum r-proteins, candidates for which were
identified by LC-MS/MS in the 50S fraction (e.g.
PAE0659 and PAE2358) (Table 3).Materials and Methods
Growth of S. acidocaldarius and P. aerophilum
S. acidocaldarius (DSM 639T) and P. aerophilum IM2T
(DSM 7523T) were obtained from the culture collection of
the Institute of Microbiology and Archaeal Center,
University of Regensburg. S. acidocaldarius was grown
under oxic conditions in modified ALLEN medium at
75 °C and pH 3.0,65,66 as described previously.67 As
substrate, 0.05% yeast extract, 0.2% saccharose, and 0.2%
peptone were added. P. aerophilum was grown in BS
medium at 97 °C, as previously described.68 The medium
was covered with a gas-phase H2/CO2 (80:20 vol/vol,
250 kPa), thereby using hydrogen as electron donor and
nitrate (0.1%) as electron acceptor. Mass cultivation for
both strains was carried out in 300 L of enamel-protected
fermenters (HTE; BioEngineering, Wald, Switzerland).
The cells were harvested by centrifugation (Padberg, Lahr,
Germany), shock-frozen in liquid nitrogen, and stored at
−80 °C until further use.
Preparation of ribosomal particles
Archaeal ribosomes were isolated and purified similarly
as previously reported,50,69 but with some modifications.
Briefly, cell pellets were dissolved in Tico buffer [20 mM
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4 mM β-mercaptoethanol] at 4 °C and subsequently
disrupted with Microfluidizer (Microfluidics M-110L
Pneumatic) at 18,000 psi. The crude homogenate was
centrifuged twice at 30,000g at 4 °C for 30 min in order to
obtain the S30 fraction. A crude ribosomal fraction was
obtained by centrifugation at 100,000g for 5 h at 4 °C and
by dissolution of the pellet in an equal volume of HSW
buffer [20 mM Hepes, 10 mM Mg(OAc)2, 500 mM
NH4OAc, and 4 mM β-mercaptoethanol (pH 7.5)]. Large
debris was removed by centrifuging the crude ribosomes
for 5 min at 18,000g at 4 °C. The clear supernatant was
diluted 10-fold in HSW buffer and layered on top of
1.3 vol of 25% (wt/vol) sucrose cushion prepared in HSW
buffer and centrifuged at 100,000g for 7 h at 4 °C. The
pellet was resuspended in aminimal volume of Tico buffer
and subsequently purified using sucrose density gradient
centrifugation (10–40% sucrose in Tico buffer) at 46,000g
for 17 h at 4 °C. Fractions corresponding to 50S and 30S
subunits were separately pooled, pelleted at 140,000g for
12 h at 4 °C, and resuspended in a minimal volume of Tico
buffer. E. coli ribosomes were prepared in accordance with
Blaha et al.70
Extraction of total r-proteins and 2D-PAGE
The total proteins from HSW ribosomes and purified
ribosomal subunits were extracted by acetic acid in accor-
dance with Nierhaus and Dohme71 Lyophilized proteins
were further processed for LC-MS/MS analysis and 2D-
PAGE. Around 2 μg of total proteins was necessary for LC-
MS/MS, whereas 5–10 μg of total proteins was required for
2D-PAGE. Two-dimensional electrophoresis was performed
as described by Kaltschmidt and Wittmann.14
Analysis of ribosomal particles by stepwise
LiCl washing
Stepwisewashing of purified 50S ribosomal subunits from
S. acidocaldariuswas performed in accordance with Homann
and Nierhaus, with minor modifications.72 Briefly, five A260
units of ribosomal particles were incubated in a total volume
of 100 μl with 10 mM Tris–HCl (pH 7.8), 10 mM MgCl2,
0.1 mM ethylenediaminetetraacetic acid, and appropriate
concentrations of LiCl (0.6M, 1M, 1.5M, 2M, 3M, and 4M)
for 4 h at 4 °C, with moderate shaking. The incubation
reaction was further centrifuged at 160,000g for 12 h at 4 °C,
and the dissociated proteins (supernatants) were precipitat-
ed with trichloroacetic acid. Lyophilized proteins were
treated as described above for LC-MS/MS analysis and
2D-PAGE. In those cases where the core particle was
analyzed (4 M LiCl core), the pellet obtained after
ultracentrifugation was dissolved in Tico buffer, and the
core proteins were extracted by acetic acid as described
previously by Nierhaus and Dohme.71
Mass spectrometry
Excision and tryptic in-gel digestion of 2D gel spots
Spots of interest were automatically excised using a
Proteineer robot (Bruker Daltonics, Leipzig, Germany)
and transferred onto 96-well reaction plates (Intavis,Köln, Germany). Digests were performed using a
DigestPro MS digest robot (Intavis) using the following
a protocol: (i) washing with 60 μl of 100% CH3CN; (ii)
rinsing with 45 μl of 50 mM NH4HCO3; (iii) washing
with 60 μl of CH3CN; (iv) 20-min incubation with 30 μl
of 10 mM dithiothreitol in water at 65 °C; (v) 20-min
incubation with 30 μl of 50 mM iodoacetamide in water;
(vi) two 20-min washes with 60 μl of 50 mM NH4HCO3;
(vii) one 20-min wash in 60 μl of CH3CN; (viii) 15-min
wash in 45 μl of CH3CN; (ix) addition of 90 ng of
modified porcine trypsin (Promega, Madison, WI, USA)
in 15 μl of 50 mM NH4HCO3 and incubation at 37 °C for
6 h; (x) addition of 15 μl of 2.5% formic acid (FA); and
(xi) collection of the supernatant peptide extracts on 96-
well collection plates (Intavis).Matrix-assisted laser desorption/ionization MS-based
identification of 2D gel spots
Matrix-assisted laser desorption/ionization (MALDI)
targets were prepared automatically using a DigestPro
MS robot (Intavis) equipped with ZipTip C-18 reversed-
phase tips (Millipore, Billerica, MA, USA) for desalting.
The following protocol was used: (i) activation of
ZipTips with 20 μl of 50% CH3CN and 0.1% trifluor-
oacetic acid (TFA); (ii) washing with 20 μl of 0.1% TFA;
(iii) loading of the tryptic digest; (iv) washing with 20 μl
of 0.1% TFA; and (v) elution of peptides onto the
MALDI target plate with 1–2 μl of matrix solution
(8 mg/ml CHCA, 65% CH3CN, and 0.1% TFA). MALDI
TOF/TOF MS was performed on a 4800 MALDI TOF/
TOF Analyzer (Applied Biosystems). For precursor ion
scans, a mass range between 800 Da and 4000 Da was
chosen, and a minimum signal-to-noise ratio of 20 was
set for peak detection. The MS/MS spectra of the 20
most intense precursors within each spot were generated
by 500 laser shots.LC-MS/MS analysis of protein samples on the LTQ
ion trap
Peptide samples were diluted in 40 μl of 0.1% FA and
centrifuged for 15 min at 14,000 rpm at room
temperature. A multidimensional liquid chromatogra-
phy system (Ettan MDLC; GE Healthcare) connected
upstream of the spectrometer was used for separation.
Peptide samples were loaded onto a trap column (C18
PepMap100, 5 μm particle size, 100 Å, 300 μm×5 mm
column size; LC Packings Dionex) at a flow rate of
10 μl/min and subsequently separated by an RP
column (C18 PepMap 100, 3 μm bead size, 75 μm i.d.,
15 cm length; LC Packings) with an 80-min gradient
from 0% solvent B to 30% solvent B (solvent A: 0.1%
FA; solvent B: 84% CH3CN/0.1% FA), followed by a 30-
min gradient to 60% solvent B at a flow rate of 280 nl/
min. Electrospray ionization was performed with a
distal coated SilicaTip (FS-360-20-10-D-20; New Objec-
tive) at a needle voltage of 1.2 kV. MS/MS of peptide
samples was performed on a linear ion-trap mass
spectrometer (LTQ; Thermo Electron). MS and MS/MS
analyses were performed using cycles of one MS scan
(mass range m/z 300–1600) and three subsequent data-
dependent MS/MS scans (“Dynamic Exclusion™ acti-
vated”; 35% collision energy).
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XL instrument
Chromatographic separation of peptides was per-
formed as described previously for LTQ ion-trap measure-
ments, but using a Reprosil-Pur C18 separation column
(Reprosil-Pur C18 AQ, 3 μm, 150 nm×75 μm; Dr. Maisch).
Electrospray ionization was performed with a distal
coated SilicaTip (FS-360-20-10-D-20; New Objective) and
a needle voltage of 1.4 kV. In order to detect low-
molecular-mass ammonium ions, we performed MS and
MS/MS analyses using cycles of one MS scan (mass range
m/z 300–2000) and three subsequent data-dependent CID
MS/MS scans, followed by three HCD MS/MS scans
(“Dynamic Exclusion™ activated”; 35% collision energy).
Database search and data analysis
MS/MS data were searched with Mascot version 2.1.03
(Matrix Science, Boston, MA, USA) using the NCBInr
20091028database and the followingparameters: (i) enzyme:
trypsin; (ii) fixed modification: carbamidomethyl (C); (iii)
variable modifications: oxidation (M), methyl (K), and N-
acetyl (protein); (iv) peptide mass tolerance: 2 Da for
electrospray ionization measurements and 100 ppm for
MALDI measurements; (v) MS/MS mass tolerance: 0.8 Da;
(vi) peptide charges: 1+, 2+, and 3+; (vii) instrument:
electrospray ionization trap; and (viii) allow up to one
missed cleavage. Mascot results were further validated with
the Scaffold software V 2.6 (Proteome Software, Inc.,
Portland, OR, USA). Protein identification was accepted if
it could be established at N99.0% probability. In order to
determine the number of false-positive identifications, we
repeatedMASCOT searches and Scaffold evaluations with a
randomized version of the NCBInr database. For the
generation of this so-called “decoy database” consisting of
random sequences with the same average amino acid
composition, the decoy PerlScript (Matrix Science)was used.
Malachite Green GTPase activity assays
GTPase and ATPase activities were measured using the
Malachite Green Phosphate Kit (BioAssay) that quantifies
the green complex formed between Malachite Green,
molybdate, and free orthophosphate, as described
previously.73 All reactions contained 30–90 nM E. coli
70S ribosomes, S. acidocaldarius 30S or 50S subunits, 20 μM
GTP or ATP, and/or 30–90 nM EF-G. Reactions were
transferred onto 96-well microtiter plates and incubated at
37 °C or 60 °C for various lengths of time. Color formation
was measured on Tecan-Infinite M1000 microplate reader
at 650 nm. Reactions performed in the absence of
ribosomes were used as background signal to account
for the spontaneous hydrolysis of ATP or GTP.
Electron microscopy
Negative-stain EM
Ribosomal particles were resuspended in Tico buffer to
a final concentration of 0.5–1 A260/ml. One drop of each
sample was deposited on carbon-coated grids. After 45 s,
the grids were washed with distilled water. The grids
were then stained with three drops of 2% aqueous uranylacetate for 15 s, and excess liquid was removed again by
touching the grids with filter paper. Micrographs were
taken with a Morgagni transmission electron microscope
(FEI; 80 kV) equipped with a wide-angle 1000 CCD
camera.
Cryo-EM and single-particle reconstruction
As described previously,74 S. acidocaldarius and P.
aerophilum 50S subunits were applied to carbon-coated
holey grids. Images were collected on a Tecnai G2 Spirit
TEM at 120 kV at a nominal magnification of 90,000×
using an Eagle 4096×4096-pixel CCD camera (FEI),
resulting in a pixel size of 3.31 Å/pixel. The data were
analyzed by determining the contrast transfer function
with CTFFIND75 and were further processed with the
SPIDER software package,76 using the H. marismortui 50S
subunit [Protein Data Bank (PDB) code 3CC2]63 filtered to
between 20 Å and 25 Å as initial reference. For the final S.
acidocaldarius and P. aerophilum 50S subunit reconstruc-
tions, 9301 and 9183 particles were used, respectively.
Modeling and figure preparation
Themodel for the S. acidocaldarius 50S subunit utilized the
crystal structure of the archaeon H. marismortui 50S subunit
(PDB code 3CC2),63 with additional missing proteins added
using the location of the homologues in the eukaryotic 80S
ribosome.8,77 The models were fitted to the maps using
Chimera,78 and Figs. 5c and 6 were prepared using PyMOL
(The PyMOL Molecular Graphics System, version 1.3,
Schrödinger LLC) and Chimera, respectively.
Accession numbers
The cryo-EM maps of the S. acidocaldarius and P.
aerophilum 50S subunits have been deposited in the
three-dimensional EM database under accession numbers
EMD-1797 and EMD-1797, respectively.
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Figure S1: Mass spectrometric identification of L12p modifications 
MS/MS spectra (panels a) and fragmentation tables (panels b) used for the identification of N-
terminal acetylation (panel 1a and 1b), mono-methylation site K39 (2a and 2b) and mono-
methylation site K89 of ribosomal protein L12p. Mono-methylated lysines within the peptide 
sequences are underlined and marked as bold. Detected b ions are highlighted in red and y ions 
are highlighted in blue. 
  
Figure S2: Mass spectrometric identification of L  modifications 7  ae
MS/MS spectra (panels a) and fragmentation tables (panels b) used for the identification of N-
terminal acetylation (panel 1a and 1b), mono-methylation site K74 (2a and 2b) and mono-
methylation site K108 of ribosomal protein L7ae. Mono-methylated lysines within the peptide 
sequences are underlined and marked as bold. Detected b ions are highlighted in red and y ions 
are highlighted in blue. 
  
Figure S3: GTPase and ATPase activities of archaeal ribosomal subunits 
The amount of ATP or GTP hydrolyzed per hour (at 37 °C) by S. acidocaldarius 30S (squares) 
or 50S subunits (circles) or E. coli EF-G, alone (open triangle) or in the presence of E. coli 70S 
ribosomes (closed triangle) is presented as function of the ribosome/factor concentration. No 
ATP or GTP activity was seen for E. coli 70S ribosomes or S. acidocaldarius 30S or 50S 
subunits within 1 hour, whereas rapid GTP hydrolysis was observed with E. coli 70S ribosomes 
in the presence of E. coli EF-G. Similarly, no ATPase or GTPase activities were detected at 
60 °C for S. acidocaldarius 30S and 50S subunits (data not shown). However, after 24 hours 
(see inset), low GTPase and ATPase activities were detected for S. acidocaldarius 30S and 50S 
subunits, at levels similar to that observed for the intrinsic GTPase activity of E. coli EF-G. After 
24 hours, no ATPase/GTPase activity was detected for E. coli 70S ribosomes (diamonds).  
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Introduction
The bacterial elongation factor Tu (EF-Tu) was first described in
1966[1] and plays a crucial role in bacterial protein biosynthe-
sis.[2] EF-Tu is a guanosine triphosphatase (GTPase) and displays
high binding affinity for aminoacyl transfer RNA (aa-tRNA) in
the GTP-bound form.[3] During translation, EF-Tu is responsible
for the delivery of aa-tRNA to the ribosome in the form of a ter-
nary complex with GTP. Upon delivering the correct aa-tRNA to
the ribosome—that is, specific for the mRNA codon—GTP hy-
drolysis occurs, allowing dissociation of EF-Tu from the ribo-
some and accommodation of the aa-tRNA. Peptide bond for-
mation then occurs, incorporating the newly delivered amino
acid into the growing peptide chain.[4]
EF-Tu has been established as a validated drug target; it is
a ubiquitous enzyme essential for bacterial protein biosynthe-
sis.[5] EF-Tu differs significantly from the human elongation
factor eEF-1, guaranteeing desirable target specificity. Current-
ly, four structurally distinct compound classes are known to in-
hibit EF-Tu efficiently, for which prototypical examples are kir-
romycin, enacycloxin IIa, pulvomycin, and GE2270 A (1). It has
been shown that the binding sites of pulvomycin and
GE2270 A are similar,[6] whereas kirromycin[7] and enacyclo-
xin IIa[8] possess a different mode of action. GE2270 A and pul-
vomycin hinder the formation of the ternary complex between
EF-Tu, GTP, and aa-tRNA by binding to domain D2 of the
enzyme. Binding of GE2270 A and related thiopeptides does
not influence the GTPase activity of EF-Tu,[9] in accordance
with the fact that binding of GE2270 A to EF-Tu does not sig-
nificantly affect the catalytically active domain D1 of the pro-
tein.[6] Structural information about the interaction between
GE2270 A and EF-Tu is based on crystallographic data obtained
for EF-Tu·GDPNP·GE2270 A (GDPNP=guanosine-5’-(b,g-imino)-
triphosphate)[6b] and EF-Tu·GDP·GE2270 A (GDP=guanosine di-
phosphate).[6a] Binding occurs essentially along the cyclic thio-
peptide, whereas peripheral substituents are less important for
binding. All known naturally occurring GE2270 analogues,[10]
Three analogues of amythiamicin D, which differ in the substi-
tution pattern at the methine group adjacent to C2 of the thia-
zole ring C, were prepared by de novo total synthesis. In amy-
thiamicin D, this carbon atom is (S)-isopropyl substituted. Two
of the new analogues carry a hydroxymethyl in place of the
isopropyl group, one at an S- (compound 3a) and the other at
an R-configured stereogenic center (3b). The third analogue,
3c, contains a benzyloxymethyl group at an S-configured ste-
reogenic center. Compounds 3b and 3c showed no inhibitory
effect toward various bacterial strains, nor did they influence
the translation of firefly luciferase. In stark contrast, compound
3a inhibited the growth of Gram-positive bacteria Staphylococ-
cus aureus (strains NCTC and Mu50) and Listeria monocytogenes
EGD. In the firefly luciferase assay it proved more potent than
amythiamicin D, and rescue experiments provided evidence
that translation inhibition is due to binding to the bacterial
elongation factor Tu (EF-Tu). The results were rationalized by
structural investigations and by molecular dynamics simula-
tions of the free compounds in solution and bound to the EF-
Tu binding site. The low affinity of compound 3b was attribut-
ed to the absence of a critical hydrogen bond, which stabilizes
the conformation required for binding to EF-Tu. Compound 3c
was shown not to comply with the binding properties of the
binding site.
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which vary in the substituents at rings D and G or at the aspar-
agine-derived amide in the southwestern part of the molecule
(Figure 1), show an inhibitory effect on EF-Tu.[9–11] Because hy-
drolysis of the oxazoline (R at ring G) to a carboxylic acid is
facile, several modification studies were devoted to derivatiza-
tion at this site. In an early study the acid and reduced deriva-
tives of it were converted by conventional nucleophilic dis-
placement reactions into a plethora of compounds.[12] It was
shown that these modifications can lead to a higher aqueous
solubility while retaining biological activity. More recently, the
same thiazole carboxylic acid was degraded by a Curtius rear-
rangement to deliver the respective 4-aminothiazole.[13] Deriva-
tives of this compound showed promising activity toward sev-
eral multi-resistant bacterial strains.[14] Optimization studies led
to the discovery of two compounds with excellent physico-
chemical properties, including high water solubility.[15] Further
development resulted in an investigational drug (LFF571),
which shows superior activity against Clostridium difficile, a bac-
terium responsible for severe infections of the large intes-
tine.[16]
Chemical modifications were also performed at the phenyl-
glycine-derived northeastern part of GE2270 A located at posi-
tion C2 of thiazole ring C.[17] Removal of the a-hydroxybenzyl
group led to a complete loss of activity, whereas some activity
was retained in other derivatives in which the phenyl group
was still present. It was thus concluded that this part is insert-
ed into a lipophilic cavity of EF-Tu. Crystallographic data con-
firmed this view regarding the position of the phenyl group,[6]
but also indicated a hydrogen bond between the hydroxy
group of the phenylglycine to amino acid Glu226 of EF-Tu.
The proximity of this binding site to domain D1 of EF-Tu and
in particular to an a helix (His85–Ala97), the C-terminal end of
which is located in direct proximity to the catalytically active
site, makes this position attractive for further studies.
The research presented herein addresses the latter issue by
studying non-natural thiopeptides[18] for the first time, which
were synthesized de novo and modified at this critical site.
Compounds 3 (Figure 2) are analogues of amythiamicin D (2).
In the amythiamicins,[19] which are closely related to the GE fac-
tors, the residue at C2 of thiazole ring C is derived from
(S)-valine. Hydrogen bond formation with Glu226 of EF-Tu is
therefore unfeasible. However, there is evidence that the amy-
thiamicins also inhibit EF-Tu,[11,20] although they have been
studied less thoroughly than GE2270 A. Compound 3a bears
a hydroxymethyl group at an S-configured stereogenic center,
mimicking the a-hydroxybenzyl group present in GE2270 A.
Compound 3b is an epimer of compound 3a, exhibiting the
non-natural R configuration at the stereogenic center. Com-
pound 3c has a lipophilic benzyloxymethyl (BOM) group in-
stead of the polar hydroxy group.
Results and Discussion
De novo synthesis of thiopeptides 3a–3c
The synthetic strategy[21] toward compounds 3 was based on
earlier work that had culminated in the total synthesis of
GE2270 A[22] and amythiamicins C and D.[23] Key to this strategy
was the use of 2,6-dibromo-3-iodopyridine as pivotal building
block, to which the various thiazolyl fragments were coupled
in successive order.
In this context, the synthesis of the southern fragment 4 of
compounds 3 was reported earlier,[23] and its synthesis is not
discussed further. It is available from (S)-valine in seven steps
and with an overall yield of 22%. While the southern trithiazol-
yl part (rings D–F) and the northern thiazolyl fragment (ring G)
of compounds 2 and 3 are identical, synthetic access to the
eastern part (rings B and C) had to be individually secured by
preparation of compounds 5 (Scheme 1, TBS= tert-butyldime-
thylsilyl).
The Grignard addition to chiral sulfinyl imines has been es-
tablished by Ellman et al. as a useful method to generate chiral
amines,[24] and it was previously shown that 4-bromthiazolyl-2-
magnesium bromide adds efficiently to various imines derived
from enantiomerically pure tert-butylsulfinamide.[23] The auxili-
ary can be cleaved after addition by acidic methanolysis. A pu-
tative starting material for the desired target compound was
consequently an appropriately protected glycolaldehyde. Upon
monosilylation of glycol, the resulting primary alcohol was oxi-
dized to the respective aldehyde by Swern oxidation, which in
turn was immediately converted into the known[25] imine 6 by
Figure 1. Ring numbering in the thiazolyl peptide GE2270 A (1). Figure 2. Molecules 2 and 3a–c, of which the antibiotic activity and mode
of action on EF-Tu was investigated in this study.
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treatment with commercially available (R)-tert-butylsulfinamide
(see Supporting Information for details). Grignard addition of
the above-mentioned thiazolyl magnesium bromide (prepared
by bromine magnesium exchange of 2,4-dibromothiazole with
isopropyl magnesium bromide in THF/Et2O
[26]) proceeded
smoothly and delivered the desired products 7 as a mixture of
diastereomers (Scheme 2). Gratifyingly, their separation by
chromatography was facile, and products 7a and 7b were em-
ployed as individual diastereomers in the next step. Given that
both enantiomeric amino alcohols 8a and 8b were required
for our further investigations, the Grignard addition was not
thoroughly optimized. When performed at 78 8C in a 6:1 sol-
vent mixture of CH2Cl2 and ethers (THF/Et2O), there was no no-
table diastereoselectivity. As previously observed,[23] a larger
fraction of CH2Cl2 was required to achieve diastereoselectivity.
In the present case, the diastereomeric ratio (7a/7b) improved
to 73:27 in a 14:1 mixture of CH2Cl2/ether. The configuration at
the newly formed stereogenic center was determined by the
Mosher method[27] upon removal of the chiral auxiliary (Sup-
porting Information). The major enantiomer of the diastereose-
lective addition was shown to be S-configured. Based on the
conventional model for the Grignard addition to chiral sulfinyl
imines,[24] the result appears surprising, but the unusual behav-
ior of imine 6 had been previously discussed by Barrow
et al.[25]
Because removal of the auxiliary also led to silyl deprotec-
tion, the silyl group was installed again by treatment of alco-
hols 8 with TBSCl/NEt3. Introduction of the BOM group was
facile at this stage and delivered the required amine 9c from
amino alcohol 8a (Supporting Information). Peptide coupling
of amines 9 to 9-fluorenylmethyloxycarbonyl (Fmoc)-protected
glycine (Fmoc-Gly-OH) was achieved by treatment of the cou-
pling partners with bromotri(pyrrolidino)phosphonium hexa-
fluorophosphate (PyBrop).[28] To convert bromides 10 into suit-
able nucleophiles for a regioselective cross-coupling reaction
with the second thiazole fragment,[29] a stannylation was per-
formed with hexamethylditin at 100 8C in toluene using tetra-
kis(triphenylphosphine)palladium as the catalyst.[30] Stannanes
11 underwent a smooth Stille cross-coupling[31] with 2,4-dibro-
mothiazole,[32] which was used in slight excess (1.4 equiv),
yielding the desired dithiazoles 12 in high yields (Scheme 3).
4-Bromodithiazoles 12 were converted into the correspond-
ing stannanes by another palladium-catalyzed stannyl debro-
mination. Removal of the Fmoc protecting group with piperi-
dine delivered the free amines 5 in high yields. The order of
events for the incorporation of building blocks 5 into a pyridine
fragment and the choice of this fragment was based on previ-
ous experience (Scheme 4). In the synthesis of GE2270 A,[22] it
had been found that a macrocyclization by Stille cross-cou-
pling after preceding amide bond formation provides signifi-
cantly higher yields than an initial Stille cross-coupling fol-
lowed by macrolactamization. In the synthesis of amythiami-
cin C,[23] it was found that amide bond formation with the acid
derived from ester 4 is feasible, but the subsequent ring clo-
sure, which requires a regioselective Stille cross-coupling at C2
of the pyridine core, is not sufficiently selective. Therefore,
Scheme 1. Retrosynthetic disconnection of compounds 3a–3c leading to
different eastern fragments 5a–5c, which were to be individually synthe-
sized. See Figure 2 for the configuration in the dashed (a) box.
Scheme 2. Preparation of enantiomeric amino alcohols 8a and 8b via the
respective diastereomeric sulfinyl amines 7a and 7b and their conversion
into the O-protected amino alcohols 9a and 9b.
Scheme 3. Synthesis of stannylated compounds 5a–5c from the respective
bromothiazoles 9a–9c, employing regioselective Stille cross-coupling reac-
tions on 2,4-dibromothiazole as the key step.
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ester 4 was converted according to known method-
ology[23] into the previously described pyridine frag-
ment 13. Coupling of the two fragments to amides
14 was achieved with diphenylphosphoryl azide
(DPPA)[33] in the presence of Hnig’s base. We were
pleased to note that the Stille cross-coupling proto-
col was also successful for substrates 14 and deliv-
ered macrolactams 15 in moderate to good yields.
Cleavage of the tert-butyl ester in ring G was possible
with trifluoroacetic acid (TFA), which also led to
cleavage of the TBS ether. Because TBS deprotection
was relatively slow for substrate 15a leading to side reactions
and a diminished yield, deprotection of substrate 15b was per-
formed by an initial treatment with TFA and subsequent addi-
tion of HF·pyridine. Yields were significantly higher with this
modification than the TFA deprotection used for 15a. Conver-
sion of the free acids into the desired methyl esters 3 was per-
formed with trimethylsilyl diazomethane.
Biological activity and translation assays
To assess the biological activities of amythiamicin D (2) and the
synthetic derivatives 3a–3c, the minimal inhibitory concentra-
tion (MIC) was determined for the Gram-positive bacteria
Staphylococcus aureus (strains NCTC and Mu50), Listeria mono-
cytegenes EGD and Streptococcus pyogenes ATCC 10231, as well
as the Gram-negative bacterium Pseudomonas aeruginosa PA01
and compared with control antibiotics kirromycin and the ami-
noglycoside kanamycin (Table 1).[34] Amythiamicin D was previ-
ously shown to inhibit the growth of many Gram-positive bac-
teria, but not Gram-negative bacteria such as E. coli.[19] We con-
sistently found that compound 2 displays excellent biological
activity against S. aureus and L. monocytogenes with an MIC50
value of 0.32 mm, yet displays no activity against S. pyogenes or
P. aeruginosa. A similar activity profile was observed for the
synthetic derivative 3a, although the MIC values were some-
what higher for the S. aureus and L. monocytogenes strains,
when compared with 2. In contrast, compounds 3b and 3c
displayed no activity against any of the strains tested, even at
concentrations up to 100 mm (Table 1).
Although amythiamicins display poor activity against Gram-
negative organisms such as P. aeruginosa (Table 1) and E. coli,[19]
inhibitory effects of amythiamicins on translation of poly(U)-di-
rected poly(Phe) synthesis using an E. coli in vitro translation
system has been demonstrated.[20] This indicates that the inac-
tivity of amythiamicins in blocking bacterial growth can be re-
lated to other factors such as membrane penetration rather
than a lack of effect on translation. Therefore, to directly assess
the effect of amythiamicin derivatives 3a–3c on protein syn-
thesis, we monitored the translation of firefly luciferase (Fluc)
in an E. coli cell-free in vitro translation system in the presence
of increasing concentrations of amythiamicin D (2) or one of
the synthetic derivatives 3a–3c (Figure 3A). As expected,[20] 2
is a potent inhibitor of protein synthesis with a half-inhibitory
concentration (IC50 value) of ~10 mm. Surprisingly, however, the
synthetic derivative 3a displayed improved inhibitory activity,
with IC50 ~4 mm, at least twofold better than amythiamicin D.
In contrast, derivatives 3b and 3c were completely inactive,
even at high drug concentrations up to 40 mm. This suggests
that the lack of effect of thiopeptides 3b and 3c on the
growth of S. aureus and L. monocytogenes strains (Table 1) may
indeed be due to an inability to inhibit protein synthesis,
rather than an inability to penetrate the cell wall.
The structural similarity between amythiamicins and
GE2270 A (1) suggests that amythiamicins also inhibit transla-
Scheme 4. Peptide bond formation between pyridine core fragment 13 and the individual building blocks 5a–5c (cf. Schemes 1–3) followed by a macrocycli-
zation via Stille cross-coupling and two functional group transformation steps toward products 3a–3c. The hydrolysis of the tert-butyl ester 15b with TFA
was followed by addition of HF·py to complete the desilylation.
Table 1. Minimal inhibitory concentrations of synthetic derivatives 3a–3c relative to
amythiamicin D (2), kirromycin, and kanamycin.
Strain MIC [mm]
kanamycin kirromycin 2 3a 3b 3c
S. aureus NCTC 8325 2.56 >100 0.32 0.64 >100 >100
S. aureus Mu50 >100 >100 0.32 1.28 >100 >100
L. monocytogenes EGD-e 12.8 2.56 0.32 5.12 >100 >100
S. pyogenes ATCC 10231 100 0.32 >100 >100 >100 >100
P. aeruginosa PA01 >100 >100 >100 >100 >100 >100
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tion by interaction with EF-Tu, consistent with the observation
that resistance to amythiamicins results from mutation with
tufA, the gene for EF-Tu.[20] We reasoned that if EF-Tu is the
target of amythiamicin derivative 3a, then increasing the con-
centration of EF-Tu within the in vitro translation assays should
relieve the inhibition of translation resulting from amythiami-
cins. As is apparent in Figure 3B, the presence of 3a at 5 mm
decreases translation to 20%, which can be restored to 100%
by the addition of an extra 5 mm recombinantly purified EF-Tu
protein. As a control, the presence of additional EF-Tu was
shown to have no significant effect on translation of Fluc in
the absence of the drug.
The rescue of translation by the presence of additional EF-Tu
is analogous to the target overexpression mechanisms that are
used by some bacteria to obtain resistance to various antibiot-
ics.[35] Consistently, when the same experiment was performed
in the presence of higher saturating concentrations of 3a
(30 mm), no rescue was observed (Figure 3C).
Next, we rationalized that if amythiamicins do indeed target
EF-Tu, then titrating in an EF-Tu mutant protein that is resistant
to thiopeptides should rescue translation to some extent, even
in the presence of saturating drug concentrations. It has been
reported that mutation of glycine at position 257 to serine in
E. coli EF-Tu confers resistance to the thiopeptide GE2270 A by
allowing simultaneous binding of the antibiotic and aa-tRNA
to EF-Tu.[36] We found that EF-Tu-G257S protein alone inhibits
translation by ~60% at 1 mm (Supporting Information). Never-
theless, in the presence of 30 mm 3a, it was indeed possible to
rescue translation with the EF-Tu-G257S mutant, but not with
wild-type EF-Tu. These findings not only support that the amy-
thiamicin D derivative 3a binds to EF-Tu, but also suggests
that it interacts with EF-Tu in a manner analogous to
GE2770 A, as expected based on the similarity in their chemical
structures.
Structural investigations
The experimental structure of GE2270 A bound to
EF-Tu·GDPNP[6b] was used to investigate the structural basis of
the binding behavior of the synthesized compounds;
GE2270 A binds competitively to the aa-tRNA binding site of
EF-Tu (Figure 4). The binding site of GE2270 A is located at the
interface between domains D1 and D2, where the aa-tRNA
binds with its 3’ end. GE2270 A predominantly binds to D2
with the upper part of its thiazolyl ring contacting D1 in EF-
Tu·GDPNP. Through binding of the antibiotic the interface ge-
ometry is widened, leading to a gap between the two domains
in which the antibiotic compound is bound. Consequently, the
binding site is blocked and thus binding of the 3’ end of the
aa-tRNA is inhibited by steric hindrance (Figure 4).
To elucidate the structural basis for the different binding be-
haviors of compounds 2 and 3a–3c we first investigated their
structures in aqueous solution by preliminary NMR experi-
ments (Supporting Information) and by more extensive molec-
ular dynamics (MD) and docking simulations. In previous
work,[38] it was established by a detailed NMR study of amythia-
micin D that a single hydrogen bond is present between the
carbonyl group at C28 and the proton at N13 (Figure 2), signifi-
cantly stabilizing the ring conformation. The same hydrogen
bond is present in the crystal structure of the EF-Tu·GDPNP·
GE2270 A complex (Figure 4),[6b] indicating that the stabilized
Figure 3. Translation inhibition by amythiamicin D and synthetic derivatives. A) Effect of increasing concentrations of amythiamicin D (2, ^) and the amythia-
micin D derivative 3a (&), 3b (~), and 3c (*) on the translation of firefly luciferase. B) Effect of increasing concentrations of EF-Tu in the presence of 5 mm
amythiamicin D derivatives 3a (^) and absence of drug (^). C) Effect of increasing concentrations of wild-type EF-Tu (^) or EF-Tu-G257S (^) in the presence
of 30 mm amythiamicin D derivatives 3a (^). The firefly luminescence in the absence of drug was assigned as 100%, and error bars display the standard devia-
tion from the mean for three individual experiments.
Figure 4. Structure of EF-Tu·GDPNP (blue/green ribbons) with bound
GE2270 A (red sticks) (PDB ID: 2C77).[6b] The additionally shown Phe-tRNA
strand (grey) was extracted from the corresponding superimposed
EF-Tu·GDPNP·Phe-tRNA structure (PDB ID: 1TTT),[37] and superimposition
was performed based on the EF-Tu backbone.
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ring conformation in solution is retained upon binding to
EF-Tu. As a result of the fixed conformation, the diastereotopic
protons at the methylene group C11 of the side chain between
rings E and F result in distinct peaks, which are clearly separat-
ed in the 1H NMR spectrum (see 1H NMR data in the Support-
ing Information). In stark contrast, a significant peak broaden-
ing was detected for the same protons in the 1H NMR spec-
trum of compound 3b. Only one peak was recorded at room
temperature, which was significantly broadened upon cooling
(Supporting Information). Although this observation could be
explained by other biophysical effects, it is most likely to indi-
cate that the unusual R-stereogenic center at R1 in compound
3b leads to significant changes in the ring conformation and
to a higher degree of ring flexibility, averaging out the environ-
ment of the two protons. The higher flexibility, in turn, appears
to be due to the lack of a hydrogen bond between the car-
bonyl group at C28 and the proton at N13 in 3b.
To further investigate this topic we performed MD simula-
tions of the free compounds in solution and bound to the EF-
Tu binding site. The solution results are shown in Figure 5. For
compounds 2, 3a, and 3c the same predominant ring confor-
mation was observed (Figure 5A–C,E and Supporting Informa-
tion (SI) figure SI4) for all three compounds. This conformation
is very similar to the bound conformation of GE2270 A in EF-Tu
(Figure 4) and is in agreement with the NMR results, as the
ring is stabilized in all three cases by the same hydrogen bond
between the C28 carbonyl group and the proton at N13 as
also observed by Lewis et al.[38] In compound 3b the R-stereo-
genic center at C2 of the thiazole ring C leads to a geometrical
inversion of its bonds to its neighboring ring atoms and its
side chain. This causes a 1808 rotation of the neighboring pep-
tide group containing C28, and thus the ring stabilizing the hy-
drogen bond between N13 and the C28 carbonyl group is
broken (Figure 5D, SI figure SI4d). Therefore, significant altera-
tions in the overall ring conformation can be observed, togeth-
er with a higher flexibility in its side chains. This leads to a dif-
ferent and less planar overall conformation than the ring con-
formation of compounds 2, 3a, and 3c (see Figure 5E,F).
Therefore compound 3b has different steric and interaction re-
quirements for successful protein binding. As the bound con-
formation of GE2270 A is close to the solution structures of
compounds 2, 3a, and 3c and also features the conserved hy-
drogen bond, it can be assumed that adopting this conforma-
tion in solution is a prerequisite for stable binding of the com-
pounds to EF-Tu, which may explain the nonbinding behavior
of compound 3b (Figure 3).
To further substantiate this hypothesis, docking-based MD
simulations were performed for all four compounds using the
docking software DynaDock.[39] As the algorithm is MD based,
it allows full flexibility of the whole system and a proper treat-
ment of the changes in the protein binding site upon ligand
binding. This is important in the case of EF-Tu, as the binding
site is very flexible, and large movements can be observed
upon ligand binding. For the docking simulations the com-
pounds were placed within the binding site based on their so-
lution conformation of the ring system. Conformational sam-
pling of all side chains and rotation and translation of the
whole compound was then performed. In a second step, MD
simulations were performed for the best-docked conforma-
tions to investigate the stability of the predicted complexes.
The final equilibrated structures after MD refinement are
provided in Figure 6 and in the Supporting Information (figur-
es SI1 and SI2). In the case of compounds 2 and 3a, stable
complexes with a bound ring conformation close to GE2270 A
could be obtained, indicating stable, strong binding to EF-Tu
(see SI figure SI1c,d). In both cases a strong hydrogen bond
network was formed between the ring system and the neigh-
boring residues Asn285 and Gln98, which is further stabilized
by an additional hydrogen bond between His67 and Gln98.
The ring-stabilizing intramolecular C28O–N13 hydrogen bond
as observed for GE2270 A was retained (SI figure SI6). In addi-
tion, for the hydroxy group at R1 in compound 3a, fluctuating
hydrogen bonds were observed with Glu226, Thr239, and
Gln98 (SI figure SI2a).
This hydrogen bond pattern is consistent with the pattern
observed for the experimental structure of the EF-Tu·GDPNP·
GE2270 A complex.[6b] In both cases the hydroxy groups of R1
(Figure 1) form additional hydrogen bonds, but the hydrogen
bond pattern of the hydroxy group is more restricted in
GE2270 A due to the steric lock position by the additional
phenyl ring. The hydroxy group in compound 3a is very flexi-
ble and is thus able to form alternative hydrogen bonds
Figure 5. Solution structures of compounds A) 2, B) 3c, C,E) 3a, and D,F) 3b
after 1 ns MD simulation. In E) and F) compounds 3a and 3b are shown
with the ring plane being rotated by 908 with respect to the perspective
shown in parts C) and D).
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throughout the surrounding lipophilic sub-pocket. Conse-
quently, its position fluctuates between the corresponding hy-
drogen bond forming residues.
The nonbinding behavior of compound 3c is more difficult
to explain: During the initial placement of compound 3c only
one favorable binding mode was found in which the BOM side
chain is located in a stretched conformation inside a side
cavity of the binding site (Figure 6c, red ligand conformation).
However, due to the large amount of charged and polar side
chains alongside this cavity, the bound conformation is not
stable during the following MD simulation, leading to an al-
tered ring conformation and movement of the BOM side chain
out of its cavity (Figure 6C, SI figure SI5). Therefore, it is unlike-
ly that BOM moves into this cavity during the real binding pro-
cess, explaining its nonbinding behavior.
In the case of compounds 3b and 3c, the MD simulations
showed that the complexes are not stable, as the compounds
slowly move out of the binding site (Figure 6B,C, SI figure SI5).
In the case of compound 3b this is due to inversion of the
binding geometry at the R-stereogenic center and thus forma-
tion of a bulky ring conformation, which is not compatible
with the rather flat b-sheet-based surface of the binding site
and its hydrogen bonding pattern, thus leading to a movement
of the ligand out of the binding site (Figure 6B, SI figures SI1b
and SI5), consistent with the lack of EF-Tu binding observed
experimentally (Figure 3).
Conclusions
Based on an expedient synthetic access, three analogues (3a–
3c) of amythiamicin D (2) have become available, which
cannot be obtained by degradation studies or any other
means. Translation studies revealed that compound 3a shows
enhanced potency in EF-Tu inhibition relative to the natural
product. The activity of both amythiamicin D and compound
3a could be nicely corroborated based on MD simulations:
Compounds 3b and 3c were inactive in both antibacterial and
in vitro translation assays. The nonbinding behavior of 3b can
be explained by a ring conformation that is—due to the ab-
sence of a crucial hydrogen bond—different from those of the
other thiopeptides. The conformational change is induced by
the stereogenic center at the crucial methine carbon atom ad-
jacent to C2 of thiazole ring C, which is distinct from the 2 and
3a R configuration. The inactivity of 3c is remarkable because
it was envisioned that the lipophilic BOM group would be
complementary to the hydrophobic pocket between domains
D2 and D3. However, due to the size, electrostatic properties,
and flexibility of the BOM group, it appears that it does not
comply with the binding properties of the binding site.
The present study is the first to have used de novo synthe-
sized non-natural thiopeptides. It provides unambiguous evi-
dence that readily available synthetic analogues of the amy-
thiamicins and the GE factors bind efficiently to the previously
described binding site of EF-Tu. In this regard, compound 3a
can serve as a versatile scaffold to study the effect of various
substitution patterns on the activity of EF-Tu and on conforma-
tional changes induced by non-natural ligands.
Experimental Section
Synthetic studies : Experimental procedures and characterization
data (including NMR spectra) for all new compounds are provided
in the Supporting Information. Analytical data for the three amy-
thiamicin derivatives 3a–3c are given below.
Thiopeptide 3a. Rf=0.35 (CH2Cl2/MeOH=10:1, UV); [a]D
20= +
33.0 cm3g1dm1 (c=0.10 in CHCl3) ;
1H NMR (CDCl3, 500 MHz): d=
0.93 (d, 3J=6.5 Hz, 3H), 1.00 (d, 3J=6.7 Hz, 3H), 2.19 (mc, 1H), 2.40
(br s, 2H), 2.62 (br s, 3H), 2.68 (s, 3H), 4.01 (s, 3H), 4.12 (br s, 2H),
4.28 (d, 2J=17.1 Hz, 1H), 4.63 (d, 2J=17.1 Hz, 1H), 5.28–5.34 (m,
2H), 5.47 (s, 1H), 6.76 (br s, 1H), 7.34 (s, 1H), 7.92 (s, 1H), 7.99–8.10
(m, 2H), 8.06 (d, 3J=7.5 Hz, 1H), 8.11 (s, 1H), 8.24–8.35 (m, 4H),
8.37 ppm (d, 3J=7.5 Hz, 1H); 13C NMR (CDCl3, 126 MHz): d=12.6,
18.5, 19.0, 26.3, 35.0, 38.3, 42.8, 49.1, 52.7, 54.7, 55.0, 64.2, 115.8,
118.9, 121.7, 123.8, 125.4, 128.2, 130.6, 139.7, 141.3, 142.2, 148.2,
148.6, 148.8, 150.0, 150.7, 154.0, 160.3, 160.7, 161.4, 161.7, 161.8,
165.1, 166.0, 168.7, 169.2, 169.8, 170.3, 170.4 ppm; IR (ATR): ~n=
2956 (w), 2924 (m), 2850 (w), 1654 (m), 1542 (m), 766 (w), 667 cm1
Figure 6. Stable binding of A) GE2270 A (1) and unstable binding of compounds B) 3b and C) 3c after 1 ns MD simulations. The final ligand conformations of
the simulations are shown in stick representation colored by atom type. The starting conformations of compounds 3b and 3c are provided in red for com-
parison. The ring-stabilizing hydrogen bond is shown in magenta.
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(w); MS (ESI): m/z (%)=1041 (45), 1019 (100); HRMS (ESI): m/z=
C41H39N12O8S6 [M+H]
+ , calcd: 1019.1333, found: 1019.1332.
Thiopeptide 3b. Rf=0.35 (CH2Cl2/MeOH=10:1, UV); [a]D
20= +
33.0 cm3g1dm1 (c=0.10 in CHCl3) ;
1H NMR (CDCl3, 500 MHz): d=
0.93 (d, 3J=6.5 Hz, 3H), 1.00 (d, 3J=6.7 Hz, 3H), 2.19 (mc, 1H), 2.40
(br s, 2H), 2.62 (br s, 3H), 2.68 (s, 3H), 4.01 (s, 3H), 4.12 (br s, 2H),
4.28 (d, 2J=17.1 Hz, 1H), 4.63 (d, 2J=17.1 Hz, 1H), 5.28–5.34 (m,
2H), 5.47 (s, 1H), 6.76 (br s, 1H), 7.34 (s, 1H), 7.92 (s, 1H), 7.99–8.10
(m, 2H), 8.06 (d, 3J=7.5 Hz, 1H), 8.11 (s, 1H), 8.24–8.35 (m, 4H),
8.37 ppm (d, 3J=7.5 Hz, 1H); 13C NMR (CDCl3, 126 MHz): d=12.6,
18.5, 19.0, 26.3, 35.0, 38.3, 42.8, 49.1, 52.7, 54.7, 55.0, 64.2, 115.8,
118.9, 121.7, 123.8, 125.4, 128.2, 130.6, 139.7, 141.3, 142.2, 148.2,
148.6, 148.8, 150.0, 150.7, 154.0, 160.3, 160.7, 161.4, 161.7, 161.8,
165.1, 166.0, 168.7, 169.2, 169.8, 170.3, 170.4 ppm; IR (ATR): ~n=
2956 (w), 2924 (m), 2850 (w), 1654 (m), 1542 (m), 766 (w), 667 cm1
(w); MS (ESI): m/z (%)=1041 (45), 1019 (100); HRMS (ESI): m/z=
C41H39N12O8S6 [M+H]
+ , calcd: 1019.1333, found: 1019.1332.
Thiopeptide 3c. Rf=0.20 (CH2Cl2/MeOH=20:1, UV); [a]D
20= +
137 cm3g1dm1 (c=0.09 in CHCl3);
1H NMR (CDCl3, 500 MHz): d=
0.88 (d, 3J=6.8 Hz, 3H), 0.96 (dd, 2J=17.5 Hz, 3J=5.9 Hz, 1H), 1.00
(d, 3J=6.8 Hz, 3H), 2.28 (mc, 1H), 2.63 (d,
3J=4.8 Hz, 3H), 2.65 (s,
3H), 2.70 (dd, 2J=17.5 Hz, 3J=3.5 Hz, 1H), 3.59 (dd, 2J=17.6 Hz,
3J=3.3 Hz, 1H), 3.94 (dd, 2J=10.7 Hz, 3J=3.6 Hz, 1H), 4.01 (dd, 2J=
10.7 Hz, 3J=4.0 Hz, 1H), 4.02 (s, 3H), 4.59 (d, 2J=11.7 Hz, 1H), 4.67
(d, 2J=11.7 Hz, 1H), 4.79 (dd, 2J=17.6 Hz, 3J=9.7 Hz, 1H), 4.84 (d,
2J=6.8 Hz, 1H), 4.89 (d, 2J=6.8 Hz, 1H), 5.23 (dd, 3J=7.9, 4.7 Hz,
1H), 5.39 (mc, 2H), 6.80 (d,
3J=4.8 Hz, 1H), 6.91 (d, 3J=6.0 Hz, 1H),
7.27 (s, 1H), 7.33–7.42 (m, 5H), 7.71 (dd, 3J=9.7, 3.3 Hz, 1H), 8.11
(s, 1H), 8.13 (d, 3J=8.1 Hz, 1H), 8.26 (s, 1H), 8.36 (s, 1H), 8.38 (s,
1H), 8.38 (d, 3J=8.1 Hz, 1H), 8.76 (d, 3J=7.9 Hz, 1H), 8.99 ppm (d,
3J=9.2 Hz, 1H); 13C NMR (CDCl3, 126 MHz): d=12.3, 18.0, 18.4, 26.2,
34.7, 38.3, 41.1, 48.2, 52.6, 53.3, 56.1, 69.9, 70.8, 95.9, 115.0, 118.7,
123.2, 123.8, 125.2, 127.7, 127.9, 128.3, 128.8, 130.5, 137.1, 140.4,
140.5, 142.1, 148.2, 148.4, 148.8, 150.2, 150.3, 150.5, 154.5, 159.8,
161.2, 161.3, 161.8, 162.0, 164.8, 167.6, 168.5, 169.0, 169.7,
170.7 ppm; IR (ATR): ~n=2928 (w), 1658 (s), 1543 (s), 1494 (m), 1210
(m), 1051 (m), 751 cm1 (s) ; MS (ESI): m/z (%)=1161 (50), 1139
(100), 1107 (4); HRMS (ESI): m/z=C49H47N12O9S6 [M+H]
+ , calcd:
1139.1907, found: 1139.1887.
Determination of MIC values :[40] Substances were added in different
concentrations to 1 mL B-broth [yeast extract (5.0 g), tryptic pep-
tone (10.0 g), NaCl (5.0 g), K2HPO4 (1.0 g), H2O (1.0 L)] including
a control with DMSO. The tubes were inoculated with 1106 bac-
teria per mL (OD: 0.6–0.8) and incubated overnight with shaking at
37 8C. The OD600 value of 1:10 diluted overnight cultures was mea-
sured to determine the minimal inhibitory concentration (MIC). All
experiments were conducted at least in triplicate, and DMSO
served as control.
Reagents, bacterial strains, and vectors : The E. coli EF-Tu gene (tufA)
cloned into pPROEX-Ht-b was a kind gift from Prof. Knud Nierhaus
(MPIMG, Berlin).
In vitro translation assays : In vitro translation assays were per-
formed using a homemade E. coli strain BL21 (Invitrogen) S12
lysate-based system, as described previously.[41] As before,[42] trans-
lation of the firefly luciferase (Fluc) reporter was monitored by
measuring the luciferase activity in the presence and absence of
antibiotic and/or EF-Tu.
Protein expression and purification : The QuikChange Site-directed
Mutagensis kit (Stratagene) was used to generate E. coli EF-Tu
mutant G257S in pPROEX-Ht-b. Wild-type EF-Tu and the G257S
mutant were overexpressed in E. coli strain BL21(DE3) and purified
using the N-terminal histidine tags via Ni-NTA affinity columns
(QIAGEN) and subsequent gel-filtration chromatography on HiLoad
16/60 Superdex 75 prep grade column (Amersham–Pharmacia) in
a buffer containing 20 mm HEPES (pH 7.8) and 150 mm NaCl.
Computational studies : Details of the methods employed for in
silico experiments as well as additional figures (SI1–SI6) and a brief
discussion of the simulation details are provided in the Supporting
Information.
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General remarks: All reactions involving water-sensitive chemicals were carried out in 
flame-dried glassware with magnetic stirring under argon. Tetrahydrofuran (THF), diethyl 
ether (Et2O) and dichloromethane (CH2Cl2) were dried using a SPS-800 solvent purification 
system (M. Braun). Chemicals were either commercially available or prepared according to 
the cited references. TLC was performed on silica coated glass plates (0.25 mm silica gel 60 
F254) with detection by UV (254 nm) or KMnO4 (0.5% in water) with subsequent heating. 
Flash chromatography was performed on silica gel 60 (Merck, 230-400 mesh) with the 
indicated eluent. Common solvents for chromatography such as pentane (P), ethyl acetate 
(EtOAc), diethyl ether, dichloromethane and methanol (MeOH) were distilled prior to use. IR: 
JASCO IR-4100 (ATR). MS and HRMS: Finnigan MAT 8200 (MS-EI) and Finnigan MAT 95S 
(HRMS-EI). 1H and 13C NMR: Bruker AV-200 and Bruker AV-360, recorded at 296 K. 
Chemical shifts are reported relative to tetramethylsilane. The multiplicities of the 13C NMR 
signal were determined by DEPT experiments, assignments are based on COSY, HMBC and 
HMQC experiments. 1H or 13C NMR signals are usually assigned using significant short 
sections of the molecular formular. Optical rotations were measured using a Perkin-Elmer 
241 MC Polarimeter. 
Compound 6[1] 
To a solution of 2-(tert-butyldimethylsilyloxy)acetaldehyd (3.19 g, 18.3 mmol) 
and (RS)-2-methyl-2-propanesulfinamide (2.01 g, 16.6 mmol) in CH2Cl2 (30 
mL) was added anhydrous CuSO4 (5.29 g, 33.2 mmol) and the resulting suspension was 
stirred overnight at room temperature. The mixture was diluted with CH2Cl2 (50 mL) and 
filtered through celite. The solvent was removed in vacuo and the residue was purified by 
flash chromatography (P/EtOAc = 8:1) yielding sulfinamide 6 (4.24 g, 15.3 mmol, 92%) as a 
colorless oil. Rf = 0.35 (P/EtOAc = 8:1, UV), [α]D20 = −157 (c = 1.28 in CHCl3); 1H-NMR 
(CDCl3, 360 MHz): δ(ppm) = 0.10 [s, 6 H, Si(CH3)2], 0.91 [s, 9 H, SiC(CH3)3], 1.20 [s, 9 H, 
                                               
[1]
 J. C. Barrow, P. L. Ngo, J. M. Pellicore, H. G. Selnick, P. G. Nantermet, Tetrahedron Lett. 2001, 42, 
2051-2054. 
   S2 
 
SC(CH3)3], 4.54 (d, 3J = 3.0 Hz, 2 H, CH2OTBS), 8.06 (t, 3J = 3.0 Hz, 1 H, N=CH); 13C-NMR 
(CDCl3, 91 MHz): δ(ppm) = −4.9 [q, Si(CH3)2], 18.8 [s, SiC(CH3)3], 22.8 [q, SC(CH3)3], 26.2 [q, 
SiC(CH3)3], 57.3 [s, SC(CH3)3], 65.9 (t, CH2OTBS), 169.2 (d, N=CH). 
Compounds 7a and 7b 
To a solution of 2,4-Dibromothiazole (4.73 g, 19.5 mmol) in THF (10 
mL) was added iPrMgBr (4.90 mL, 19.5 mmol, 4.0 M in Et2O) at 0 °C 
and the mixture was stirred for 2 h. The obtained Grignard reagent was 
then added to a solution of sulfinamide 6 (3.00 g, 10.5 mmol) in CH2Cl2 
(200 mL), cooled to −78 °C. The mixture was allowed to warm up to 
room temperature overnight, before the reaction was quenched by 
addition of sat. NH4Cl solution (200 mL). The layers were separated 
and the aqueous layer was extracted with CH2Cl2 (2 × 100 mL). The 
combined extracts were washed with brine (1 × 200 mL) and dried over Na2SO4. After 
filtration the solvent was removed under reduced pressure. Purification by flash 
chromatography (P/EtOAc = 4:1) yielded the major diastereoisomer 7a (3.15 g, 7.13 mmol, 
66%), the minor diastereoisomer 7b (1.18 g, 2.67 mmol, 25%) and mixed fractions (86.2 mg, 
0.20 mmol, 2%) as yellow oils. Diastereoisomer 7a: Rf = 0.25 (P/EtOAc = 4:1, UV); [α]D20 = 
−49.7 (c = 1.15 in CHCl3); IR (ATR): ν~ [cm-1] = 2942 (m, NH), 2856 (m), 1470 (m), 1252 (m), 
1077 (s), 834 (s), 776 (m), 757 (m); 1H-NMR (CDCl3, 360 MHz): δ(ppm) = −0.07 (s, 3 H, 
SiCH3), −0.04 (s, 3 H, SiCH3), 0.81 [s, 9 H, SiC(CH3)3], 1.30 [s, 9 H, SC(CH3)3], 4.08 (dd, 2J = 
9.8 Hz, 3J = 3.8 Hz, 1 H, CHHOTBS), 4.16 (dd, 2J = 9.8 Hz, 3J = 3.7 Hz, 1 H, CHHOTBS), 
4.65 (d, 3J = 6.5 Hz, 1 H, NH), 4.77-4.82 (m, 1 H, CHNH), 7.16 (s, 1 H, C: 5-H); 13C-NMR 
(CDCl3, 91 MHz): δ(ppm) = −5.7 (q, SiCH3), −5.4 (q, SiCH3), 18.1 [s, SiC(CH3)3], 22.6 [q, 
SC(CH3)3], 25.7 [q, SiC(CH3)3], 56.4 [s, SC(CH3)3], 59.1 (d, CHNH), 66.1 (t, CH2OTBS), 
117.4 (d, C: C5), 125.1 (s, C: C4), 173.8 (s, C: C2); MS (EI, 70 eV): m/z (%) = 386 (10) 
[(M(81Br)−C4H8)+], 384 (10) [(M(79Br)−C4H8)+], 329 (10), 327 (10), 264 (22), 190 (25), 89 (38), 
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75 (58), 73 (54), 57 (100) [C4H9+]; HRMS (EI): m/z = C11H2179BrN2O2S2Si [(M(79Br)−C4H8)+], 
calcd.: 383.9997, found: 383.9998; Diastereoisomer 7b: Rf = 0.15 (P/EtOAc = 4:1, UV); [α]D20 
= −1.30 (c = 1.10 in CHCl3); 1H-NMR (CDCl3, 360 MHz): δ(ppm) = −0.06 (s, 3 H, SiCH3), 
−0.01 (s, 3 H, SiCH3), 0.82 [s, 9 H, SiC(CH3)3], 1.23 [s, 9 H, SC(CH3)3], 3.89 (dd, 2J = 9.8 Hz, 
3J = 5.0 Hz, 1 H, CHHOTBS), 4.04 (dd, 2J = 9.8 Hz, 3J = 3.6 Hz, 1 H, CHHOTBS), 4.65 (d, 2J 
= 6.5 Hz, 1 H, NH), 4.75-4.80 (m, 1 H, CHNH), 7.18 (s, 1 H, C: 5-H); 13C-NMR (CDCl3, 91 
MHz): δ(ppm) = −5.7 (q, SiCH3), −5.6 (q, SiCH3), 18.1 [s, SiC(CH3)3], 22.5 [q, SC(CH3)3], 25.7 
[q, SiC(CH3)3], 56.7 [s, SC(CH3)3], 57.1 (d, CHNH), 66.4 (t, CH2OTBS), 117.6 (d, C: C5), 
124.5 (s, C: C4), 172.2 (s, C: C2). 
Compound 8a 
To a solution of sulfinamide 7a (5.64 g, 12.8 mmol) in MeOH (100 mL) 
was added 4 M HCl in dioxane (6.40 mL, 25.6 mmol) and the mixture 
was stirred for 1 h at room temperature. The solvent was removed under 
reduced pressure and the residue was taken up in EtOAc (150 mL). 2 M NaOH (150 mL) 
was added, the layers were separated and the aqueous layer was extracted with EtOAc (2 × 
100 mL). The combined organic layers were washed with brine (1 × 100 mL) and dried over 
Na2SO4. After filtration and evaporation of the solvent the crude product was purified by flash 
chromatography (CH2Cl2/MeOH = 10:1) to yield 8a (2.41 g, 10.8 mmol, 84%) as a pale-
yellow solid. Rf = 0.35 (CH2Cl2/MeOH = 10:1); [α]D20 = −31.7 (c = 1.03 in CHCl3); M.p. 112 °C; 
IR (ATR): ν~ [cm-1] = 3323 (m), 3250 (m, NH), 3091 (m), 2924 (m), 1582 (m), 1471 (s), 1092 
(m), 1049 (m), 967 (m), 767 (m); 1H-NMR (CDCl3, 360 MHz): δ(ppm) = 2.11 (br. s, 3 H, NH2 
and OH), 3.89 (mc, 2 H, CH2OH), 4.30 (virt. t, 3J ≅ 5.4 Hz, 1 H, CHNH2), 7.20 (s, 1 H, C: 5-H); 
13C-NMR (CDCl3, 91 MHz): δ(ppm) = 55.2 (d, CHNH2), 66.9 (t, CH2OH), 117.2 (d, C: C5), 
124.6 (s, C: C4), 175.9 (s, C: C2); MS (EI, 70 eV): m/z (%) = 224 (1) [M(81Br)+], 222 (1) 
[M(79Br)+], 193 (100) [(M(81Br)−CH2OH)+], 191 (95) [(M(79Br)−CH2OH)+], 166 (25), 164 (23), 
NH2
OHS
N
Br C
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139 (10), 137 (10); HRMS (EI): m/z = C4H479BrN2S [(M(79Br)−CH2OH)+], calcd.: 190.9279, 
found.: 190.9284. 
Compound 8b 
This compound was prepared from sulfinamide 7b according to the 
procedure described above. Aminoalcohol 8b (0.56 g, 2.51 mmol, 94%) 
was obtained as a pale-yellow solid. [α]D20 = +32.5 (c = 1.03 in CHCl3). 
Compound 9a 
A solution of aminoalcohol 8a (223 mg, 1.00 mmol) in CH2Cl2 (8 mL) 
were added NEt3 (0.42 mL, 303 mg, 3.00 mmol) and TBSCl (332 mg, 
2.20 mmol) at 0 °C. The reaction was allowed to warm up to room temperature overnight and 
it was then quenched by the addition of sat. NaHCO3 (10 mL). The mixture was extracted 
with CH2Cl2 (3 × 20 mL). The combined organic layers were washed with brine (1 × 30 mL) 
and dried over Na2SO4. Filtration and evaporation of the solvent yielded the crude product 
that was purified by flash chromatography (P/EtOAc = 10:1). The title compound 9a (273 mg, 
0.81 mmol, 81%) was obtained as a yellow oil. Rf = 0.30 (P/EtOAc = 4:1, UV); 1H-NMR 
(CDCl3, 360 MHz): δ(ppm) = 0.01 (s, 3 H, SiCH3), 0.05 (s, 3 H, SiCH3), 0.87 [s, 9 H, 
SiC(CH3)3], 1.94 (br. s, 2 H, NH2), 3.76 (dd, 2J = 9.8 Hz, 3J = 6.4 Hz, 1 H, CHHOTBS), 3.96 
(dd, 2J = 9.8 Hz, 3J = 4.1 Hz, 1 H, CHHOTBS), 4.33 (dd, 3J = 6.4, 4.1 Hz, 1 H, CHNH2), 7.15 
(s, 1 H, C: 5-H). 
Compound 9b 
This compound was prepared from 8b according to the procedure 
described above for 9a. Aminoalcohol 9b (0.11 g, 0.32 mmol, 72%) 
was obtained as a yellow oil. 
NH2
OHS
N
Br C
NH2
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Configurational assignments by formation of Mosher amides from amine 9a[2] 
To a solution of 9a (7.90 mg, 23.4 µmol) in dry CDCl3 (0.7 mL) were added pyridine (5.37 µL, 
5.56 mg, 70.2 µmol) and (R)-MTPACl (8.76 µL, 11.8 mg, 46.8 µmol). After 1 h at room 
temperature conversion into (S,S)-M was complete. The mixture was transferred into a NMR 
tube and subjected to 1H-NMR analysis. The diastereoisomer (S,R)-M was obtained following 
the identical procedure, reacting 9a with (R)-MTPACl. Data of relevant signals is given in the 
table below (Table S1). 
 
Table S1. δS = chemical shifts of (S,S)-M, δR = chemical shifts of (S,R)-M, δδSR =  δS−δR. 
assignment multiplicity δS [ppm] δR [ppm] δδS,R [ppm] 
SiCH3 s −0.10 −0.08 −0.02 
SiCH3 s −0.04 +0.01 −0.05 
SiC(CH3)3 s +0.80 +0.81 −0.01 
CHHOTBS dd +3.88 +3.93 −0.05 
CHHOTBS dd +4.13 +4.15 −0.02 
C: 5-H s +7.16 +7.11 +0.05 
                                               
[2]
 D. A. Allen, A. E. Tomaso, O. P. Priest, J. Chem. Ed. 2008, 85, 698-700. 
   S6 
 
 
Figure S1. Shielding effects in Mosher amides (S,S)-M and (S,R)-M. 
 
Compound 10a 
To a solution of amine 9a (1.98 g, 5.87 mmol) in CH2Cl2 (100 mL) 
were added iPr2NEt (2.99 mL, 2.27 g, 17.6 mmol), Fmoc-Gly-OH 
(2.09 g, 7.04 mmol) and PyBrOP (3.28 g, 7.04 mmol) at 0 °C. 
After stirring for 4 h at 0 °C the reaction was quenched by the addition of sat. NaHCO3 (100 
mL). The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 × 50 
mL). Drying over Na2SO4, filtration, evaporation of the solvent and purification by flash 
chromatography (P/EtOAc = 2:1) yielded the title compound 10a (3.39 g, 5.50 mmol, 94%) as 
a colorless foam. Rf = 0.30 (P/EtOAc = 2:1, UV); [α]D20 = −0.7 (c = 1.06 in CHCl3); IR (ATR): 
ν~ [cm-1] = 2943 (w), 2856 (w), 1679 (m), 1510 (m), 1471 (w), 1251 (s), 1102 (m), 833 (s), 780 
(m), 737 (s); 1H-NMR (CDCl3, 360 MHz): δ(ppm) = −0.06 (s, 3 H, SiCH3), −0.01 (s, 3 H, 
SiCH3), 0.82 [s, 9 H, SiC(CH3)3], 3.86 (mc, 1 H, CHHOTBS), 3.98 [mc, 2 H, C(=O)CH2NH], 
4.16 (dd, 2J = 10.0 Hz, 3J = 3.2 Hz, 1 H, CHHOTBS), 4.24 (t, 3J = 6.7 Hz, 1 H, Fmoc: 
CHCH2O), 4.44 (d, 3J = 6.7 Hz, 2 H, Fmoc: CHCH2O), 5.35 (mc, 1 H, CHNH), 5.42 [br. s, 1 H, 
C(=O)CH2NH], 7.00 (br. d, 3J = 7.2 Hz, 1 H, CHNH), 7.13 (s, 1 H, C: 5-H), 7.31 (virt. t, 3J ≅ 
HN
OTBSS
N
Br
O
NHFmoc
C
   S7 
 
7.4 Hz, 2 H, Fmoc: 2-H and 7-H), 7.41 (virt. t, 3J ≅ 7.4 Hz, 2 H, Fmoc: 3-H and 6-H), 7.58 (d, 
3J = 7.3 Hz, 2 H, Fmoc: 1-H and 8-H), 7.77 (d, 3J = 7.5 Hz, 2 H, Fmoc: 4-H and 5-H); 13C-
NMR (CDCl3, 91 MHz): δ(ppm) = −5.7 (q, SiCH3), −5.6 (q, SiCH3), 18.1 [s, SiC(CH3)3], 25.7 
[q, SiC(CH3)3], 44.6 (d, Fmoc: CHCH2O), 47.1 [t, C(=O)CH2NH], 53.1 (d, CHNH), 64.7 (t, 
CH2OTBS), 67.4 (t, Fmoc: CHCH2O), 117.1 (d, C: C5), 120.0 (d, Fmoc: C4 and C5), 124.6 
(s, C: C4), 125.0 (d, Fmoc: C1 and C8), 127.1 (d, Fmoc: C2 and C7), 127.8 (d, Fmoc: C3 
and C6), 141.3 (s, Fmoc: C4a und C4b), 143.7 (s, Fmoc: C8a and C8b), 156.6 [s, 
CH2OC(=O)NH], 168.7 [s, C(=O)CH2NH], 170.8 (s, C: C2); MS (ESI): m/z (%) = 640 (100) 
[(M(81Br)+Na)+], 638 (100) [(M(79Br)+Na)+], 618 (13) [(M(81Br)+H)+], 616 (13) [(M(79Br)+H)+], 
536 (1) [(M−Br)+], 441 (4), 179 (2); HRMS (ESI): m/z = C28H3479BrN3O4SSiNa [(M(79Br)+Na)+], 
calcd.: 638.1120, found: 638.1107. 
Compound 10b 
This compound was prepared from 9b according to the 
procedure described above. Compound 10b (0.73 g, 1.18 
mmol, 99%) was obtained as a colorless foam. [α]D20 = +0.5 (c 
= 0.44 in CHCl3). 
Compound 11a 
To a solution of bromothiazole 10a (1.54 g, 2.50 mmol) in 
degassed toluene (30 mL) were added Pd(PPh3)4 (290 mg, 
0.25 mmol) and hexamethylditin (2.08 mL, 3.28 g, 10.0 
mmol). After stirring for 1.5 h at 100 °C the mixture was concentrated in vacuo. The residue 
was purified by flash chromatography (P/EtOAc = 2:1) to yield stannane 11a (1.43 g, 2.04 
mmol, 82%) as a colorless foam. Rf = 0.30 (P/EtOAc = 2:1, UV); 1H-NMR (CDCl3, 360 MHz): 
δ(ppm) = −0.11 (s, 3 H, SiCH3), −0.05 (s, 3 H, SiCH3), 0.34 [s, 9 H, Sn(CH3)3], 0.80 [s, 9 H, 
SiC(CH3)3], 3.86 (mc, 1 H, CHHOTBS), 4.01 [mc, 2 H, C(=O)CH2NH], 4.17 (dd, 2J = 9.7 Hz, 3J 
HN
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= 3.1 Hz, 1 H, CHHOTBS), 4.23 (t, 3J =  7.1 Hz, 1 H, Fmoc: CHCH2O), 4.42 (d, 3J = 7.1 Hz, 2 
H, Fmoc: CHCH2O), 5.43 (mc, 1 H, CHNH), 5.51 [br. s, 1 H, C(=O)CH2NH], 7.16 (br. d, 3J = 
7.4 Hz, 1 H, CHNH), 7.27 (s, 1 H, C: 5-H), 7.31 (virt. t, 3J ≅ 7.3 Hz, 2 H, Fmoc: 2-H and 7-H), 
7.40 (virt. t, 3J ≅ 7.4 Hz, 2 H, Fmoc: 3-H and 6-H), 7.60 (d, 3J = 7.3 Hz, 2 H, Fmoc: 1-H and 8-
H), 7.77 (d, 3J = 7.5 Hz, 2 H, Fmoc: 4-H and 5-H). After 1H-NMR stannane 11a was quickly 
subjected to the next step. 
Compound 11b 
This compound was prepared from 10b according to the 
procedure described above. Compound 11b (0.23 g, 0.33 
mmol, 80%) was obtained as a colorless foam. After 1H-NMR 
stannane 11b was quickly subjected to the next step. 
Compound 12a 
Stannane 11a (1.40 g, 2.00 mmol) was dissolved in 
degassed toluene (30 mL). Pd(PPh3)4 (230 mg, 0.20 
mmol) and 2,4-dibromothiazole (0.68 g, 2.80 mmol) were 
sequentially added and the solution was stirred for 16 h at 90 °C. Sat. NaHCO3 (30 mL) was 
added and the mixture was extracted with EtOAc (3 × 30 mL). The combined organic layers 
were dried over Na2SO4 and after filtration the solvents were removed under reduced 
pressure. Flash chromatography (P/EtOAc = 2:1) yielded the bithiazole 12a (1.20 g, 1.71 
mmol, 86%) as a colorless solid. Rf = 0.25 (P/EtOAc = 2:1, UV); M.p. 82 °C; [α]D20 = −7.2 (c = 
1.01 in CHCl3); IR (ATR): ν~ [cm-1] = 2846 (w), 1716 (s, C=O), 1678 (s, C=O), 1513 (s), 1450 
(s), 1252 (m), 1106 (w), 839 (w), 752 (m); 1H-NMR (CDCl3, 360 MHz): δ(ppm) = −0.07 (s, 3 
H, SiCH3), −0.01 (s, 3 H, SiCH3), 0.81 [s, 9 H, SiC(CH3)3], 3.89 (mc, 1 H, CHHOTBS), 4.01 
(mc, 2 H, C(=O)CH2NH), 4.20-4.26 (m, 2 H, CHHOTBS and Fmoc: CHCH2O), 4.42-4.47 (m, 2 
H, Fmoc: CHCH2O), 5.39 (mc, 1 H, CHNH), 5.49 [br. s, 1 H, C(=O)CH2NH], 7.15 (br. d, 3J = 
HN
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8.3 Hz, 1 H, CHNH), 7.17 (s, 1 H, B: 5-H), 7.30 (virt. t, 3J ≅ 7.4 Hz, 2 H, Fmoc: 2-H and 7-H), 
7.40 (virt. t, 3J ≅ 7.5 Hz, 2 H, Fmoc: 3-H and 6-H), 7.59 (d, 3J = 7.2 Hz, 2 H, Fmoc: 1-H and 8-
H), 7.77 (d, 3J = 7.5 Hz, 2 H, Fmoc: 4-H and 5-H), 7.92 (s, 1 H, C: 5-H); 13C-NMR (CDCl3, 91 
MHz): δ(ppm) = −5.6 (q, SiCH3), −5.6 (q, SiCH3), 18.1 [s, SiC(CH3)3], 25.7 [q, SiC(CH3)3], 
44.8 (d, Fmoc: CHCH2O), 47.1 [t, C(=O)CH2NH], 53.1 (d, CHNH), 64.7 (t, CH2OTBS), 67.5 (t, 
Fmoc: CHCH2O), 117.0 (d, C: C5), 117.4 (d, B: C5), 120.0 (d, Fmoc: C4 and C5), 125.0 (d, 
Fmoc: C1 and C8), 126.0 (s, B: C4), 127.1 (d, Fmoc: C2 and C7), 127.8 (d, Fmoc: C3 and 
C6), 141.3 (s, Fmoc: C4a and C4b), 143.6 (s, Fmoc: C8a and C8b), 147.9 (s, C: C4), 156.6 
[s, CH2OC(=O)NH], 163.2 (s, B: C2), 168.7 [s, C(=O)CH2NH], 170.7 (s, C: C2); MS (ESI): 
m/z (%) = 834 (10), 832 (20), 806 (30), 804 (55), 723 (70) [(M(81Br)+Na)+], 721 (70) 
[(M(79Br)+Na)+], 701 (16) [(M(81Br)+H)+], 699 (14) [(M(79Br)+H)+], 413 (100); HRMS (ESI): m/z 
= C31H3579BrN4O4S2Si [(M(79Br)+H)+], calcd.: 699.1131, found: 699.1118. 
Compound 12b 
This compound was prepared from 11b according to the 
procedure described above. Compound 12b (0.53 g, 0.76 
mmol, 94%) was obtained as colorless solid. [α]D20 = +6.4 
(c = 0.76 in CHCl3). 
Compound 5a 
To a solution of bithiazole 12a (140 mg, 200 µmol) in 
degassed toluene (3 mL) was added Pd(PPh3)4  (23.1 mg, 
20.0 µmol, 10 mol%) and hexamethyldtin (166 µL, 262 mg, 
800 µmol). After stirring for 2.5 h at 90 °C the solvent was removed under reduced pressure 
and the residue was purified by flash chromatography (P/EtOAc = 2:1). The obtained 
stannane was dissolved in DMF (3 mL). Piperidine (0.3 mL) was added and the solution was 
stirred for 3 h at room temperature. The solvent was removed in vacuo and the crude product 
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was then purified by flash chromatography (CH2Cl2/MeOH = 10:1) to yield 5a (105 mg, 187 
µmol, 94% over 2 steps) as a pale-yellow oil. Rf = 0.15 (CH2Cl2/MeOH = 10:1, UV); [α]D20 = 
−25.5 (c = 1.30 in CHCl3); IR (ATR): ν~ [cm-1] = 2952 (m), 2928 (m), 2851 (w), 1721 (m), 1678 
(s, C=O), 1503 (s), 1465 (m), 1281 (m), 1256 (s), 1096 (s), 1023 (w), 834 (s), 776 (s); 1H-
NMR (CDCl3, 360 MHz): δ(ppm) = −0.06 (s, 3 H, SiCH3), 0.01 (s, 3 H, SiCH3), 0.38 [s, 9 H, 
Sn(CH3)3], 0.83 [s, 9 H, SiC(CH3)3], 1.59 (br. s, 2 H, NH2), 3.47 (s, 2 H, CH2NH2), 3.92 (dd, 2J 
= 9.8 Hz, 3J = 4.9 Hz, 1 H, CHHOTBS), 4.27 (dd, 2J = 9.8 Hz, 3J = 3.2 Hz, 1 H, CHHOTBS), 
5.43 (ddd, 3J = 8.2, 4.9, 3.2 Hz, 1 H, CHNH), 7.37 (s, 1 H, B: 5-H), 7.89 (s, 1 H, C: 5-H), 8.34 
(br. d, 3J = 8.2 Hz, 1 H, CHNH); 13C-NMR (CDCl3, 91 MHz) δ(ppm) = −8.8 [q, Sn(CH3)3], −5.6 
[q, Si(CH3)2], 18.1 [s, SiC(CH3)3], 25.7 [q, SiC(CH3)3], 44.6 (t, CH2NH2), 52.7 (d, CHNH), 64.9 
(t, CH2OTBS), 115.7 (d, C: C5), 126.1 (d, B: C5), 149.6 (s, C: C4), 161.0 (s, B: C4), 163.4 (s, 
B: C2), 170.7 (s, C: C2), 172.1 (s, C=O); MS (ESI): m/z (%) = 603 (1), 563 (39) 
[(M(120Sn)+H)+], 282 (100) [(M(120Sn)+H2)2+]; HRMS (ESI): m/z = C19H35N4O2S2Si120Sn 
[(M(120Sn)+H)+], calcd.: 563.0987, found: 563.0978. 
Compound 5b 
The corresponding enantiomer 5b (166 µmol, 83% over 2 
steps) was obtained from 12a using the identical procedure 
as described above for eastern building block 5a; [α]D20 = 
+28.5 (c = 1.10 in CHCl3). 
Compound 14a 
To a solution of building block 13 (81.7 mg, 90.4 µmol) in THF (0.90 mL) and tBuOH (1.80 
mL) was dropwise added 1 M LiOH (0.90 mL, 0.90 mmol) and the mixture was stirred at 
room temperature for 3 h. The solvents were removed under reduced pressure and the 
residue was taken up in water (10 mL). The mixture was adjusted to pH 3 by addition of 10% 
citric acid and then extracted with CH2Cl2 (3 × 20 mL).After drying over Na2SO4 and filtration 
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the solvent was removed in vacuo. The obtained carboxylic acid was dissolved in DMF (10 
mL) and then 5a (66.2 mg, 118 µmol), iPr2NEt (61.6 µL, 46.8 mg, 362 µmol) and DPPA (38.9 
µL, 49.8 mg, 181 µmol) were added at 0 °C. The reaction was allowed to warm up to room 
temperature overnight before it was quenched by the addition of sat. NH4Cl (20 mL). The 
mixture was extracted with CH2Cl2 (3 × 20 mL) and the combined organic layers were dried 
over Na2SO4. Filtration, evaporation of the solvent in vacuo and purification by flash 
chromatography (EtOAc) yielded organostannane 14a (80.4 mg, 56.6 µmol, 63%) as a pale-
yellow oil. Rf = 0.50 (EtOAc, UV); 1H-NMR (CDCl3, 500 MHz): δ(ppm) = −0.09 (s, 3 H, SiCH3), 
−0.03 (s, 3 H, SiCH3), 0.36 [s, 9 H, Sn(CH3)3], 0.79 
[s, 9 H, SiC(CH3)3], 1.00 [virt. t, 3J ≅ 6.2 Hz, 6 H, 
CH(CH3)2], 1.64 [s, 9 H, OC(CH3)3], 2.36 [mc, 1 H, 
CH(CH3)2], 2.67 (d, 3J = 4.7 Hz, 3 H, NHCH3), 2.75 
(s, 3 H, E: 5-CH3), 2.92 [dd, 2J = 15.8 Hz, 3J = 5.0 
Hz, 1 H, CHHC(=O)NHMe], 3.18 [dd, 2J = 15.8 Hz, 
3J = 4.5 Hz, 1 H, CHHC(=O)NHMe], 3.90 (dd, 2J = 
10.0 Hz, 3J = 5.1 Hz, 1 H, CHHOTBS), 4.11-4.23 [m, 
2 H, CHHOTBS and C(=O)CHHNH], 4.47 [dd, 2J = 
16.7 Hz, 3J = 6.6 Hz, 1 H, C(=O)CHHNH], 5.31-5.37 
(m, 2 H, C: CHNH and D: CHNH), 5.74 (mc, 1 H, E: 
CHNH), 6.60 (d, 3J = 4.7 Hz, 1 H, NHCH3), 7.20 (d, 3J = 7.9 Hz, 1 H, C: CHNH), 7.35 (s, 1 H, 
C: 5-H), 7.91 (s, 1 H, B: 5-H), 8.06-8.10 (m, 1 H, D: CHNH), 8.09 (s, 1 H, D: 5-H), 8.16-8.22 
[m, 1 H, C(=O)CHHNH], 8.21 (s, 1 H, G: 5-H), 8.34 (s, 1 H, F: 5-H), 8.39 (d, 3J = 8.2 Hz, 1 H, 
A: 5-H), 8.74 (d, 3J = 8.2 Hz, 1 H, A: 4-H), 9.58 (d, 3J = 8.8 Hz, 1 H, E: CHNH). After 1H-NMR 
stannane 14a was quickly subjected to the cyclization step. 
 
Compound 14b 
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This compound was prepared as described above for 14a starting from compounds 13 and 
5b yielding compound 14b (97.4 mg, 68.6 µmol, 79%) as a pale-yellow oil. Rf = 0.50 (EtOAc, 
UV), 1H-NMR (CDCl3, 500 MHz): δ(ppm) = −0.08 (s, 
3 H, SiCH3), −0.01 (s, 3 H, SiCH3), 0.35 [s, 9 H, 
Sn(CH3)3], 0.81 [s, 9 H, SiC(CH3)3], 1.00 [d, 3J = 6.6 
Hz, 3 H, CH(CH3)2], 1.02 [d, 3J = 6.9 Hz, 3 H, 
CH(CH3)2], 1.64 [s, 9 H, OC(CH3)3], 2.37 [mc, 1 H, 
CH(CH3)2], 2.58 (d, 3J = 4.7 Hz, 3 H, NHCH3), 2.75 
(s, 3 H, E: 5-CH3), 2.96 [dd, 2J = 15.8 Hz, 3J = 4.8 
Hz, 1 H, CHHC(=O)NHMe], 3.18 [dd, 2J = 15.8 Hz, 
3J = 4.5 Hz, 1 H, CHHC(=O)NHMe], 3.93 (dd, 2J = 
9.9 Hz, 3J = 4.9 Hz, 1 H, CHHOTBS), 4.15 [dd, 2J = 
16.8 Hz, 3J = 4.6 Hz, 1 H, C(=O)CHHNH], 4.22 (dd, 
2J = 9.9 Hz, 3J = 3.2 Hz 1 H, CHHOTBS), 4.52 [dd, 2J = 16.8 Hz, 3J = 6.5 Hz, 1 H, 
C(=O)CHHNH], 5.33-5.39 (m, 2 H, C: CHNH and D: CHNH), 5.77 (mc, 1 H, E: CHNH), 6.58 
(mc, 1 H, NHCH3), 7.24-7.26 (m, 1 H, NH, C: CHNH), 7.33 (s, 1 H, C: 5-H), 7.82 (s, 1 H, B: 5-
H), 8.08 (s, 1 H, D: 5-H), 8.06-8.10 (m, 1 H, D: CHNH), 8.19-8.22 [m, 1 H, C(=O)CHHNH], 
8.20 (s, 1 H, G: 5-H), 8.33 (s, 1 H, F: 5-H), 8.37 (d, 3J = 8.2 Hz, 1 H, A: 5-H), 8.73 (d, 3J = 8.2 
Hz, 1 H, A: 4-H), 9.53 (d, 3J = 8.7 Hz, 1 H, E: CHNH). After 1H-NMR stannane epi-78a was 
quickly subjected to the cyclization step. 
Macrocycle 15a 
To a solution of compound 14a (19.9 mg, 14.0 µmol) in degassed toluene (14 mL) was 
added Pd(PPh3)4  (3.24 mg, 2.80 µmol, 20 mol%) and the mixture was stirred for 20 h at 85 
°C. The solvent was removed in vacuo and the crude product was purified by flash 
chromatography (EtOAc/MeOH = 60:1) yielding macrocycle 15a (10.5 mg, 8.96 µmol, 64%) 
as a pale-yellow wax. Rf = 0.50 (EtOAc/MeOH = 60:1, UV); 1H-NMR (CDCl3, 500 MHz): 
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δ(ppm) = 0.01 (s, 3 H, SiCH3), 0.03 (s, 3 H, SiCH3), 0.88 [d, 3J = 6.8 Hz, 3 H, CH(CH3)2], 0.92 
[s, 9 H, SiC(CH3)3], 1.00 [d, 3J = 6.8 Hz, 3 H, CH(CH3)2], 1.01 [mc, 1 H, CHHC(=O)NHMe], 
1.65 [s, 9 H, OC(CH3)3], 2.28 [mc, 1 H, CH(CH3)2], 2.64 
(d, 3J = 6.0 Hz, 3 H, NHCH3), 2.65 (s, 3 H, E: 5-CH3), 
2.70 [dd, 2J = 17.1 Hz, 3J = 3.5 Hz, 1 H, 
CHHC(=O)NHMe], 3.85-3.91 [m, 1 H, C(=O)CHHNH], 
3.90-3.95 (m, 1 H, CHHOTBS), 4.05 (dd, 2J = 10.3 Hz, 
3J = 3.5 Hz, 1 H, CHHOTBS), 4.99 [dd, 2J = 17.5 Hz, 3J 
= 9.4 Hz, 1 H, C(=O)CHHNH], 5.24 (dd, 3J = 7.9, 4.6 
Hz, 1 H, D: CHNH), 5.35 (mc, 1 H, C: CHNH), 5.41 (mc, 
1 H, E: CHNH), 6.75-6.85 (m, 2 H, NHCH3 and C: 
CHNH), 7.25 (s, 1 H, C: 5-H), 7.76 [dd, 3J = 9.4, 2.8 
Hz, 1 H, C(=O)CHHNH], 8.11 (d, 3J = 8.2 Hz, 1 H, A: 4-H), 8.11 (s, 1 H, D: 5-H), 8.20 (s, 1 H, 
B: 5-H), 8.25 (s, 1 H, G: 5-H), 8.37 (s, 1 H, F: 5-H), 8.38 (d, 3J = 8.2 Hz, 1 H, A: 5-H), 8.78 (d, 
3J = 7.9 Hz, 1 H, D: CHNH), 8.97 (d, 3J = 9.2 Hz, 1 H, E: CHNH). This compound was 
obtained as a mixture together with triphenylphosphine oxide and was directly used in the 
next step. 
Macrocycle 15b 
Starting from compound 14b macrocycle 15b (25.7 
mg, 21.9 µmol, 62%) was obtained as a pale-yellow 
wax, using the procedure given above for macrocycle 
15a. Rf = 0.50 (EtOAc/MeOH = 60:1, UV), 1H-NMR 
(CDCl3, 500 MHz): δ(ppm) = −0.09 (s, 3 H, SiCH3), 
−0.06 (s, 3 H, SiCH3), 0.84 [s, 9 H, SiC(CH3)3], 0.95 [d, 
3J = 6.8 Hz, 3 H, CH(CH3)2], 1.03 [d, 3J = 6.7 Hz, 3 H, 
CH(CH3)2], 1.65 [s, 9 H, OC(CH3)3], 2.20 [mc, 1 H, CH(CH3)2], 2.26-2.37 [m, 2 H, 
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CH2C(=O)NHMe], 2.56 (d, 3J = 4.5 Hz, 3 H, NHCH3), 2.68 (s, 3 H, E: 5-CH3), 4.03-4.12 [m, 2 
H, CH2OTBS), 4.24 [dd, 2J = 17.8 Hz, 3J = 3.4 Hz, 1 H, C(=O)CHHNH], 4.53 [dd, 2J = 17.8 
Hz, 3J = 5.6 Hz, 1 H, C(=O)CHHNH], 5.26-5.31 (m, 2 H, C: CHNH and D: CHNH), 5.45 (mc, 1 
H, E: CHNH), 6.57 (br. s, 1 H, NHCH3), 6.85 (d, 3J = 6.8 Hz, 1 H, C: CHNH), 7.39 (s, 1 H, C: 
5-H), 7.91 (s, 1 H, B: 5-H), 8.08 (d, 3J = 9.0 Hz, 1 H, A: 4-H), 8.08 (s, 1 H, D: 5-H), 8.11-8.18 
(m, 2 H, D: CHNH and C(=O)CH2NH], 8.20 (s, 1 H, F: 5-H), 8.24 (d, 3J = 9.8 Hz, 1 H, E: 
CHNH), 8.33 (s, 1 H, G: 5-H), 8.41 (d, 3J = 9.0 Hz, 1 H, A: 5-H). This compound was 
obtained as a mixture together with triphenylphosphine oxide and was directly used in the 
next step. 
Thiopeptide 3a 
To a solution of 15a (7.50 mg, 6.37 µmol) in CH2Cl2 (1 mL) was added TFA (0.2 mL) and the 
mixture was stirred for 6 h at room temperature. The solvent was removed under reduced 
pressure and TFA was co-evaporated with toluene (2 × 1 mL). The residue was dried in 
vacuo and dissolved in THF (0.2 mL) and MeOH (0.2 mL). TMSCHN2 (4.14 µL, 8.28 µmol, 
2.0 M in Et2O) was added and the solution was stirred for 1 h at room temperature. The 
solvents were removed in vacuo and the crude 
product was purified by flash chromatography 
(CH2Cl2/MeOH = 10:1) to yield thiopeptide 3a (3.40 
mg, 3.34 µmol, 52% over 2 steps) as a colorless 
solid. Rf = 0.25 (CH2Cl2/MeOH = 10:1, UV); [α]D20 = 
+172 (c = 0.26 in CHCl3); IR (ATR): ν~ [cm-1] = 3280 
(w), 2939 (w), 1725 (w), 1658 (s, C=O), 1539 (m), 
1492 (m), 1224 (m), 911 (w), 728 (m); 1H-NMR 
(CDCl3, 500 MHz): δ(ppm) = 0.91 [d, 3J = 6.8 Hz, 3 H, 
CH(CH3)2], 1.01 [d, 3J = 6.9 Hz, 3 H, CH(CH3)2], 1.28 
[mc, 1 H, CHHC(=O)NHMe], 2.31 [mc, 1 H, CH(CH3)2], 2.65 (d, 3J = 4.7 Hz, 3 H, NHCH3), 
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2.67 (s, 3 H, E: 5-CH3), 2.68-2.72 [m, 1 H, CHHC(=O)NHMe], 3.37 (br. s, 1 H, OH), 3.96 [dd, 
2J = 17.5 Hz, 3J = 3.5 Hz, 1 H, C(=O)CHHNH], 4.01-4.05 (m, 1 H, CHHOH), 4.02 (s, 3 H, 
OCH3), 4.12 (dd, 2J = 11.6 Hz, 3J = 3.2 Hz, 1 H, CHHOH), 4.95 [dd, 2J = 17.5 Hz, 3J = 9.2 Hz, 
1 H, C(=O)CHHNH], 5.26 (dd, 3J = 8.1, 5.0 Hz, 1 H, D: CHNH), 5.37 (mc, 1 H, C: CHNH), 
5.42 (virt. dt, 3J ≅ 8.8, 4.3 Hz, 1 H, E: CHNH), 6.79 (d, 3J = 4.7 Hz, 1 H, NHCH3), 7.30 (s, 1 H, 
C: 5-H), 7.39 (br. d, 3J = 6.0 Hz, 1 H, C: CHNH), 7.95 [dd, 3J = 9.2, 3.5 Hz, 1 H, 
C(=O)CHHNH], 8.13 (d, 3J = 8.1 Hz, 1 H, A: 4-H), 8.14 (s, 1 H, D: 5-H), 8.16 (s, 1 H, B: 5-H), 
8.35 (s, 1 H, G: 5-H), 8.36 (s, 1 H, F: 5-H), 8.39 (d, 3J = 8.1 Hz, 1 H, A: 5-H), 8.66 (d, 3J = 8.1 
Hz, 1 H, D: CHNH), 8.78 (br. d, 3J = 8.8 Hz, 1 H, E: CHNH); 13C-NMR (CDCl3, 126 MHz): 
δ(ppm) = 12.4 (q, E: 5-CH3), 18.2 [q, CH(CH3)2], 18.4 [q, CH(CH3)2], 26.3 (q, NHCH3), 34.7 
[d, CH(CH3)2], 38.6 [t, CH2C(=O)NHMe], 41.8 [t, C(=O)CH2NH], 48.2 (d, E: CHNH), 52.7 (q, 
OCH3), 55.0 (d, C: CHNH), 56.1 (d, D: CHNH), 63.8 (t, CH2OH), 115.2 (d, C: C5), 118.8 (d, 
A: C5), 122.9 (d, B: C5), 124.1 (d, D: C5), 125.3 (d, F: C5), 127.8 (s, A: C3), 130.6 (d, G: 
C5), 140.3 (d, A: C4), 140.9 (s, E: C5), 142.1 (s, E: C4), 148.2 (s, G: C4), 148.3 (s, D: C4), 
148.9 (s, C: C4), 150.1 (s, F: C4), 150.3 (s, A: C2), 150.5 (s, A: C6), 154.6 (s, B: C4), 159.9 
(s, B: C2), 161.2 [s, D: C(=O)NH], 161.7 [s, E: C(=O)NH], 161.8 [s, C(=O)OMe], 161.9 [s, F: 
C(=O)NH], 164.9 (s, F: C2), 167.1 (s, E: C2), 168.8 (s, D: C2), 169.0 (s, G: C2), 169.2 [s, 
C(=O)CH2NH], 169.8 [s, C(=O)NHMe], 170.6 (s, C: C2); MS (ESI): m/z (%) = 1019 (100) 
[(M+H)+]; HRMS (ESI): m/z = C41H39N12O8S6 [(M+H)+], calcd.: 1019.1333, found: 1019.1311. 
Thiopeptide 3b 
To a solution of 15b (24.7 mg, 21.0 µmol) in CH2Cl2 (3 mL) was added TFA (0.6 mL) and the 
mixture was stirred for 3 h at room temperature. One drop of 70% HFPy complex was added 
and the mixture was stirred for another 1 h at room temperature. The solvent was removed 
under reduced pressure and TFA was co-evaporated with toluene (2 × 1 mL). The residue 
was dried in vacuo and dissolved in THF (0.6 mL) and MeOH (0.6 mL). TMSCHN2 (13.7 µL, 
27.3 µmol, 2.0 M in Et2O) was added and the solution was stirred for 1 h at room 
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temperature. The solvents were removed in vacuo and the crude product was purified by 
flash chromatography (CH2Cl2/MeOH = 10:1) to yield thiopeptide 3b (19.8 mg, 19.4 µmol, 
92% over 2 steps) as a colorless solid. Rf = 0.35 (CH2Cl2/MeOH = 10:1, UV); [α]D20 = +33.0 
(c = 0.10 in CHCl3); IR (ATR): ν~ [cm-1] = 2956 (w), 2924 (m), 2850 (w), 1654 (m, C=O), 1542 
(m), 766 (w), 667 (w); 1H-NMR (CDCl3, 500 MHz): δ(ppm) = 0.93 [d, 3J = 6.5 Hz, 3 H, 
CH(CH3)2], 1.00 [d, 3J = 6.7 Hz, 3 H, CH(CH3)2], 2.19 [mc, 1 H, CH(CH3)2], 2.40 [br. s, 2 H, 
CH2C(=O)NHMe], 2.62 (br. s, 3 H, NHCH3), 2.68 (s, 3 
H, E: 5-CH3), 4.01 (s, 3 H, OCH3), 4.12 (br. s, 2 H, 
CH2OH), 4.28 [d, 2J = 17.1 Hz, 1 H, C(=O)CHHNH], 
4.63 [d, 2J = 17.1 Hz, 1 H, C(=O)CHHNH], 5.28-5.34 
(m, 2 H, C: CHNH and D: CHNH), 5.47 (s, 1 H, E: 
CHNH), 6.76 (br. s, 1 H, NHCH3), 7.34 (s, 1 H, C: 5-
H), 7.92 (s, 1 H, B: 5-H), 7.99-8.10 [m, 2 H, C: CHNH 
and C(=O)CH2NH], 8.06 (d, 3J = 7.5 Hz, 1 H, A: 4-H), 
8.11 (s, 1 H, D: 5-H), 8.24-8.35 (m, 4 H, D: CHNH 
and E: CHNH and F: 5-H and G: 5-H), 8.37 (d, 3J = 7.5 Hz, 1 H, A: 5-H); 13C-NMR (CDCl3, 
126 MHz): δ(ppm) = 12.6 (q, E: 5-CH3), 18.5 [q, CH(CH3)2], 19.0 [q, CH(CH3)2], 26.3 (q, 
NHCH3), 35.0 [d, CH(CH3)2], 38.3 [t, CH2C(=O)NHMe], 42.8 [t, C(=O)CH2NH], 49.1 (d, E: 
CHNH), 52.7 (q, OCH3), 54.7 (d, C: CHNH), 55.0 (d, D: CHNH), 64.2 (t, CH2OH), 115.8 (d, C: 
C5), 118.9 (d, A: C5), 121.7 (d, B: C5), 123.8 (d, D: C5), 125.4 (d, F: C5), 128.2 (s, A: C3), 
130.6 (d, G: C5), 139.7 (d, A: C4), 141.3 (s, E: C5), 142.2 (s, E: C4), 148.2 (s, G: C4), 148.6 
(s, A: C2 and D: C4), 148.8 (s, C: C4), 150.0 (s, F: C4), 150.7 (s, A: C6), 154.0 (s, B: C4), 
160.3 (s, B: C2), 160.7 [s, D: C(=O)NH], 161.4 [s, E: C(=O)NH], 161.7 [s, C(=O)OMe], 161.8 
[s, F: C(=O)NH], 165.1 (s, F: C2), 166.0 (s, E: C2), 168.7 (s, D: C2), 169.2 (s, G: C2), 169.8 
[s, C(=O)CH2NH], 170.3 [s, C(=O)NHMe], 170.4 (s, C: C2); MS (ESI): m/z (%) = 1041 (45) 
[(M+Na)+], 1019 (100) [(M+H)+]; HRMS (ESI): m/z = C41H39N12O8S6 [(M+H)+], calcd.: 
1019.1333, found: 1019.1332. 
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Compound 9c 
Aminoalcohol 8a (0.56 g, 2.51 mmol) was dissolved in CH2Cl2 (30 
mL) and cooled to 0 °C. NEt3 (0.42 mL, 0.30 g, 3.01 mmol) and 
Boc2O (0.60 g, 2.76 mmol) were added and the reaction was allowed 
to warm up to room temperature overnight. The mixture was washed with 1 N KHSO4 (1 × 30 
mL) and brine (1 × 30 mL). The organic layer was dried over Na2SO4 and solids were 
removed by filtration. The solvent was removed under reduced pressure and the residue was 
purified by flash chromatography (P/EtOAc = 4:1). The obtained N-Boc-protected 
aminoalcohol (0.57 g, 1.76 mmol) was dissolved in THF (4 mL). At room temperature iPr2NEt  
(0.90 mL, 0.68 g, 5.28 mmol), BOMCl (0.44 mL, 0.47 g, 3.17 mmol) and TBAI (196 mg, 0.53 
mmol) were added and the mixture was stirred for 16 h. The reaction was quenched by the 
addition of MeOH (2 mL) and stirred for another 1 h. It was then diluted by the addition of 
EtOAc (50 mL) and washed sequentially with 1 N KHSO4 (1 × 50 mL), sat. NaHCO3 (1 × 50 
mL) and brine (1 × 50 mL). The organic layer was dried over Na2SO4, filtered and 
concentrated in vacuo. The crude product was purified by flash chromatography (P/EtOAc = 
4:1). The double protected aminoalcohol (0.59 g, 1.33 mmol) was dissolved in CH2Cl2 (8 mL) 
and TFA (2 mL) was added. After stirring for 5 h at room temperature the reaction was 
quenched by the addition of sat. NaHCO3 (10 mL). The layers were separated and the 
aqueous phase was extracted with CH2Cl2 (2 × 10 mL). The combined extracts were dried 
over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by 
flash chromatography to yield the O-BOM-protected aminoalcohol 9c (196 mg, 0.57 mmol, 
23% over 3 steps) as a yellow oil. Rf = 0.20 (P/EtOAc = 2:1, UV); 1H-NMR (CDCl3, 360 MHz): 
δ(ppm) = 2.26 (br. s, 2 H, NH2), 3.83 (dd, 2J = 9.8 Hz, 3J = 6.7 Hz, 1 H, CHHOBOM), 3.99 
(dd, 2J = 9.8 Hz, 3J = 4.0 Hz, 1 H, CHHOBOM), 4.49 (dd, 3J = 6.7, 4.0 Hz, 1 H, CHNH2), 4.57 
NH2
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(s, 2 H, OCH2Ph), 4.78 (d, 2J = 6.7 Hz, 1 H, OCHHO), 4.80 (d, 2J = 6.7 Hz, 1 H, OCHHO), 
7.18 (s, 1 H, C: 5-H), 7.27-7.39 (m, 5 H, Ph). 
Compound 10c 
A solution of amine 9c (185 mg, 0.54 mmol) in CH2Cl2 (10 mL) 
was cooled to 0 °C and iPr2NEt (0.28 mL, 209 mg, 1.62 mmol), 
Fmoc-Gly-OH (193 mg, 0.65 mmol) and PyBrOP (303 mg, 0.65 
mmol) were sequentially added. After stirring for 4 h at this temperature the reaction was 
quenched by the addition of sat. NaHCO3 (10 mL). The layers were separated, the aqueous 
layer was extracted with CH2Cl2 (2 × 10 mL) and the combined extracts were dried over 
Na2SO4. Filtration and evaporation of the solvent yielded the crude product that was purified 
by flash chromatography (P/EtOAc = 1:1). The title compound 10c (317 mg, 0.51 mmol, 
94%) was obtained as a colorless foam. Rf = 0.40 (P/EtOAc = 1:1, UV); [α]D20 = −8.7 (c = 
1.00 in CHCl3); IR (ATR): ν~ [cm-1] = 3304 (w), 1791 (m), 1677 (s, C=O), 1523 (m), 1248 (m), 
1046 (w), 737 (m); 1H-NMR (CDCl3, 360 MHz): δ(ppm) = 3.83-3.94 [m, 3 H, CHHOBOM and 
C(=O)CH2NH], 4.17-4.25 (m, 2 H, Fmoc: CHCH2O and CHHOBOM), 4.42 (d, 3J = 6.9 Hz, 2 
H, Fmoc: CHCH2O), 4.45 (s, 2 H, OCH2Ph), 4.70 (mc, 2 H, OCH2O), 5.30 [br. s, 1 H 
C(=O)CH2NH], 5.50 (dd, 3J = 8.3, 4.2 Hz, 1 H, CHNH), 7.14 (s, 1 H, C: 5-H), 7.17 (mc, 1 H, 
CHNH), 7.24-7.34 (m, 7 H, Ph and Fmoc: 2-H and 7-H), 7.40 (virt. t, 3J ≅ 7.4 Hz, 2 H, Fmoc: 
3-H and 6-H), 7.57 (d, 3J = 7.3 Hz, 2 H, Fmoc: 1-H and 8-H), 7.77 (d, 3J = 7.5 Hz, 2 H, Fmoc: 
4-H and 5-H); 13C-NMR (CDCl3, 91 MHz): δ(ppm) = 44.5 (d, Fmoc: CHCH2O), 47.0 [t, 
C(=O)CH2NH], 51.4 (d, CHNH), 67.3 (t, Fmoc: CHCH2O), 69.4 (t, CH2OBOM), 69.8 (t, 
OCH2Ph), 94.9 (t, OCH2O), 117.1 (d, C: C5), 120.0 (d, Fmoc: C4 and C5), 124.8 (s, C: C4), 
125.0 (d, Fmoc: C1 and C8), 127.1 (d, Fmoc: C2 and C7), 127.7 (d, Ph: C4), 127.9 (d, Ph: 
C2 and C6 and Fmoc: C3 and C6), 128.5 (d, Ph: C3 and C5), 137.2 (s, Ph: C1), 141.3 (s, 
Fmoc: C4a and C4b), 143.6 (s, Fmoc: C8a and C8b), 156.5 [s, CH2OC(=O)NH], 168.9 [s, 
C(=O)CH2NH], 170.3 (s, C: C2); MS (ESI): m/z (%) = 646 (27) [(M(81Br)+Na)+], 644 (27) 
HN
OBOMS
N
Br
O
NHFmoc
C
   S19 
 
[(M(79Br)+Na)+], 624 (100) [(M(81Br)+H)+], 622 (13) [(M(79Br)+H)+], 445 (2), 443 (2); HRMS 
(ESI): m/z = C30H2979BrN3O5S [(M(79Br)+H)+], calcd.: 622.1006, found: 622.1000. 
Compound 11c 
To a solution of bromothiazole 10c (288 mg, 0.46 mmol) in 
degassed toluene (6 mL) were added Pd(PPh3)4 (53.5 mg, 
46.3 µmol) and hexamethylditin (0.38 mL, 0.60 g, 1.84 mmol). 
After stirring for 1.5 h at 100 °C the mixture was concentrated in vacuo. The residue was 
purified by flash chromatography (P/EtOAc = 2:1) to yield stannane 11c (224 mg, 0.32 mmol, 
69%) as a colorless foam. Rf = 0.40 (P/EtOAc = 1:1, UV); 1H-NMR (CDCl3, 500 MHz): δ(ppm) 
= 0.33 [s, 9 H, Sn(CH3)3], 3.87-3.97 (m, 3 H, CHHOBOM and C(=O)CH2NH), 4.19 (dd, 2J = 
10.1 Hz, 3J = 4.2 Hz, 1 H, CHHOBOM), 4.23 (t, 3J = 7.4 Hz, 1 H, Fmoc: CHCH2O), 4.41 (d, 3J 
= 7.4 Hz, 2 H, Fmoc: CHCH2O), 4.45 (s, 2 H, OCH2Ph), 4.70 (d, 2J = 6.8 Hz, 1 H, OCHHO), 
4.72 (d, 2J = 6.8 Hz, 1 H, OCHHO), 5.39 [br. s, 1 H, C(=O)CH2NH], 5.59 (mc, 1 H, CHNH), 
7.12 (br. d, 3J = 6.8 Hz, 1 H, CHNH), 7.28 (s, 1 H, C: 5-H), 7.28-7.35 (m, 7 H, Ph and Fmoc: 
2-H and 7-H), 7.40 (virt. t, 3J ≅ 7.4 Hz, 2 H, Fmoc: 3-H and 6-H), 7.58 (d, 3J = 7.3 Hz, 2 H, 
Fmoc: 1-H and 8-H), 7.76 (d, 3J = 7.5 Hz, 2 H, Fmoc: 4-H and 5-H). After 1H-NMR stannane 
11c was quickly subjected to the next step. 
Compound 12c 
To solution of stannane 11c (210 mg, 0.30 mmol) in 
degassed toluene (5 mL) were added Pd(PPh3)4 (34.3 mg, 
29.7 µmol) and 2,4-dibromothiazole (102 mg, 0.42 mmol). 
After stirring for 16 h at 90 °C the reaction was quenched by the addition of sat. NaHCO3 (5 
mL). The mixture was extracted with EtOAc (3 × 20 mL) and the combined organic layers 
were dried over Na2SO4. After filtration, the solvents were removed under reduced pressure. 
Flash chromatography (P/EtOAc = 1:1) yielded bithiazole 12c (207 mg, 0.29 mmol, 98%) as 
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a colorless foam. Rf = 0.40 (P/EtOAc = 1:1, UV); [α]D20 = −13.7 (c = 1.00 in CHCl3); IR (ATR): 
ν~ [cm-1] = 3302 (w), 2923 (w), 1669 (s, C=O), 1516 (m), 1449 (m), 1253 (m), 1167 (w), 1042 
(s), 736 (s), 698 (w); 1H-NMR (CDCl3, 360 MHz): δ(ppm) = 3.85-3.98 (m, 3 H, CHHOBOM 
and C(=O)CH2NH), 4.21 (t, 3J = 7.0 Hz, 1 H, Fmoc: CHCH2O), 4.28 (dd, 2J = 10.2 Hz, 3J = 
3.9 Hz, 1 H, CHHOBOM), 4.40-4.44 (m, 2 H, Fmoc: CHCH2O), 4.45 (s, 2 H, OCH2Ph), 4.70 
(d, 2J = 6.8 Hz, 1 H, OCHHO), 4.73 (d, 2J = 6.8 Hz, 1 H, OCHHO), 5.45 [br. s, 1 H, 
C(=O)CH2NH], 5.54 (mc, 1 H, CHNH), 7.16 (s, 1 H, B: 5-H), 7.20-7.31 (m, 8 H, Ph and CHNH 
and Fmoc: 2-H and 7-H), 7.39 (virt. t, 3J ≅ 7.5 Hz, 2 H, Fmoc: 3-H and 6-H), 7.56 (d, 3J = 7.5 
Hz, 2 H, Fmoc: 1-H and 8-H), 7.77 (d, 3J = 7.5 Hz, 2 H, Fmoc: 4-H and 5-H), 7.92 (s, 1 H, C: 
5-H); 13C-NMR (CDCl3, 91 MHz): δ(ppm) = 44.7 (d, Fmoc: CHCH2O), 47.1 [t, C(=O)CH2NH], 
51.5 (d, CHNH), 67.4 (t, Fmoc: CHCH2O), 69.4 (t, CH2OBOM), 69.8 (t, OCH2Ph), 95.0 (t, 
OCH2O), 117.5 (d, C: C5), 117.4 (d, B: C5), 120.0 (d, Fmoc: C4 and C5), 125.0 (d, Fmoc: C1 
and C8), 126.0 (s, B: C4), 127.1 (d, Fmoc: C2 and C7), 127.8 (d, Ph: C2 and C6, Fmoc: C3 
and C6), 127.9 (d, Ph: C4), 128.5 (d, Ph: C3 and C5), 137.2 (s, Ph: C1), 141.3 (s, Fmoc: C4a 
and C4b), 143.6 (s, Fmoc: C8a and C8b), 148.1 (s, C: C4), 156.6 [s, CH2OC(=O)NH], 163.1 
(s, B: C2), 168.9 [s, C(=O)CH2NH], 170.2 (s, C: C2); MS (ESI): m/z (%) = 745 (4) 
[(M(81Br)+K)+], 743 (4) [(M(79Br)+K)+], 729 (80) [(M(81Br)+Na)+], 727 (80) [(M(79Br)+Na)+], 707 
(100) [(M(81Br)+H)+], 705 (100) [(M(79Br)+H)+]; HRMS (ESI): m/z = C33H2979BrN4O5S2Na 
[(M(79Br)+Na)+], calcd.: 727.0660, found: 727.0660. 
Compound 5c 
Compound 5c was prepared as described above for 5a, 
starting from bromide 12c. It was obtained as a pale-yellow 
oil (84.3 µmol, 73%). Rf = 0.25 (CH2Cl2/MeOH = 10:1, UV); 
[α]D20 = −27.5 (c = 0.45 in CHCl3); IR (ATR): ν~ [cm-1] = 2950 (w), 1672 (s, C=O), 1504 (s), 
1262 (m), 1046 (s), 1026 (m), 770 (s); 1H-NMR (CDCl3, 360 MHz): δ(ppm) = 0.38 [s, 9 H, 
Sn(CH3)3], 1.53 (br. s, 2 H, NH2), 3.45 (mc, 2 H, CH2NH2), 3.98 (dd, 2J = 9.9 Hz, 3J = 4.6 Hz, 
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1 H, CHHOBOM), 4.31 (dd, 2J = 9.9 Hz, 3J = 4.1 Hz, 1 H, CHHOBOM), 4.51 (s, 2 H, 
OCH2Ph), 4.77 (s, 2 H, OCH2O), 5.60 (mc, 1 H, CHNH), 7.26-7.31 (m, 5 H, Ph), 7.37 (s, 1 H, 
B: 5-H), 7.93 (s, 1 H, C: 5-H), 8.25 (d, 3J = 8.7 Hz, 1 H, CHNH); 13C-NMR (CDCl3, 91 MHz): 
δ(ppm) = −8.8 [q, Sn(CH3)3], 44.9 (t, CH2NH2), 51.0 (d, CHNH), 69.4 (t, CH2OBOM), 69.5 (t, 
OCH2Ph), 94.7 (t, OCH2O), 115.8 (d, C: C5), 126.2 (d, B: C5), 127.7 (d, Ph: C4), 127.9 (d, 
Ph: C2 and C6), 128.4 (d, Ph: C3 and C5), 137.4 (s, Ph: C1), 149.9 (s, C: C4), 161.1 (s, B: 
C4), 163.3 (s, B: C2), 170.1 (s, C: C2), 172.7 (s, C=O); MS (ESI): m/z (%) = 569 (100) 
[(M(120Sn)+H)+], 539 (17), 449 (23); HRMS (ESI): m/z = C21H29N4O3S2120Sn [(M(120Sn)+H)+], 
calcd.: 569.0698, found: 569.0699. 
Compound 14c 
This compound was prepared as described above starting from compounds 13 and 5c to 
yield compound 14c (29.3 mg, 20.5 µmol, 54%) as a pale-yellow oil. Rf = 0.40 (EtOAc, UV), 
1H-NMR (CDCl3, 360 MHz): δ(ppm) = 0.36 [s, 9 H, Sn(CH3)3], 0.96 [d, 3J = 6.5 Hz, 3 H, 
CH(CH3)2], 0.99 [d, 3J = 6.7 Hz, 3 H, CH(CH3)2], 
1.63 [s, 9 H, OC(CH3)3], 2.33 [mc, 1 H, CH(CH3)2], 
2.65 (d, 3J = 4.8 Hz, 3 H, NHCH3), 2.73 (s, 3 H, E: 
5-CH3), 2.95 [dd, 2J = 15.7 Hz, 3J = 5.2 Hz, 1 H, 
CHHC(=O)NHMe], 3.20 [dd, 2J= 15.7 Hz, 3J = 4.5 
Hz, 1 H, CHHC(=O)NHMe], 3.93 (dd, 2J = 10.1 Hz, 
3J = 4.5 Hz, 1 H, CHHOBOM), 4.11 [dd, 2J = 16.9 
Hz, 3J = 4.5 Hz, 1 H, C(=O)CHHNH], 4.22 (dd, 2J = 
10.1 Hz, 3J = 4.2 Hz, 1 H, CHHOBOM), 4.46 (s, 2 
H, OCH2Ph), 4.48 [dd, 2J = 16.9 Hz, 3J = 6.5 Hz, 1 
H, C(=O)CHHNH], 4.71 (s, 2 H, OCH2O), 5.31 (mc, 
1 H, D: CHNH), 5.52 (mc, 1 H, C: CHNH), 5.74 (mc, 1 H, E: CHNH), 6.72 (d, 3J = 4.8 Hz, 1 H, 
NHCH3), 7.20-7.30 (m, 5 H, Ph), 7.34 (s, 1 H, C: 5-H), 7.62 (mc, 3J = 1 H, NH), 7.93 (s, 1 H, 



























	








   S22 
 
B: 5-H), 8.05 (s, 1 H, D: 5-H), 8.11 (mc, 1 H, NH), 8.19-8.22 (m, 1 H, NH), 8.20 (s, 1 H, G: 
5-H), 8.33 (s, 1 H, F: 5-H), 8.36 (d, 3J = 8.4 Hz, 1 H, A: 4-H), 8.73 (d, 3J = 8.4 Hz, 1 H, A: 
5-H), 9.56 (mc, 1 H, NH). After 1H-NMR stannane 14c was quickly subjected to the 
cyclization step. 
Macrocycle 15c 
Starting from compound 14c macrocycle 15c (11.1 mg, 9.40 µmol, 52%) was obtained as a 
pale-yellow wax, using the procedure given above for compound 14a. Rf = 0.50 
(EtOAc/MeOH = 60:1); 1H-NMR (CDCl3, 360 MHz): 
δ(ppm) = 0.89 [d, 3J = 6.7 Hz, 3 H, CH(CH3)2], 1.00 [d, 
3J = 6.9 Hz, 3 H, CH(CH3)2], 1.01-1.05 [m, 1 H, 
CHHC(=O)NHMe], 1.66 [s, 9 H, OC(CH3)3], 2.27 [mc, 1 
H, CH(CH3)2], 2.62 (d, 3J = 4.7 Hz, 3 H, NHCH3), 2.65 
(s, 3 H, E: 5-CH3), 2.71 [dd, 2J = 16.9 Hz, 3J = 3.6 Hz, 
1 H, CHHC(=O)NHMe], 3.63 [dd, 2J = 17.6 Hz, 3J = 3.2 
Hz, 1 H, C(=O)CHHNH], 3.93 (dd, 2J = 10.6 Hz, 3J = 
3.6 Hz, 1 H, CHHOBOM), 4.01 (dd, 2J = 10.6 Hz, 3J = 
4.1 Hz, 1 H, CHHOBOM), 4.55 (d, 2J = 11.7 Hz, 1 H, OCHHPh), 4.62 (d, 2J = 11.7 Hz, 1 H, 
OCHHPh), 4.79 (d, 2J = 6.5 Hz, 1 H, OCHHO), 4.80-4.84 [m, 1 H, C(=O)CHHNH], 4.84 (d, 2J 
= 6.5 Hz, 1 H, OCHHO), 5.23 (dd, 3J = 7.9, 4.6 Hz, 1 H, D: CHNH), 5.36-5.44 (m, 2 H, C: 
CHNH and E: CHNH), 6.72 (d, 3J = 4.7 Hz, 1 H, NHCH3), 7.20 (d, 3J = 6.0 Hz, 1 H, C: 
CHNH), 7.26 (s, 1 H, C: 5-H)*, 7.29-7.39 (m, 5 H, Ph), 8.10 (s, 1 H, D: 5-H), 8.11 (d, 3J = 8.3 
Hz, 1 H, A: 4-H), 8.21 (s, 1 H, G: 5-H), 8.25 (s, 1 H, B: 5-H), 8.37 (s, 1 H, F: 5-H), 8.39 (d, 3J 
= 8.3 Hz, 1 H, A: 5-H), 8.77 (d, 3J = 7.9 Hz, 1 H, D: CHNH), 8.98 (d, 3J = 9.1 Hz, 1 H, E: 
CHNH). *Signal is overlain by CHCl3. This compound was obtained as a mixture together 
with triphenylphosphine oxide and was directly used in the next step. The triphenylphosphine 
oxide multiplet overlays one NH signal. 
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Thiopeptide 3c 
To a solution of 15c (8.49 mg, 7.19 µmol) in CH2Cl2 (1 mL) was added TFA (0.2 mL) and the 
mixture was stirred for 3 h at room temperature. The solvent was removed under reduced 
pressure and TFA was co-evaporated with toluene (2 × 1 mL). The residue was dried in 
vacuo and dissolved in THF (0.2 mL) and MeOH (0.2 mL). TMSCHN2 (4.68 µL, 9.35 µmol, 
2.0 M in Et2O) was added and the solution was stirred for 1 h at room temperature. The 
solvents were removed in vacuo and the crude product was purified by flash chromatography 
(CH2Cl2/MeOH = 10:1) followed by reversed phase HPLC to remove residual 
triphenylphosphine oxide. Thiopeptide 3c (4.91 mg, 4.31 µmol, 60% over 2 steps) was 
obtained as a colorless solid. Rf = 0.20 (CH2Cl2/MeOH = 20:1, UV); [α]D20 = +137 (c = 0.09 in 
CHCl3); IR (ATR): ν~ [cm-1] = 2928 (w), 1658 (s, 
C=O), 1543 (s), 1494 (m), 1210 (m), 1051 (m), 751 
(s); 1H-NMR (CDCl3, 500 MHz): δ(ppm) = 0.88 [d, 3J 
= 6.8 Hz, 3 H, CH(CH3)2], 0.96 [dd, 2J = 17.5 Hz, 3J = 
5.9 Hz, 1 H, CHHC(=O)NHMe], 1.00 [d, 3J = 6.8 Hz, 
3 H, CH(CH3)2], 2.28 [mc, 1 H, CH(CH3)2], 2.63 (d, 3J 
= 4.8 Hz, 3 H, NHCH3), 2.65 (s, 3 H, E: 5-CH3), 2.70 
[dd, 2J = 17.5 Hz, 3J = 3.5 Hz, 1 H, 
CHHC(=O)NHMe], 3.59 [dd, 2J = 17.6 Hz, 3J = 3.3 
Hz, 1 H, C(=O)CHHNH], 3.94 (dd, 2J = 10.7 Hz, 3J = 3.6 Hz, 1 H, CHHOBOM), 4.01 (dd, 2J = 
10.7 Hz, 3J = 4.0 Hz, 1 H, CHHOBOM), 4.02 (s, 3 H, OCH3), 4.59 (d, 2J = 11.7 Hz, 1 H, 
OCHHPh), 4.67 (d, 2J = 11.7 Hz, 1 H, OCHHPh), 4.79 [dd, 2J = 17.6 Hz, 3J = 9.7 Hz, 1 H, 
C(=O)CHHNH], 4.84 (d, 2J = 6.8 Hz, 1 H, OCHHO), 4.89 (d, 2J = 6.8 Hz, 1 H, OCHHO), 5.23 
(dd, 3J = 7.9, 4.7 Hz, 1 H, D: CHNH), 5.39 (mc, 2 H, C: CHNH and E: CHNH), 6.80 (d, 3J = 
4.8 Hz, 1 H, NHCH3), 6.91 (d, 3J = 6.0 Hz, 1 H, C: CHNH), 7.27 (s, 1 H, C: 5-H), 7.33-7.42 
(m, 5 H, Ph), 7.71 [dd, 3J = 9.7, 3.3 Hz, 1 H, C(=O)CHHNH], 8.11 (s, 1 H, D: 5-H), 8.13 (d, 3J 
= 8.1 Hz, 1 H, A: 4-H), 8.26 (s, 1 H, B: 5-H), 8.36 (s, 1 H, G: 5-H), 8.38 (s, 1 H, F: 5-H), 8.38 
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(d, 3J = 8.1 Hz, 1 H, A: 5-H), 8.76 (d, 3J = 7.9 Hz, 1 H, D: CHNH), 8.99 (d, 3J = 9.2 Hz, 1 H, E: 
CHNH); 13C-NMR (CDCl3, 126 MHz): δ(ppm) = 12.3 (q, E: 5-CH3), 18.0 [q, CH(CH3)2], 18.4 
[q, CH(CH3)2], 26.2 (q, NHCH3), 34.7 [d, CH(CH3)2], 38.3 [t, CH2C(=O)NHMe], 41.1 [t, 
C(=O)CH2NH], 48.2 (d, E: CHNH), 52.6 (q, OCH3), 53.3 (d, C: CHNH), 56.1 (d, D: CHNH), 
69.9 (t, CH2OBOM), 70.8 (t, OCH2Ph), 95.9 (t, OCH2O), 115.0 (d, C: C5), 118.7 (d, A: C5), 
123.2 (d, B: C5), 123.8 (d, D: C5), 125.2 (d, F: C5), 127.7 (s, A: C3), 127.9 (d, Ph: C3 and 
C5), 128.3 (d, Ph: C4), 128.8 (d, Ph: C2 and C6), 130.5 (d, G: C5), 137.1 (s, Ph: C1), 140.4 
(d, A: C4), 140.5 (s, E: C5), 142.1 (s, E: C4), 148.2 (s, G: C4), 148.4 (s, D: C4), 148.8 (s, C: 
C4), 150.2 (s, F: C4), 150.3 (s, A: C2), 150.5 (s, A: C6), 154.5 (s, B: C5), 159.8 (s, B: C2), 
161.2 [s, D: C(=O)NH], 161.3 [s, E: C(=O)NH], 161.8 [s, C(=O)OMe], 162.0 [s, F: C(=O)NH], 
164.8 (s, F: C2), 167.6 (s, E: C2), 168.5 [s, C(=O)CH2NH], 169.0 (s, D: C2 and G: C2), 169.7 
[s, C(=O)NHMe], 170.7 (s, C: C2); MS (ESI): m/z (%) = 1161 (50) [(M+Na)+], 1139 (100) 
[(M+H)+], 1107 (4) [(M−OCH3)+]; HRMS (ESI): m/z = C49H47N12O9S6 [(M+H)+], calcd.: 
1139.1907, found: 1139.1887. 
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Compounds 5a and 5b, 1H-NMR 
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Compounds 5a and 5b, 13C-NMR 
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Compound 5c, 1H-NMR 
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Compound 5c, 13C-NMR 
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Thiopeptide 3a, 1H-NMR 
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Thiopeptide 3a, 13C-NMR 
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Thiopeptide 3b, 1H-NMR 
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1H-NMR Spectra of thiopeptide 3b at different temperatures in CDCl3: 
 
For the two diastereotopic protons at the methylene group C11 of the side chain between 
ring E and F only one broad singlet at 2.40 ppm can be observed at room temperature 
whereas at 10 °C the spectrum provides clear evidence for a separation of the signal 
(arrows). The observation supports the hypothesis that 3b lacks hydrogen bonding between 
the proton at N13 and the oxygen atom at C28 and thus adopts a more flexible conformation 
than 2, 3a and 3c. 
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Thiopeptide 3b, 13C-NMR 
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Thiopeptide 3c, 1H-NMR 
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Thiopeptide 3c, 13C-NMR 
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Materials and methods for in silico studies 
Computational investigations: As structural basis for the computational studies the 
experimental structure of EF-TU-GDPNP with bound GE2270A (PDB-ID: 2C77) was used.[1] 
Calculations were performed by the program DynaCell[4] together with the GROMOS 53A1 
force field[6] and illustrations were created using VMD.[7] The 3D structures of the compounds 
2 and 3a-c were constructed using the programs ChemDraw and ChemDraw3D[8]. Force field 
parameters for the compounds were assigned based on GROMOS53A1 compatible 
topologies created by PRODRG.[9] Afterwards we manually checked all atom types, 
protonation states, and charges and adjusted parameters if necessary In addition, we 
checked the consistency of the topology with respect to the compounds geometry using an 
in-house protocol of combined energy minimizations and short MD simulations, which was 
especially developed for the assignment of consistent ligand parameters (Topologies are 
available from the authors upon request). 
Simulation settings: All simulations were performed using the simulation module of our in 
house modeling program DynaCell. The same general simulation conditions were applied for 
the initial equilibration, the simulations of the compounds in solution, in complex with EF-Tu, 
and the OPMD refinement simulations. As energy function the GROMOS 53A1 force field 
was used[6] and a General Born implicit solvent model was applied.[10] Due to the use of the 
implicit solvent model no cutoffs were applied for the electrostatic and van-der-Waals 
interactions. Based on this energy function the leapfrog algorithm[11] was used and a time 
step of 2 fs (1 fs during heatup and for the OPMD refinement) was chosen. Due to the use of 
an implicit solvent model, additional stochastic forces were applied to keep the system 
stable[12], a stochastic force constant of 10 kJ/(molnm) was used and a cutoff for the 
stochastic force calculations of 3 Å was chosen. The SHAKE algorithm[13] was applied to 
constrain all bond lengths. During heatup the temperature was controlled by velocity scaling, 
afterwards the temperature was kept at 300 K using the Berendsen’s weak coupling 
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method[14] with a coupling constant of 0.005 (the coupling constant was especially optimized 
for the settings of the simulations, i.e. solv ent model, stochastic dynamics conditions, etc.)[4].  
Solution simulations: All simulations in solution were performed using the general simulation 
conditions described above. The systems were heated up to 300 K over a period of 100 ps 
and afterwards the simulation was continued for 1000ps and afterwards extended to 5000 
ps. As the analysis of the 5 ns trajectories showed that after 500 ps stable ring conformations 
were observed in all cases the most common structure (largest structural cluster) of the last 
200 ps of simulation (800-1000 ps) was taken as starting structure for the docking studies, as 
at that time point the ring conformations had reached convergence and as an independent 
sampling of the side chain conformations was performed during in the docking calculations 
anyhow, convergence of these was not required. 
Docking calculations: The bound complex of GE2270A was heated up over 100 ps to 300 K 
and afterwards equilibrated at 300 K for another 400 ps using the simulation conditions 
described above. Subsequently, the ligand was cut out and the final protein structure of the 
complex was used as starting structure for the docking procedure. The solution structures of 
the compounds 2 and 3a-c were placed into the EF-Tu binding site with the ring system 
close to the bound conformation of GE2270 A. Afterwards random sampling was performed 
of the compounds position (rigid body rotation (10° steps) and translation (< ± 2 Å) and its 
side chain conformations until 200 docking poses with an overlap with the protein of less that 
80% were found. All poses were refined for 100 ps using the OPMD method[4]. Afterwards 
ligand positional clustering was performed with a cutoff of 2 Å and the cluster representatives 
(the poses within the cluster with the best pepscore interaction energy) were ranked 
according to their pepscore-based interaction energy.[4] For the best ranked poses stochastic 
dynamics simulations were performed for 2 ns until equilibration was reached. 
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Discussion of the technical aspects of the in silico studies 
Solution studies: In Figures SI3 and SI4 the results of the simulations of the compounds in 
implicit solvent are shown. In SI3 it can be observed that the simulations converge very fast, 
between 500 and 1000ps the central rind conformation stabilizes and the side chain 
conformations become stable within 2000 ps. In Figure SI4 it can be observed that the intra-
molecular hydrogen bond between the C28 carbonyl group and the proton at N13, which 
stabilizes the EF-Tu bound ring conformation, is retained during the simulations in solution in 
all compounds except 3c.  
EF-Tu complex docking and simulation studies: In Figures SI5 and SI6 the corresponding 
results are provided for the MD refinement simulations of the best scored docking poses. In 
Figure SI5a the backbone RMSD of the protein with respect to its energy minimized X-Ray 
structure (PDB-ID: 2C77) is shown. It can be seen that the protein has reached a stable 
conformation after 1000ps in all four cases. In Figure SI5b the all–atom RMSD of the docked 
compounds from their starting docking poses are given. Also in this case the complexes 
reach a local equilibrium after 1000 ps. However for two compounds (3b and 3c) the RMSD 
of this equilibrium is rather high. The reason for this is that in these cases the docked 
conformations are not stable and the compounds start moving out of the binding site very 
quickly due to unfavorable interactions (see also discussion in the main paper and Figure 6). 
They stabilize in an intermediate position half out of the binding site, in which only stabilizing 
interactions are retained (Figure 6), before dissolving in solution. As this last step might take 
a long time, we stopped the simulations at that point, as our interests are focused on the 
stability of the bound complexes and by then it is already clear that no stable binding occurs. 
In Figure SI6 the hydrogen binding pattern of the intra-molecular hydrogen bond between the 
C28 carbonyl group and the proton at N13 during the time course of the simulations is given. 
Here the same trend can be observed as for the solution simulations, namely that for the 
compounds 2, 3a, and 3c this hydrogen bond is rather stable, but for compound 3b it is not. 
This underlines the importance of this interaction for the formation of stable bound 
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complexes. Overall the hydrogen bonds are less stable in the EF-Tu complex than in 
solution. 
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Figure SI1: Bound structures of compounds GE2270 A (a) (X-ray structure), and 3b (b), 2 
(c), and 3a (d) after 1 ns of molecular dynamics simulation (largest structural cluster within 
the last 200 ps of simulation). The ligands are shown in atom colored licorice representation 
and the binding site is given either in surface representation for (a) and (b) or cartoon 
representation for (c) and (d). 
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Figure SI2: Equilibrated bound structure of compound 3a after 1 ns of MD simulation (largest 
structural cluster within the last 200 ps of simulation). The ligand and important residues in 
the binding site are shown in atom-colored licorice representation and the binding site is 
given in cartoon representation, Hydrogen bonds are shown in magenta. Switching hydrogen 
bonds of the hydroxyl group are given as pointed line.  
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Figure SI3: All-atom RMSD [Å] from the starting structures (energy minimised structures 
based on the EF-Tu complex bound ring conformation with minimized side chains) for the 
compounds 2 (red), 3a (black), 3b (blue), and 3c (green) during the time course of the 
simulations in solution (starting after 100ps of heatup from 0 K to 300 K). 
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Figure SI4: Hydrogen bond pattern for the intramolecular hydrogen bond between the C28 
carbonyl group and the proton at N13 of the compounds 2 (a), 3a (b), 3c (c), and 3b (d) 
during the time course of the simulations in solution (starting after 100 ps of heatup from 0 K 
to 300 K). 1 = hydrogen bond exists, 0 = no hydrogen bond, hydrogen bonds were calculated 
using VMD[7] default parameters.  
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Figure SI5: RMSD [Å] from the starting structures for the EF-Tu bound compounds 2 (red), 
3a (black), 3b (blue), and 3c (green) during the time course of the 2 ns refinement 
simulations of the EF-Tu complexes (starting after 500 ps of heatup from 0 K to 300 K and 
primary equilibration). (a) Backbone RMSD [Å] of the protein from its energy minimized X-ray 
conformation, (b) all-atom RMSD [Å] of the compounds from the docked conformations (the 
first 100 ps of OPMD refinement are not shown). 
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Figure SI6: Hydrogen bond pattern for the intra-molecular hydrogen bond between the C28 
carbonyl group and the proton at N13 of the compounds 2 (a), 3a (b), 3c (c), and 3b (d) 
during the time course of the simulations in complex with EF-Tu (starting after 500 ps of 
heatup from 0 K to 300 K and primary equilibration). 1 = hydrogen bond exists, 0 = no 
hydrogen bond, hydrogen bonds were calculated using VMD[7] default parameters.  
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Translational assays 
 
 
Supplementary figure. Effect of EF-Tu G257S mutant on in vitro translation: In vitro trans-
lation of firefly luciferase in the presence of increasing concentrations of wildtype (WT) EF-Tu 
(open circles) and EF-Tu-G257S (closed circles). The firefly luminescence in the absence of 
EF-Tu was assigned as 100% and error bars display the standard deviation from the mean 
for three individual experiments. 
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ABSTRACT
Instead of a classical single-stranded deoxyri-
bonuleic acid (DNA)-binding protein (SSB), some hy-
perthermophilic crenarchaea harbor a non-canonical
SSB termed ThermoDBP. Two related but poorly
characterized groups of proteins, which share the
ThermoDBP N-terminal DNA-binding domain, have a
broader phylogenetic distribution and co-exist with
ThermoDBPs and/or other SSBs. We have investi-
gated the nucleic acid binding properties and crys-
tal structures of representatives of these groups
of ThermoDBP-related proteins (ThermoDBP-RPs) 1
and 2. ThermoDBP-RP 1 and 2 oligomerize by differ-
ent mechanisms and only ThermoDBP-RP2 exhibits
strong single-stranded DNA affinity in vitro. A crystal
structure of ThermoDBP-RP2 in complex with DNA
reveals how the NTD common to ThermoDBPs and
ThermoDBP-RPs can contact the nucleic acid in a
manner that allows a symmetric homotetrameric pro-
tein complex to bind single-stranded DNA molecules
asymmetrically. While single-stranded DNA wraps
around the surface or binds along channels of pre-
viously investigated SSBs, it traverses an internal,
intersubunit tunnel system of a ThermoDBP-RP2
tetramer. Our results indicate that some archaea have
acquired special SSBs for genome maintenance in
particularly challenging environments.
INTRODUCTION
Deoxyribonucleic acid (DNA) replication, repair, recom-
bination and telomere maintenance require the transient
unwinding of duplex DNA (1,2). To maintain and protect
DNA in the single-stranded (ss) state, all organisms harbor
essential single-strandedDNA-binding proteins (SSBs) that
bind ssDNAwith high affinity and low sequence specificity.
Classical SSBs harbor one of four distinct DNA-binding
domains: the oligonucleotide/oligosaccharide-binding
(OB) fold; the K homology (KH) domain; the ribonu-
cleic acid (RNA) recognition motif (RRM) or the whirly
domain (3). The sequences of the proteins are poorly
conserved in either group (4) and different SSBs adopt a
variety of oligomeric states (5), thereby bringing several
ssDNA-binding domains together (6).
Recently, a group of hyperthermophilic crenarchaea has
been found to lack a classical SSB and instead to contain
a distinct SSB, termed ThermoDBP (7). The crystal struc-
ture of the ssDNA-binding N-terminal domain (NTD) of
Thermoproteus tenax (tte) ThermoDBP, comprising a four-
stranded -sheet packed against four -helices (7), differs
markedly from the classical SSB DNA-binding domains,
and tteThermoDBP was predicted to dimerize in a paral-
lel fashion via a C-terminal leucine zipper (7). However, the
exact mode of oligomerization and the mechanism of DNA
binding of ThermoDBPs so far remained elusive.
ThermoDBPs share sequence similarity with domain
of unknown function (DUF) 2258 proteins, which have
a broader phylogenetic distribution in archaea (Thermo-
proteales, Sulfolobales,Desulfurococcales, Thermococci and
Archaeoglobi). DUF2258 proteins can be divided into
two groups that we term ThermoDBP-related proteins
(ThermoDBP-RPs) 1 and 2. Both groups contain a
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ThermoDBP-like NTD but differ from ThermoDBPs and
from each other in their C-terminal regions (Supple-
mentary Figure S1). The ThermoDBP-like NTD sug-
gests that ThermoDBP-RPs might also be SSBs. However,
tteThermoDBP-RP1 was not recovered from cell lysates
via a biotinylated oligodeoxynucleotide used for isolation
of tteThermoDBP (7). Furthermore, Sulfolobus solfataricus
(sso) ThermoDBP-RP1 was reported to associate with box
C/D small (s) RNAs and with the 30S ribosomal subunit
(8), but the protein was not detected in a subsequent pro-
teomic characterization of sso ribosomes (9). We therefore
set out to further characterize the structures and functions
of ThermoDBP-RPs.
Our analyses show that ThermoDBP-RP2s are uncon-
ventional SSBs that bind ssDNA in an asymmetric fashion
at an internal, intersubunit tunnel system of a symmetric
protein tetramer. The apo-structure of ThermoDBP-RP1
suggests thatDNAbinding by this group of proteinsmay be
auto-inhibited, explaining their weak nucleic acid affinities
observed in vitro. Structural comparisons reveal that the eu-
karyotic DNA polymerase eta has acquired a domain that
closely resembles the N-terminal ssDNA-binding domain
of ThermoDBPs and ThermoDBP-RPs but employs a dif-
ferentmolecular surface for binding to double-stranded (ds)
DNA.
MATERIALS AND METHODS
Protein production
Coding sequences of Pyrococcus furiosus (pfu)
ThermoDBP-RP1 and Aeropyrum pernix (ape)
ThermoDBP-RP2 were polymerase chain reaction (PCR)-
amplified from P. furious and A. pernix genomic DNA.
The PCR fragments encoding full-length ThermoDBP-RP
genes were cloned into pET-M11 (EMBL, Heidelberg)
via NcoI/BamHI restriction sites in frame with an N-
terminal His6-tag followed by a Tobacco Etch Virus (TEV)
protease cleavage site. For expression, cells were grown
in auto-inducing medium (10) at 37◦C to an OD600 of
0.8, transferred to 18◦C and harvested after 60 h. Cell
pellets were resuspended in 20 mM HEPES-NaOH, pH
7.5, 500 mM NaCl and 5 mM -mercaptoethanol sup-
plemented with 10 g/ml DNaseI, 3 mM MgCl2 and
100 g/ml lysozyme. Cells were lyzed by four passes
through a microfluidizer at 80 kPsi. The cell lysates were
clarified by centrifugation. For purification, clarified
lysates were loaded onto Ni2+-NTA resin equilibrated
with lysis buffer. Beads were washed with one bed vol-
ume of 20 mM HEPES-NaOH, pH 7.5, 2 M LiCl and
5 mM -mercaptoethanol followed by washing with 5
bed volumes of 20 mM HEPES-NaOH, pH 7.5, 500 mM
NaCl, 20 mM imidazole and 5 mM -mercaptoethanol.
Proteins were eluted with 20 mM HEPES-NaOH, pH
7.5, 200 mM NaCl, 5 mM -mercaptoethanol and 300
mM imidazole. Eluates were mixed with TEV protease
(mass ratio protease/protein 1:50) and dialyzed overnight
at 4◦C against 20 mM HEPES–NaOH, pH 7.5, 100 mM
NaCl and 2 mM -mercaptoethanol. The dialyzed samples
were again loaded on Ni2+-NTA resin equilibrated with
dialysis buffer to remove the TEV protease and uncleaved
protein. The flow-throughs were further purified by ion
exchange chromatography. Samples were loaded on a
MonoQ column (GEHealthcare) equilibrated with dialysis
buffer. Proteins were eluted with a linear gradient from
100 mM to 500 mM NaCl over 50 column volumes.
Fractions containing the proteins of interest were loaded
on Superdex 75 (pfuThermoDBP-RP1) or Superdex 200
(apeThermoDBP-RP2) size-exclusion chromatography
columns (GE Healthcare) pre-equilibrated with 10 mM
Tris–HCl, pH 7.6, 50 mMNaCl and 1 mMDTT. Fractions
containing pure protein were pooled and concentrated
to 20 mg/ml using Amicon concentrators (Millipore). To
prepare selenomethionine (SeMet)-labeled proteins, E.
coli BL21(DE3) cells were grown in SeMet auto-inducing
medium (10). The other steps for expression and protein
purification were the same as described above.
Electrophoretic gel mobility shift assays
Box C/D small RNAs (sRNAs) were synthesized by in vitro
transcription using T7 RNA polymerase and PCR ampli-
fied templates from P. furious genomic DNA. Transcription
products were purified on a 6% urea-TBE denaturing poly-
acrylamide gel followed by phenol-chloroform extraction
and ethanol precipitation. All other oligonucleotides (Sup-
plementary Table S1) were chemically synthesized (Dhar-
macon and MWG/Operon). To prepare DNA or RNA du-
plexes, complementary strands were mixed in equimolar ra-
tios, heated to 80◦C and slowly cooled (0.2◦C/min) in a
thermocycler to 20◦C. The samples were then separated on
agarose gels and duplex bands were extracted and ethanol
precipitated. For electrophoretic gel mobility shift assays,
oligonucleotides were 5′-end labeled with  -[32P]-ATP. La-
beled oligonucleotides were mixed with recombinant pro-
teins in 20 mM Tris–HCl, pH 8.0, 150 mM NaCl, 2 mM
DTT and incubated at 20◦C or 80◦C for 10 min. To com-
pete RNA binding, 0.5 g/l E. coli transferRNAs (tRNAs)
were added to the reactions. Samples were then fraction-
ated on a 6% (60:1) polyacrylamide gel and visualized using
a PhosphorImager (Typhoon 8600, GE Healthcare). Bind-
ing of apeThermoDBP-RP2 to single-stranded and circular
M13 phage DNA was tested on a 1% agarose gel. Increas-
ing concentrations of the protein were mixed with 100 ng
DNA and incubated at 4◦C for 1 h. DNA was visualized by
ethidium bromide staining.
Ribosome binding assays
Ribosomes and ribosomal subunits from Thermococcus ko-
dakarensis were prepared as described (9). In a total re-
action volume of 150 l, 50 pmoles of 30S, 50S or 70S
T. kodakarensis ribosomal subunits or ribosomes were in-
cubated with 400 pmoles of His6-tagged pfuThermoDBP-
RP1 or apeThermoDBP-RP2 in a buffer containing 10
mM Tris–HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 45
mM NH4Cl and the varying concentrations of NaCl. The
mixture was incubated for 20 min at 37◦C and was then
placed on 90 l of a 20% sucrose cushion. The cushion
was centrifuged for 30 min at 78 000 rpm in a TLA 100
rotor. After centrifugation the supernatant was removed
and the pellet was resuspended. The input sample before
centrifugation, the supernatant and the pellet were ana-
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lyzed by sodium dodecyl sulphate-polyacrylamide gel elec-
trophoresis followed by Western blotting. The membranes
were stained by amido black to check the protein content in
each lane and were then treated by anti-His6 antibody for
detection of ThermoDBP-RPs.
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were
performed at 25◦C on an iTC200 microcalorimeter
equipped with a 300-l syringe (Microcal, GE Healthcare).
DNAoligonucleotides and apeThermoDBP-RP2were dial-
ysed against the same buffer overnight. apeThermoDBP-
RP2 was titrated at 10Mconcentration in a cell volume of
250 l with 50–100 M of different DNA oligonucleotides
in 16 injections of 2.5 l volumes with 5-min intervals. The
released heat was obtained by integrating the calorimetric
output curves. Binding parameters were calculated using
the Origin5 software using the ‘One Set of Sites’ curve
fitting model provided by the software.
Analytical size-exclusion chromatography
Analytical size-exclusion chromatography was conducted
on Superdex 75 (pfuThermoDBP-RP1) or Superdex 200
(apeThermoDBP-RP2) PC 3.2/30 analytical size-exclusion
columns (GE Healthcare) in 20 mM HEPES-NaOH, pH
7.5, 100 mMNaCl. Exclusion volumes (Vo) were estimated
using Blue Dextran (approximate molecular mass 2 MDa).
Bovine  -globulin (158 kDa), rabbit lactate dehydrogenase
(140 kDa), chicken conalbumin (75 kDa), bovine serum al-
bumin (67 kDa), chicken ovalbumin (45 kDa) and horse
myoglobin (17 kDa) were used as molecular mass stan-
dards. Linear regression of plots of log (molecular mass)
versus the ratios of the observed elution and exclusion vol-
umes (Ve/Vo) allowed calculation of the apparent molec-
ular masses of pfuThermoDBP-RP1 and apeThermoDBP-
RP2 based on the observed elution volumes of the proteins.
Crystallization of ThermoDBP-RPs and of an
apeThermoDBP-RP2-dT10 complex
Crystallization of pfuThermoDBP-RP1 was carried out
at 20◦C using the sitting drop vapor diffusion method.
pfuThermoDBP-RP1 crystallized in two different crystal
forms. Form 1 crystals of SeMet-labeled pfuThermoDBP-
RP1 were obtained by mixing 1 l of SeMet-labeled pro-
tein solution with 1 l of reservoir solution containing 50
mM sodium cacodylate, pH 6.4, 2.3 M (NH4)2SO4 and 10
mMMgSO4. Prior to flash-cooling in liquid nitrogen, form
1 crystals of pfuThermoDBP-RP1 were soaked in reservoir
buffer supplemented with 25% (v/v) glycerol. Form 2 crys-
tals of SeMet-labeled pfuThermoDBP-RP1 were obtained
by mixing 0.5 l of protein solution with 1 l of reservoir
solution containing 0.1 M Tris–HCl, pH 8.5, 0.2 M Li2SO4
and 40% (v/v) PEG400. These crystals were flash-cooled in
a 100 K cryogenic stream in their mother liquor. Crystals of
apeThermoDBP-RP2 were produced by mixing equal vol-
umes of SeMet-labeled apeThermoDBP-RP2 with a reser-
voir solution containing 0.1 M imidazole, pH 8.0, 0.4 M
NaH2PO4, 1.6MK2HPO4, 0.2MNaCl and 0.25Mglycine.
Crystals were cryo-protected by addition of 25% (v/v) glyc-
erol to the mother liquor.
For co-crystallization with ssDNA, apeThermoDBP-
RP2 (17 mg/ml) was mixed with a 10-fold molar excess of
dT10 in 10 mM Tris–HCl, pH 7.6, 50 mM NaCl and 1 mM
DTT. The mixture was incubated for 5 min at 80◦C. Crys-
tallization experiments were performed in a sitting drop for-
mat at 18◦C. Crystals appeared after three days over a reser-
voir solution composed of 200 mMNaOAc, pH 4.3, 1.3 M
NaH2PO4 and 0.7 M K2HPO4. For cryo-protection, crys-
tals were transferred to mother liquor supplemented with
15% (v/v) glycerol and subsequently flash-cooled in liquid
nitrogen.
Crystallographic procedures
Diffraction data were collected at beamline BL14.2 of the
BESSY II storage ring (Berlin, Germany; Supplementary
Table S2). Data were processed with the XDS package (11).
The structure of pfuThermoDBP-RP1 form 1 crystals was
solved by the multiple-wavelength anomalous dispersion
method using the program SHARP/autoSHARP (12). The
structure of the second crystal form of pfuThermoDBP-
RP1 was solved by molecular replacement using the
structure coordinates of the crystal form 1 as a search
model with the program MOLREP (13). The struc-
ture of apeThermoDBP-RP2 was solved via the single-
wavelength anomalous dispersion method using the pro-
gram HKL2MAP (14,15). Finally, the crystal structure
of an apeThermoDBP-RP2-dT10 complex was solved by
molecular replacement using the structure coordinates of an
apeThermoDBP-RP2 tetramer as a search model with the
program PHASER (16). Model building was done manu-
ally with COOT (17). For all the structures, refinement was
done with phenix.refine (18,19) or Refmac5 (20) including
TLS refinement (21). Intermediate and final structures were
evaluated with MOLPROBITY (22). All structure figures
were drawn using PYMOL (23). Electrostatic surfaces were
calculated with APBS (24).
RESULTS
Nucleic acid binding by ThermoDBP-RPs
To investigate the possible cellular functions of
ThermoDBP-RPs, we first tested the reported interac-
tions of the proteins with box C/D sRNAs and ribosomes
or ribosomal subunits in vitro. In electrophoretic mo-
bility shift assays (EMSAs), pfuThermoDBP-RP1 and
apeThermoDBP-RP2 bound to box C/D sRNAs but the
interactions were efficiently competed by the addition
of unlabeled Escherichia coli tRNAs (Supplementary
Figure S2), suggesting that the proteins do not recognize
sequence or structural features of box C/D sRNAs with
high specificity. At low salt concentrations (20–120 mM
NaCl), the proteins were pelleted by 30S and 50S ribosomal
subunits and by 70S ribosomes (Supplementary Figure
S3A; left and middle panels; lanes 3, 6 and 9). Increasing
the salt concentration to 200 mM abrogated binding to the
subunits and ribosomes, suggesting that these interactions
are only marginally stable (Supplementary Figure S3B; left
and middle panels; lanes 3, 6 and 9).
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While these results do not rule out the possibility that
ThermoDBP-RP proteins interact with box C/D sRNAs
or ribosomes in vivo, they prompted us to investigate if
the proteins interact also with other nucleic acids. In-
deed, EMSAs (Figure 1A and B) and isothermal titration
calorimetry (ITC; Supplementary Figure S4) showed that
apeThermoDBP-RP2 bound to a 21-mer ssDNA of mixed
sequence or to 21-mer homo-pyrimidine ssDNAs with ap-
parent Kd values of about 50–100 nM but very weakly or
not at all to homo-purine ssDNAs, DNAduplexes, ssRNAs
or an RNAduplex of the same length. A longer (45-mer) ss-
DNAwas gradually shifted in EMSAs (Figure 1C), indicat-
ing a stepwise binding of more than one apeThermoDBP-
RP2 molecule or complex. Under the same experimental
conditions, pfuThermoDBP-RP1 did not bind to any of the
21-mer nucleic acids (Figure 1A and B) but weakly bound
to a 45-mer ssDNA (about 50% shift at 50–100 M pro-
tein concentration; Figure 1C). Increasing the temperature
or time of incubation had no effect on any of these inter-
actions. These data suggest that at least ThermoDBP-RP2
proteins can act as SSBs.
Crystal structures and modes of oligomerization of
pfuThermoDBP-RP1 and apeThermoDBP-RP2
We next determined the crystal structures of
pfuThermoDBP-RP1 and apeThermoDBP-RP2 at 2.43
and 2.05 A˚ resolution, respectively (Figure 1A, B and Sup-
plementary Table S2). As expected from sequence analysis
(Supplementary Figure S1), pfuThermoDBP-RP1 contains
an NTD similar to the tteThermoDBP NTD (Figure
2C; root-mean-square deviation (r.m.s.d.) of 2.0 A˚ for 81
pairs of C atoms). Compared to the pfuThermoDBP-
RP1 NTD, the tteThermoDBP NTD is expanded by
two additional N-terminal -strands and an extra helix
between pfuThermoDBP-RP1 helices 1 and 2 (Figure
2C and Supplementary Figure S1). The C-terminal part
of pfuThermoDBP-RP1 forms an amphipathic -helix.
The C-terminal 3-helices of four pfuThermoDBP-RP1
molecules associate as an antiparallel, four-helix bundle,
positioning two pairs of NTDs at the opposite ends of a
central four-helix rod (Figure 2A). About 14 000 A˚2 of sol-
vent accessible surface area is buried upon tetramerization,
and an interface analysis (25) suggested that the observed
tetramer is stable in solution. In agreement with this
analysis, pfuThermoDBP-RP1 eluted from an analytical
size-exclusion column consistent with the size of a tetramer
(apparent molecular mass 65.5 kDa; calculated tetramer
molecular mass 68.9 kDa).
apeThermoDBP-RP2 contains two globular domains,
an NTD and a C-terminal domain (CTD) that are con-
nected by a bent, -helical linker (helix 3; Figure 2B). The
NTD is again similar to those of tteThermoDBP and of
pfuThermoDBP-RP1 (r.m.s.d. of 2.1 A˚ and 0.8 A˚, respec-
tively, for 87 C atoms; Figure 2C). The apeThermoDBP-
RP2 CTD is composed of a five-stranded, anti-parallel
-sheet sandwiched between two -helices (Figure 2B).
apeThermoDBP-RP2 also crystallized as a tetramer, which
was arranged as a dimer of tightly intertwined dimers
(Figure 2B). Analytical gel filtration analyses indicated
that apeThermoDBP-RP2 also forms tetramers in solution
(apparent molecular mass 111.3 kDa; calculated tetramer
molecular mass 105.4 kDa). Within a tight dimer (sub-
units A/A′ and B/B′; Figure 2B), each molecule cradles the
NTD of the partner molecule between its own CTD and
the connecting helix 3 (interface I; Figure 2B), thereby
burying ∼3300 A˚2 of solvent accessible surface area. Each
molecule of a tight dimer interacts via its ownNTDwith the
NTD of one molecule of a neighboring tight dimer (bury-
ing ∼1300 A˚2 of solvent accessible surface area; interface II;
Figure 2B), and via its own CTDwith the CTD of the other
molecule of the neighboring tight dimer (burying∼1600 A˚2
of solvent accessible surface area; interface III; Figure 2B).
Only interface I within a tight dimer is predicted to be sta-
ble in isolation, while isolated interfaces II and III (between
tight dimers) are predicted to be unstable (25). Consistently,
interface I is largely hydrophobic (0.24 salt bridges/100 A˚2)
while interfaces II and III aremore hydrophilic (1.5 and 0.38
salt bridges/100 A˚2, respectively). Based the interface anal-
yses, we expect that pfuThermoDBP-RP1 forms permanent
tetramers but that interfaces II and III in apeThermoDBP-
RP2 may intermittently break either partly (forming open
tetramers) or entirely (forming isolated tight dimers).
Crystal structure of a ThermoDBP-RP2-DNA complex
The apeThermoDBP-RP2 tetramer in the crystal exhibits
largely electronegative outer surfaces and an interior tun-
nel system that is lined with electropositive surface poten-
tial (Figure 2D), possibly suitable for ssDNA binding. To
reveal how apeThermoDBP-RP2 binds ssDNA, we deter-
mined its crystal structure in complex with a decameric
oligo-dT DNA (dT10) at 2.9 A˚ resolution (Figure 3A,
B and Supplementary Table S2). The crystals contained
two crystallographically independent apeThermoDBP-RP2
tetramers per asymmetric unit, each associated with two
dT10 molecules (Figure 3A). We will focus our description
on one of these virtually identical complexes with better de-
fined electron density.
All 10 nucleotides of the first DNA strand (DNA1) could
be traced, whereas only seven nucleotides of the second
DNA strand (DNA2) were visible in the electron density.
As shown in Figure 3A–C, the two DNA molecules mean-
der in the 5′-to-3′ direction from the bottom of the com-
plex into the interior of the apeThermoDBP-RP2 tetramer,
where they are cradled between the juxtaposedNTDs of the
four subunits. The central portions of both DNAmolecules
are bound in the same orientation across equivalent sur-
faces of two non-contacting NTDs of two tight dimers; i.e.
DNA1 lies across the NTD of the A subunit (NTDA), while
DNA2 binds across NTDB
′
(Figure 3B). Superimposing the
subunit B′-DNA2 sub-complex on the subunit A-DNA1
sub-complex revealed that nucleotides 5–9 of DNA1 and
the first five nucleotides visible inDNA2 are bound in a sim-
ilar fashion across NTDA and NTDB
′
, respectively (Figure
3B). We attributed the same numbers to those nucleotides
of the twoDNAmolecules that occupy equivalent positions
on NTDA and NTDB′ and engage in similar contacts, irre-
spective of the total length of the oligos (ten nucleotides).
Thus, visible nucleotides of DNA1 were numbered dT1–
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Figure 1. Nucleic acid binding properties of ThermoDBP-RP proteins. (A) Electrophoretic gel mobility shift assays testing the nucleic acid
binding capabilities and preferences of pfuThermoDBP-RP1 and apeThermoDBP-RP2. ssDNA–d(ACTGCTAGAGATTTTCCACAT); ssRNA–
r(ACTGCTAGAGATTTTCCACAT); dsDNA and dsRNA additionally contained the corresponding complementary strands. (B) Binding of
pfuThermoDBP-RP1 and apeThermoDBP-RP2 to a 21-mer homo-pyrimidine (dT21) DNA. (C) Binding of pfuThermoDBP-RP1 and apeThermoDBP-
RP2 to a 45-mer ssDNA–d(CTTGCTAGGACGGATCCCTCGAGGTTTTTTTTTTTTTTTTTTTT).
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Figure 2. Structures and oligomerization of ThermoDBP-RP proteins. (A) Ribbon plot of the pfuThermoDBP-RP1 tetramer (subunits A–D). Subunits
A–D are colored in beige, brown, black and gray (or shaded differently). The NTD and the C-terminal 3 helices forming an antiparallel coiled-coil are
labeled. (B) Ribbon plot of the apeThermoDBP-RP2 tetramer. Monomers are colored/shaded as in A. Subunits A/A′ and B/B′ form the tight dimers
that associate into tetramers. NTDs, connecting helices 3 and CTDs are labeled. Roman numerals (I–III) denote the different interfaces through which
the tetramer forms. (C) Comparison of the NTDs of pfuThermoDBP-RP1 (top), apeThermoDBP-RP2 (center) and tteThermoDBP (bottom). Secondary
structure elements are labeled. (D)Electrostatic surface representation of an apeThermoDBP-RP2 tetramer (electrostatic coloring/shading scaled in the
range of ±5 kT/e). Entries/exits of an intersubunit tunnel system, which is lined with electropositive surface potential, are indicated.
dT10 while visible nucleotides of DNA2 were numbered
dT5′–dT11′, with nucleotides dT5–dT9 of DNA1 and nu-
cleotides dT5′–dT9′ of DNA2 being bound in an equiv-
alent fashion on NTDA and NTDB
′
, respectively (Figure
3B and Supplementary Figure S6). The two DNAs meet
in the center of the apeThermoDBP-RP2 tetramer, with
the 3′-terminal nucleobase (dT10) of DNA1 stacking on
the fifth nucleobase (dT9′) of DNA2 (Figure 3B and Sup-
plementary Figure S6). The 3′-terminal two nucleotides of
DNA2 (dT10′ and dT11′) are deflected from the center of
the tetramer towards the upper part of the complex (Figure
3B and C).
We observed contacts of the protein subunits to the
sugar-phosphate backbone as well as to the nucleobases
of the DNA molecules (Supplementary Table S3; Figure
3B and Supplementary Figure S6). In addition to the in-
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Figure 3. Binding of ssDNA by apeThermoDBP-RP2. (A)Ribbon plot of the apeThermoDBP-RP2-dT10 complex with the DNAs in cartoon representa-
tion (DNA1: green/dark; DNA2: yellow/light). Monomers are labeled and colored/shaded as in Figure 2B. (B) Close-up view of two neighboring NTDs
of the apeThermoDBP-RP2 (from subunits A and B′; ribbons) in contact with two dT10 molecules (DNA1 and DNA2 with nucleotides dT1–dT10 and
dT5′–dT11′, respectively; ball-and-stick; coloring/shading as in A). The two DNA strands run across the 1 helices of the respective NTDs. The rotation
symbol in this and the following panels indicates the orientation relative to (A). (C) Views on the DNA-binding surfaces of the two tight dimers (A/A′ left;
B/B′ right) with the associated DNA1 and DNA2. Relative orientations of the two tight dimers with respect to the tetramer are indicated by the rotation
symbols. Two surface representations are shown for each tight dimer. Representations on the left show coloring/shading by molecules (as in Figure 2B).
Black and gray patches on tight dimer A/A′ indicate contact residues to subunits B′ and B, respectively, of their neighboring tight dimer (belonging to
interfaces II or III as labeled); beige and brown/light and dark patches on tight dimer B/B′ indicate contact residues to subunits A and A′, respectively,
of their neighboring tight dimer. Representations on the right show surfaces of the tight dimers colored/shaded by electrostatic surface potential (as in
Figure 2A). DNA1 is proposed to outline part of the path that an elongated ssDNA molecule could take through the tetramer. This molecule could ei-
ther traverse the tetramer diagonally (green/dark dashed extensions; path 1), or turn back along the path that DNA2 is bound in opposite orientation
(yellow/light dashed extensions; path 2). Both putative paths are lined with electropositive surface potential. (D) Electrophoretic gel mobility shift assay
testing the binding of increasing amounts of apeThermoDBP-RP2 to oligo-dT ssDNAs of increasing length. Interpretation of bands is given on the right.
dT15, dT20, dT25 and dT30 show only one shifted band, a second, slower migrating band appears with dT30 at higher apeThermoDBP-RP2 concentrations,
indicating that a ssDNA molecule of 35 nucleotides can accommodate two apeThermoDBP-RP2 tetramers. (E) Electrophoretic gel mobility shift assay
testing the binding of apeThermoDBP-RP2 to circular M13 phage ssDNA on a 1% agarose gel. DNA was visualized by ethidium bromide staining. Upon
addition of increasing concentrations of the protein (indicated below the gel), the DNA migrates progressively slower, indicating that increasing numbers
of apeThermoDBP-RP2 molecules bind to the circularly closed DNA. (F)Model for binding of long ssDNAs to an apeThermoDBP-RP2 tetramer along
path1 (top) and path 2 (bottom). Left panels: Views on the ssDNAs running across the apeThermoDBP-RP2 A/A′ tight dimer with the other dimers
shown as a semi-transparent outline. Right panels: Same views with the B/B′ tight dimer as solid surfaces.
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teractions of the central portions of DNA1 and DNA2
with NTDA and NTDB
′
, respectively, they both engage
in additional contacts to all other protein subunits of the
apeThermoDBP-RP2 tetramer. These interactions again in-
volve primarily residues from the NTDs of the other sub-
units (Supplementary Table S3 and Supplementary Fig-
ure S6). Thus, the NTD of one protein subunit provides
the main binding platform for one ssDNA molecule and
NTDs from the other subunits engage in different contacts
to this DNA molecule and thereby guide it asymmetrically
through the symmetric protein tetramer.
In DNA1, dT1 and dT2 stack on each other and on
N211 of helix 6 from CTDB (the only CTD-DNA inter-
action seen in the entire structure). The side chain of dT3
is rotated outwards, introducing a first kink in the DNA
backbone. The kinked backbone is stabilized by contacts
to K63 and L64, originating from the loop following he-
lix 2 of NTDB
′
. The following dT4, dT5 and dT6 again
form a continuous stack that is capped by F23 from he-
lix 1 of NTDA. This helix is wedged between nucleotides
dT6 and dT7, introducing a second kink in the nucleic acid.
dT8 stacks on dT7 and the two nucleotides are sandwiched
between the central portions of the NTDA and NTDB 1
helices. NTDB helix 1 imposes a third kink and guides
the 3′-terminal two-nucleotide stack (dT9–dT10) towards
the center of the apeThermoDBP-RP2 tetramer, where the
backbone of dT10 is held between K17 and R20 from he-
lix 1 of NTDA
′
. The conformation and path through the
apeThermoDBP-RP2 tetramer of the second DNA strand
is similar except for its last two nucleotides, dT10′ and dT11′
(see above). While the protein imposes a multiply kinked
structure on the DNA ligands, the apeThermoDBP-RP2
tetramer itself did not undergo any significant conforma-
tional changes upon DNA binding (r.m.s.d. ∼0.9 A˚ for 880
C-pairs between DNA-free and DNA-bound forms).
Molecular basis for the nucleic acid-binding preferences of
apeThermoDBP-RP2
The kinks in theDNAbackbone are incompatible with con-
tinuous Watson-Crick base pairing in a DNA duplex and
the size of the central tunnel system in an apeThermoDBP-
RP2 tetramer could not accommodate duplex DNA (or
RNA), rendering apeThermoDBP-RP2 specific for single-
stranded nucleic acids. Purines could be accommodated at
most positions but a purine at positions 9/9′ would clash
with the 1 helices of NTDB/NTDA
′
, respectively, explain-
ing why apeThermoDBP-RP2 can bind ssDNA of mixed
sequence but fails to bind homo-purine sequences (Supple-
mentary Figure S4). Alternatively or additionally, homo-
purine sequencesmay be excluded because of their tendency
to form higher-order structures, such as dG-quadruplexes
(26) or poly-dA parallel helices (27), which could not be
accommodated in the restricted internal tunnel system of
the apeThermoDBP-RP2 tetramer. Although the protein
interacts with several nucleic acid bases, none of these con-
tacts would be expected to further restrict the nucleic acid
sequence that can be bound. Furthermore, a 2′-hydroxyl
group on nucleotides 2/2′ would clash with the base of
nucleotides 4/4′, a 2′-hydroxyl group on nucleotides 4/4′
would sterically interfere with the ribose of nucleotides 5/5′
and a 2′-hydroxyl on nucleotides 6/6′ would clash with the
backbone of Arg20 of NTDA, explaining the preference of
apeThermoDBP-RP2 for ssDNA over ssRNA.
Extent of an apeThermoDBP-RP2 binding site and engage-
ment of ssDNA lacking free termini
The precise stoichiometry and ssDNA binding mode seen
in the present crystal structure may be a consequence
of the short DNA oligomers and high DNA concen-
trations used during the crystallization experiment. To
estimate the number of nucleotides occupied by one
apeThermoDBP-RP2 tetramer on ssDNA in solution,
we conducted EMSA experiments with increasing length
oligo-dT ssDNAs (Figure 3D). Up to a length of 30
nucleotides only a single shifted band was detected, in-
dicating binding of one apeThermoDBP-RP2 tetramer
(Figure 3D). However, starting with a length of 35 nu-
cleotides, a second, slower migrating band appeared at
higher apeThermoDBP-RP2 concentrations (Figure 3D),
indicative of two apeThermoDBP-RP2 tetramers being ac-
commodated on a dT35 ssDNA. These results suggest that
one apeThermoDBP-RP2 tetramer occupies a stretch of 17
to 18 nucleotides on a ssDNA target, very similar to the
combined number of nucleotides from DNA1 and DNA2
that we see bound to an apeThermoDBP-RP2 tetramer in
the crystal structure (17 nucleotides).
Physiologically, apeThermoDBP-RP2 may engage ex-
tended ssDNA stretches that lack free ends. While we
also obtained crystals of apeThermoDBP-RP2 with longer
DNA oligomers, they diffracted poorly (about 5 A˚ resolu-
tion) and the electron densities for the DNA ligand(s) were
poorly defined. To test whether apeThermoDBP-RP2 is ca-
pable of binding ssDNA molecules that lack free termini,
we performed EMSAs with single-stranded circular M13
phage DNA (Figure 3E). Upon addition of increasing con-
centrations of apeThermoDBP-RP2, the ssDNA was pro-
gressively retarded on the gels, indicative of the protein oc-
cupying multiple binding sites in a stepwise manner. Due
to the large size of the M13 DNA (7249 nucleotides) and
the limited number of nucleotides required to accommo-
date one apeThermoDBP-RP2 tetramer, it is likely that at
each increment in protein concentrationmultiple additional
apeThermoDBP-RP2 tetramers bind.
DNA-binding may be auto-inhibited in the pfuThermoDBP-
RP1 tetramer
Residues of apeThermoDBP-RP2 that contact the DNA
molecules in the present structure are conserved in
pfuThermoDBP-RP1 (Supplementary Figure S1). To inves-
tigate why the latter protein nevertheless binds poorly to ss-
DNA (Figure 1B and C), we superimposed the NTDA do-
main of apeThermoDBP-RP2 in complex with the DNA1
molecule on an NTD of the pfuThermoDBP-RP1 tetramer
(Supplementary Figure S5A, left panel). The superposition
revealed that in pfuThermoDBP-RP1, the putative DNA-
binding surface on the NTD is occluded by the C-terminal
tail of another pfuThermoDBP-RP1 subunit (Supplemen-
tary Figure S5A; close-up in left panel). Residues 128–
139 of subunit B clash with a DNA molecule modeled on
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the NTD of subunit A. Thus, the present crystal structure
of pfuThermoDBP-RP1 may represent an auto-inhibitory
conformation with respect to ssDNA binding. We at-
tempted to test whether the NTD of pfuThermoDBP-RP1
alone interacts more strongly with nucleic acids but failed to
produce the protein in soluble form. The weak affinity for
longer DNA oligonucleotides seen with pfuThermoDBP-
RP1 (Figure 1C) may indicate that the protein can bind ss-
DNA only in special contexts, where the presumed auto-
inhibition is relieved, for example by other interacting pro-
teins.
DISCUSSION
ThermoDBP-RP2 proteins can act as non-canonical SSBs
We have demonstrated that the NTD, conserved among
ThermoDBPs and ThermoDBP-RPs, is a versatile ssDNA-
binding domain in ThermoDBP-RP2 proteins in vitro. ss-
DNA can come to lie on various sites and in different ori-
entations onmultiple copies of this domain in an oligomeric
protein. While these results show that ThermoDBP-RP2
proteins can function as SSBs in vitro, a similar activity in
vivo remains to be demonstrated.
The fold and mode of ssDNA binding of ThermoDBP-
RP2 differ markedly from previously characterized SSBs
(3). Canonical SSBs typically bind ssDNA or ssRNA on
their outer surfaces with the bases pointing towards the pro-
tein and the backbone solvent exposed. In the case of bac-
teriophage T4 gene 32 protein, ssDNA binds along a deep
channel formed between two subdomains (28). In contrast,
a ThermoDBP-RP2 tetramer binds ssDNA inside an inter-
nal, intersubunit tunnel system. This unprecedented bind-
ing mode may be particularly useful to protect ssDNA in
challenging environments such as high temperatures.
Molecular mechanism of ssDNA engagement
Our crystal structure of an apeThermoDBP-RP2-DNA
complex shows directly that the protein can bind short or
nicked ssDNAs. Such a function could be required to in-
termittently hold on to DNA ends during recombination
or repair events. It is even imaginable that such an activity
could be used to detect linear, foreign DNA molecules as
part of a simple immune system, but there is no direct evi-
dence supporting this latter idea.
On the other hand, we could show that apeThermoDBP-
RP2 can bind efficiently to a circular ssDNA molecule that
lacks free termini, suggesting that it could also substitute
for canonical SSBs in general ssDNA-binding functions.We
suggest that the short oligomers bound in our co-crystal
structure also mark the possible paths that a single, long
ssDNA molecule would take through the tetramer. The
DNA1 molecule most likely outlines a major part of the
binding site, as it represents that largest coherent stretch
of DNA that could be traced in the electron density. The
5′-end of that molecule emerges from the internal tunnel
system and lies on the surface of the apeThermoDBP-
RP2 tetramer. Additional nucleotides on this side of the
DNA most likely simply extend into the solvent. Addi-
tional nucleotides at 3′-end would come to lie in positions
that in our crystal structure are occupied by the DNA2
molecule. Topologically, the 3′-end of DNA1 could be di-
rectly connected to the 3′-terminal two nucleotides (dT10′
and dT11′) of theDNA2molecule. Thus, these terminal two
nucleotides of DNA2 point out a possible exit path for an
extended ssDNA molecule between the CTDs of subunits
A and B and the NTDs of subunits A’ and B (path 1; green
dashed line or tube in Figure 3C and F). Alternatively, an
extended DNA1 molecule could bind along the path out-
lined by nucleotides dT9′–dT5′ of the DNA2 molecule but
in opposite direction (path 2; yellow dashed line or tube
in Figure 3C and F). Although in this scenario it would
traverse the same surfaces of NTDA and NTDB
′
in oppo-
site orientation as seen for DNA2 in the present structure,
such a binding mode is not entirely unlikely given the ver-
satile contacts that are seen between different NTDs and
portions of the bound DNAmolecules in our crystal struc-
ture. It is also supported by the quasi-continuous stacking
interaction observed between the 3′-terminal nucleotide of
DNA1 (dT10) and an internal nucleotide (dT9′) of DNA2.
Both putative paths for extended ssDNAmolecules through
the apeThermoDBP-RP2 tetramer are lined with positive
electrostatic surface potential on the protein (Figure 3C).
However, due to ensuing steric hindrance, it would be im-
possible to bind two extended ssDNA molecules to an
apeThermoDBP-RP2 tetramer at the same time (e.g. along
both of the two putative paths through the internal tunnel
system).
Another immediate question is how an apeThermoDBP-
RP2 tetramer can engage a ssDNA stretch that lacks free 3′-
ends and thus could not be threaded end-on into the tunnel
system of the tetramer. Given the predicted lability of in-
terfaces II and III of the apeThermoDBP-RP2 tetramer, we
envision that the protein complex can open up along these
interfaces to engage extended ssDNA molecules at its cen-
ter. The complex would not have to completely dissociate
into tight dimers; opening of one interface III at the top or
bottom of the tetramer would suffice to allow accommoda-
tion of an extended ssDNA molecule at the internal tunnel
system.
Proteins bearing ThermoDBP-RP2-like NTDs
Although the ThermoDBP-RP1NTD closely resembles the
NTDof ThermoDBP-RP2 proteins, the physiological func-
tion of ThermoDBP-RP1 proteins remains unclear. Our in
vitro binding studies do not support, but also do not ul-
timately rule out, a specific ribosome or box C/D sRNA
association of these proteins, as had been reported previ-
ously (8). Weak DNA binding and the observation that
the equivalent of the main ssDNA-binding surface of the
ThermoDBP-RP2 NTD is obstructed in the tetrameric or-
ganization of pfuThermoDBP-RP1 suggest that the pro-
teins may require special activatory mechanisms to engage
ssDNA or other nucleic acids. Such activation (or relief of
auto-inhibition) may be provided by other interacting pro-
teins that force the pfuThermoDBP-RP1 NTDs into a dif-
ferent relative arrangement with respect to the central four-
helix bundle.
Gel filtration and sequence analyses suggested that Ther-
moDBPs form parallel dimers via a C-terminal leucine zip-
per motif (7). If these putative, parallel ThermoDBP dimers
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resemble a parallel dimer of our present pfuThermoDBP-
RP1 structure (e.g. subunits A and D; Figure 2A and Sup-
plementary Figure S5A), the main ThermoDBP-RP2-like
ssDNA binding surface of the ThermoDBP NTDs would
remain unobstructed (Supplementary Figure S5A; right
panel). However, most of the ssDNA-contacting residues
of the apeThermoDBP-RP2 NTDs are poorly conserved
in ThermoDBPs (Supplementary Figure S1), suggesting
that ssDNA could also be bound via a different surface
in the latter proteins. The NTDs in the presumed paral-
lel ThermoDBP dimers also would not cluster as seen in
the apeThermoDBP-RP2 tetramer and must bind ssDNA
non-cooperatively or cooperate in a different fashion in ss-
DNA binding than observed in apeThermoDBP-RP2. Ir-
respective of the exact mode of ssDNA binding in Ther-
moDBPs, the observation of strong ssDNA binding by full-
length tteThermoDBP (7) indicates that ThermoDBPs are
not auto-inhibited.
A search of the Protein Data Bank with the Dali server
(29) using the NTD of apeThermoDBP-RP2 revealed its
similarity to a C-terminal dsDNA-binding domain in the
eukaryotic DNA polymerase eta (r.m.s.d. of 1.75 A˚ for 97
C atoms; Supplementary Figure S5B). Unlike the binding
of the apeThermoDBP-RP2 NTDs to ssDNA, the DNA
polymerase eta dsDNA-binding domain employs its -
sheet surface to engage dsDNA along its major groove. To-
gether, our analyses show that the ThermoDBP-RP2-like
NTD provides a structural scaffold that can be adapted in
diverse ways for ssDNA binding (as in the cases of Ther-
moDBPs and ThermoDBP-RP2s) or for dsDNA binding
(as in the case of the C-terminal domain of DNA poly-
merase eta).
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Supplementary Tables 
Supplementary Table S1. DNA and RNA oligonucleotides of mixed sequence used in 
binding assays 
 
Nucleic acid Sequence 
ssDNA+ 5’-d(ATGTGGAAAATCTCTAGCAGT)-3’ 
ssDNA- 5’-d(ACTGCTAGAGATTTTCCACAT)-3’ 
ssRNA+ 5’-r(AUGUGGAAAAUCUCUAGCAGU)-3’ 
ssRNA- 5’-r(ACUGCUAGAGAUUUUCCACAU)-3’ 
45-mer ssDNA 5’-d(CTTGCTAGGACGGATCCCTCGAGGTTTTTTTTTTTTTTTTTTTT)-3’ 
mixed 20-mer 
ssDNA 5’-d(CATGGTCAGTTAGCAGGTTC)-3’ 
sR2 sRNA 5’-r(GGGGGAUGAUGAGUUUUUCCCUCACUCUGA UUAGUGAUGAGGAGCCGAUGCACUGACCUC)-3’ 
sR12 sRNA 5’-r(GGAGGGGAUGAUGAGCGUUUACCGGUCUGAGUUGUGAUGAUA CUGGCACUGUCUGACCUUCC)-3’ 
 
 
3 
Supplementary Table S2. Diffraction data collection, phasing and refinement statistics 
 
 pfuThermoDBP-RP1 apeThermoDBP-RP2 apeThermoDBP-RP2-dT10 
Data Collection Form 1 Form 2   
Wavelength (Å) 0.97962 
(peak) 
0.98003 
(inflection) 
0.97185 
(remote) 
1.0385 0.98000 0.91841 
Space Group P64 P64 P64 C2221 P212121 P212121 
Unit Cell Parameters (Å) 
a 
b 
c 
 
136.6 
136.6 
122.1 
 
136.6 
136.6 
122.1 
 
136.6 
136.6 
122.1 
 
61.3 
199.3 
114.9 
 
61.2 
108.6 
154.9 
 
61.2 
108.6 
154.9 
Resolution (Å)a 35.00 - 3.75 
(3.85 - 3.75) 
35.00 - 3.75 
(3.85 - 3.75) 
35.00 - 3.50 
(3.59 - 3.50) 
35.00 - 2.43 
(2.49 - 2.43) 
35.00 - 2.05 
(2.10 - 2.05) 
30.00 - 2.90f
(3.00 - 2.90) 
Reflections 
Unique a 
Completeness (%)a 
Redundancy a 
 
26034 (1914)
99.6 (99.6) 
5.9 (5.9) 
 
26103 (1940)
99.6 (99.5) 
5.9 (5.9) 
 
32116 (2387)
99.7 (99.6) 
5.9 (5.9) 
 
150600 (10942)
99.3 (98.9) 
5.6 (5.7) 
 
125145 (9242) 
99.9 (100.0) 
7.4 (5.9) 
 
46414 (4433) 
99.8 (99.9) 
4.5 (4.6) 
I/(I) a 10.8 (2.9) 11.1 (2.7) 16.1 (2.9) 11.5 (4.2) 15.5 (3.8) 11.07 (1.23) 
Rmeas a,b 0.149 (0.665) 0.152 (0.722) 0.094 (0.659) 0.105 (0.670) 0.090 (0.614) 0.194 (1.725) 
Phasing       
Heavy Atoms 24    12  
FOMc 0.41      
Phasing Powerc 
(isomorphous 
anomalous) 
 
0.0 
0.792 
 
0.591 
0.098 
 
1.102 
1.190 
   
Rcullis c 0.792 0.976 0.792    
Overall CCd     0.168  
Pseudo free CCd     0.631  
CCall/CCweaka, d     0.278/0.165  
Refinement 
Resolution (Å) a 34.16 - 3.50 
(3.59 - 3.50) 
  33.41 - 2.43 
(2.52 - 2.43) 
32.73 - 2.05 
(2.08 - 2.05) 
30.00 - 2.90f
(3.00 - 2.90) 
Reflections 
Number a 
Completeness (%)a 
Test Set (%)a 
 
15568 (1148)
100.0 (100.0)
5.0 
   
26694 (2612) 
99.0 (99.0) 
5.0 
 
63473 (2581) 
96.7 (93.0) 
5.0 
 
46426 (2541) 
99.9 (100.0) 
5.0 
Rwork a, e 20.7 (27.3)   22.3 (26.7) 17.9 (24.2) 26.7 (37.5) 
Rfree a,e 26.7 (35.0)   27.6 (36.5) 21.6 (29.8) 31.1 (40.6) 
4 
 
Refined Residues 
Protein 
Water molecules 
Ligands molecules 
 
 
590 
31 
3 sulfate 
   
 
586 
68 
4 sulfate 
 
 
881 
289 
2 glycerol, 6 imidazole
 
 
1754 
38 
1 phosphate 
DNA 
Mean B-Factors (Å2) 
Wilson 
Protein 
Water molecules 
Ligand molecules 
 
 
69.5 
69.4 
39.9 
164.0 
   
 
37.5 
61.3 
46.6 
112.6 
 
 
28.8 
37.4 
40.8 
53.3 
4 strands 
 
56.2 
59.3 
44.72 
88.7 
DNA 
Ramachandran Plotg (%) 
Favored 
Outliers 
 
 
97.42 
0.17 
 
   
 
98.96 
0.0 
 
 
99.31 
0.0 
98.2 
 
97.60 
0.0 
R.m.s.d. Geometry 
Bond Lengths (Å) 
Bond Angles (°) 
 
0.009 
1.158 
   
0.005 
0.992 
 
0.008 
1.082 
 
0.004 
0.909 
 
a Data for the highest resolution shell in parentheses 
b Rmeas = h [n/(n-1)]1/2 i  Ih - Ih,i/ hi Ih,i.where Ih is the mean intensity of symmetry-equivalent reflections and n is the redundancy. 
c Figure of merit (FOM), phasing power and Rcullis as output by SHARP (1) 
d Correlation coefficients as output by ShelxD/E (2,3) 
e R = hklFobs - Fcalc / hklFobs; Rwork – hkl  T; Rfree – hkl  T; T – test set 
f observed anisotropy with resolution limits along a* = 2.6 Å, b* = 2.9 Å and c* = 3.1 Å 
g Calculated with MolProbity (4) 
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Supplementary Table S3. List of protein-DNA contacts 
 
 DNA1 DNA2 
Sugars: Asn211B - O4´dT1 Arg27B´ - O3´dT11´ 
 Asn211B - sugardT1 Val21A´ - sugardT7´ 
 Val207B - sugardT2 Arg204A´ - O4dT10´
 Leu64A´ - sugardT4  
 Ala12A´’ - sugardT4  
 Arg27A – O3´dT5  
 Lys31A – sugardT5  
 Arg20A – sugardT6  
 Val21A – sugardT7  
 Ala24B - sugardT9  
 Arg20B´ – O3´dT10  
   
Phosphates: Arg137B - O1dT2 Arg68B´ - O1dT6´ 
 Lys203B - O1dT3 Arg27A´ – O1dT6´ 
 Arg68B - O1dT5 Lys17A´ - O1dT8´ 
 Arg27A - O2dT6  
 Lys17A - O1dT8  
   
Base: Asn211B - basedT1 Arg204A´ - O2dT10´
 Arg204B - O2dT6 Phe23A´ - basedT6´ 
 Phe23A - basedT6 Ala24A - basedT6 
 Ala24A - basedT7 Gln25B´ - O2, N3dT8´
 Gln25A - basedT8 Arg5B´ -O4, basedT6´ 
 Arg5B - O2dT8 Lys17B´ - O2, N3dT9´
 Lys17B - N3, O2dT9 Val21B´ - basedT7´ 
 Val21B - basedT9  
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Supplementary Figure S1. Multiple sequence alignment. Multiple structure-based sequence alignment of the proteins containing the DUF2258 
domain. Secondary structure elements of apeThermoDBP-RP2, pfuThermoDBP-RP1 and tteThermoDBP are shown (α-helices – blue; β 
strands – red). Darker background indicates higher conservation with respect to apeThermoDBP-RP2. Residue with green background contact 
DNA in the apeThermoDBP-RP2–dT10 structure. Regions corresponding to the NTDs are indicated. Proteins listed: Aeropyrum pernix - 
APE_1866.1, Ignisphaera aggregans - IGAG-0238, Thermosphaera aggregans - TAGG_0476, Desulfurococcus fermentans - DESFE_1124, 
Desulfurococcus kamchatkensis - DKAM_1006, Desulfurococcus mucosus - DESMU_0072, Thermosphaera aggregans - TAGG_0069, 
Staphylothermus marinus - SMAR_1160, SMAR_0213, Staphylothermus hellenicus - SHELL_1311, SHELL_0606, Thermogladius cellulolyticus 
- TCELL_0577, Hyperthermus butylicus - HBUT_1217, Pyrolobus fumarii - PYRFU_0856, Acidilobus saccharovorans - ASAC_0853, 
ASAC_0999, Vulcanisaeta moutnovskia - VMUT_0250, Pyrobaculum aerophilum - PAE3173, Pyrobaculum sp. 1860 - P186_1371, 
Pyrobaculum arsenaticum - PARS_1656, Pyrobaculum islandicum - PISL_0538, Thermoproteus neutrophilus - TNEU_1621, Pyrobaculum 
calidifontis - PCAL_1811, Thermoproteus uzoniensis - TUZN_1647, Vulcanisaeta distributa - VDIS_1809, Sulfolobus islandicus - LS215_1226, 
Sulfolobus islandicus - M1425_1129, Sulfolobus solfataricus - SSO1098, SSOL_2070, Ssol98_010100004655, Sulfolobus tokodaii - ST0853, 
Sulfolobus acidocaldarius - SACI_1216, Acidianus hospitalis - Ahos_0932, Metallosphaera sedula - MSED_1043, Metallosphaera 
yellowstonensis - METMK1DRAFT_00029730, Archaeoglobus profundus - ARCPR_1830, Ferroglobus placidus - FERP_2293, Thermococcus 
sp. AM4 - TAM4_671, Thermococcus gammatolerans - TGAM_0941, Thermococcus zilligii - TZILA_05110, Thermococcus kodakarensis - 
TK0813, Thermococcus onnurineus - TON_0781, Thermococcus sibiricus - TSIB_0836, Thermococcus litoralis - OCC_01989, Thermococcus 
barophilus - TERMP_00659, Pyrococcus yayanosii - PYCH_06080, Pyrococcus horikoshii - PH1118, Pyrococcus abyssi - PAB1631, 
Pyrococcus furiosus - PF1044 
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Supplementary Figure S2. Binding of ThermoDBP-RPs to box C/D sRNAs. Electrophoretic 
gel mobility shift assays testing the binding of pfuThermoDBP-RP1 and of apeThermoDBP-
RP2 to sR2 and sR12 box C/D sRNAs from Pyrococcus furiosus. 
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Supplementary Figure S3. Interactions of ThermoDBP-RPs with ribosomal subunits and 
ribosomes. Interactions were probed by co-sedimentation binding assays of ThermoDBP-
RPs and 30S, 50S and 70S ribosomal particles of Thermococcus kodakarensis. Ribosomal 
particles were isolated from T. kodakarensis lysates as previously described (5) and 
incubated in the presence of 120 mM NaCl (A) or 200 mM NaCl (B) together with purified 
ThermoDBP-RPs from A. pernix and P. furiosus and subsequently separated by ultra-
centrifugation. Upper panels: Proteins were separated by SDS-PAGE and stained with 
Coomassie Brilliant Blue. Lower panels: Proteins, after separation by SDS-PAGE, were 
transferred onto a nitrocellulose membrane for immuno-detection using an anti-His6 
antibody. Signals for proteins co-sedimented with ribosomal particles are detected in the 
pellet fractions (P). Whole-reaction-samples and samples after ribosomal particles 
separation are labeled (IN) and (SN), respectively. 
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Supplementary Figure S4. Quantification of apeThermoDBP-RP2-ssDNA interactions by 
ITC. Both the raw data and the integrated data are shown. Oligonucleotide sequences are 
listed in Supplementary Table S3. Data were fitted based on the “One Set of Sites” model. 
The stoichiometry (N) gives the number of DNA molecules bound per apeThermoDBP-RP2 
monomer. 
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Supplementary Figure S5. Structural comparisons. (A) Cartoon view of pfuThermoDBP-
RP1 superposed with tteThermoDBP NTD (left panel; tteThermoDBP NTD – magenta; PDB 
ID 3TEK) and one ssDNA molecule from the apeThermoDBP-RP2 co-crystal structure (right 
panel; DNA - green). Additional helices of tteThermoDBP NTD do not clash with the helical 
extensions of pfuThermoDBP-RP1 (left). However, a ssDNA bound on subunit A of a 
pfuThermoDBP-RP1 tetramer in the same conformation as observed in the apeThermoDBP-
RP2 structure would clash with helix α3 of subunit B. (B) Superposition of yeast polymerase 
eta (grey; C-terminal domain – cyan; PDB ID 3OHB) with the NTD of apeThermoDBP-RP2 
(beige). A ssDNA molecule as observed in the apeThermoDBP-RP2 structure is colored in 
green. dsDNA (orange) binds to a different site on the polymerase eta CTD, which is 
structurally related to the NTDs of ThermoDBP and ThermoDBP-RP proteins. 
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Supplementary Figure S6. Schematic representation of the DNA contacts. Schematic 
representation of the interactions of apeThermoDBP-RP2 with one dT10 oligonucleotide. 
Color coding as in Figure 3B and C. Orange dashed lines indicate protein-phosphate 
contacts, green dashed lines are protein-sugar contacts and red (polar) and black 
(hydrophobic) dashed lines represent protein-nucleobase interactions. Black slashed lines 
represent stacking interactions. 
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Structure of the Bacillus subtilis 70S ribosome
reveals the basis for species-speciﬁc stalling
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Ribosomal stalling is used to regulate gene expression and can occur in a species-speciﬁc
manner. Stalling during translation of the MifM leader peptide regulates expression of the
downstream membrane protein biogenesis factor YidC2 (YqjG) in Bacillus subtilis, but not in
Escherichia coli. In the absence of structures of Gram-positive bacterial ribosomes, a molecular
basis for species-speciﬁc stalling has remained unclear. Here we present the structure of a
Gram-positive B. subtilis MifM-stalled 70S ribosome at 3.5–3.9Å, revealing a network of
interactions between MifM and the ribosomal tunnel, which stabilize a non-productive
conformation of the PTC that prevents aminoacyl-tRNA accommodation and thereby induces
translational arrest. Complementary genetic analyses identify a single amino acid within
ribosomal protein L22 that dictates the species speciﬁcity of the stalling event. Such insights
expand our understanding of how the synergism between the ribosome and the nascent chain
is utilized to modulate the translatome in a species-speciﬁc manner.
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T
he ribosome is the major protein-synthesizing machine in
the cell that converts the genetic information present
within the codons of the mRNA into an amino-acid
sequence within the polypeptide chain1. Ribosomes can
transiently pause or even become stalled for prolonged periods
during the translation of mRNAs due to many intrinsic factors,
such as secondary structure within the mRNA2 or the presence of
particular amino-acid sequences within the nascent polypeptide
chain, such as polyproline sequences3,4. In many cases, ribosome
stalling occurs during translation of short upstream open reading
frames, so-called leader peptides, which is utilized by both
bacteria and eukaryotes to regulate expression of downstream
genes5,6. These regulatory events can be ligand-dependent, as
exempliﬁed by the ErmCL and TnaC leader peptides that
require the presence of a macrolide antibiotic or free
tryptophan, respectively, to induce ribosome stalling7,8, or
ligand independent, with well-characterized examples including
the E. coli SecM and B. subtilis MifM leader peptides, where
translation of the amino-acid sequence is sufﬁcient to induce the
translational arrest9–11.
In B. subtilis, the MifM leader peptide is located upstream of
the yidC2 (yqjG) gene (Fig. 1a), which cannot be translated
independently of MifM because the ribosome-binding site of
yidC2 is sequestered within a stem-loop structure in the mRNA
(Fig. 1a)10. Ribosome stalling during translation of MifM leads to
unwinding of the stem-loop structure and maintains the
ribosome-binding site accessible for ribosome binding and
induction of YidC2 expression (Fig. 1b). YidC2 is a homologue
of the constitutively expressed SpoIIIJ (YidC1), a protein involved
in membrane protein insertion and folding12. The B. subtilis
MifM leader peptide is 95 amino-acids long and comprises a
C-terminal region (residues 69–89) that is critical for ribosome
stalling as well as an N-terminal transmembrane (TM) segment
that targets the MifM peptide for membrane insertion,
presumably via SpoIIIJ10. Interaction between SpoIIIJ and the
TM segment of MifM as it emerges from the ribosomal tunnel is
thought to prevent ribosome stalling by providing a pulling force
on the MifM nascent chain11, analogous to SecA relief of SecM
stalling13–15. Subsequently, canonical translation termination and
ribosome-recycling ensues, leading to rapid refolding of the
mRNA and repression of YidC2 expression (Fig. 1a). In contrast,
when cellular levels of SpoIIIJ are low, ribosome stalling occurs
on MifM, maintaining the unfolded conformation of the mRNA
and thereby promoting expression of YidC2. In this manner, B.
subtilis ensures that sufﬁcient levels of SpoIIIJ or YidC2 are
present in the membrane to direct membrane protein insertion
and/or protein folding10,16.
Biochemical studies have demonstrated that four major
ribosome-stalling sites are present in the MifM leader peptide;
the ﬁrst occurring when the codon for residue D89 is present in
the P-site, then ribosomes stall at the following three codon
positions corresponding to residues A90, G91 and S92 (Fig. 1b)6.
Mutagenesis studies have identiﬁed six residues (R69, I70, W73,
I74, M80 and N81) as well as the negatively charged DEED
sequence (residues 86–89) within the C-terminal region of MifM
(Fig. 1b) that are important for ribosome stalling6,10. Despite the
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Figure 1 | Cryo-EM structure and molecular model of the B. subtilis MifM-stalled ribosome complex. (a,b) Schematic of the mifM-yidC2 mRNA
illustrating the N-terminal transmembrane (TM) segment (black, helix) and C-terminal stalling region (green) of the MifM leader peptide with the stem-
loop structure that sequesters the ribosome-binding site (RBS) of the yidC2 gene (blue). In (b) the multisite ribosome stalling (0, þ 1, þ 2 and þ 3) during
translation of MifM maintains the unfolded conformation of the mRNA allowing ribosome binding and induction of yidC2 expression. The MifM
stalling sequence (residues 69–89) is shown with critical residues boxed in green. Asterisks indicate stop codons. (c) MifM-stalled ribosome complex used
for cryo-EM. (d) Transverse section of the cryo-EM structure of the MifM-SRC (30S, yellow; 50S, grey) showing P-tRNA and MifM nascent chain (green)
within the ribosomal tunnel and enlargement where ribosomal proteins L4 (cyan) and L22 (orange) are coloured. (e) Electron density (grey mesh)
for selected regions of large subunit ribosomal protein and rRNA of the MifM-SRC. (f) Molecular model of the B. subtilis 70S ribosome.
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high conservation of the ribosomal tunnel, translational stalling
by MifM occurs on B. subtilis ribosomes, but not efﬁciently
on E. coli ribosomes11; however, a molecular basis for this species
speciﬁcity has remained unclear.
Here we have developed a B. subtilis cell-free in vitro
translation system, which was subsequently used to generate a
B. subtilis MifM-stalled ribosome complex (MifM-SRC). We
present a cryoelectron microscopy (cryo-EM) reconstruction of
the MifM-SRC at 3.5–3.9Å resolution, which was used to build
the ﬁrst molecular model of a Gram-positive 70S ribosome. The
only contacts of the MifM nascent chain with the ribosome that
are not conserved between B. subtilis and E. coli are located
within the lower region of the exit tunnel where they involve
ribosomal protein L22. Consistently, our complementary genetic
mutagenesis studies identiﬁed a single amino-acid residue, Met90
of L22, which modulates the speciﬁcity of MifM-dependent
stalling. Interaction of the MifM nascent chain within the
ribosomal tunnel positions the sidechain of Glu88 of MifM in a
manner that prevents accommodation of an incoming aminoacyl-
transfer RNA (tRNA) at the peptidyltransferase centre (PTC) of
the ribosome, thus providing a structural basis for the MifM-
dependent translational arrest.
Results
Cryo-EM structure of B. subtilis MifM-SRC. To understand the
structural basis for the mechanism of MifM-dependent transla-
tional stalling and provide structural insight into the species
speciﬁcity of MifM stalling, we set out to structurally characterize
the B. subtilis MifM-SRC. Unlike for E. coli, translation systems
for B. subtilis are not commercially available. Therefore, to
generate complexes of translating B. subtilis ribosomes, we
developed and optimized a B. subtilis S12 lysate-based in vitro
coupled transcription–translation system (Supplementary Fig. 1
and Methods). This system was used to prepare B. subtilis MifM-
SRCs by translation of a template encoding the B. subtilis MifM
leader peptide (Supplementary Fig. 1 and Methods). Homo-
geneity of the MifM-SRC was increased by replacing Ala90 of
MifM with a UAA stop codon (Supplementary Fig. 1), which
arrests ribosomes at the ﬁrst stall site (Fig. 1c), and thereby
prevents further translation and subsequent arrest at downstream
stall sites6. Like the wildtype MifM-SRC, the MifM-Ala90UAA
stalled ribosomes are refractory to the action of puromycin, and
are also not subject to the action of the termination release factors
RF1 and RF26,10. This MifM-SRC (Fig. 1c) was separated from
non-translating ribosomes and polysomes using sucrose gradient
centrifugation and afﬁnity chromatography, as performed
previously for other SRCs17,18. A single MifM-peptidyl-tRNA
product, and no free MifM peptide, was detected in the ﬁnal
MifM-SRC (Supplementary Fig. 1), indicating the homogeneity of
the sample and its suitability for structural analysis. A single-
particle reconstruction of the MifM-SRC was obtained from
305,045 particles using cryo-EM (Fig. 1d). The MifM-SRC has an
average resolution of 3.9 Å, with local resolution calculations19
indicating that the resolution of the core of the 50S subunit
reaches 3.5 Å (Supplementary Fig. 2). This is consistent with the
features of the cryo-EM map, such as strand separation in
b-sheets, the pitch of a-helices as well as density for many side
chains of the ribosomal proteins (Fig. 1e). In addition, the rRNA
backbone and nucleotides are well resolved, as well as the position
of many putative magnesium ions (Fig. 1e). The distinct features
of the electron density (Supplementary Figs 3 and 4), together
with the high homology to E. coli and T. thermophilus 70S
ribosomal structures20,21, allowed a molecular model of the
B. subtilis 70S ribosome to be built (Fig. 1f, Table 1 and
Supplementary Figs 5 and 6), encompassing a total of 4,579 of the
4,602 (99.5%) nucleotides of the 5S, 16S and 23S rRNAs, 19 small
subunit ribosomal proteins and 29 of the 32 large subunit
proteins (L1, L7/L12 and L9 were excluded). The slightly lower
resolution of the small subunit (4.0 Å, Supplementary Fig. 2)
restricted the modelling of the small subunit ribosomal proteins
to a backbone trace, whereas sidechains were modelled for the
large subunit proteins.
The majority of the rRNA in the core of B. subtilis 70S
ribosome is structurally conserved with E. coli and T. thermo-
philus ribosomes, however, speciﬁc regions resemble only E. coli
(h26, h33, h44 in the 30S; H27, H68 and H79 in the 50S) or
T. thermophilus (h9 in the 30S; H15 and H63 in the 50S), whereas
others appear to be Bacillus speciﬁc (h6, h10, h17 in the 30S; H25
and H54 in the 50S; Supplementary Fig. 8). As expected from the
genome sequence, the B. subtilis 70S ribosome lacks density for
S21 (Supplementary Fig. 9), which is present in E. coli but absent
in T. thermophilus. Surprisingly, density for L9 and L25 (also
referred to as the general stress protein CTC) is also absent in the
B. subtilis 70S ribosome (Supplementary Fig. 9), despite L9 and
L25 being encoded in the B. subtilis genome. Only one tRNA is
present in the MifM-SRC, located at the P-site, where it makes
codon–anticodon interactions with P-site codon of the mRNA
(Fig. 2a,b). No density for the mRNA is observed in the A-site,
nor within the downstream mRNA channel, whereas in contrast,
the upstream 50 end of the mRNA can be unambiguously traced
from the P-site through the E-site to the back of 30S subunit
where it establishes a number of non-canonical base-pairs with
the 30 end of the 16S rRNA resulting in a 8-basepair helix
(Fig. 2c–e), analogous to the Shine–Dalgarno (SD)-anti-SD
helices observed during elongation22,23 (Fig. 2f). The CCA-end
of the P-tRNA adopts its canonical position at the PTC of the
ribosome, with clear density for the MifM nascent polypeptide
chain extending from the ribose of A76 and traversing the entire
Table 1 | Reﬁnement and Model Statistics.
Data collection and reﬁnement
Particles 305,045
Pixel size (Å) 1.108
Defocus range (mm) 1.0–2.5
Voltage (kV) 300
Electron dose (e/Å 2) 28
Map sharpening B factor (Å2)  124.35
Resolution (Å, 0.143 FSC) 3.9
Model Composition
Non-hydrogen atoms 135,413
Protein residues 5660
RNA bases 4675
R.m.s. deviations
Bonds (Å) 0.0094
Angles (Å) 1.46
Validation (proteins)
Molprobity score (79th percentile) 1.94
Clashscore, all atoms (80th percentile) 8.38
Good rotamers (%) 99.85
Ramachandran plot
Favored (%) 91.95
Outliers (%) 1.98
Validation (RNA)
Correct sugar puckers (%) 97.75
Good backbone conformation (%) 100
FSC,Fourier Shell Correlation; R.m.s., root-mean square.
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length of the ribosomal exit tunnel (Fig. 1b). Local resolution
calculations indicate that the MifM nascent chain exhibits some
degree of ﬂexibility (Supplementary Fig. 2), particularly in regions
that do not appear to establish contacts with components of the
ribosomal tunnel.
MifM interactions with the ribosome. In the upper region of the
tunnel, the density for the MifM nascent chain is well resolved at
the sites of contact, namely adjacent to the PTC and at the
constriction, enabling side chains of MifM residues E87/D89 and
R79-N81 to be modelled (Fig. 3a–c). In contrast, the MifM
nascent chain becomes fragmented in the lower region of the
tunnel, indicating a higher degree of ﬂexibility, and was therefore
ﬁltered to 4Å to obtain continuous uninterrupted electron den-
sity (Fig. 3d–f). For the less resolved regions, that is, S82-E86 and
W73-F78, we present a model for the backbone trace and
acknowledge that the register for MifM may become lost after the
constriction in the lower regions of the tunnel. The model loca-
lizes the three pairs of critical MifM residues, M80-N81, W73-I74
and R69-I70, at the sites of contact with components of the
ribosomal tunnel (Fig. 3b,f).
In addition to the PTC (discussed later), four main interactions
are observed between MifM and the ribosome: Two contacts are
observed at the constriction, which sandwich the MifM nascent
chain between Arg66 of L4 on one side of the tunnel and A751
(E. coli numbering is used throughout the text) of the 23S rRNA
on the other (Fig. 3a–c). The contact to A751 is one of the
strongest fusions of density between the tunnel wall and MifM,
and appears to involve the backbone in the vicinity of R79 of
MifM (Fig. 3a), whereas Arg79 and Asn81 coordinate interaction
with the sidechain of Arg66 of L4. Consistently, the N81A
mutation that abrogates MifM-stalling6,10 would also abolish the
potential hydrogen bond formed with Arg66 of L4. Two contacts
are observed within the lower region of the tunnel, one between
Phe85 of L22 and Ile74 of MifM (Fig. 3d) and another between
A1321 in H50 of the 23S rRNA in the vicinity of His68 of
MifM (Fig. 3f). These contacts are likely to be important since
insertions within L22 compromise MifM-dependent stalling, as
do mutations of Trp73, Ile74 or His68 to alanine10. However,
because the H68A only partially affected YidC2 induction using
the mifM-yidC20-lacZ reporter10, the latter contact with A1321
may instead reﬂect the importance of the neighbouring MifM
residues Arg69 and Ile70 for stalling10. While a fully extended
backbone conformation for MifM in the lower tunnel region does
not bring these residues into direct proximity of A1321, because
of the limited resolution for this region of the nascent chain we
cannot rule out that the side chain of Arg69 can reach down to
directly contact A1321. In agreement with the observed contacts
between MifM and the ribosome, we could demonstrate using a
B. subtilis in vivo GFP–MifM–LacZ (translational fusion) reporter
(Fig. 3g) that both L22 and L4, but not L23 (the only other
ribosomal protein that contributes to the exit tunnel), are
important for MifM stalling (Fig. 3h–j): In a wildtype B. subtilis
strain, translation of the GFP–MifM–LacZ reporter leads to
stalling within the MifM sequence and therefore negligible
b-galactosidase is produced (Fig. 3h,j), whereas B. subtilis
strains bearing internal deletions within the tunnel lumen
regions of L22 and L4 lead to an increase in b-galactosidase
activity, consistent with a reduction in MifM stalling. In contrast,
b-galactosidase activities remained low when deletions were made
in L23 (Fig. 3j), consistent with the absence of a direct interaction
between MifM and L23 in the MifM-SRC.
Species speciﬁcity of MifM stalling. To understand the species
speciﬁcity of MifM stalling, we analysed the sequence and
structure conservation of the ribosomal tunnel between B. subtilis
and E. coli, revealing that the rRNA components are highly
conserved, including nucleotides A751 and A1321 (Fig. 4a) and,
similarly, the luminal region of L4 is invariant between B. subtilis
and E. coli (Fig. 4b). In contrast, the b-hairpin of L22 exhibits a
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Figure 2 | The path of the mRNA through the B. subtilis MifM-SRC. (a) Location of Shine–Dalgarno(SD)-anti-SD-like helix on 70S ribosome (30S, yellow;
50S, grey, P-tRNA, green). (b) Codon–anticodon interaction between P-tRNA (dark green) and mRNA (pale green). (c) Electron density (grey mesh) and
molecular model for the path of the mifM mRNA (green) from the P-site to back of the 30S subunit (d) where it forms an 8 base pair SD-anti-SD-like
helix with the 3’ end of the 16S rRNA (blue). (e) Schematic for the non-canonical base-pairing observed in the SD-anti-SD-like helix of the MifM-SRC.
(f) Comparison of SD-anti-SD-like helix observed in B. subtilis MifM-SRC (blue) with initiation SD-anti-SD helix (grey) and post-initiation SD-anti-SD helix
(red) observed previously22.
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number of amino-acid differences between B. subtilis and E. coli
(Fig. 4b–d), suggesting that the speciﬁcity of MifM stalling may
be conferred by L22. To test this possibility, we utilized the GFP–
MifM–LacZ reporter assay and demonstrated that replacing the
b-hairpin of B. subtilis L22 with corresponding sequence from
E. coli L22 led to an increase in b-galactosidase levels (Fig. 4e),
consistent with a reduction in stalling at the MifM-derived
sequence. Strikingly, reverting a single amino acid (K90M) in the
b-hairpin of L22 from the E. coli sequence (K90) back to
B. subtilis (M90) was sufﬁcient to restore the low levels of
b-galactosidase activity indicative of efﬁcient stalling at MifM,
whereas other reversions, such as the IM to FR double mutation
at positions 85–86 of L22 retained the elevated b-galactosidase
levels (Fig. 4e). These ﬁndings suggest that the nature of the
amino acid at position 90 of L22 can markedly inﬂuence the
efﬁciency and speciﬁcity of stalling. Therefore, we introduced all
19 amino-acid substitutions at position 90 of B. subtilis L22 and
monitored the b-galactosidase activity using the GFP–MifM–
LacZ reporter (Fig. 4f). A wide range of b-galactosidase activities
was observed, with K90, as present in E. coli L22, producing the
highest levels, whereas hydrophobic or aromatic amino acids,
such as F, Y, L and I, in position 90 exhibited b-galactosidase
activities similar to the wildtype L22 with M90 (Fig. 4f). While
g-proteobacteria, such as E. coli usually have K90 and most
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Bacillus species have M90, other bacterial lineages generally
contain positively charged amino acids such as R, Q, K or H at
the equivalent position (Supplementary Fig. 10), and are therefore
unlikely to promote efﬁcient MifM stalling.
M90 of L22 does not directly contact MifM but rather forms a
Met–Sulfur aromatic interaction with G748 of the 23S rRNA
(Fig. 4g), suggesting that the inﬂuence of this residue on MifM
stalling may be indirect. One possibility is that M90 inﬂuences the
interaction of MifM with nucleotide A751, either indirectly
through G748, or more directly since the backbone nitrogen of
M90 is within hydrogen bonding distance of the phosphate-
oxygen of A751 (Fig. 4g). In fact, the entire tip of the b-hairpin of
L22 forms an intricate network of interactions with the 750-loop
of 23S rRNA helix H35 (Supplementary Fig. 11), suggesting that
M90 mutations which alter the interaction with G748 as well as
the conformation of the L22 tip could lead to rearrangements in
the A750-loop. While the A751 region is structurally similar
between B. subtilis and E. coli, the resolution does not allow us to
exclude subtle changes or shifts in the positions of the nucleotides
that could inﬂuence interaction with the MifM nascent chain. In
addition, M90 mutations could alter the conformation of the b-
hairpin of L22 and thereby inﬂuence the interaction between
MifM and F85 of L22 (Fig. 3f). Support for the interplay between
the b-hairpin of L22 and MifM residues located below the
constriction comes from rescue experiments: Random
mutagenesis of the b-hairpin (positions 80–89 and 91–98) of
B. subtilis L22-M90K was performed to search for second site
mutations that restore MifM stalling and induce expression of a
YidC20–LacZ fusion, which led to the identiﬁcation of mutations
at position G91 of L22 that restored induction by up toB70% of
the wildtype level, as well as lesser effects at positions R92, A93
and F85 (Supplementary Fig. 12). Second site mutations that
could restore MifM stalling and induce expression of a YidC20–
LacZ fusion in the presence of B. subtilis L22-M90K were also
identiﬁed within the MifM nascent chain. In this latter case,
random mutagenesis was performed at MifM positions 72–81,
leading to the identiﬁcation of the T72R mutation that restored
induction by up toB60% of the wildtype level, with lesser effects
also being observed at positions R75, K76 and F78
(Supplementary Fig. 12).
MifM inactivation of the PTC. To understand how the interac-
tion of the MifM nascent chain with components of exit tunnel
prevents stable binding of the A-tRNA and therefore leads to
inhibition of peptide bond formation, we compared the con-
formation of nucleotides at the PTC in different states of peptide
bond formation24–27 with the PTC of the MifM-SRC (Fig. 5a–c).
U2584 and U2585 shift by 2–3Å on A-tRNA accommodation,
that is, when moving from the unaccommodated (uninduced) to
the accommodated (induced) state24–26 (Fig. 5a). In the MifM-
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SRC, U2584 and U2585 resemble the uninduced state, consistent
with the absence of A-tRNA (Fig. 5b). The shift in U2585 that
occurs during A-tRNA accommodation also requires a
corresponding rotation of U2506 (Fig. 5c). In the MifM-SRC,
the side chain of E87 overlaps in position with the induced
conformation of U2506 (Fig. 5d), suggesting that the MifM
nascent chain prevents A-tRNA accommodation by sterically
preventing PTC nucleotides U2506, and thereby also U2585, from
adopting their induced conformational states. E87 comprises part
of the DEED sequence that is critical for MifM stalling2, however,
single mutation of any of the amino acids within the DEED motif,
including E87A, does not markedly reduce stalling6. To
completely abolish stalling, multiple D/E to A mutations within
this motif are required6, indicating some functional redundancy.
One could speculate that within the context of the E87A mutation
the role of E87 in blocking the U2506 shift is assumed by a
neighbouring D/E amino acids, however, without determining
structures of the individual mutant MifM-RNCs it would be
difﬁcult to address this question.
In addition, during normal translation A2602 undergoes a
slight shift on A-tRNA accommodation (Fig. 5e), whereas in the
MifM-SRC, A2602 appears to adopt a deﬁned position (Fig. 5f),
which would restrict the entry of the incoming aminoacyl-tRNA
to the A-site of the PTC. The conformation of the PTC of the
MifM-SRC also provides an explanation as to why the MifM-
stalled ribosomes are resistant to the action of the RF1 and RF2
when the A90 position is a stop codon6,10: Peptidyl-tRNA
hydrolysis by RF1 and RF2 requires the accurate placement of the
GGQ motif in domain 3 at the PTC of the ribosome, which
induces speciﬁc conformations of PTC nucleotides, such as
A260228–32 (Fig. 5g). This conformational change would be
incompatible with the uninduced state of the PTC observed in the
MifM-SRC (Fig. 5h). Indeed, the conformation of A2602 in the
MifM-SRC is similar to that observed in the cryo-EM structure of
the TnaC-SRC33, where translational arrest occurs because RF2-
dependent peptidyl-tRNA hydrolysis is inhibited7.
Although our structure does not provide direct insight into the
mechanism of PTC inhibition when the ribosome stalls at
subsequent downstream residues, we note that the SD-like helix
formed between the MifM mRNA and the 50 end of the 16S
rRNA (Fig. 2) is likely to contribute to multisite stalling, as SD-
like sequences within the open reading frames of mRNAs have
been reported to induce translational pausing in bacteria34.
However, the introduction of frameshifts within the MifM leader
peptide abolished translational stalling at all sites10, indicating
that the SD-like helix alone is insufﬁcient to induce pausing
independently of the MifM nascent chain-induced stall, possibly
because the helix cannot form in the absence of stalling or that
SD-dependent pausing is actually negligible35.
Discussion
Collectively, our biochemical and structural ﬁndings lead us to
propose a model for the mechanism and speciﬁcity of MifM
stalling (Fig. 6): Residue M90 of L22 contributes to the species
speciﬁcity of stalling, either through structural constraint given to
A751 or residue F85 of L22. In the absence of any obvious relay of
conformational changes to the PTC through the rRNA, we
propose that these interactions, together with contacts between
MifM and A1321 in 23S rRNA helix H50 and R66 of L4, promote
a deﬁned conformation of the MifM nascent chain such that
residue E87 of MifM interacts with U2506 and U2585, thereby
stabilizing the uninduced state of the PTC and preventing
accommodation of the incoming A-tRNA (Fig. 6). In addition, we
envisage that the pulling force exerted on the MifM nascent chain
by interaction of the MifM TM with the YidC1/2 translocon
during membrane insertion would release the MifM-dependent
stalling by disrupting interactions between MifM and the
ribosomal tunnel as well as displacing the E87 side chain of
MifM and thus allowing U2506 and U2585 to adopt the induced
state of the PTC that is necessary for aminoacyl-tRNA
accommodation at the A-site. The mechanism of ligand-
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independent translation arrest by MifM as described here is
structurally distinct from previously characterized peptide-
dependent stalling systems, such as Erm36,37, TnaC33,38 and
SecM18, illustrating the plasticity of the ribosome to employ
diverse mechanisms to sense the nascent chain in the tunnel and
evoke silencing of the PTC.
Methods
Strain and plasmid construction. B. subtilis strains and plasmids used in this
study are listed in Supplementary Tables 1 and 2, respectively. B. subtilis strains
were derivatives of PY79 (wildtype)39 and constructed by transformation with
either plasmid or puriﬁed B. subtilis chromosomal DNA. Plasmids were
constructed by standard cloning methods, fusion PCR and site-directed
mutagenesis40 using primers and template plasmids listed in Supplementary
Tables 2 and 3. Constructions of plasmids pCH735, pCH835, pCH913, pCH1142
and pEB71 were described previously (references shown in Supplementary
Table 2). Plasmid pCH1517 was constructed by cloning an SphI-BglII-digested
PCR fragment ampliﬁed from pCH913 using primers SP26 and SP27 into the
SphI-BamHI site of pCH735. Plasmid pCH1570 was constructed by cloning a
BamHI-SphI fragment of pCH1567 into pCH1142. Plasmid pCH1567 was
constructed by cloning a XbaI-SphI-digested PCR fragment ampliﬁed from PY79
chromosomal DNA using primers SP66 and SP67 into pCH1557. Plasmid
pCH1557 was constructed as follows. A PCR fragment ampliﬁed from PY79
chromosomal DNA using primers SP68 and SP69 and another PCR fragment
ampliﬁed from pEB71 using primers SP70 and SP71 were fused by the following
PCR using primers SP68 and SP72, digested with both BamHI and XbaI and then
cloned into pUC118. Plasmid pCH1587 was constructed as follows. A PCR
fragment ampliﬁed from PY79 chromosomal DNA using primers SP28 and SP29
and another PCR fragment ampliﬁed from pEB71 using primers SP30 and SP31
were fused by the following PCR using primers SP28 and SP31, digested with both
SacI and SphI and then cloned into pCH1142. Plasmid pCH1901 was constructed
as follows. A PCR fragment ampliﬁed from pCH1587 using primers SP34 and SP35
and another PCR fragment ampliﬁed from pCH1587 using primers SP36 and SP37
were fused by the following PCR using primers SP34 and SP37, digested with both
XhoI and SphI and then cloned into pCH1590. Other plasmids were constructed by
site-directed mutagenesis using primers and templates shown in Supplementary
Tables 2 and 3.
Bacillus subtilis S12 translation extract. The B. subtilis S12 translation extract
was prepared following a procedure described for E. coli S12 translation
extract41,42, with some modiﬁcations. Brieﬂy, cells (B. subtilis strain 168) were
grown to OD600 4.5 in an ‘INFORCE HT minifors’ bench-top fermenter in 2
YPTG medium (16 g l 1 peptone, 10 g l 1 yeast extract, 5 g l 1 NaCl, 22mM
NaH2PO4, 40mM Na2HPO4, 19.8 g l 1 glucose (sterile ﬁltered)), with extra
glucose feeding (feed: 10) at 37 C while maintaining pH 7.0 and oxygen level
(60%). Cells were collected at 5,000 g at 4 C for 15min and subsequently washed
3 in cold Buffer A (10mM Tris–acetate (pH 8.2), 14mM magnesium acetate,
60mM potassium glutamate, 1mM dithiothreitol and 6mM 2-mercaptoethanol).
Cells were snap-frozen in liquid nitrogen and stored at  80 C. About 15 g of cells
were thawed on ice, resuspended in 10ml of cold buffer B (buffer A without
2-mercaptoethanol) and broken open in an ‘microﬂuidics model 110I lab
homogenizer’, 3 at 15,000 psi. The lysate was cleared subsequently at 12,000 g
and 4 C for 10min and incubated for 30min at 37 C in a water bath. The cell
extract was aliquoted, snap frozen and stored at  80 C.
PCR and in vitro transcription. PCR reaction (Phusion Master Mix (NEB), 98 C
5min (98 C 5 s; 52 C 5 s; 72 C 20 s) 28 72 C 10 s, 12 C) was prepared with
MifMfor and MifMrev (Supplementary Table 3) and template DNA containing the
sequence: (50-TAATACGACTCACTATAGGGCGAATTGGCGGAAGGCCGTCA
AGGCCACGTGTCTTGTCCATTAATTAACGTTTAACTTTAAGAAGGAGATA
TACCAATGGGTCATCACCATCACCATCACCATCACGATTACGATATTCC
AACGACCCTGGAAGTTCTGTTCCAGGGACCCGGTACCATGTTTGTGGAA
TCGATAAATGACGTTTTATTCTTAGTCGATTTTTTCACAATTATTCTTCCT
GCTCTAACGGCAATCGGGATTGCATTCCTCTTACGGGAGTGCCGTGCGG
GCGAGCAATGGAAATCAAAACGAACAGATGGGCCCTACCCATACGATG
TTCCAGATTACGCTGACTTTCTTATTATTATATATCATCGCATTACAACT
TGGATACGTAAAGTCTTCCGCATGAATTCGCCTGTGAACGATGAGGAAG
ACGCCGGTTCTCTTCTTTTATAA-30 ; underlined are the T7 promoter region,
ribosomal binding site, start codon, 8His-tag and stop codon, respectively). PCR
product was puriﬁed via spin columns and in vitro transcription reaction was set
up using 1 mg PCR product per 50 ml reaction volume and T7 RNA polymerase.
RNA was puriﬁed by LiCl/ethanol precipitation.
Preparation of the MifM-SRC. A volume of 1,360 ml of reaction mix containing
240mM HEPES-KOH (pH 8.2), 60mM glucose, 1.2mM ATP, 0.85mM CTP,
GTP, and UTP, 2mM DTT, 0.17mgml 1 E. coli total tRNA mixture (from strain
MRE600), 90mM potassium glutamate, 80mM of ammonium acetate, 8mM
magnesium acetate, 20mM potassium phosphate dibasic (pH 7.2), 34 mgml 1
L-5-formyl-5, 6, 7, 8-tetrahydrofolic acid (folinic acid), 2.1mM (each) amino-acid
mix, 2mM cysteine, 2% (w/v) PEG 8000 was preheated to 30 C before the addition
of 540ml (27% (v/v)) cell extract (S12 extract). The whole reaction was incubated at
30 C for 2min before the addition of 100 ml mifM mRNA (Supplementary Fig. 1)
and further incubated at 30 C for 33min, shaking at 1,000 r.p.m.
Puriﬁcation of the MifM-SRC. In vitro translation reactions (4 500ml) were
loaded onto 500 ml sucrose cushion (750mM sucrose) in Buffer C (50mM HEPES,
250mM KOAc, 10mM MgOAc, 0.1% DDM, 1/1,000 complete protease inhibitor
(Roche), 0.2Uml 1 RNasin, pH 7.2 at 4 C) and centrifuged for 150min (45,000
r.p.m., 4 C) in a Beckman Coulter TLA 120.2 ﬁxed-angle rotor. Pellets were
resuspended in 4 300 ml 250mM sucrose in ice cold buffer C and loaded onto a
Talon metal afﬁnity chromatography column (750 ml resin) pre-equilibrated in
10ml buffer C containing 10 mg ml 1 bulk tRNA. The column was washed with
25ml buffer C until no signiﬁcant absorption (A260) could be detected in the wash
fractions. The MifM-SRC, bound to the Talon matrix by MifM’s N-terminal 8
His-tag, was eluted in 4 500 ml buffer C containing 150mM Imidazole. The
eluate was loaded onto 10–40% sucrose gradients (prepared with buffer C)
and centrifuged for 13 h in a Beckman coulter SW40 Ti swinging bucket rotor
(20,000 r.p.m., 4 C). Gradients were separated on a Biocomp Gradient Station ip
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and fractions containing 70S ribosomal particles were collected and pelleted for 3 h
in a Beckman Coulter TLA 120.2 ﬁxed-angle rotor (45,000 r.p.m., 4 C). The
MifM-SRC pellet was resuspended in 28 ml 30mM sucrose in buffer C, on ice
(69 OD ml 1), aliquoted and snap-frozen. Samples were further analysed by
SDS–PAGE and western blotting.
MifM-SRC/SRP sample and cryogrid preparation. For grid preparation 2.5 ml
in vitro reconstituted B. subtilis signal recognition particle (20 pmolml 1 in SRP
buffer: 25mM HEPES, 100mM KOAc, 10mM MgOAc, 1mM DTT, 10% Glycerol,
pH 7.2 at 4 C) were diluted to a ﬁnal volume of 44.2 ml with buffer E (50mM
HEPES, 250mM KOAc, 2mM 2-mercaptoethanol, 0.06% Nikkol, pH 7.2 at 4 C)
and activated by incubation at 30 C for 10min. Subsequently, 5.8 ml (9.6 pmol) of
MifM-SRC was added and incubated for 10min at 30 C. Finally the prepared mix
was diluted with 22.5 ml buffer F (50mM HEPES, 250mM KOAc, 2mM 2-mer-
captoethanol, pH 7.2 at 4 C) for optimal grid coverage.
Cryoelectron microscopy and single particle reconstruction. The MifM-SRC/
SRP sample was applied to 2 nm precoated Quantifoil R3/3 holey carbon supported
grids and vitriﬁed using a Vitrobot Mark IV (FEI Company). Data collection was
performed using the EPU software (FEI) at NeCEN (Leiden, Netherlands) on a
Titan Krios transmission electron microscope (FEI, Eindhoven, Netherlands)
equipped with a Falcon II direct electron detector. Data were collected with the
microscope set to 300 kV, a magniﬁcation of 125,085x (pixel size: 1.108Å) in a
defocus range of 1.0–2.5 mm (Table 1). The data were provided as a series of seven
frames (grid was pre-exposed for 55ms, 4 e Å 2 before recording; dose per
recorded frame: 8 e Å 2, exposure-time/ recorded frame: 110ms). Frames 1–3
(accumulated dose of 28 e Å 2) were summed after alignment using Motion
Correction software43. Images were processed using a frequency-limited reﬁnement
protocol that helps prevent over-ﬁtting44, speciﬁcally by truncation of high
frequencies (in this case at 8 Å). As reported and expected44, we found that using
this processing regime the 0.143 Fourier Shell Correlation (FSC) value provides a
good indicator for the true average resolution of the map (Supplementary Fig. 2).
In addition, the local resolution of the ﬁnal map was calculated using ResMap19.
Power spectra and defocus values were determined using the SPIDER TF ED
command and recorded images were manually inspected for good areas and
power-spectra quality. Data were processed further using the SPIDER software
package45, in combination with an automated workﬂow as described previously46.
After initial, automated particle selection based on the program SIGNATURE47,
initial alignment was performed with 529,488 particles, using an E. coli 70S
ribosome as reference structure36. After removal of noisy particles (101,109
particles; 19%), the data set was further sorted using an incremental K-means-like
method of unsupervised 3D sorting48. Particles lacking density for P-tRNA (75,984
particles; 14%) and those that did not improve in resolution during reﬁnement
were omitted from the data set. The major subpopulation (305,045 particles; 58%)
showed the presence of stoichiometric densities for P-tRNA and could be reﬁned to
an average resolution of 3.9 Å (0.143 FSC) and a local resolution extending to 3.5 Å
for the core of the ribosome as computed using ResMap19 (Supplementary Fig. 2)
and was used for modelling. Subsequently, this main volume could be sorted
further into a subvolume containing the signal recognition particle bound to the
ribosome (158,726 particles; 30%), which will be described elsewhere (Beckert et al.,
unpublished). The ﬁnal volumes were subjected to the program EM-BFACTOR49
in order to apply an automatically determined negative B-factor for sharpening of
the map.
Molecular modelling and map-docking procedures. The B. subtilis 5S, 16S and
23S rRNA sequences were taken from GeneBank; Gene ID 2914271, 936774 and
939981, respectively. Structure-based sequence alignments were generated using
Sequence to Structure (S2S)50 based on X-ray structure derived models of the small
and large ribosomal subunit of E. coli (PDB ID 4KIX/Y)51. Molecular dynamics
ﬂexible ﬁtting (MDFF)52 in VMD53 was used for initial ﬁtting and reﬁnement of
the rRNA models into the electron density. The resulting models of the B. subtilis
rRNAs were manually inspected and adjusted according to features of the electron-
density using Coot54, followed by reﬁnement using erraser55 and the real-space
reﬁne tool in PHENIX56 (Table 1). A total of 29 of the 32 large subunit proteins
(L1, L7/L12 and L9 were excluded) from the B. subtilis 50S subunit were generated
using the homology with the equivalent E. coli and T. thermophilus protein
templates (PDB codes 4KIX and 3I8I, respectively). The models were initially ﬁtted
to the density using Chimera57, followed by real-space reﬁnement using PHENIX56
(Table 1). For the 19 proteins of the B. subtilis 30S subunit, homology models were
generated based on protein templates from T. thermophilus (PDB code 3V2C)
using HHPred58 and ﬁtted to the density using Chimera57 and reﬁned in Coot54.
The resolution of the core of the large subunit (3.5 Å, Supplementary Fig. 2)
enabled the majority of the sidechains for the large ribosomal proteins to be
modelled (Supplementary Fig. 3), whereas the lower resolution of the core of the
small subunit (4.0 Å, Supplementary Fig. 2) limited the molecular modelling to the
backbone of the small subunit ribosomal proteins. The ﬁt of the atomic models was
validated as described59 by calculating the FSC between a theoretical density
derived from the atomic models for the B. subtilis 70S ribosome (generated using
the CP FROM PDB SPIDER command) and the unsharpened cryo-EM map of
MifM-SRC (Supplementary Fig. 4). The volumes were multiplied (using the MU
SPIDER command) with a ‘soft’ mask generated from the theoretical model density
(using the TH M and FQ NP SPIDER commands) previous to calculating their
Fourier shell correlation (using the RF 3 SPIDER command).
Figure preparation. Figures showing electron densities and atomic models were
generated using UCSF Chimera57.
b-galactosidase assays. B. subtilis cells were cultured at 37 C in LB media for
b-galactosidase activity assay60. Cells were collected from cultures of OD600¼
0.5–1.0. To test b-galactosidase activities on agar plates, cells were grown on Difco
sporulation medium (DSM) agar plates containing 60 mgml 1 5-bromo-4-chloro-
3-indolyl-b-D-galactoside (X-gal) at 37 C6.
Isolation of suppressor mutants. Plasmid library for isolation of intragenic
suppressor mutants of the rplV(M90K) mutant were prepared as follows. The
second point mutation was introduced into either of the 80–89th or the 91st–98th
codons of rplV(M90K) on the original plasmid pCH1897 by site-directed muta-
genesis using random mixed mutagenic primers listed in Supplementary Table 3
(SP38-SP55). B. subtilis strain SCB3378 (gfp-mifM35 95-yidC20-lacZOcat, rplV94)
was transformed with the mutagenized plasmid library and then blue colonies were
isolated on DSM agar plates including 3 mgml 1 kanamycin and 60 mgml 1 X-gal
at 37 C. The original strain SCB3378 harbours the rplV94 mutation, which has a
seven codon insertion within the rplV, resulting in arrest-defective phenotype.
Strain SCB3378 was made from SCB824 (gfp-mifM35 95-yidC20-lacZOcat, rplVþ )
by isolating a spontaneous erythromycin resistant mutant. Suppressor mifM
mutants were isolated as follows: Plasmid library was prepared by site-directed
mutagenesis using template plasmid pCH835 (gfp-mifM35 95-yidC20-lacZOcat)
and random mixed mutagenic primers listed in Supplementary Table 3 (SP56–65)
that are designed to introduce a point mutation into either one of the 72nd–81st
codons of mifM. B. subtilis strain SCB3348 (rplV(M90K)) was transformed with the
mutagenized plasmid library and then blue colonies were isolated on DSM-
chloramphenicol-X-gal agar plates at 37 C.
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Supplementary Figures  
 
Supplementary Figure 1: Preparation of the MifM-SRC.  
a, Comparison of the amino acid sequence of wildtype MifM with the stalling construct used to 
generate the MifM-SRC. The MifM stalling window (red), transmembrane segment (gold), 
8xHis-tag for purification (orange) and HA-tag (cyan) for detection by Western blotting are 
coloured. b,c, Optimization of b, magnesium (Mg2+) concentration and c, time (min) for 
translation of firefly luciferase (Fluc) in the B. subtilis S12 lysate-based in vitro translation 
system. Fluc activity was monitored using luminescence and the error bars represent the standard 
deviation from the mean for triplicate reactions. d, Sucrose gradient profile of translation 
reaction of MifM stalling construct (from a) used in the optimized B. subtilis S12 lysate in vitro 
translation system. Fractions from the 70S peak were collected to remove polysomes. e, SDS-
PAGE and HA-tag Western blotting revealed a single band for the MifM peptidyl-tRNA and no 
free MifM peptide.  
Supplementary Figure 2: Average and local resolution of the cryo-EM map of the MifM-
SRC 
a, Average resolution of the MifM-SRC was 3.9 Å using the Fourier shell correlation (FSC) cut-
off value of 0.143, which was employed since the microscopy images were processed in the 
absence of spatial frequencies higher than 8 Å1. b, Histogram generated by ResMap2 showing 
that the local resolution of the final MifM-SRC map reaches resolutions of 3.5 Å. c, Transverse 
section of the cryo-EM structure of the MifM-SRC (30S, yellow; 50S, grey) showing P-tRNA 
and MifM nascent chain (green) within the ribosomal tunnel and enlargement where ribosomal 
proteins L4 (cyan) and L22 (orange) are coloured. d, Same views as c but coloured according to 
local resolution as determined using ResMap2. 
 Supplementary Figure 3: Differences in amino acid sequence for ribosomal proteins of the 
B. subtilis, E. coli and T. thermophilus 50S subunit 
a-d, Comparison of selected regions where single amino acid positions differ between B. subtilis 
(blue) and E. coli (green, PDB4KIX/Y)3, 4. The electron density for the MifM-SRC is shown as a 
grey mesh.  
 
Supplementary Figure 4: Differences in conformation of rRNA nucleotides between B. 
subtilis, E. coli and T. thermophilus ribosomes  
a-d, Comparison of selected regions where single rRNA nucleotide positions differ between 
B. subtilis (blue), E. coli (green, PDB4KIX/Y)3, 4 and T. thermophilus (yellow, PDB3I8H/I)5 70S 
ribosomes. The electron density for the MifM-SRC is shown as a grey mesh. 
 Supplementary Figure 5: Validation of the molecular model of the B. subtilis 50S subunit 
a-c, Overlay of the FSC of the cryo-EM map of the MifM-SRC (black line from fig. S2) 
compared to the FSC calculation between the molecular model and cryo-EM map (red line) for 
a, L22, b, L4, and c, the complete B. subtilis 50S subunit. d-f, Fit of the molecular models into 
the cryo-EM map (grey mesh) of the MifM-SRC for d, L22 (orange), e, L4 (cyan) and the f, 50S 
subunit.  
 Supplementary Figure 6: Molecular model for the Bacillus subtilis 70S ribosome 
a-d, Molecular model for the B. subtilis a,b, large 50S subunit and c,d, small 30S subunit. In b, 
and d, the molecular models are shown within the electron density (grey mesh) for the cryo-EM 
map of the MifM-SRC. Ribosomal proteins are coloured distinctly and labeled using the new 
nomenclature6.  
 
 
 
Supplementary Figure 7: Secondary structures of the B. subtilis 5S, 16S and 23S rRNA.  
a, Secondary structure of the B. subtilis 16S rRNA coloured according to the 5’ (blue), central 
(C, magenta), 3’ major (3’M, green) and 3’ minor (3’m, yellow) domains. b-c, Secondary 
structure of the B. subtilis 5S and 23S rRNA coloured differently for domains I-VI. The 
secondary structures were modified from that available at the comparative RNA web (CRW) 
site7 based on the molecular model of the B. subtilis 16S rRNA from the cryo-EM structure of 
the MifM-SRC. 
 Supplementary Figure 8: Comparison of B. subtilis, E. coli and T. thermophilus 70S 
ribosome structures. 
a-d, Regions of difference in 23S rRNA (red) mapped onto a, the B. subtilis 50S subunit (rRNA, 
blue and r-proteins, grey) and b, the secondary B. subtilis 23S rRNA. c, Panels show electron 
density (grey mesh) and rRNA models (blue) as well as secondary structures for regions of the 
B. subtilis 50S subunit that are distinct from the equivalent regions of the E. coli (green) and 
T. thermophilus (yellow) 50S subunit, namely H25 and H54. d, Panels show electron density 
(grey mesh) and rRNA models (blue) for regions of the B. subtilis 50S subunit that are either 
similar to E. coli (green, PDB4KIX/Y)3, 4 and distinct from T. thermophilus (yellow, 
PDB3I8H/I)5, for example H27, H68 and H10/H79, or similar to T. thermophilus and distinct 
from E. coli, namely, H16 and H63. e-h, Regions of difference in 16S rRNA (red) mapped onto 
e, the B. subtilis 30S subunit (rRNA, blue and r-proteins, grey) and f, the secondary B. subtilis 
16S rRNA. g, Panels show electron density (grey mesh) and rRNA models (blue) for regions of 
the B. subtilis 50S subunit that are either similar to E. coli and distinct from T. thermophilus, for 
example h9 or similar to T. thermophilus and distinct from E. coli, namely, h44, h26 and h33. h, 
Panels show electron density (grey mesh) and 16S rRNA models (blue) as well as secondary 
structures for regions of the B. subtilis 30S subunit that are distinct from the equivalent regions 
of the E. coli (green) and T. thermophilus (yellow) 30S subunit, namely h10/h17 and h6. 
 Supplementary Figure 9: Differences in ribosomal proteins between B. subtilis, E. coli and 
T. thermophilus ribosomes. 
a, Overview and b, zoom of the cryo-EM map of the MifM-SRC (grey with map filtered to 
~10 Å), showing the absence of density for ribosomal proteins S21, L9 and L25. The binding 
positions of S21 and L9 were taken from the E. coli (PDB4KIX/Y)3, 4 and for L25 (red) from the 
T. thermophilus 70S ribosome (PDB3I8I)5. 
 Supplementary Figure 10: Sequence alignment of the tunnel lumen region of bacterial 
ribosomal protein L22. 
Boxshade representation of a Clustal W sequence alignment of selected bacterial ribosomal 
protein L22 sequences to highlight the sequence diversity at the position equivalent M90 in 
B. subtilis L22 (arrowed).  
 Supplementary Figure 11: Network of interactions between the tip of the β-hairpin of L22 
and H35 of the 23S rRNA.  
a, Schematic illustrating the network of interactions between the tip of the β-hairpin of L22 and 
the residues in H35 of the 23S rRNA. b, The backbone and the side chain of R88 of L22 are 
within hydrogen bonding distance to the phosphate-oxygens of G748. c, M90 of L22 can form 
sulphur-Pi interaction with the nucleobase of G748, whereas the backbone nitrogen of M90 is 
within hydrogen bonding distance to the phosphate-oxygen of A751. d, The backbone 
phosphate-oxygens of A751 and A1614 coordinate a Mg2+ ion, while the nucleobase of A1614 
comes within hydrogen bonding distance of the backbone of A89 and R92 of L22. 
 Supplementary Figure 12: Identification of second site mutations in MifM or L22 that 
restore stalling in the context of the L22-M90K mutation. a, Schematic for the GFP-MifM-
YidC2’-LacZ induction reporter used to monitor translational arrest via β-galactosidase activity 
in B. subtilis in vivo. In contrast to the GFP-MifM-LacZ reporter (see Figure 3g), translational 
arrest using the GFP-MifM-YidC2’-LacZ reporter leads to induction of β-galactosidase activity. 
b, β-galactosidase activity from the GFP-MifM-YidC2’-LacZ reporter using B. subtilis strains 
bearing the B. subtilis L22-M90K mutation selected for second site suppressor mutations within 
L22 (residues 80-98) that restore stalling and induction of β-galactosidase activity. c, Overview 
of relative positions of MifM to tunnel lumen residues of L22 that rescue the L22-M90K 
mutation. d, β-galactosidase activity from the GFP-MifM-YidC2’-LacZ reporter when using 
B. subtilis strains bearing the B. subtilis L22-M90K mutation selected for second site suppressors 
within MifM (residues 72-81) that restore stalling and induction of β-galactosidase activity. e, 
Overview of relative positions of tunnel lumen residues of L22 to MifM residues that rescue the 
L22-M90K mutation. In b and d, the error bars indicate the standard deviation of three 
independent biological replicates. 
 Supplementary Table 1: Strains 
Strains genotype 
BKG80 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90C) 
NAB263 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90V) 
NAB264 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90D) 
NAB265 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90F) 
NAB269 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90S) 
NAB270 amyE:: rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90N) 
NAB272 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90L) 
NAB275 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90I) 
NAB276 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90R) 
NAB277 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90E) 
NAB278 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90A) 
NAB279 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90T) 
NAB280 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90Q) 
NAB281 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90Y) 
NAB285 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90G) 
NAB286 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90P) 
NAB287 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90W) 
NAB291 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90H) 
SCB824 amyE::gfp-mifM35-95-yidC2'-lacZΩcat 
SCB2592 amyE::rbsm1-gfp-mifM35-95-lacZΩcat 
SCB2619 rplWΩkanΩrplB 
SCB2634 rplW(d65-69)Ωkan 
SCB2656 rpsSΩkan 
SCB2939 rplD(d63-67)Ωkan 
SCB2942 rplD(d66-70)Ωkan 
SCB2912 rpsSΩkanΩrplV(d82-86) 
SCB2917 rpsSΩkanΩrplV(d86-90) 
SCB2920 rpsSΩkanΩrplV(d91-95) 
SCB3348 rpsSΩkanΩrplV(M90K) 
SCB2639 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rplWΩkan 
SCB2639 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rplWΩkan 
SCB2655 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rplW(d65-69)Ωkan   
SCB2924 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV 
SCB2956 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rplD(d63-67)Ωkan 
SCB2957 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rplD(d66-70)Ωkan 
SCB2958 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV 
SCB2959 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(d82-86) 
SCB2960 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(d86-90) 
SCB2961 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(d91-95) 
SCB3247 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3251 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(Ec-tip) 
SCB3272 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(Ec-tip)-I85F/M86R 
SCB3274 amyE::rbsm1-gfp-mifM35-95-lacZΩcat, rpsSΩkanΩrplV(Ec-tip)-K90M 
SCB3353 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3353 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3378 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rplV94 
SCB3523 amyE::gfp-mifM(T72H)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3524 amyE::gfp-mifM(T72Y)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3525 amyE::gfp-mifM(T72S)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3527 amyE::gfp-mifM(R75S)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3529 amyE::gfp-mifM(K76M)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3530 amyE::gfp-mifM(K76L)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3532 amyE::gfp-mifM(F78R)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3533 amyE::gfp-mifM(R75A)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3572 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/F85R) 
SCB3573 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/F85K) 
SCB3574 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/P87G) 
SCB3575 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/R88P) 
SCB3576 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/A89D) 
SCB3577 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/A89T) 
SCB3578 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/G91K) 
SCB3579 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/G91L) 
SCB3580 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/G91F) 
SCB3581 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/G91H) 
SCB3582 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/G91Y) 
SCB3583 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/R92P) 
SCB3584 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/A93R) 
SCB3585 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/A93K) 
SCB3586 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/G91R) 
SCB3605 amyE::gfp-mifM35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K/N97A) 
SCB3607 amyE::gfp-mifM(T72R)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV(M90K) 
SCB3610 amyE::gfp-mifM(T72R)35-95-yidC2'-lacZΩcat, rpsSΩkanΩrplV 
 
 Supplementary Table 2: Plasmids 
plasmid genotype Primer Template ref 
pCH735 amyE::mifM-lacZΩcat    8 
pCH835 amyE::GFP-mifM35-95-yidC2'-lacZΩcat   8 
pCH913 amyE::rbsm1-GFP-mifM35-95-yidC2'-lacZΩcat   8 
pCH1142 spcRΩloxP-kanR-loxP   9 
pCH1517 amyE::rbsm1-GFP-mifM35-95-lacZΩcat   This study 
pCH1570 rplWΩkanΩrplB   This study 
pCH1584 rplW(d65-69)ΩkanΩrplB SP1 pCH1570 This study 
pCH1587 rpsSΩkanΩrplV   This study 
pCH1590 rpsSΩkanΩrplV(d82-86) SP2 pCH1587 This study 
pCH1591 rpsSΩkanΩrplV(d86-90) SP3 pCH1587 This study 
pCH1592 rpsSΩkanΩrplV(d91-95) SP4 pCH1587 This study 
pCH1745 spcRΩrplCD(d63-67)WΩkanΩrplB SP5 pCH1744 This study 
pCH1746 spcRΩrplCD(d66-70)WΩkanΩrplB SP6 pCH1744 This study 
pCH1897 rpsSΩkanΩrplV(M90K) SP7 pCH1587 This study 
pCH1901 rpsSΩkanΩrplV(Ec-tip)   This study 
pCH1904 rpsSΩkanΩrplV(Ec-tip)-I85F-M86R SP8 pCH1901 This study 
pCH1905 rpsSΩkanΩrplV(Ec-tip)-K90M SP9 pCH1901 This study 
pCH1958 amyE::GFP-mifM(T72H)35-95-yidC2'-lacZΩcat  SP10 pCH835 This study 
pCH1959 amyE::GFP-mifM(T72Y)35-95-yidC2'-lacZΩcat  SP11 pCH835 This study 
pCH1960 amyE::GFP-mifM(T72S)35-95-yidC2'-lacZΩcat  SP12 pCH835 This study 
pCH1962 amyE::GFP-mifM(R75S)35-95-yidC2'-lacZΩcat  SP13 pCH835 This study 
pCH1964 amyE::GFP-mifM(K76M)35-95-yidC2'-lacZΩcat  SP14 pCH835 This study 
pCH1965 amyE::GFP-mifM(K76L)35-95-yidC2'-lacZΩcat  SP15 pCH835 This study 
pCH1967 amyE::GFP-mifM(F78R)35-95-yidC2'-lacZΩcat  SP16 pCH835 This study 
pCH1968 amyE::GFP-mifM(R75A)35-95-yidC2'-lacZΩcat  SP17 pCH835 This study 
pCH1978 amyE::GFP-mifM(T72R)35-95-yidC2'-lacZΩcat SP18 pCH835 This study 
pEB71 loxP-kanR-loxP   10 
pKG11 rpsSΩkanΩrplV(M90C) SP19 pCH1587 This study 
pNAR479 rpsSΩkanΩrplV(M90V) SP20 pCH1587 This study 
pNAR483 rpsSΩkanΩrplV(M90D) SP20 pCH1587 This study 
pNAR484 rpsSΩkanΩrplV(M90F) SP20 pCH1587 This study 
pNAR485 rpsSΩkanΩrplV(M90S) SP20 pCH1587 This study 
pNAR487 rpsSΩkanΩrplV(M90N) SP20 pCH1587 This study 
pNAR489 rpsSΩkanΩrplV(M90L) SP20 pCH1587 This study 
pNAR490 rpsSΩkanΩrplV(M90I) SP20 pCH1587 This study 
pNAR491 rpsSΩkanΩrplV(M90R) SP20 pCH1587 This study 
pNAR494 rpsSΩkanΩrplV(M90E) SP20 pCH1587 This study 
pNAR495 rpsSΩkanΩrplV(M90A) SP20 pCH1587 This study 
pNAR496 rpsSΩkanΩrplV(M90T) SP20 pCH1587 This study 
pNAR498 rpsSΩkanΩrplV(M90Q) SP20 pCH1587 This study 
pNAR499 rpsSΩkanΩrplV(M90Y) SP21 pCH1587 This study 
pNAR500 rpsSΩkanΩrplV(M90G) SP22 pCH1587 This study 
pNAR501 rpsSΩkanΩrplV(M90P) SP23 pCH1587 This study 
pNAR502 rpsSΩkanΩrplV(M90W) SP24 pCH1587 This study 
pNAR503 rpsSΩkanΩrplV(M90H) SP25 pCH1587 This study 
 
 Supplementary Table 3: Primers 
primer sequence 
MifMfor  5'- GAAATTAATACGACTCACTATAGGG -3' 
MifMrev 5'- TTATTATTATTAGTCTTCCTCATCGTTCACAGG -3' 
SP1  5'-ACTACAAAGGCAAATCAAAAACTGGTATGACTAGCCGTCG-3' 
SP2 5'-TCGTTGACGAAGGCCCTACGCCACGTGCTATGGGACGTGC-3' 
SP3 5'-GCCCTACGTTAAAAAGATTCGGACGTGCGAGCCAAATCAA-3' 
SP4 5'-GATTCCGCCCACGTGCTATGATCAACAAACGTACGAGCCA-3' 
SP5 5'-AAGTACGCGGCGGAGGTCGTAAAGGTACTGGACGTGCCCG-3' 
SP6 5'-GCGGAGGTCGTAAACCATGGGGACGTGCCCGTCAAGGTTC-3' 
SP7 5'-AGATTCCGCCCACGTGCTAAAGGACGTGCGAGCCAAATC-3' 
SP8 5'-GGCCCTAGCATGAAGCGCTTCCGCCCGCGTGCAAAAGGTCGT-3' 
SP9 5'-CGCATTATGCCGCGTGCAATGGGTCGTGCAGATCGCATC-3' 
SP10 5'-ATATATCATCGCATTACACATTGGATACGTAAAGTCTTC-3' 
SP11 5'-ATATATCATCGCATTACATATTGGATACGTAAAGTCTTC-3' 
SP12 5'-ATATATCATCGCATTACAAGCTGGATACGTAAAGTCTTC-3' 
SP13 5'-CGCATTACAACTTGGATAAGCAAAGTCTTCCGCATGAAT-3' 
SP14 5'-ATTACAACTTGGATACGTATGGTCTTCCGCATGAATTCG-3' 
SP15 5'-ATTACAACTTGGATACGTCTGGTCTTCCGCATGAATTCG-3' 
SP16 5'-ACTTGGATACGTAAAGTCCGCCGCATGAATTCGCCTGTG-3' 
SP17 5'-CGCATTACAACTTGGATAGCGAAAGTCTTCCGCATGAA-3' 
SP18 5'-ATATATCATCGCATTACACGCTGGATACGTAAAGTCTTC-3' 
SP19 5'-AGATTCCGCCCACGTGCTTGCGGACGTGCGAGCCAAATC-3' 
SP20 5'-AGATTCCGCCCACGTGCTNNNGGACGTGCGAGCCAAATC-3' 
SP21 5'-AGATTCCGCCCACGTGCTTATGGACGTGCGAGCCAAATC-3' 
SP22 5'-AGATTCCGCCCACGTGCTGGCGGACGTGCGAGCCAAATC-3' 
SP23 5'-AGATTCCGCCCACGTGCTCCGGGACGTGCGAGCCAAATC-3' 
SP24 5'-AGATTCCGCCCACGTGCTTGGGGACGTGCGAGCCAAATC-3' 
SP25 5'-AGATTCCGCCCACGTGCTCATGGACGTGCGAGCCAAATC-3' 
SP26 5'-CAAGGAATGGTGCATGCAAGG-3' 
SP27 5'-TCCATAGATCTTAAAAGAAGAGAACCGGCGTC-3' 
SP28 5'-AATAAGAGCTCCAGGTTCTTGGTAAAGAAGGT-3' 
SP29 5'-TCCTCTTTTCTACAGTATTTAGGATCCTTAGCGTCTTGTTTTTTTGTC-3' 
SP30 5'-TTTTACTGGATGAATTGTTTTAGCTCGAGTAATTAAACAAGACGCTAAGAGAGGA-3' 
SP31 5'-TTATTGCATGCTCTTCAGACACACCAGAAATT-3' 
SP32 5'-TAAGGATCCTAAATACTGTAGAAAAGAGGA-3' 
SP33 5'-AATTACTCGAGCTAAAACAATTCATCCAGTAAAA-3' 
SP34 5'-GGGAAGAACAGTATGTCGAGC-3' 
SP35 5'-CTGCACGACCTTTTGCACGCGGCATAATGCGCTTCATGCTAGGGCCTTCGTCAACGAATGC-3' 
SP36 5'-GCATTATGCCGCGTGCAAAAGGTCGTGCAGATCGCATCCTGAAACGTACGAGCCACATTACA-3' 
SP37 5'-TGTGGAATTGTGAGCGG-3' 
SP38 5'-GCATTCGTTGACGAAGGCNNNACGTTAAAAAGATTCCGC-3' 
SP39 5'-TTCGTTGACGAAGGCCCTNNNTTAAAAAGATTCCGCCCA-3' 
SP40 5'-GTTGACGAAGGCCCTACGNNNAAAAGATTCCGCCCACGT-3' 
SP41 5'-GACGAAGGCCCTACGTTANNNAGATTCCGCCCACGTGCT-3' 
SP42 5'-GAAGGCCCTACGTTAAAANNNTTCCGCCCACGTGCTAAA-3' 
SP43 5'-GGCCCTACGTTAAAAAGANNNCGCCCACGTGCTAAAGGA-3' 
SP44 5'-CCTACGTTAAAAAGATTCNNNCCACGTGCTAAAGGACGT-3' 
SP45 5'-ACGTTAAAAAGATTCCGCNNNCGTGCTAAAGGACGTGCG-3' 
SP46 5'-TTAAAAAGATTCCGCCCANNNGCTAAAGGACGTGCGAGC-3' 
SP47 5'-AAAAGATTCCGCCCACGTNNNAAAGGACGTGCGAGCCAA-3' 
SP48 5'-TTCCGCCCACGTGCTAAANNNCGTGCGAGCCAAATCAAC-3' 
SP49 5'-CGCCCACGTGCTAAAGGANNNGCGAGCCAAATCAACAAA-3' 
SP50 5'-CCACGTGCTAAAGGACGTNNNAGCCAAATCAACAAACGT-3' 
SP51 5'-CGTGCTAAAGGACGTGCGNNNCAAATCAACAAACGTACG-3' 
SP52 5'-GCTAAAGGACGTGCGAGCNNNATCAACAAACGTACGAGC-3' 
SP53 5'-AAAGGACGTGCGAGCCAANNNAACAAACGTACGAGCCAC-3' 
SP54 5'-GGACGTGCGAGCCAAATCNNNAAACGTACGAGCCACATT-3' 
SP55 5'-CGTGCGAGCCAAATCAACNNNCGTACGAGCCACATTACA-3' 
SP56 5'-ATATATCATCGCATTACANNNTGGATACGTAAAGTCTTC-3' 
SP57 5'-TATCATCGCATTACAACTNNNATACGTAAAGTCTTCCGC-3' 
SP58 5'-CATCGCATTACAACTTGGNNNCGTAAAGTCTTCCGCATG-3' 
SP59 5'-CGCATTACAACTTGGATANNNAAAGTCTTCCGCATGAAT-3' 
SP60 5'-ATTACAACTTGGATACGTNNNGTCTTCCGCATGAATTCG-3' 
SP61 5'-ACAACTTGGATACGTAAANNNTTCCGCATGAATTCGCCT-3' 
SP62 5'-ACTTGGATACGTAAAGTCNNNCGCATGAATTCGCCTGTG-3' 
SP63 5'-TGGATACGTAAAGTCTTCNNNATGAATTCGCCTGTGAAC-3' 
SP64 5'-ATACGTAAAGTCTTCCGCNNNAATTCGCCTGTGAACGAT-3' 
SP65 5'-CGTAAAGTCTTCCGCATGNNNTCGCCTGTGAACGATGAG-3' 
SP66 5'-TTTAGTCTAGATAATTATCTGTAAAAAGAAGG-3' 
SP67 5'-ATATTGCATGCACCACGAACTGTAGGACGGAT-3' 
SP68 5'-AATAAGGATCCCCAAAACGGTTCTACTGCTGG-3' 
SP69 5'-TTAAGCTTCAAAAATTTCGAT-3' 
SP70 5'-GAAATCGAAATTTTTGAAGCTTAAATACTGTAGAAAAGAGGAAGG-3' 
SP71 5'-CTAAAACAATTCATCCAGTAAAA-3' 
SP72 5'-AATTATCTAGACTAAAACAATTCATCCAGTAAAA-3' 
‘N’ represents mixture of A, G, T and C. 
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Abstract:
Signal recognition particle (SRP) recognizes signal sequences of nascent polypeptides and 
targets ribosome-nascent-chain complexes to membrane translocation sites. In eukaryotes, the 
translating ribosome is slowed-down by the Alu domain of SRP for efficient targeting. In 
prokaryotes, however, very little is known about structure and function of Alu domain containing 
SRPs. Here, we report a complete molecular model of SRP from the Gram-positive bacterium 
Bacillus subtilis based on cryo-electron microscopy. It consists only of two subunits, 6S RNA 
and SRP54 and facilitates elongation slow-down similar to its eukaryotic counterpart. Moreover, 
comparison with the ribosome-bound mammalian Alu domain shows that protein contacts with 
the small ribosomal subunit are substituted in bacteria by RNA-51$ LQWHUDFWLRQVZLWK WKH Į-
sarcin-ricin loop and helices H43/H44 of the 23S rRNA. Our findings provide the functional and 
structural basis for co-translational targeting and RNA-driven elongation arrest in prokaryotes.
Main Text: 
The signal recognition particle (SRP) plays an essential role in co-translational targeting 
of secretory and membrane proteins mediated by the interaction with its membrane-bound
cognate SRP receptor (SR)1,2. SRP is a ribonucleoprotein complex conserved in all three 
domains of life with a high diversity regarding size and composition3. In eukaryotes SRP is most 
complex and contains six proteins assembled on a 7SL RNA (Fig. 1a). It can be divided into two 
functional domains: the S domain with the SRP54 protein that recognizes N-terminal signal 
sequences as soon as they emerge from the ribosomal tunnel exit4 , and the Alu domain that 
imposes an elongation arrest/slow-down by blocking the elongation factor entry site on the 
ribosome5-7. By arresting or delaying translation, it is believed that SRP prevents fast folding 
secretory proteins or aggregation-prone membrane proteins from being prematurely released 
from the ribosome before the ribosome-nascent chain complex (RNC) has correctly engaged 
with the translocation channel at the membrane1. The Alu domain of higher eukaryotes interacts 
with two Alu RNA binding proteins, SRP9 and SRP14 (Fig. 1a). The proteins stabilize the 
complex tertiary structure of the Alu RNA and contribute to ribosome binding by interaction 
with the small ribosomal subunit5,7. The Alu RNA itself establishes a direct contact with the 
large ribosomal subunit and thereby occludes the translation factor binding site7. Surprisingly, 
Gram-negative bacteria such as E. coli possess only a minimalistic SRP comprising a short RNA 
(4.5S) and the SRP54 subunit (Ffh) (Fig. 1a). This SRP lacks an Alu domain and, accordingly, is 
thought to be unable to promote elongation arrest. However, many prokaryotes such as archaea 
and Gram-positive bacteria possess an SRP with a large RNA (6S and 7S RNA, respectively; 
Fig. 1a) that also contains an Alu domain, usually carrying somewhat extended 5’ and 3’ regions 
compared to higher eukaryotes3. Yet, homologues of the SRP9/14 proteins have not been found 
in the genomes of archaea or bacteria so far. Crystal structures of the isolated RNA Alu domain 
of B. subtilis and P. horikoshii have recently been reported7,8 and, as expected, show a high 
degree of similarity to each other (Extended Data Fig. 1) and to the eukaryotic one8,9. However, 
very little is known about the function of prokaryotic Alu containing SRPs in the context of the 
translating ribosome.
RNC binding and elongation arrest
For the characterization of a prokaryotic, Alu domain-containing SRP we chose that of 
the Gram-positive bacterium B. subtilis that consists of a 6S RNA and an SRP54 protein (Fig. 
1a). We reconstituted B. subtilis SRP (BsSRP) from in vitro transcribed RNA and purified 
recombinant SRP54 (Extended Data Fig. 2a). The histone-like DNA-binding protein HU1, that 
had previously been suggested to be part of the bacterial Alu domain10,11 did not co-purify during 
in vivo pull-outs and could not be co-reconstituted (Extended Data Fig. 2a). We, therefore, 
conclude that HU1 lacks specific Alu RNA association or any function in SRP, and that the 6S 
RNA and the SRP54 subunit represent the complete set of BsSRP constituents. 
Activity of the reconstituted SRP was first tested in pelleting assays for binding to either 
empty ribosomes or B. subtilis ribosome-nascent chain complexes (BsRNCs). The BsRNCs were 
generated using a cell-free translation system and carried a nascent peptide containing the FtsQ 
signal anchor sequence fused to the B. subtilis MifM stalling sequence (Extended Data Fig. 
2b)12. While binding of the reconstituted BsSRP to empty 70S ribosomes was not detected, a 
specific and stable interaction with the signal sequence carrying RNCs was clearly observable 
(Fig. 1b and Extended Data Fig. 2c). Microscale thermophoresis (MST) was also used to 
further characterize the binding properties of the BsSRP to BsRNCs. To that end programmed 
and empty ribosomes were labeled with fluorescent dyes (Extended Data Fig. 3a) and different
SRPs were titrated, so the complex assembly could be probed due to changes in ribosome 
thermophoretic. For the BsSRP we observed association constants in the low nanomolar range 
(5-15 nM) with BsRNCs carrying the signal anchor sequence of FtsQ (Fig. 1c). An even higher 
association constant was determined for an artificial more hydrophobic leucine-rich signal
sequence (Fig. 1c), indicating that BsSRP has a preference for high hydrophobicity, as observed 
also for E. coli SRP13. In contrast, BsSRP exhibited a very low association rate for BsRNCs 
lacking a signal sequence (luciferase) and was too low to be determined for empty ribosomes 
under our conditions (Extended Data Fig. 3b). Validating these findings and in agreement with 
the literature1,14, similar binding properties and affinities (in the low nanomolar range) were 
observed using MST for E. coli SRP and E. coli RNCs carrying the FtsQ or the Foc signal 
sequences; also here the affinity to empty 70S ribosomes could not be determined (Extended 
Data Fig. 3c). Notably, B. subtilis and E. coli SRPs displayed essentially the same binding 
behavior when using E. coli RNCs carrying the Foc signal sequence (Extended Data Fig. 3c). 
These data suggest that the overall binding properties of BsSRP essentially resemble those of E. 
coli SRP due to a high degree of structural and functional conservation of both the SRP S-
domain and the SRP binding site at the ribosomal tunnel exit. This is in agreement with the 
earlier finding that the B. subtilis and E. coli SRPs can indeed complement for each other in 
vivo15-18. However, unlike E.coli SRP, BsSRP contains an Alu domain, therefore we tested 
whether it can induce elongation arrest similar to its eukaryotic counterparts. Using an in vitro
cell free translation system the SRP substrate protein FtsQ was translated carrying either a 
mutated dysfunctional or a wild-type signal anchor sequence (Extended Data Fig. 3d). When 
translating the mutated FtsQ the presence of BsSRP did not cause any detectable differences in 
translation efficiency, however, translation of the wild-type FtsQ in the presence of BsSRP led to 
a delay in expression (Fig. 1d). Therefore, we conclude that similar to eukaryotic SRPs19,20 the 
presence of the Alu domain in bacterial SRPs, such as B. subtilis SRP, confers elongation 
arrest/slow-down activity. By analogy, it is likely that the Alu domain containing SRPs of the 
archaeal kingdom are also endowed with an elongation arrest activity.
Structures of Bacillus and mammalian SRP
For structural analysis, we reconstituted a B. subtilis. SRP-RNC consisting of purified 
stalled FtsQ-carrying BsRNCs bound to reconstituted BsSRP and subjected it to cryo-electron 
microscopy (cryo-EM) and single particle analysis. Cryo-EM data collected using a conventional 
CCD detector resulted in a reconstruction of ~7 Å resolution that clearly revealed the 
programmed ribosome and additional “L”-shaped density for the SRP reaching from the 
ribosomal tunnel exit to the translation factor binding site (Fig. 2a-c). In an attempt to obtain the 
highest possible resolution, we also collected data sets on both K2 Summit and Falcon 2 direct 
electron detectors. As expected these reconstructions revealed details to below 4 Å in the 
conserved core of the ribosome, but unfortunately, however, the local resolution for SRP did not 
improve. In fact, the SRP density was only weakly represented in the highest resolution 
reconstruction (Extended Data Fig. 4), indicative of the flexible nature of the ribosome-bound 
SRP. Although the SRP54 interaction of the S domain confers the high affinity for the RNC, the 
SRP flexibility was more pronounced for the S domain than for the Alu domain. Further sub-
sorting attempts failed, suggesting that there is an apparent lack of distinct conformational sub-
states of SRP. 
Nevertheless, we could use the 7-12 Å cryo-EM map to build the first complete 
molecular model of the ribosome-bound BsSRP. For the Alu domain a rigid-body docking of the 
recently reported crystal structure of the B. subtilis SRP8 was possible with only very minor 
changes necessary; the S domain, including the SRP54 M domain, was first built based on its 
high degree of similarity to the known S domain of E. coli SRP21,22 and then flexibly docked into 
the corresponding density (Fig. 2d, e). The linker part between the fixed Alu domain and S 
domain fragments was then built de novo23. The full 6S RNA model revealed the presence of a 
major kink (~90°), with a single hinge located between H5e and H5d. The presence of this hinge 
facilitates the bending of the RNA structure to orient the Alu domain for interaction at the 
intersubunit space of the ribosome.
To enable a detailed comparison with the eukaryotic SRP, we also improved the 
molecular model of mammalian SRP (Canis familiaris) in the functional context of a ribosome 
targeting complex7,24 based on a new cryo-EM reconstruction (Extended Data Fig. 5a) and 
available crystal structures of the SRP68 bound to the S domain of 7S RNA25 (Fig. 2f, g). 
Despite the fact that the density for the SRP68 remains weakly represented and the density for 
SRP72 appears to be not visible , indicating a clear flexibility of this region, it appears that the 
SRP68 binding restructures the distal end of helix H5f as suggested in25. While the 6S RNA 
seems to adopt an “L-shape”, the 7S RNA appears to adopt a more intricate structure mainly due 
to the presence of two hinges: A major kink between the distal end of H5e and H5d (Hinge 1), 
which forms a 90° turn similar to the 6S RNA structure, and a second kink of ~30° between the 
distal end of H5b and H5a (Hinge 2), which is required for the correct positioning of the Alu 
domain in the translation factor binding site as previously observed7.
SRP S-domain ribosome interaction
A structural alignment of eukaryotic and bacterial SRPs with respect to the large 
ribosomal subunit was then performed (Fig. 3a). The overall positioning of the SRPs between 
tunnel exit and translation factor-binding site appeared very similar, however, there were some 
noticeable differences in both the Alu and the S domains. While the S domains of BsSRP and E. 
coli SRP superpose almost perfectly, the very distal end of the E. coli 4.5S RNA appeared to be 
more flexible than the corresponding region in the BsSRP connecting S and Alu domains (Fig. 
3a). In contrast, the S domain of the mammalian SRP is bound in a position that is displaced by 
10-15 Å from the ribosome compared to the bacterial SRP positions. This difference between 
bacterial and eukaryotic SRPs may be due to the eukaryotic-specific C-terminal extension of the 
SRP54 M domain that mediates the interaction between SRP and the ribosomal RNA helix 24 
(H24) at the tunnel exit. The SRP54 NG domain that can also participate in ribosome interactions 
at the tunnel exit appeared highly flexible in the BsSRP SRP, and, similar to the E. coli SRP26,
could only be seen when filtering the map to 15 Å resolution (Fig. 3b). This is different for the 
mammalian SRP54 in which the NG domain is rigidly bound to the 80S ribosome (Extended 
Data Fig. 5b), as observed previously7. At the given resolution of the BsSRP map, we can follow 
the nascent polypeptide chain from the PTC of the ribosome through the ribosomal tunnel into 
the M domain of SRP54 (Fig. 2b, Extended Data Fig. 5c). Here, a rod-like additional density, 
most likely representing the alpha-helical signal anchor sequence of FtsQ, is accommodated by 
the M domain in an open conformation (Fig. 3c). The overall position of the signal sequence 
agrees well with previously observed arrangements (Fig. 3c, d)7,24,27. Notably, however, in this 
BsSRP. complex the signal sequence points towards and also interacts with ribosomal rRNA 
helix 59 (H59) via its N-terminal end (Fig. 3e, f and Extended Data Fig. 5c). An interaction of 
transmembrane (TM) domains of nascent chains with H59 has been observed before28 and may 
contribute to the correct orientation of signal sequences or TM domains for transfer to the 
secYEG translocon or for adopting the correct orientation in the lipid bilayer. Apart from the 
SRP54-mediated interactions, we observed one additional RNA-RNA interaction between rRNA 
helix 100 (H100) of the ribosome and the 6S RNA of SRP (Fig. 3f). This interaction has also 
been observed for ribosome-bound E. coli26 and mammalian SRP (7 and this study) and may be 
of regulatory importance for NG domain GTPase activation25,29.
SRP Alu-domain ribosome interaction
For a detailed understanding of the elongation arrest function of SRP in bacteria and
mammalian cells, we analyzed the Alu domains within the ribosomal context (Fig. 4a, b and 
Extended Data Fig 6a, b). Interestingly, the docking of the mammalian Alu domain revealed an 
interaction mode purely driven by protein-RNA interactions (Fig. 4a): the tips of 7S RNA L3 
and L4 loops directly contact the N-terminal part of the ribosomal protein uL11, providing the 
only detectible connection to the large ribosomal subunit (Fig 4a and Extended Data Fig. 6a). 
Contact between the 7S RNA and the small ribosomal subunit is established via the SRP9/14 
SURWHLQGLPHUZKHUHPDLQO\WKHWZR653Į-helices participate in contacts with h5 and h18 of 
the 18S rRNA (Fig. 4a and Extended Data Fig. 6a). Whereas the binding of the Alu domain to 
the ribosome competes directly with binding of elongation factors such as eEF2, the interaction 
mode of the SRP Alu domain appears to be different from that of canonical elongation factors: 
neither the tip of the rRNA helix 43 in the stalk base that was shown to interact with eEF230 nor 
the XQLYHUVDOO\FRQVHUYHGĮ-sarcin-ricin loop (SRL, H95) (Fig. 4a) are likely to participate in the 
stabilization of the mammalian Alu domain. 
Similar to the mammalian Alu domain also the BsSRP Alu domain was found to bind to 
the translation factor site and thereby competing with elongation factors (Extended Data Fig. 7), 
however, using an entirely different mode of interaction (Fig. 4b and Extended Data Fig. 6b): 
First, binding occurs essentially by RNA-RNA interactions rather than protein-RNA as observed 
for the mammalian SRP. Second, the B. subtilis Alu domain maintains a distance of at least 10 Å 
from the small ribosomal subunit. Thus, the absence of any SRP9/14-like proteins in the bacterial 
Alu domain results in the complete lack of interaction with the small ribosomal subunit (Fig. 4b
and Extended Data Fig. 6b). The additional B. subtilis Alu RNA helix 1, which was found to 
point into the intersubunit space, is also too far away as to provide any contacts. However, this 
apparent lack of contact to the small subunit is compensated by a unique mode of tertiary RNA 
interaction between the 6S RNA and the large ribosomal subunit. Remarkably, the B. subtilis Alu 
RNA directly binds to the stalk base rRNA helices H43/H44 as well as to the rigidly positioned 
Į-sarcin-ricin loop (SRL, H95) (Fig. 4b). Here, the extended loop-loop pseudoknot t1 of SRP8
appears to play an essential role in this docking by facilitating a continuous stacking from stalk 
base to SRL (Fig. 4c, d). The conformational changes observed in the stalk base, moving from 
an “open state” (unbound SRP) to a “half-closed state” (bound SRP) (Extended Data Fig. 6c)
provide a perfect “landing pad” for the A24:U50 base pair of the 6S loop-loop pseudoknot t1. 
The A24:U50 base pair stacks effectively onto A1141 and A1113 of ribosomal rRNA helices 
H44 and H43, respectively (Fig. 4c). In this region, extra stability appears to be provided by 
interaction between uL11 proline 22 and C51 of the Alu RNA. Moreover, A44 from the Alu
L4.1 lobe also stacks onto A2689 of the SRL tetraloop, thereby inducing a minor remodeling of 
the Alu L4.1 lobe. As a consequence, an induced base paring appears to be possible between 
A44 and U29 providing in this way extra stability to the structure. Additional stability appears to 
be also provided by ribose interactions involving Alu A21 and A2689 of H95 as well as Alu G30 
and G2690 of H95 (Fig. 4c, d). Finally, in this region the C-terminal extension of uL6 appears to 
stabilize this conformation by directly interacting with Alu C46. 
Taken together, the bacterial Alu domain appears to have developed an distinctive way of 
interacting with the ribosome, relying mainly on RNA:RNA interactions. It exclusively interacts 
with the large ribosomal subunit essentially by establishing a connected RNA stacking system 
between the ribosomal stalk base and the Į-sarcin-ricin loop. The 3D structure of the 6S Alu 
RNA domain forms a unique tetraloop receptor allowing docking onto the SRL. Thus, the entire 
Alu domain acts as a ‘dock and lock’ system in which the translation factor binding site of the 
ribosome is locked temporarily in order to slow down the translation machinery for efficient 
targeting to a membrane translocation site.
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Fig. 1. Reconstitution, affinity and elongation arrest/slow-down activity of Bacillus subtilis
SRP.
(A) Schematic representation of the bacterial, archaeal and mammalian SRP. (B) Binding assays 
using B. subtilis RNCs with an excess of reconstituted BsSRP. Supernatant (S) and pellet (P) 
fraction were analyzed by SDS-polyacrylamide gel electrophoresis and Coomassie blue staining. 
(C) BsSRP binding affinity determination using microscale thermophoresis (MST). 
Thermophoretic mobility of labeled ribosomes was affected upon binding of SRP (top: raw MST 
trace, bottom left: measured MST response) allowing calculation of the affinity (bottom right). 
Bar diagram representing the association rate constants for different BsSRP-RNCs (bottom
right). (D) BsSRP induces translation delay/slow-down of reporters containing a signal anchor 
transmembrane segment in vitro. Plot representing time-course translation experiments of full 
length product reporters encoding FtsQ wt or FtsQ mutant (mutated transmembrane segment) 
subjected to [35S] Met-labeled in vitro translation in absence or presence of BsSRP.
Fig. 2. Cryo-EM structures of SRP-RNC complexes.
(A) Cryo-EM reconstruction of the BsSRP-RNC. Small 30S subunit (yellow), large 50S subunit 
(grey), P-site tRNA (green), 6S RNA (red) and the density corresponding to Ffh M-domain 
(blue). (B) Transverse section of the BsSRP-RNC, visualizing the nascent chain (green) that can 
be traced from the PTC through the entire ribosomal tunnel to the Ffh M-domain (blue). (C) 
Local resolution map of the BsSRP-RNC. (D) BsSRP model fitted into the density with 
corresponding secondary structure diagram. (E) Full BsSRP model, including 6S RNA model 
(red) and Ffh M-domain (blue). The delocalized Ffh NG-domain is represented by dashed lines.
(F). Mammalian SRP model fitted into the density with corresponding secondary structure 
diagram. (G) Full mammalian SRP Model, including the 7S RNA model (red), SRP9 (orange), 
SRP14 (purple), SRP54 (Blue), SRP68 (orange), SRP19 (yellow).
Fig. 3. Behavior of SRP54 and signal sequence binding
(A) Relative positions of prokaryotic (E. coli 4.5A and B. subtilis 6S) and eukaryotic SRP 
(mammalian 7S) with respect to the large ribosomal subunit. (B) The Ffh NG domain remains 
delocalized and can only be visualized by filtering the BsSRP SRP-RNC cryo-EM map at 15 Å
(red mesh). (C, D) Structural alignment of the M domain underlying the position of the nascent 
chain with respect to H4. All M domains adopt an open conformation where the signal sequence 
could dock. (E and F) Contacts between BsSRP and the tunnel exit environment. The Ffh M-
domain is represented in blue, the 6S RNA in red, the signal sequence in green. The ribosomal 
RNA helices that interact with the M-domain (H24), with the signal sequence (H59) and with the 
6S RNA (H100) are colored in grey. uL24 contacting the nascent chain is colored in pale yellow.
Fig. 4. SRPs Alu domain interaction with the ribosome.
(A) Interaction of the mammalian SRP Alu domain with both ribosomal subunits at elongation 
factor binding site. (B) Interaction of the BsSRP Alu domain with the large ribosomal subunits.  
(C) Molecular model of B. subtilis. 6S Alu domain locking in by generating a continuous 
stacking between sarcin-ricin loop and helix H43/H44 of 23S rRNA. (D) Schematic 
representation of the molecular basis of the BsSRP Alu domain ribosome interaction. 
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Purification of Ffh, HU1, 6S RNA and SRP reconstitution: 
Ffh (ffh,BSU15980) and HU1 (HU1, BSU22790) were amplified from Bacillus subtilis, 
strain 168 genomic DNA using respectively oligonucleotides M18 (ATG CAT TTG AAG GAT 
TAG CCG ACC GAC TGC AGC AGA CG)/M19 (ATG GCA TTT GAA GGA TTA GCC GAC 
CGA CTG C), M16 (ATG AAC AAA ACA GAA CTT ATC AAT GCG GTT GCA GAA 
GC)/M17 (TTA TTT TCC GGC AAC TGC GTC TTT AAG CGC TTT ACC) and then cloned 
into pET46 vector. His6-ffh, His6-HU1 and HU1-His6 protein were overexpress in E. coli BL21 
at 28°C for 4h after induction with 1 mM IPTG. Cells were harvested and the pellet was 
suspended in FlB buffer (25 mM HEPES KOH pH 7.5, 500 mM KCl, 10 mM MgCl2, 10 mM 
imidazole, 10% glycerol). Lysis was achieved using a microfluidizer (Microfluidics) by 3 pass at 
15.000 psi. The proteins were then purified from the supernatant by his-tag affinity purification 
using Ni-NTA agarose beads. The bound protein were washed with FwB buffer (25 mM HEPES 
KOH pH 7.5, 1 M KCl, 10 mM MgCl2, 25 mM imidazole, 10% glycerol) and then eluted with 
FeB buffer (25 mM HEPES KOH pH 7.5, 200 mM KOAc, 10 mM Mg(OAc)2, 150 mM 
imidazole, 10% glycerol). 
 
6S RNA gene (scRNA, X06802) was amplified from Bacillus subtilis strain 168 genomic 
DNA, using oligonucleotides M14 (ATC GGA TCC CTA ATA CGA CTC ACT ATA GGC 
TTT GCC GTG CTA AGC GGG GAG GTA GCG GTG CCC TGT ACC TGC AAT CCG CTC 
TAG CAG GGC) /M15 (GC AAG CTT ACC GTG CAC CTT CTG TCG ATT CGC TAC CCT 
AAG CGT TAC TTA AGC AGT TAG CTC GGC CC) and then cloned into pUC19 -T7. The 6S 
RNA was produced by in vitro transcription using in-house prepared T7 polymerase and 
HindIIII-linearized plasmid template. The RNA was then purified on 10% urea polyacrylamide 
gel, eluated from the gel and reconcentrated by ethanol precipitation followed size-exclusion 
chromatography (S200). 
 
Prior to SRP complex formation, the 6S RNA was first heat-denatured and then refolded 
by slowly-cooled to 30°C in Cfb buffer (25 mM HEPES KOH pH 7.5, 150 mM KOAc, 10 mM 
Mg(OAc)2, 2% glycerol). SRP complex formation was performed by mixing folded 6S RNA 
with 10 fold excess of freshly purified proteins with an incubation of 20 min at 30°C. SRP 
complex were then purified by size-exclusion chromatography (S200), aliquoted and stored at -
80°C.  
 
Bacillus subtilis strain 168, S12 translation extract preparation: 
 Bacillus subtilis, strain 168 cells were grown in an “INFORCE HT minifors” bench-top 
fermenter in 2x YPTG medium (16 g/L peptone, 10 g/L yeast extract, 5 g/l NaCl, 22 mM 
NaH2PO4, 40 mM Na2HPO4, 19.8 g/L glucose (sterile filtered)) feeding extra glucose (feed: 10) 
at 37°C, maintaining pH 7.0 and oxygen level (60%) to OD600 4.5. Cells were harvested at 5.000 
g at 4°C for 15min and subsequently washed 3 times with cold Buffer A (10 mM Tris–acetate 
(pH 8.2), 14 mM Mg(OAc)2, 60 mM potassium glutamate, 1 mM dithiothreitol and 6 mM 2-
beat-mercaptoethanol). Cells were flash-frozen in liquid nitrogen and stored at -80°. About 15g 
of cells were thawed on ice and resuspended in 10ml of cold buffer B (buffer A without 2-
mercaptoethanol) and broken open using a microfluidizer (Microfluidics M-110L) by 3 pass at 
15.000 psi. The lysate was cleared subsequently via centrifugation at 12.000 g and 4°C for 10 
min and incubated for 30 min at 37°C in a water bath. The cell extract was aliquoted, flash-
frozen and stored at -80°C.  
 
In vitro translation reaction and purification of unlabeled and 488 labeled MifM-stalled RNC: 
1 ml of reaction mix containing 240 mM HEPES-KOH (pH 8.2), 60 mM glucose, 1.2 
mM ATP, 0.85 mM CTP, GTP, and UTP, 2 mM DTT, 0.17 mg/mL E. coli total tRNA mixture 
(from strain MRE600 Sigma), 90 mM potassium glutamate, 80 mM of ammonium acetate, 8 mM 
magnesium acetate, 20 mM potassium phosphate dibasic (pH 7.2), 34 μg/mL L-5-formyl-5, 6, 7, 
8tetrahydrofolic acid (folinic acid), 2.1 mM (each) amino acids mix, 2 mM Cysteine, 2 % (w/v) 
PEG 8000 was preheated to 30°C before the addition of 27 % (v/v) cell-extract (S12 extract). 
The whole reaction was incubated at 30°C for 2 min before the addition of MifM mRNA and 
further incubation at 30°C for 33 min. 
 
The ribosomes were first isolated from the in vitro reaction mix by centrifugation through 
sucrose cushion (50 mM HEPES KOH pH 7.2, 250 mM KOAc, 25 mM Mg(OAc)2, 750 mM 
Sucrose, 0.1% DDM) for 180 min at 72000 g using TLA120.2 rotor. The pellet was then 
suspended in 250 buffer (50 mM HEPES KOH pH 7.2, 250 mM KOAc, 25 mM Mg(OAc)2, 500 
mM Sucrose, 0.1% DDM) and the MifM-RNCs were isolated using TALON metal-chelate 
affinity resin (Clontech). The bound MifM-RNCs were washed with 500 buffer (50 mM HEPES 
KOH pH 7.2, 500 mM KOAc, 25 mM Mg(OAc)2, 500 mM Sucrose, 0.1% DDM) and eluted 
using 250i buffer (50 mM HEPES KOH pH 7.2, 250 mM KOAc, 25 mM Mg(OAc)2, 500 mM 
Sucrose, 250 mM imidazole, 0.1% DDM). The eluted MifM-stalled RNC were then loaded onto 
a linear sucrose gradient (5%-40% (w/v) sucrose in 250 buffer) for 18h at 43000 g in SW28 and 
the isolated RNC peak was then pelleted by centrifugation 3h at 139000 g Ti70.1 and the pellet 
was resuspended in RNC buffer (20 mM HEPES pH 7.2, 50mM KOAc, 6mM Mg(OAc)2, 250 
mM sucrose, 0.05% DDM).  
 
Binding assays of BsRNC-SRP complexes and translation slowdown experiments:  
Prior to the reconstitution of SRP-MifM-stalled RNC complexes, SRP was incubated in 
SRP buffer (25 mM HEPES KOH pH 7.5, 150 mM KOAc, 10 mM Mg(OAc)2, 1 mM DTT. 
0.005 % Nikkol) at 32°C for 10 min. Then SRP-MifM-stalled RNC complexes were 
reconstituted by incubating 2 pmol RNCs with 10 pmol pre-incubated SRP for 20 min at 32°C. 
Binding was then tested by centrifugation through a sucrose cushion followed by SDS-PAGE 
analysis. 
 
Independent in vitro translation triplicate experiments were performed using PURExpress 
system (NEB), according to the manufacturer`s instruction. Briefly, reporter wt FtsQ or mutant 
FtsQ were cloned and translation was coupled to transcription using PCR templates containing a 
T7 promoter and supplemented with [35 S]-methionine (Perkin Elmer) plus/minus B.s SRP. 
Reactions were then incubated at 37°C, and 2.5 µl aliquots were removed at specific time points 
and stopped by placing them on ice. The translation reactions were then loaded on 18% SDS-
PAGE and the products were detected by autoradiography using Amersham Hyperfilm MP film. 
The bands were quantified using ImageJ.  
 
Microscale thermophoresis of ribosome:SRP complexes 
Binding affinities of SRP to translating and empty ribosomes were measured using 
microscale thermophoresis (MST). MifM-stalled RNCs with exposed FtsQ, Leu rich, or 
luciferase nascent chain were prepared as described above. For the labelling of MifM-stalled 
RNC and empty 70S ribosomes, after the optional in vitro translation reaction and the sucrose 
cushion step, the ribosomal pellet was resuspended in 250 buffer supplemented with 100 µM 
AlexaFluor 488 C5-maleimide (Invitrogen/Life technologies). Ribosomes were incubated with 
the fluorophore for 30 min and further purified following the described protocol. Prior MST 
experiments ribosomes were diluted to 20 nM into 20 mM HEPES-KOH pH 7.2, 100 mM 
KOAc, 10 mM Mg(OAc)2, 2% glycerol, and 0.005% Nikkol. SRP composed of 6S RNA and the 
Ffh protein was titrated within the concentration range of 0.2 nM to 250 nM. Ribosome:SRP 
binding reactions were loaded into Premium coated capillaries (NanoTemper Technologies) and 
the thermophoretic response of fluorescently labeled ribosomes was measured using the 
Monolith .115 instrument (NanoTemper Technologies) at 40% and 60% infra-red (IR) laser 
power. Upon local, micrometer-sized heating with the IR laser a change in the fluorescence due 
to influx or efflux of labeled ribosomes was measured and then plotted versus the corresponding 
SRP concentration to form a binding trace. Binding constants were calculated as averages from 
independent duplicates or triplicates.  
 
E. coli RNCs translating FtsQ was prepared in vivo and purified as previously described 
27,30. RNCs were fluorescently labeled with AlexaFluor 488-c5-maleimide during the metal 
chelating chromatography purification and used for MST measurements as described above. E. 
coli SRP was purified as previously described 23. 
 
Preparation the eukaryotic RNC-SRP complex: 
Dog pancreas SRP, wheat germ DP90 RNCs and the complex reconstitution were prepared as 
described before 6. 
 
Cryo-EM specimen preparation and data collection: 
   
For grid preparation 2.5 µl in vitro reconstituted B. subtilis signal recognition particle (20 
pmol/µl in SRP buffer: 25 mM HEPES, 100 mM KOAc, 10 mM MgOAc, 1 mM DTT, 2% 
Glycerol, pH 7.2 at 4°C) were diluted to a final volume of 44.2 µl with buffer E (50 mM HEPES, 
250 mM KOAc, 2 mM 2-mercaptoethanol, 0.06% Nikkol, pH 7.2 at 4°C) and activated by 
incubation at 30°C for 10 min. Subsequently, 5.8 µl (9.6 pmol) of RNC was added and incubated 
for 10 min at 30°C. Finally the prepared mix was diluted with 22.5 µl buffer F (50 mM HEPES, 
250 mM KOAc, 2 mM 2-mercaptoethanol, pH 7.2 at 4°C) for optimal grid coverage. The 
prepared mix was then applied to 2 nm pre-coated Quantifoil R3/3 holey carbon supported grids 
and vitrified using a Vitrobot Mark IV (FEI Company).  
  For the 8k data collection, the micrographs were collected under low-dose conditions on 
a FEI TITAN KRIOS operating at 300 kV using a 8k x 8k TemCam-F416 CMOS camera and a 
final pixel size of 0.97 Å for the B. s. SRP and 1.035 Å for the WG DP90-SRP on the object 
scale. 20 910 for B.s. SRP, 3 627 for WG DP90-SRP were selected for single-particle analysis. 
Automated particle selection was performed using the program Signature 31, resulting in 333 617 
for B.s. SRP and 83 659 for WG DP90-SRP. Three dimensional reconstructions were then 
performed using the SPIDER software package 32. Datasets were first cleaned from non-
ribosomal particles and then sorted for the presence of a stoichiometric, homogenous P-site 
tRNA.  The homogenous P-site tRNA particles were then sorted for the presence/absence of SRP 
bound close to the ribosomal exit tunnel. A final sub-dataset sorting contain 75 900 particles for 
B.s. SRP and 19 096 particles for WG DP90-SRP was refined to a final average resolution at 
FSC 0.5 of respectively 7.1 Å and 9 Å. To exclude potential over-fitting the data was processed 
using a frequency limited refinement protocol by truncating high frequencies (low-pass filter at 
12 Å) during the whole refinement process 33. 
 
  The first direct detector data collection was performed on a Titan Krios at 300 keV and 
magnification of 39 400 x at the plane of the K2 Summit direct detector camera (Gatan) resulting 
in an image pixel size of 1.27 Å per pixel on the object scale. Images were recorded using 
resolution counting mode following an establish protocol 34.The dose rate on the camera was set 
was set to be 5e- counts per physical pixel per second. The total exposure time was 5 s, leading to 
a total accumulated dose of 20 electrons per Å2 on the specimen. Each image was fractionated 
into 25 subframes, each with an accumulation time of 0.2 s per frame. All dose-fractionated cryo-
EM images were recorded using a semi-automated acquisition program 35. Images were recorded 
with a defocus in a range from 0.8 to 3.0 µm. 12000 micrographs were selected for single-
particle analysis and the same procedure as previously describe above was used for three 
dimensional reconstruction. 32 045 Particles were used for three dimensional reconstruction and 
the final volume after sorting contains 10 434 particles and reaches the resolution of 7.4 Å at 0.5 
FSC. 
 
The second direct detector data collection was performed at collected at NeCEN (Leiden, 
Netherlands) on a Titan Krios TEM (FEI Company) operated at 300 keV equipped with a Cs-
corrector and a back-thinned FEI Falcon II direct electron detector. The camera was calibrated 
for a nominal magnification of 125,085x resulting and a pixelsize of 1.10 Å at the specimen. 8 s-
1 frames were recorded in automatic mode with a dose of 4 e-/Å per frame at defocus values 
between 0.8 μm and 2.2 μm. The first and the last image were excluded from the dataset. The 
remaining frames were aligned using the .2389 micrographs were selected for single-particle 
analysis and the same procedure as previously describe above was used for three dimensional 
reconstruction. 236 436 Particles were used for three dimensional reconstruction and the final 
volume after sorting contains 78 812 particles and reaches the resolution of 5.2 Å at 0.5 FSC. 
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Extended Data Figure 1: Structural alignment of RNA Alu domains 
Comparison of the B. subtilis RNA Alu domain vith the archaea Pyrococcus horikoshii. A 
structural superposition of the archaea Pyrococcus horikoshii Alu domain model (blue, 
PDB:4UYK), onto the B. subtilis RNA Alu domain (red) highlights the highly conserved tertiary 
fold of the Alu RNA core with an RMSD of 1.25 Å.  
  
 Extended Data Figure 2: In vitro B. subitilis SRP reconstitution, stalled BsRNC construct 
and binding assays. 
(A) Size exclusion chromatography diagram of the in vitro reconstitution of BsSRP and SDS-
PAGE analysis of the fractions. The different components of BsSRP were either loaded 
separately or mixed together and subjected to size-exclusion chromatography. From the diagram 
profile and the SDS-PAGE analysis, Ffh and the 6S RNA co-elute while HU1 remains unbound. 
(B) Construct used for the preparation of B. subtilis stalled RNC carrying FtsQ signal sequence. 
(C) Binding assays using purified 70S with an excess of reconstituted BsSRP. Supernatant (S) 
and pellet (P) fraction were analyzed by SDS-polyacrylamide gel electrophoresis and Coomassie 
blue staining. 
 Extended Data Figure 3: Microscale thermophoresis and translation assays  
(A) Purified and labeled (AlexaFluor 488 C5-maleimide) RNCs after SDS-PAGE analysis. (B) 
Typical MST recording using puromycin-treated empty 70S ribosomes with SRP. (C) Bar 
diagram representing the association rate constants for different control experiments using E. coli 
SRP-RNC. (D) Time-course translation reaction. The formation of full length product reporters 
encoding FtsQ wt or FtsQ mutant were motored by [35S] Met-labeled in vitro translation in 
absence or presence of BsSPR. 
 Extended Data Figure 4: Cryo-EM reconstruction and resolution of BsSRP-RNC 
complexes 
(A) Resolution curve, cryo-EM reconstruction and local resolution of BsRNC-SRP complex 
using the 8 K CCD detector data. (B) Same as in (A) using K2 direct detector data. (C) same as 
in (A) using Falcon 2 direct detector data. 
 Extended Data Figure 5: Behavior of SRP54 and signal sequence binding. 
(A). Cryo EM of the mammalian SRP. Small 30S subunit (yellow), large 50S subunit (grey), P-
site tRNA (green), SRP (red). (B) Isolated density of C. familiaris SRP54 at the ribosome exit 
tunnel. In contrast to the B. subtilis Ffh NG domain, the SRP54 NG domain adopts a more rigid 
conformation. The signal sequence could be fitted unambiguously into the mammalian SRP54 M 
domain. (C) Models of BsSRP54 M domain and the signal sequence could be fitted into the 
density filtered at 8 Å. 
 Extended Data Figure 6: Focusing on the Alu domain. 
(A) Alu domain mode of interaction in the mammalian case. Density with the fitted model of the 
mammalian SRP model highlights the interaction mode of the Alu domain with the 80S 
ribosome by bridging the small and the large subunit at the A-site entry. SRP9/SRP14 interact 
with h5 and h15 of the 18S RNA. The 7S Alu domain interacts only with uL11. (B) Alu domain 
mode of interaction in the bacterial case. SRP density with the 6S model in an orientation similar 
to (A). In contrast to the mammalian SRP, BsSRP contacts only the LSU. Those interactions are 
mainly mediated by RNA:RNA interactions and a docking onto the sarcin-ricin loop. (C) 
Movement of H43-H44 upon binding of BsSRP. Binding of the SPR induces a structural change 
of H43-H44 from an “open” (cyan) to a “close” state (dark blue). 
 Extended Data Figure 7: Blocking of the translation factor binding site. 
(A and B) 6S Alu domain complex at the ribosome translation factor binding site. (C and D) 
EF-Tu-tRNA-GTP ternary complex at the ribosome translation factor binding site (pdb:2WRO). 
BsSRP Alu domain binds to the translation factor site (red contour) and thereby competes with 
elongation factors binding. Binding of the SPR induces a structural change of the stalk base 
(H43/H44 grey contour)  
